CINXE.COM

Pharmafocus Magazine - covering pharma and biotech since 1986

<!DOCTYPE html><html lang="en"><head><link rel="stylesheet" data-href="https://fonts.googleapis.com/css?family=Trade+Gothic+Lt+Bold%7COpen+Sans%7CTrade+Gothic+Lt&amp;display=swap" data-optimized-fonts="true"/><title>Pharmafocus Magazine - covering pharma and biotech since 1986</title><link rel="icon" href="https://cdn.magloft.com/pwa-664/pwa/logo/8eb186e1-b2cb-4384-a0b7-515f62171b22.png"/><link rel="shortcut icon" type="image/x-icon" href="https://cdn.magloft.com/pwa-664/pwa/logo/8eb186e1-b2cb-4384-a0b7-515f62171b22.png?optimizer=image&amp;format=webp&amp;width=180&amp;aspectRatio=1"/><link rel="apple-touch-icon" sizes="180x180" href="https://cdn.magloft.com/pwa-664/pwa/logo/8eb186e1-b2cb-4384-a0b7-515f62171b22.png?optimizer=image&amp;format=webp&amp;width=180&amp;aspectRatio=1"/><meta name="application-name" content="Pharmafocus Magazine - covering pharma and biotech since 1986"/><meta name="apple-mobile-web-app-capable" content="yes"/><meta name="apple-mobile-web-app-status-bar-style" content="default"/><meta name="apple-mobile-web-app-title" content="Pharmafocus Magazine - covering pharma and biotech since 1986"/><meta name="format-detection" content="telephone=no"/><meta name="mobile-web-app-capable" content="yes"/><meta name="msapplication-TileColor" content="#1976D2"/><meta name="msapplication-tap-highlight" content="no"/><link rel="manifest" href="/manifest.json"/><meta name="twitter:url" content="https://www.pharmafocus.com"/><meta name="theme-color" content="#1976D2"/><meta name="viewport" content="width=device-width, initial-scale=1"/><meta charSet="utf-8"/><meta itemProp="name" content="Pharmafocus Magazine - covering pharma and biotech since 1986"/><meta itemProp="description" content="Pharmafocus Magazine - covering pharma and biotech since 1986"/><meta name="description" content="Pharmafocus Magazine - covering pharma and biotech since 1986"/><meta itemProp="image" content="https://cdn.magloft.com/pwa-664/seo/image/270800d8-b1de-41b8-86ad-5d262d2b9adf.png"/><meta property="og:description" content="Pharmafocus Magazine - covering pharma and biotech since 1986"/><meta property="og:title" content="Pharmafocus Magazine - covering pharma and biotech since 1986"/><meta property="og:site_name" content="Pharmafocus Magazine - covering pharma and biotech since 1986"/><meta property="og:image" content="https://cdn.magloft.com/pwa-664/seo/image/270800d8-b1de-41b8-86ad-5d262d2b9adf.png"/><meta property="og:type" content="website"/><meta name="twitter:card" content="summary_large_image"/><meta name="twitter:title" content="Pharmafocus Magazine - covering pharma and biotech since 1986"/><meta name="twitter:description" content="Pharmafocus Magazine - covering pharma and biotech since 1986"/><meta name="twitter:image" content="https://cdn.magloft.com/pwa-664/seo/image/270800d8-b1de-41b8-86ad-5d262d2b9adf.png"/><meta name="twitter:site" content="@Pharmafocus"/><meta name="twitter:creator" content="@Pharmafocus"/><style>html{--heading-font: &quot;Trade Gothic Lt Bold&quot;;--body-font: &quot;Open Sans&quot;;--ui-font: &quot;Trade Gothic Lt Bold&quot;;--top-menu-title-font: &quot;Trade Gothic Lt Bold&quot;;--top-menu-subtitle-font: &quot;Trade Gothic Lt&quot;;--top-menu-items-font: &quot;Trade Gothic Lt&quot;;--footer-menu-title-font: &quot;Trade Gothic Lt Bold&quot;;--footer-menu-items-font: &quot;Trade Gothic Lt Bold&quot;;--background-color: #FFFFFF;--background-color-dark: #808080;--primary-color: #1976D2;--primary-color-dark: #0C3B69;--secondary-color: #795FF4;--secondary-color-dark: #250B9F;--accent-color: #D76FD6;--accent-color-dark: #80237F;--info-color: #41638C;--info-color-dark: #213246;--warning-color: #EF9338;--warning-color-dark: #89490B;--success-color: #20AD27;--success-color-dark: #105714;--danger-color: #DF4241;--danger-color-dark: #7B1515;--top-menu-background-color: #EE1C25;--top-menu-background-color-dark: #7C090E;--footer-menu-background-color: #DF1111;--footer-menu-background-color-dark: #6F0808;--navbar-height: 64px; }</style><link rel="stylesheet" href="https://cdn.magloft.com/reader/fonts/trade-gothic-lt.css"/><link rel="stylesheet" href="https://cdn.magloft.com/reader/fonts/trade-gothic-lt-bold.css"/><script type="text/javascript" src="https://cdn.jsdelivr.net/npm/cookie-bar/cookiebar-latest.min.js?customize=1&amp;always=1&amp;showNoConsent=1"></script><meta name="google-site-verification" content="kuOvGxaH_NjG3aS7GSmbjjV-OjdOAWyiM3gEPGESeHQ"/><style> #billboard-banner { text-align:center;} #billboard-banner img {width:100%; max-width:970px; height:auto; position:relative; top:70px;} .Layout_spacer__qTBD3 {margin-top:70px;} </style><meta name="next-head-count" content="39"/><link rel="preconnect" href="https://fonts.googleapis.com"/><link rel="preconnect" href="https://fonts.gstatic.com"/><link rel="preload" href="/_next/static/css/229efe2956472d85.css" as="style"/><link rel="stylesheet" href="/_next/static/css/229efe2956472d85.css" data-n-g=""/><link rel="preload" href="/_next/static/css/48a92ac417d1fe49.css" as="style"/><link rel="stylesheet" href="/_next/static/css/48a92ac417d1fe49.css" data-n-p=""/><noscript data-n-css=""></noscript><script defer="" nomodule="" src="/_next/static/chunks/polyfills-c67a75d1b6f99dc8.js"></script><script defer="" src="https://fonts.googleapis.com/css?family=Open+Sans&amp;display=swap" data-nscript="beforeInteractive"></script><script src="/_next/static/chunks/webpack-b653c683a51d8b57.js" defer=""></script><script src="/_next/static/chunks/framework-73b8966a3c579ab0.js" defer=""></script><script src="/_next/static/chunks/main-34cb81d5753e1fc4.js" defer=""></script><script src="/_next/static/chunks/pages/_app-9cc101b503fd5646.js" defer=""></script><script src="/_next/static/chunks/174-d95909d2aa5e8ec8.js" defer=""></script><script src="/_next/static/chunks/302-d0f1826200f9f2a4.js" defer=""></script><script src="/_next/static/chunks/pages/domains/%5Bdomain%5D-2ba0a324eebaed62.js" defer=""></script><script src="/_next/static/1bBCYhXOG7wsYuaBifvjK/_buildManifest.js" defer=""></script><script src="/_next/static/1bBCYhXOG7wsYuaBifvjK/_ssgManifest.js" defer=""></script><style data-styled="" data-styled-version="5.3.9"></style><link rel="stylesheet" href="https://fonts.googleapis.com/css?family=Trade+Gothic+Lt+Bold%7COpen+Sans%7CTrade+Gothic+Lt&display=swap"/></head><body><div id="__next"><div class="Layout_container__gktH6"><div class="Layout_navbar-container__gCfDZ" style="height:64px"><nav class="_wrapper_jbnbd_1"><div class="_container_jbnbd_15"><a class="_navbar-brand_jbnbd_29" aria-label="Pharmafocus" href="/"><div class="_navbar-image_jbnbd_40"><img alt="Logo" loading="lazy" decoding="async" data-nimg="fill" class="_image_jbnbd_43" style="position:absolute;height:100%;width:100%;left:0;top:0;right:0;bottom:0;color:transparent" sizes="100vw" srcSet="https://media.magloft.app/pwa-664/pwa/top-menu-icon/c215ba48-44be-411d-8753-7438a6acf8fb.png 54w, https://media.magloft.app/pwa-664/pwa/top-menu-icon/c215ba48-44be-411d-8753-7438a6acf8fb.png 70w, https://media.magloft.app/pwa-664/pwa/top-menu-icon/c215ba48-44be-411d-8753-7438a6acf8fb.png 82w, https://media.magloft.app/pwa-664/pwa/top-menu-icon/c215ba48-44be-411d-8753-7438a6acf8fb.png 96w, https://media.magloft.app/pwa-664/pwa/top-menu-icon/c215ba48-44be-411d-8753-7438a6acf8fb.png 110w, https://media.magloft.app/pwa-664/pwa/top-menu-icon/c215ba48-44be-411d-8753-7438a6acf8fb.png 128w, https://media.magloft.app/pwa-664/pwa/top-menu-icon/c215ba48-44be-411d-8753-7438a6acf8fb.png 138w, https://media.magloft.app/pwa-664/pwa/top-menu-icon/c215ba48-44be-411d-8753-7438a6acf8fb.png 192w, https://media.magloft.app/pwa-664/pwa/top-menu-icon/c215ba48-44be-411d-8753-7438a6acf8fb.png 200w, https://media.magloft.app/pwa-664/pwa/top-menu-icon/c215ba48-44be-411d-8753-7438a6acf8fb.png 252w, https://media.magloft.app/pwa-664/pwa/top-menu-icon/c215ba48-44be-411d-8753-7438a6acf8fb.png 260w, https://media.magloft.app/pwa-664/pwa/top-menu-icon/c215ba48-44be-411d-8753-7438a6acf8fb.png 298w, https://media.magloft.app/pwa-664/pwa/top-menu-icon/c215ba48-44be-411d-8753-7438a6acf8fb.png 378w, https://media.magloft.app/pwa-664/pwa/top-menu-icon/c215ba48-44be-411d-8753-7438a6acf8fb.png 384w, https://media.magloft.app/pwa-664/pwa/top-menu-icon/c215ba48-44be-411d-8753-7438a6acf8fb.png 520w, https://media.magloft.app/pwa-664/pwa/top-menu-icon/c215ba48-44be-411d-8753-7438a6acf8fb.png 640w, https://media.magloft.app/pwa-664/pwa/top-menu-icon/c215ba48-44be-411d-8753-7438a6acf8fb.png 756w, https://media.magloft.app/pwa-664/pwa/top-menu-icon/c215ba48-44be-411d-8753-7438a6acf8fb.png 828w, https://media.magloft.app/pwa-664/pwa/top-menu-icon/c215ba48-44be-411d-8753-7438a6acf8fb.png 1080w, https://media.magloft.app/pwa-664/pwa/top-menu-icon/c215ba48-44be-411d-8753-7438a6acf8fb.png 1200w, https://media.magloft.app/pwa-664/pwa/top-menu-icon/c215ba48-44be-411d-8753-7438a6acf8fb.png 1920w, https://media.magloft.app/pwa-664/pwa/top-menu-icon/c215ba48-44be-411d-8753-7438a6acf8fb.png 2048w" src="https://media.magloft.app/pwa-664/pwa/top-menu-icon/c215ba48-44be-411d-8753-7438a6acf8fb.png"/></div><div class="_navbar-title_jbnbd_58 _navbar-title-hide_jbnbd_101"></div></a><div id="navbar-children-container" class="_navbar-children_jbnbd_116"><div class="_menu_1jhrl_1"><div class="_menu-wrapper_1jhrl_22"><div class="_menu-items_1jhrl_38"><a class="_menu-item_1jhrl_38 _active_1jhrl_70" href="/"><div class="_menu-home_1lm7t_255 _menu-item-icon_1jhrl_97 _icon_1lm7t_1 icon"></div><div class="_menu-item-title_1jhrl_88">Home</div><div class="_indicator_1jhrl_63 _active_1jhrl_70"></div></a><a class="_menu-item_1jhrl_38" href="/articles"><div class="_menu-articles_1lm7t_259 _menu-item-icon_1jhrl_97 _icon_1lm7t_1 icon"></div><div class="_menu-item-title_1jhrl_88">Articles</div><div class="_indicator_1jhrl_63"></div></a><a class="_menu-item_1jhrl_38" href="/collections"><div class="_menu-issues_1lm7t_263 _menu-item-icon_1jhrl_97 _icon_1lm7t_1 icon"></div><div class="_menu-item-title_1jhrl_88">Magazines</div><div class="_indicator_1jhrl_63"></div></a><a class="_menu-item_1jhrl_38" href="/account/login"><div class="_menu-account_1lm7t_411 _menu-item-icon_1jhrl_97 _icon_1lm7t_1 icon"></div><div class="_menu-item-title_1jhrl_88">Log in</div><div class="_indicator_1jhrl_63"></div></a></div></div></div></div><div id="navbar-suffix" class="_navbar-suffix_jbnbd_108"><div class="Layout_menu-actions__vsDbI"><div class="Layout_install-button__FBfSr"><div class="Tooltip_tooltip__98Sw9"></div><button class="_button_19h3g_1 _text_19h3g_12 _medium_19h3g_38 _secondary_19h3g_22" type="button" style="color:var(--top-menu-item-icon-color, var(--background-color))" role="button" aria-label="Search" aria-labelledby="labeldiv" title="Search"><div class="_action-search_1lm7t_15 _icon-button_19h3g_19 _icon_1lm7t_1 icon" style="background-color:var(--top-menu-item-icon-color, var(--background-color))"></div></button></div></div></div></div></nav></div><div class="Layout_main__evUHx"><div class="Layout_spacer__qTBD3" style="height:64px"></div><div class="section-container"><div class="HomeSection_home-section__C9q51 section" style="width:100%;background-color:transparent"><div class="HomeSection_block-layout-container___5hZr" style="max-width:100%"><div style="flex:5" class="HomeSection_block-layout-column__7m2l1"></div></div></div><div class="HomeSection_home-section__C9q51 section" style="width:1280px;background-color:transparent"><div class="HomeSection_block-layout-container___5hZr" style="max-width:1280px"><div style="flex:8.5" class="HomeSection_block-layout-column__7m2l1"><div class="AdvertisementBlock_advertisement-block__8EDkY AdvertisementBlock_placeholder__jhbpI"><div class="AdvertisementBlock_placeholder-inner__UakOd spinner"></div></div><div id="article-list-block" class="Block_block__MHhr4"><div style="height:auto" class="BlockHeader_block-header__JmokO"><div class="BlockHeader_container-title__l5lHB"><h2 style="border-bottom-color:#F90505">Top Content</h2></div><a style="color:#F90505" href="/articles"><span>view more</span><div class="Icon_nav-arrow-right__JFm_F Icon_icon__t_YgI icon" style="background-color:#F90505;min-width:24px"></div></a></div><div class="Block_article-layout__527Uy Block_variant-b__dx0X4"><a class="Block_article-card__mncKE" href="/articles/precision-medicine-and-the-role-of-pathologists-in-multidiscipli"><div class="Block_article-cover__vLhzO spinner"><img alt="article-block" loading="lazy" decoding="async" data-nimg="fill" style="position:absolute;height:100%;width:100%;left:0;top:0;right:0;bottom:0;color:transparent;background-size:cover;background-position:50% 50%;background-repeat:no-repeat;background-image:url(&quot;data:image/svg+xml;charset=utf-8,%3Csvg xmlns=&#x27;http%3A//www.w3.org/2000/svg&#x27;%3E%3Cimage style=&#x27;filter:blur(20px)&#x27; preserveAspectRatio=&#x27;none&#x27; x=&#x27;0&#x27; y=&#x27;0&#x27; height=&#x27;100%25&#x27; width=&#x27;100%25&#x27; href=&#x27;data:image/gif;base64,R0lGODlhAQABAPAAANzc3P///yH5BAAAAAAALAAAAAABAAEAAAICRAEAOw==&#x27;/%3E%3C/svg%3E&quot;)" sizes="260px" srcSet="https://media.magloft.app/pdf-import/1110/images/img_14-2.jpg?optimizer=image&amp;format=webp&amp;width=16&amp;aspectRatio=1.33 16w, https://media.magloft.app/pdf-import/1110/images/img_14-2.jpg?optimizer=image&amp;format=webp&amp;width=32&amp;aspectRatio=1.33 32w, https://media.magloft.app/pdf-import/1110/images/img_14-2.jpg?optimizer=image&amp;format=webp&amp;width=48&amp;aspectRatio=1.33 48w, https://media.magloft.app/pdf-import/1110/images/img_14-2.jpg?optimizer=image&amp;format=webp&amp;width=54&amp;aspectRatio=1.33 54w, https://media.magloft.app/pdf-import/1110/images/img_14-2.jpg?optimizer=image&amp;format=webp&amp;width=64&amp;aspectRatio=1.33 64w, https://media.magloft.app/pdf-import/1110/images/img_14-2.jpg?optimizer=image&amp;format=webp&amp;width=70&amp;aspectRatio=1.33 70w, https://media.magloft.app/pdf-import/1110/images/img_14-2.jpg?optimizer=image&amp;format=webp&amp;width=82&amp;aspectRatio=1.33 82w, https://media.magloft.app/pdf-import/1110/images/img_14-2.jpg?optimizer=image&amp;format=webp&amp;width=96&amp;aspectRatio=1.33 96w, https://media.magloft.app/pdf-import/1110/images/img_14-2.jpg?optimizer=image&amp;format=webp&amp;width=96&amp;aspectRatio=1.33 96w, https://media.magloft.app/pdf-import/1110/images/img_14-2.jpg?optimizer=image&amp;format=webp&amp;width=110&amp;aspectRatio=1.33 110w, https://media.magloft.app/pdf-import/1110/images/img_14-2.jpg?optimizer=image&amp;format=webp&amp;width=128&amp;aspectRatio=1.33 128w, https://media.magloft.app/pdf-import/1110/images/img_14-2.jpg?optimizer=image&amp;format=webp&amp;width=128&amp;aspectRatio=1.33 128w, https://media.magloft.app/pdf-import/1110/images/img_14-2.jpg?optimizer=image&amp;format=webp&amp;width=138&amp;aspectRatio=1.33 138w, https://media.magloft.app/pdf-import/1110/images/img_14-2.jpg?optimizer=image&amp;format=webp&amp;width=192&amp;aspectRatio=1.33 192w, https://media.magloft.app/pdf-import/1110/images/img_14-2.jpg?optimizer=image&amp;format=webp&amp;width=200&amp;aspectRatio=1.33 200w, https://media.magloft.app/pdf-import/1110/images/img_14-2.jpg?optimizer=image&amp;format=webp&amp;width=252&amp;aspectRatio=1.33 252w, https://media.magloft.app/pdf-import/1110/images/img_14-2.jpg?optimizer=image&amp;format=webp&amp;width=256&amp;aspectRatio=1.33 256w, https://media.magloft.app/pdf-import/1110/images/img_14-2.jpg?optimizer=image&amp;format=webp&amp;width=260&amp;aspectRatio=1.33 260w, https://media.magloft.app/pdf-import/1110/images/img_14-2.jpg?optimizer=image&amp;format=webp&amp;width=298&amp;aspectRatio=1.33 298w, https://media.magloft.app/pdf-import/1110/images/img_14-2.jpg?optimizer=image&amp;format=webp&amp;width=378&amp;aspectRatio=1.33 378w, https://media.magloft.app/pdf-import/1110/images/img_14-2.jpg?optimizer=image&amp;format=webp&amp;width=384&amp;aspectRatio=1.33 384w, https://media.magloft.app/pdf-import/1110/images/img_14-2.jpg?optimizer=image&amp;format=webp&amp;width=384&amp;aspectRatio=1.33 384w, https://media.magloft.app/pdf-import/1110/images/img_14-2.jpg?optimizer=image&amp;format=webp&amp;width=520&amp;aspectRatio=1.33 520w, https://media.magloft.app/pdf-import/1110/images/img_14-2.jpg?optimizer=image&amp;format=webp&amp;width=640&amp;aspectRatio=1.33 640w, https://media.magloft.app/pdf-import/1110/images/img_14-2.jpg?optimizer=image&amp;format=webp&amp;width=756&amp;aspectRatio=1.33 756w, https://media.magloft.app/pdf-import/1110/images/img_14-2.jpg?optimizer=image&amp;format=webp&amp;width=828&amp;aspectRatio=1.33 828w, https://media.magloft.app/pdf-import/1110/images/img_14-2.jpg?optimizer=image&amp;format=webp&amp;width=1080&amp;aspectRatio=1.33 1080w, https://media.magloft.app/pdf-import/1110/images/img_14-2.jpg?optimizer=image&amp;format=webp&amp;width=1200&amp;aspectRatio=1.33 1200w, https://media.magloft.app/pdf-import/1110/images/img_14-2.jpg?optimizer=image&amp;format=webp&amp;width=1920&amp;aspectRatio=1.33 1920w, https://media.magloft.app/pdf-import/1110/images/img_14-2.jpg?optimizer=image&amp;format=webp&amp;width=2048&amp;aspectRatio=1.33 2048w" src="https://media.magloft.app/pdf-import/1110/images/img_14-2.jpg?optimizer=image&amp;format=webp&amp;width=2048&amp;aspectRatio=1.33"/></div><div class="Block_article-contents__M6B6V"><h3>Precision medicine and the role of pathologists in multidisciplinary bladder cancer care</h3><p>How can the combined power of multidisciplinary teams and precision medicine be harnessed for people living with bladder cancer?</p><small></small>  <small>5 September 2024</small></div></a><a class="Block_article-card__mncKE" href="/articles/sustainable-drug-delivery-devices-striking-a-balance-between-fu"><div class="Block_article-cover__vLhzO spinner"><img alt="article-block" loading="lazy" decoding="async" data-nimg="fill" style="position:absolute;height:100%;width:100%;left:0;top:0;right:0;bottom:0;color:transparent;background-size:cover;background-position:50% 50%;background-repeat:no-repeat;background-image:url(&quot;data:image/svg+xml;charset=utf-8,%3Csvg xmlns=&#x27;http%3A//www.w3.org/2000/svg&#x27;%3E%3Cimage style=&#x27;filter:blur(20px)&#x27; preserveAspectRatio=&#x27;none&#x27; x=&#x27;0&#x27; y=&#x27;0&#x27; height=&#x27;100%25&#x27; width=&#x27;100%25&#x27; href=&#x27;data:image/gif;base64,R0lGODlhAQABAPAAANzc3P///yH5BAAAAAAALAAAAAABAAEAAAICRAEAOw==&#x27;/%3E%3C/svg%3E&quot;)" sizes="260px" srcSet="https://media.magloft.app/pdf-import/1085/images/img_14-4.jpg?optimizer=image&amp;format=webp&amp;width=16&amp;aspectRatio=1.33 16w, https://media.magloft.app/pdf-import/1085/images/img_14-4.jpg?optimizer=image&amp;format=webp&amp;width=32&amp;aspectRatio=1.33 32w, https://media.magloft.app/pdf-import/1085/images/img_14-4.jpg?optimizer=image&amp;format=webp&amp;width=48&amp;aspectRatio=1.33 48w, https://media.magloft.app/pdf-import/1085/images/img_14-4.jpg?optimizer=image&amp;format=webp&amp;width=54&amp;aspectRatio=1.33 54w, https://media.magloft.app/pdf-import/1085/images/img_14-4.jpg?optimizer=image&amp;format=webp&amp;width=64&amp;aspectRatio=1.33 64w, https://media.magloft.app/pdf-import/1085/images/img_14-4.jpg?optimizer=image&amp;format=webp&amp;width=70&amp;aspectRatio=1.33 70w, https://media.magloft.app/pdf-import/1085/images/img_14-4.jpg?optimizer=image&amp;format=webp&amp;width=82&amp;aspectRatio=1.33 82w, https://media.magloft.app/pdf-import/1085/images/img_14-4.jpg?optimizer=image&amp;format=webp&amp;width=96&amp;aspectRatio=1.33 96w, https://media.magloft.app/pdf-import/1085/images/img_14-4.jpg?optimizer=image&amp;format=webp&amp;width=96&amp;aspectRatio=1.33 96w, https://media.magloft.app/pdf-import/1085/images/img_14-4.jpg?optimizer=image&amp;format=webp&amp;width=110&amp;aspectRatio=1.33 110w, https://media.magloft.app/pdf-import/1085/images/img_14-4.jpg?optimizer=image&amp;format=webp&amp;width=128&amp;aspectRatio=1.33 128w, https://media.magloft.app/pdf-import/1085/images/img_14-4.jpg?optimizer=image&amp;format=webp&amp;width=128&amp;aspectRatio=1.33 128w, https://media.magloft.app/pdf-import/1085/images/img_14-4.jpg?optimizer=image&amp;format=webp&amp;width=138&amp;aspectRatio=1.33 138w, https://media.magloft.app/pdf-import/1085/images/img_14-4.jpg?optimizer=image&amp;format=webp&amp;width=192&amp;aspectRatio=1.33 192w, https://media.magloft.app/pdf-import/1085/images/img_14-4.jpg?optimizer=image&amp;format=webp&amp;width=200&amp;aspectRatio=1.33 200w, https://media.magloft.app/pdf-import/1085/images/img_14-4.jpg?optimizer=image&amp;format=webp&amp;width=252&amp;aspectRatio=1.33 252w, https://media.magloft.app/pdf-import/1085/images/img_14-4.jpg?optimizer=image&amp;format=webp&amp;width=256&amp;aspectRatio=1.33 256w, https://media.magloft.app/pdf-import/1085/images/img_14-4.jpg?optimizer=image&amp;format=webp&amp;width=260&amp;aspectRatio=1.33 260w, https://media.magloft.app/pdf-import/1085/images/img_14-4.jpg?optimizer=image&amp;format=webp&amp;width=298&amp;aspectRatio=1.33 298w, https://media.magloft.app/pdf-import/1085/images/img_14-4.jpg?optimizer=image&amp;format=webp&amp;width=378&amp;aspectRatio=1.33 378w, https://media.magloft.app/pdf-import/1085/images/img_14-4.jpg?optimizer=image&amp;format=webp&amp;width=384&amp;aspectRatio=1.33 384w, https://media.magloft.app/pdf-import/1085/images/img_14-4.jpg?optimizer=image&amp;format=webp&amp;width=384&amp;aspectRatio=1.33 384w, https://media.magloft.app/pdf-import/1085/images/img_14-4.jpg?optimizer=image&amp;format=webp&amp;width=520&amp;aspectRatio=1.33 520w, https://media.magloft.app/pdf-import/1085/images/img_14-4.jpg?optimizer=image&amp;format=webp&amp;width=640&amp;aspectRatio=1.33 640w, https://media.magloft.app/pdf-import/1085/images/img_14-4.jpg?optimizer=image&amp;format=webp&amp;width=756&amp;aspectRatio=1.33 756w, https://media.magloft.app/pdf-import/1085/images/img_14-4.jpg?optimizer=image&amp;format=webp&amp;width=828&amp;aspectRatio=1.33 828w, https://media.magloft.app/pdf-import/1085/images/img_14-4.jpg?optimizer=image&amp;format=webp&amp;width=1080&amp;aspectRatio=1.33 1080w, https://media.magloft.app/pdf-import/1085/images/img_14-4.jpg?optimizer=image&amp;format=webp&amp;width=1200&amp;aspectRatio=1.33 1200w, https://media.magloft.app/pdf-import/1085/images/img_14-4.jpg?optimizer=image&amp;format=webp&amp;width=1920&amp;aspectRatio=1.33 1920w, https://media.magloft.app/pdf-import/1085/images/img_14-4.jpg?optimizer=image&amp;format=webp&amp;width=2048&amp;aspectRatio=1.33 2048w" src="https://media.magloft.app/pdf-import/1085/images/img_14-4.jpg?optimizer=image&amp;format=webp&amp;width=2048&amp;aspectRatio=1.33"/></div><div class="Block_article-contents__M6B6V"><h3>Sustainable drug delivery devices: striking a balance between aspirations and current possibilities</h3><p>Alex Fong and Olivia Houselander from Owen Mumford Pharmaceutical Services consider the action needed to make drug discovery processes more sustainable</p><small></small>  <small>17 July 2024</small></div></a><a class="Block_article-card__mncKE" href="/articles/exploring-disease-modification-to-change-the-future-of-epilepsy"><div class="Block_article-cover__vLhzO spinner"><img alt="article-block" loading="lazy" decoding="async" data-nimg="fill" style="position:absolute;height:100%;width:100%;left:0;top:0;right:0;bottom:0;color:transparent;background-size:cover;background-position:50% 50%;background-repeat:no-repeat;background-image:url(&quot;data:image/svg+xml;charset=utf-8,%3Csvg xmlns=&#x27;http%3A//www.w3.org/2000/svg&#x27;%3E%3Cimage style=&#x27;filter:blur(20px)&#x27; preserveAspectRatio=&#x27;none&#x27; x=&#x27;0&#x27; y=&#x27;0&#x27; height=&#x27;100%25&#x27; width=&#x27;100%25&#x27; href=&#x27;data:image/gif;base64,R0lGODlhAQABAPAAANzc3P///yH5BAAAAAAALAAAAAABAAEAAAICRAEAOw==&#x27;/%3E%3C/svg%3E&quot;)" sizes="260px" srcSet="https://media.magloft.app/pdf-import/1085/images/img_13-3.jpg?optimizer=image&amp;format=webp&amp;width=16&amp;aspectRatio=1.33 16w, https://media.magloft.app/pdf-import/1085/images/img_13-3.jpg?optimizer=image&amp;format=webp&amp;width=32&amp;aspectRatio=1.33 32w, https://media.magloft.app/pdf-import/1085/images/img_13-3.jpg?optimizer=image&amp;format=webp&amp;width=48&amp;aspectRatio=1.33 48w, https://media.magloft.app/pdf-import/1085/images/img_13-3.jpg?optimizer=image&amp;format=webp&amp;width=54&amp;aspectRatio=1.33 54w, https://media.magloft.app/pdf-import/1085/images/img_13-3.jpg?optimizer=image&amp;format=webp&amp;width=64&amp;aspectRatio=1.33 64w, https://media.magloft.app/pdf-import/1085/images/img_13-3.jpg?optimizer=image&amp;format=webp&amp;width=70&amp;aspectRatio=1.33 70w, https://media.magloft.app/pdf-import/1085/images/img_13-3.jpg?optimizer=image&amp;format=webp&amp;width=82&amp;aspectRatio=1.33 82w, https://media.magloft.app/pdf-import/1085/images/img_13-3.jpg?optimizer=image&amp;format=webp&amp;width=96&amp;aspectRatio=1.33 96w, https://media.magloft.app/pdf-import/1085/images/img_13-3.jpg?optimizer=image&amp;format=webp&amp;width=96&amp;aspectRatio=1.33 96w, https://media.magloft.app/pdf-import/1085/images/img_13-3.jpg?optimizer=image&amp;format=webp&amp;width=110&amp;aspectRatio=1.33 110w, https://media.magloft.app/pdf-import/1085/images/img_13-3.jpg?optimizer=image&amp;format=webp&amp;width=128&amp;aspectRatio=1.33 128w, https://media.magloft.app/pdf-import/1085/images/img_13-3.jpg?optimizer=image&amp;format=webp&amp;width=128&amp;aspectRatio=1.33 128w, https://media.magloft.app/pdf-import/1085/images/img_13-3.jpg?optimizer=image&amp;format=webp&amp;width=138&amp;aspectRatio=1.33 138w, https://media.magloft.app/pdf-import/1085/images/img_13-3.jpg?optimizer=image&amp;format=webp&amp;width=192&amp;aspectRatio=1.33 192w, https://media.magloft.app/pdf-import/1085/images/img_13-3.jpg?optimizer=image&amp;format=webp&amp;width=200&amp;aspectRatio=1.33 200w, https://media.magloft.app/pdf-import/1085/images/img_13-3.jpg?optimizer=image&amp;format=webp&amp;width=252&amp;aspectRatio=1.33 252w, https://media.magloft.app/pdf-import/1085/images/img_13-3.jpg?optimizer=image&amp;format=webp&amp;width=256&amp;aspectRatio=1.33 256w, https://media.magloft.app/pdf-import/1085/images/img_13-3.jpg?optimizer=image&amp;format=webp&amp;width=260&amp;aspectRatio=1.33 260w, https://media.magloft.app/pdf-import/1085/images/img_13-3.jpg?optimizer=image&amp;format=webp&amp;width=298&amp;aspectRatio=1.33 298w, https://media.magloft.app/pdf-import/1085/images/img_13-3.jpg?optimizer=image&amp;format=webp&amp;width=378&amp;aspectRatio=1.33 378w, https://media.magloft.app/pdf-import/1085/images/img_13-3.jpg?optimizer=image&amp;format=webp&amp;width=384&amp;aspectRatio=1.33 384w, https://media.magloft.app/pdf-import/1085/images/img_13-3.jpg?optimizer=image&amp;format=webp&amp;width=384&amp;aspectRatio=1.33 384w, https://media.magloft.app/pdf-import/1085/images/img_13-3.jpg?optimizer=image&amp;format=webp&amp;width=520&amp;aspectRatio=1.33 520w, https://media.magloft.app/pdf-import/1085/images/img_13-3.jpg?optimizer=image&amp;format=webp&amp;width=640&amp;aspectRatio=1.33 640w, https://media.magloft.app/pdf-import/1085/images/img_13-3.jpg?optimizer=image&amp;format=webp&amp;width=756&amp;aspectRatio=1.33 756w, https://media.magloft.app/pdf-import/1085/images/img_13-3.jpg?optimizer=image&amp;format=webp&amp;width=828&amp;aspectRatio=1.33 828w, https://media.magloft.app/pdf-import/1085/images/img_13-3.jpg?optimizer=image&amp;format=webp&amp;width=1080&amp;aspectRatio=1.33 1080w, https://media.magloft.app/pdf-import/1085/images/img_13-3.jpg?optimizer=image&amp;format=webp&amp;width=1200&amp;aspectRatio=1.33 1200w, https://media.magloft.app/pdf-import/1085/images/img_13-3.jpg?optimizer=image&amp;format=webp&amp;width=1920&amp;aspectRatio=1.33 1920w, https://media.magloft.app/pdf-import/1085/images/img_13-3.jpg?optimizer=image&amp;format=webp&amp;width=2048&amp;aspectRatio=1.33 2048w" src="https://media.magloft.app/pdf-import/1085/images/img_13-3.jpg?optimizer=image&amp;format=webp&amp;width=2048&amp;aspectRatio=1.33"/></div><div class="Block_article-contents__M6B6V"><h3>Exploring disease modification to change the future of epilepsy treatment</h3><p>Konrad Werhahn from UCB discusses how disease-modifying solutions may introduce a new era in treatment for epilepsies</p><small></small>  <small>17 July 2024</small></div></a><a class="Block_article-card__mncKE" href="/articles/the-role-of-ai-in-patient-support"><div class="Block_article-cover__vLhzO spinner"><img alt="article-block" loading="lazy" decoding="async" data-nimg="fill" style="position:absolute;height:100%;width:100%;left:0;top:0;right:0;bottom:0;color:transparent;background-size:cover;background-position:50% 50%;background-repeat:no-repeat;background-image:url(&quot;data:image/svg+xml;charset=utf-8,%3Csvg xmlns=&#x27;http%3A//www.w3.org/2000/svg&#x27;%3E%3Cimage style=&#x27;filter:blur(20px)&#x27; preserveAspectRatio=&#x27;none&#x27; x=&#x27;0&#x27; y=&#x27;0&#x27; height=&#x27;100%25&#x27; width=&#x27;100%25&#x27; href=&#x27;data:image/gif;base64,R0lGODlhAQABAPAAANzc3P///yH5BAAAAAAALAAAAAABAAEAAAICRAEAOw==&#x27;/%3E%3C/svg%3E&quot;)" sizes="260px" srcSet="https://media.magloft.app/pdf-import/1085/images/img_16-4.jpg?optimizer=image&amp;format=webp&amp;width=16&amp;aspectRatio=1.33 16w, https://media.magloft.app/pdf-import/1085/images/img_16-4.jpg?optimizer=image&amp;format=webp&amp;width=32&amp;aspectRatio=1.33 32w, https://media.magloft.app/pdf-import/1085/images/img_16-4.jpg?optimizer=image&amp;format=webp&amp;width=48&amp;aspectRatio=1.33 48w, https://media.magloft.app/pdf-import/1085/images/img_16-4.jpg?optimizer=image&amp;format=webp&amp;width=54&amp;aspectRatio=1.33 54w, https://media.magloft.app/pdf-import/1085/images/img_16-4.jpg?optimizer=image&amp;format=webp&amp;width=64&amp;aspectRatio=1.33 64w, https://media.magloft.app/pdf-import/1085/images/img_16-4.jpg?optimizer=image&amp;format=webp&amp;width=70&amp;aspectRatio=1.33 70w, https://media.magloft.app/pdf-import/1085/images/img_16-4.jpg?optimizer=image&amp;format=webp&amp;width=82&amp;aspectRatio=1.33 82w, https://media.magloft.app/pdf-import/1085/images/img_16-4.jpg?optimizer=image&amp;format=webp&amp;width=96&amp;aspectRatio=1.33 96w, https://media.magloft.app/pdf-import/1085/images/img_16-4.jpg?optimizer=image&amp;format=webp&amp;width=96&amp;aspectRatio=1.33 96w, https://media.magloft.app/pdf-import/1085/images/img_16-4.jpg?optimizer=image&amp;format=webp&amp;width=110&amp;aspectRatio=1.33 110w, https://media.magloft.app/pdf-import/1085/images/img_16-4.jpg?optimizer=image&amp;format=webp&amp;width=128&amp;aspectRatio=1.33 128w, https://media.magloft.app/pdf-import/1085/images/img_16-4.jpg?optimizer=image&amp;format=webp&amp;width=128&amp;aspectRatio=1.33 128w, https://media.magloft.app/pdf-import/1085/images/img_16-4.jpg?optimizer=image&amp;format=webp&amp;width=138&amp;aspectRatio=1.33 138w, https://media.magloft.app/pdf-import/1085/images/img_16-4.jpg?optimizer=image&amp;format=webp&amp;width=192&amp;aspectRatio=1.33 192w, https://media.magloft.app/pdf-import/1085/images/img_16-4.jpg?optimizer=image&amp;format=webp&amp;width=200&amp;aspectRatio=1.33 200w, https://media.magloft.app/pdf-import/1085/images/img_16-4.jpg?optimizer=image&amp;format=webp&amp;width=252&amp;aspectRatio=1.33 252w, https://media.magloft.app/pdf-import/1085/images/img_16-4.jpg?optimizer=image&amp;format=webp&amp;width=256&amp;aspectRatio=1.33 256w, https://media.magloft.app/pdf-import/1085/images/img_16-4.jpg?optimizer=image&amp;format=webp&amp;width=260&amp;aspectRatio=1.33 260w, https://media.magloft.app/pdf-import/1085/images/img_16-4.jpg?optimizer=image&amp;format=webp&amp;width=298&amp;aspectRatio=1.33 298w, https://media.magloft.app/pdf-import/1085/images/img_16-4.jpg?optimizer=image&amp;format=webp&amp;width=378&amp;aspectRatio=1.33 378w, https://media.magloft.app/pdf-import/1085/images/img_16-4.jpg?optimizer=image&amp;format=webp&amp;width=384&amp;aspectRatio=1.33 384w, https://media.magloft.app/pdf-import/1085/images/img_16-4.jpg?optimizer=image&amp;format=webp&amp;width=384&amp;aspectRatio=1.33 384w, https://media.magloft.app/pdf-import/1085/images/img_16-4.jpg?optimizer=image&amp;format=webp&amp;width=520&amp;aspectRatio=1.33 520w, https://media.magloft.app/pdf-import/1085/images/img_16-4.jpg?optimizer=image&amp;format=webp&amp;width=640&amp;aspectRatio=1.33 640w, https://media.magloft.app/pdf-import/1085/images/img_16-4.jpg?optimizer=image&amp;format=webp&amp;width=756&amp;aspectRatio=1.33 756w, https://media.magloft.app/pdf-import/1085/images/img_16-4.jpg?optimizer=image&amp;format=webp&amp;width=828&amp;aspectRatio=1.33 828w, https://media.magloft.app/pdf-import/1085/images/img_16-4.jpg?optimizer=image&amp;format=webp&amp;width=1080&amp;aspectRatio=1.33 1080w, https://media.magloft.app/pdf-import/1085/images/img_16-4.jpg?optimizer=image&amp;format=webp&amp;width=1200&amp;aspectRatio=1.33 1200w, https://media.magloft.app/pdf-import/1085/images/img_16-4.jpg?optimizer=image&amp;format=webp&amp;width=1920&amp;aspectRatio=1.33 1920w, https://media.magloft.app/pdf-import/1085/images/img_16-4.jpg?optimizer=image&amp;format=webp&amp;width=2048&amp;aspectRatio=1.33 2048w" src="https://media.magloft.app/pdf-import/1085/images/img_16-4.jpg?optimizer=image&amp;format=webp&amp;width=2048&amp;aspectRatio=1.33"/></div><div class="Block_article-contents__M6B6V"><h3>The role of AI in patient support</h3><p>Rajul Jain from ProPharma considers how AI can be used in patient support, especially considering how it can be used to streamline operations and supplement human expertise</p><small></small>  <small>17 July 2024</small></div></a><a class="Block_article-card__mncKE" href="/articles/pride-month-and-lgbtq-healthcare"><div class="Block_article-cover__vLhzO spinner"><img alt="article-block" loading="lazy" decoding="async" data-nimg="fill" style="position:absolute;height:100%;width:100%;left:0;top:0;right:0;bottom:0;color:transparent;background-size:cover;background-position:50% 50%;background-repeat:no-repeat;background-image:url(&quot;data:image/svg+xml;charset=utf-8,%3Csvg xmlns=&#x27;http%3A//www.w3.org/2000/svg&#x27;%3E%3Cimage style=&#x27;filter:blur(20px)&#x27; preserveAspectRatio=&#x27;none&#x27; x=&#x27;0&#x27; y=&#x27;0&#x27; height=&#x27;100%25&#x27; width=&#x27;100%25&#x27; href=&#x27;data:image/gif;base64,R0lGODlhAQABAPAAANzc3P///yH5BAAAAAAALAAAAAABAAEAAAICRAEAOw==&#x27;/%3E%3C/svg%3E&quot;)" sizes="260px" srcSet="https://media.magloft.app/pdf-import/1071/images/img_18-4.jpg?optimizer=image&amp;format=webp&amp;width=16&amp;aspectRatio=1.33 16w, https://media.magloft.app/pdf-import/1071/images/img_18-4.jpg?optimizer=image&amp;format=webp&amp;width=32&amp;aspectRatio=1.33 32w, https://media.magloft.app/pdf-import/1071/images/img_18-4.jpg?optimizer=image&amp;format=webp&amp;width=48&amp;aspectRatio=1.33 48w, https://media.magloft.app/pdf-import/1071/images/img_18-4.jpg?optimizer=image&amp;format=webp&amp;width=54&amp;aspectRatio=1.33 54w, https://media.magloft.app/pdf-import/1071/images/img_18-4.jpg?optimizer=image&amp;format=webp&amp;width=64&amp;aspectRatio=1.33 64w, https://media.magloft.app/pdf-import/1071/images/img_18-4.jpg?optimizer=image&amp;format=webp&amp;width=70&amp;aspectRatio=1.33 70w, https://media.magloft.app/pdf-import/1071/images/img_18-4.jpg?optimizer=image&amp;format=webp&amp;width=82&amp;aspectRatio=1.33 82w, https://media.magloft.app/pdf-import/1071/images/img_18-4.jpg?optimizer=image&amp;format=webp&amp;width=96&amp;aspectRatio=1.33 96w, https://media.magloft.app/pdf-import/1071/images/img_18-4.jpg?optimizer=image&amp;format=webp&amp;width=96&amp;aspectRatio=1.33 96w, https://media.magloft.app/pdf-import/1071/images/img_18-4.jpg?optimizer=image&amp;format=webp&amp;width=110&amp;aspectRatio=1.33 110w, https://media.magloft.app/pdf-import/1071/images/img_18-4.jpg?optimizer=image&amp;format=webp&amp;width=128&amp;aspectRatio=1.33 128w, https://media.magloft.app/pdf-import/1071/images/img_18-4.jpg?optimizer=image&amp;format=webp&amp;width=128&amp;aspectRatio=1.33 128w, https://media.magloft.app/pdf-import/1071/images/img_18-4.jpg?optimizer=image&amp;format=webp&amp;width=138&amp;aspectRatio=1.33 138w, https://media.magloft.app/pdf-import/1071/images/img_18-4.jpg?optimizer=image&amp;format=webp&amp;width=192&amp;aspectRatio=1.33 192w, https://media.magloft.app/pdf-import/1071/images/img_18-4.jpg?optimizer=image&amp;format=webp&amp;width=200&amp;aspectRatio=1.33 200w, https://media.magloft.app/pdf-import/1071/images/img_18-4.jpg?optimizer=image&amp;format=webp&amp;width=252&amp;aspectRatio=1.33 252w, https://media.magloft.app/pdf-import/1071/images/img_18-4.jpg?optimizer=image&amp;format=webp&amp;width=256&amp;aspectRatio=1.33 256w, https://media.magloft.app/pdf-import/1071/images/img_18-4.jpg?optimizer=image&amp;format=webp&amp;width=260&amp;aspectRatio=1.33 260w, https://media.magloft.app/pdf-import/1071/images/img_18-4.jpg?optimizer=image&amp;format=webp&amp;width=298&amp;aspectRatio=1.33 298w, https://media.magloft.app/pdf-import/1071/images/img_18-4.jpg?optimizer=image&amp;format=webp&amp;width=378&amp;aspectRatio=1.33 378w, https://media.magloft.app/pdf-import/1071/images/img_18-4.jpg?optimizer=image&amp;format=webp&amp;width=384&amp;aspectRatio=1.33 384w, https://media.magloft.app/pdf-import/1071/images/img_18-4.jpg?optimizer=image&amp;format=webp&amp;width=384&amp;aspectRatio=1.33 384w, https://media.magloft.app/pdf-import/1071/images/img_18-4.jpg?optimizer=image&amp;format=webp&amp;width=520&amp;aspectRatio=1.33 520w, https://media.magloft.app/pdf-import/1071/images/img_18-4.jpg?optimizer=image&amp;format=webp&amp;width=640&amp;aspectRatio=1.33 640w, https://media.magloft.app/pdf-import/1071/images/img_18-4.jpg?optimizer=image&amp;format=webp&amp;width=756&amp;aspectRatio=1.33 756w, https://media.magloft.app/pdf-import/1071/images/img_18-4.jpg?optimizer=image&amp;format=webp&amp;width=828&amp;aspectRatio=1.33 828w, https://media.magloft.app/pdf-import/1071/images/img_18-4.jpg?optimizer=image&amp;format=webp&amp;width=1080&amp;aspectRatio=1.33 1080w, https://media.magloft.app/pdf-import/1071/images/img_18-4.jpg?optimizer=image&amp;format=webp&amp;width=1200&amp;aspectRatio=1.33 1200w, https://media.magloft.app/pdf-import/1071/images/img_18-4.jpg?optimizer=image&amp;format=webp&amp;width=1920&amp;aspectRatio=1.33 1920w, https://media.magloft.app/pdf-import/1071/images/img_18-4.jpg?optimizer=image&amp;format=webp&amp;width=2048&amp;aspectRatio=1.33 2048w" src="https://media.magloft.app/pdf-import/1071/images/img_18-4.jpg?optimizer=image&amp;format=webp&amp;width=2048&amp;aspectRatio=1.33"/></div><div class="Block_article-contents__M6B6V"><h3>Pride month and LGBTQ+ healthcare</h3><p>Betsy Goodfellow from Pharmafocus considers Pride month and the state of LGBTQ+ healthcare in the UK</p><small></small>  <small>4 June 2024</small></div></a><a class="Block_article-card__mncKE" href="/articles/european-commission-approves-pfizer-s-velsipity-for-ulcerative-c"><div class="Block_article-cover__vLhzO spinner"><img alt="article-block" loading="lazy" decoding="async" data-nimg="fill" style="position:absolute;height:100%;width:100%;left:0;top:0;right:0;bottom:0;color:transparent;background-size:cover;background-position:50% 50%;background-repeat:no-repeat;background-image:url(&quot;data:image/svg+xml;charset=utf-8,%3Csvg xmlns=&#x27;http%3A//www.w3.org/2000/svg&#x27;%3E%3Cimage style=&#x27;filter:blur(20px)&#x27; preserveAspectRatio=&#x27;none&#x27; x=&#x27;0&#x27; y=&#x27;0&#x27; height=&#x27;100%25&#x27; width=&#x27;100%25&#x27; href=&#x27;data:image/gif;base64,R0lGODlhAQABAPAAANzc3P///yH5BAAAAAAALAAAAAABAAEAAAICRAEAOw==&#x27;/%3E%3C/svg%3E&quot;)" sizes="260px" srcSet="https://media.magloft.app/pdf-import/1020/images/img_8-1.jpg?optimizer=image&amp;format=webp&amp;width=16&amp;aspectRatio=1.33 16w, https://media.magloft.app/pdf-import/1020/images/img_8-1.jpg?optimizer=image&amp;format=webp&amp;width=32&amp;aspectRatio=1.33 32w, https://media.magloft.app/pdf-import/1020/images/img_8-1.jpg?optimizer=image&amp;format=webp&amp;width=48&amp;aspectRatio=1.33 48w, https://media.magloft.app/pdf-import/1020/images/img_8-1.jpg?optimizer=image&amp;format=webp&amp;width=54&amp;aspectRatio=1.33 54w, https://media.magloft.app/pdf-import/1020/images/img_8-1.jpg?optimizer=image&amp;format=webp&amp;width=64&amp;aspectRatio=1.33 64w, https://media.magloft.app/pdf-import/1020/images/img_8-1.jpg?optimizer=image&amp;format=webp&amp;width=70&amp;aspectRatio=1.33 70w, https://media.magloft.app/pdf-import/1020/images/img_8-1.jpg?optimizer=image&amp;format=webp&amp;width=82&amp;aspectRatio=1.33 82w, https://media.magloft.app/pdf-import/1020/images/img_8-1.jpg?optimizer=image&amp;format=webp&amp;width=96&amp;aspectRatio=1.33 96w, https://media.magloft.app/pdf-import/1020/images/img_8-1.jpg?optimizer=image&amp;format=webp&amp;width=96&amp;aspectRatio=1.33 96w, https://media.magloft.app/pdf-import/1020/images/img_8-1.jpg?optimizer=image&amp;format=webp&amp;width=110&amp;aspectRatio=1.33 110w, https://media.magloft.app/pdf-import/1020/images/img_8-1.jpg?optimizer=image&amp;format=webp&amp;width=128&amp;aspectRatio=1.33 128w, https://media.magloft.app/pdf-import/1020/images/img_8-1.jpg?optimizer=image&amp;format=webp&amp;width=128&amp;aspectRatio=1.33 128w, https://media.magloft.app/pdf-import/1020/images/img_8-1.jpg?optimizer=image&amp;format=webp&amp;width=138&amp;aspectRatio=1.33 138w, https://media.magloft.app/pdf-import/1020/images/img_8-1.jpg?optimizer=image&amp;format=webp&amp;width=192&amp;aspectRatio=1.33 192w, https://media.magloft.app/pdf-import/1020/images/img_8-1.jpg?optimizer=image&amp;format=webp&amp;width=200&amp;aspectRatio=1.33 200w, https://media.magloft.app/pdf-import/1020/images/img_8-1.jpg?optimizer=image&amp;format=webp&amp;width=252&amp;aspectRatio=1.33 252w, https://media.magloft.app/pdf-import/1020/images/img_8-1.jpg?optimizer=image&amp;format=webp&amp;width=256&amp;aspectRatio=1.33 256w, https://media.magloft.app/pdf-import/1020/images/img_8-1.jpg?optimizer=image&amp;format=webp&amp;width=260&amp;aspectRatio=1.33 260w, https://media.magloft.app/pdf-import/1020/images/img_8-1.jpg?optimizer=image&amp;format=webp&amp;width=298&amp;aspectRatio=1.33 298w, https://media.magloft.app/pdf-import/1020/images/img_8-1.jpg?optimizer=image&amp;format=webp&amp;width=378&amp;aspectRatio=1.33 378w, https://media.magloft.app/pdf-import/1020/images/img_8-1.jpg?optimizer=image&amp;format=webp&amp;width=384&amp;aspectRatio=1.33 384w, https://media.magloft.app/pdf-import/1020/images/img_8-1.jpg?optimizer=image&amp;format=webp&amp;width=384&amp;aspectRatio=1.33 384w, https://media.magloft.app/pdf-import/1020/images/img_8-1.jpg?optimizer=image&amp;format=webp&amp;width=520&amp;aspectRatio=1.33 520w, https://media.magloft.app/pdf-import/1020/images/img_8-1.jpg?optimizer=image&amp;format=webp&amp;width=640&amp;aspectRatio=1.33 640w, https://media.magloft.app/pdf-import/1020/images/img_8-1.jpg?optimizer=image&amp;format=webp&amp;width=756&amp;aspectRatio=1.33 756w, https://media.magloft.app/pdf-import/1020/images/img_8-1.jpg?optimizer=image&amp;format=webp&amp;width=828&amp;aspectRatio=1.33 828w, https://media.magloft.app/pdf-import/1020/images/img_8-1.jpg?optimizer=image&amp;format=webp&amp;width=1080&amp;aspectRatio=1.33 1080w, https://media.magloft.app/pdf-import/1020/images/img_8-1.jpg?optimizer=image&amp;format=webp&amp;width=1200&amp;aspectRatio=1.33 1200w, https://media.magloft.app/pdf-import/1020/images/img_8-1.jpg?optimizer=image&amp;format=webp&amp;width=1920&amp;aspectRatio=1.33 1920w, https://media.magloft.app/pdf-import/1020/images/img_8-1.jpg?optimizer=image&amp;format=webp&amp;width=2048&amp;aspectRatio=1.33 2048w" src="https://media.magloft.app/pdf-import/1020/images/img_8-1.jpg?optimizer=image&amp;format=webp&amp;width=2048&amp;aspectRatio=1.33"/></div><div class="Block_article-contents__M6B6V"><h3>European Commission approves Pfizer’s Velsipity for ulcerative colitis treatment</h3><p>Pfizer has announced that the EC has granted marketing authorisation for Velsipity (etrasimod) in the EU.</p><small></small>  <small>4 March 2024</small></div></a></div></div><div id="article-list-block" class="Block_block__MHhr4"><div style="height:auto" class="BlockHeader_block-header__JmokO"><div class="BlockHeader_container-title__l5lHB"><h2 style="border-bottom-color:#2873B0">Industry Insights</h2></div><a style="color:#2873B0" href="/articles"><span>view more</span><div class="Icon_nav-arrow-right__JFm_F Icon_icon__t_YgI icon" style="background-color:#2873B0;min-width:24px"></div></a></div><div class="Block_article-layout__527Uy Block_variant-b__dx0X4"><a class="Block_article-card__mncKE" href="/articles/sustainable-drug-delivery-devices-striking-a-balance-between-fu"><div class="Block_article-cover__vLhzO spinner"><img alt="article-block" loading="lazy" decoding="async" data-nimg="fill" style="position:absolute;height:100%;width:100%;left:0;top:0;right:0;bottom:0;color:transparent;background-size:cover;background-position:50% 50%;background-repeat:no-repeat;background-image:url(&quot;data:image/svg+xml;charset=utf-8,%3Csvg xmlns=&#x27;http%3A//www.w3.org/2000/svg&#x27;%3E%3Cimage style=&#x27;filter:blur(20px)&#x27; preserveAspectRatio=&#x27;none&#x27; x=&#x27;0&#x27; y=&#x27;0&#x27; height=&#x27;100%25&#x27; width=&#x27;100%25&#x27; href=&#x27;data:image/gif;base64,R0lGODlhAQABAPAAANzc3P///yH5BAAAAAAALAAAAAABAAEAAAICRAEAOw==&#x27;/%3E%3C/svg%3E&quot;)" sizes="260px" srcSet="https://media.magloft.app/pdf-import/1085/images/img_14-4.jpg?optimizer=image&amp;format=webp&amp;width=16&amp;aspectRatio=1.33 16w, https://media.magloft.app/pdf-import/1085/images/img_14-4.jpg?optimizer=image&amp;format=webp&amp;width=32&amp;aspectRatio=1.33 32w, https://media.magloft.app/pdf-import/1085/images/img_14-4.jpg?optimizer=image&amp;format=webp&amp;width=48&amp;aspectRatio=1.33 48w, https://media.magloft.app/pdf-import/1085/images/img_14-4.jpg?optimizer=image&amp;format=webp&amp;width=54&amp;aspectRatio=1.33 54w, https://media.magloft.app/pdf-import/1085/images/img_14-4.jpg?optimizer=image&amp;format=webp&amp;width=64&amp;aspectRatio=1.33 64w, https://media.magloft.app/pdf-import/1085/images/img_14-4.jpg?optimizer=image&amp;format=webp&amp;width=70&amp;aspectRatio=1.33 70w, https://media.magloft.app/pdf-import/1085/images/img_14-4.jpg?optimizer=image&amp;format=webp&amp;width=82&amp;aspectRatio=1.33 82w, https://media.magloft.app/pdf-import/1085/images/img_14-4.jpg?optimizer=image&amp;format=webp&amp;width=96&amp;aspectRatio=1.33 96w, https://media.magloft.app/pdf-import/1085/images/img_14-4.jpg?optimizer=image&amp;format=webp&amp;width=96&amp;aspectRatio=1.33 96w, https://media.magloft.app/pdf-import/1085/images/img_14-4.jpg?optimizer=image&amp;format=webp&amp;width=110&amp;aspectRatio=1.33 110w, https://media.magloft.app/pdf-import/1085/images/img_14-4.jpg?optimizer=image&amp;format=webp&amp;width=128&amp;aspectRatio=1.33 128w, https://media.magloft.app/pdf-import/1085/images/img_14-4.jpg?optimizer=image&amp;format=webp&amp;width=128&amp;aspectRatio=1.33 128w, https://media.magloft.app/pdf-import/1085/images/img_14-4.jpg?optimizer=image&amp;format=webp&amp;width=138&amp;aspectRatio=1.33 138w, https://media.magloft.app/pdf-import/1085/images/img_14-4.jpg?optimizer=image&amp;format=webp&amp;width=192&amp;aspectRatio=1.33 192w, https://media.magloft.app/pdf-import/1085/images/img_14-4.jpg?optimizer=image&amp;format=webp&amp;width=200&amp;aspectRatio=1.33 200w, https://media.magloft.app/pdf-import/1085/images/img_14-4.jpg?optimizer=image&amp;format=webp&amp;width=252&amp;aspectRatio=1.33 252w, https://media.magloft.app/pdf-import/1085/images/img_14-4.jpg?optimizer=image&amp;format=webp&amp;width=256&amp;aspectRatio=1.33 256w, https://media.magloft.app/pdf-import/1085/images/img_14-4.jpg?optimizer=image&amp;format=webp&amp;width=260&amp;aspectRatio=1.33 260w, https://media.magloft.app/pdf-import/1085/images/img_14-4.jpg?optimizer=image&amp;format=webp&amp;width=298&amp;aspectRatio=1.33 298w, https://media.magloft.app/pdf-import/1085/images/img_14-4.jpg?optimizer=image&amp;format=webp&amp;width=378&amp;aspectRatio=1.33 378w, https://media.magloft.app/pdf-import/1085/images/img_14-4.jpg?optimizer=image&amp;format=webp&amp;width=384&amp;aspectRatio=1.33 384w, https://media.magloft.app/pdf-import/1085/images/img_14-4.jpg?optimizer=image&amp;format=webp&amp;width=384&amp;aspectRatio=1.33 384w, https://media.magloft.app/pdf-import/1085/images/img_14-4.jpg?optimizer=image&amp;format=webp&amp;width=520&amp;aspectRatio=1.33 520w, https://media.magloft.app/pdf-import/1085/images/img_14-4.jpg?optimizer=image&amp;format=webp&amp;width=640&amp;aspectRatio=1.33 640w, https://media.magloft.app/pdf-import/1085/images/img_14-4.jpg?optimizer=image&amp;format=webp&amp;width=756&amp;aspectRatio=1.33 756w, https://media.magloft.app/pdf-import/1085/images/img_14-4.jpg?optimizer=image&amp;format=webp&amp;width=828&amp;aspectRatio=1.33 828w, https://media.magloft.app/pdf-import/1085/images/img_14-4.jpg?optimizer=image&amp;format=webp&amp;width=1080&amp;aspectRatio=1.33 1080w, https://media.magloft.app/pdf-import/1085/images/img_14-4.jpg?optimizer=image&amp;format=webp&amp;width=1200&amp;aspectRatio=1.33 1200w, https://media.magloft.app/pdf-import/1085/images/img_14-4.jpg?optimizer=image&amp;format=webp&amp;width=1920&amp;aspectRatio=1.33 1920w, https://media.magloft.app/pdf-import/1085/images/img_14-4.jpg?optimizer=image&amp;format=webp&amp;width=2048&amp;aspectRatio=1.33 2048w" src="https://media.magloft.app/pdf-import/1085/images/img_14-4.jpg?optimizer=image&amp;format=webp&amp;width=2048&amp;aspectRatio=1.33"/></div><div class="Block_article-contents__M6B6V"><h3>Sustainable drug delivery devices: striking a balance between aspirations and current possibilities</h3><p>Alex Fong and Olivia Houselander from Owen Mumford Pharmaceutical Services consider the action needed to make drug discovery processes more sustainable</p><small></small>  <small>17 July 2024</small></div></a><a class="Block_article-card__mncKE" href="/articles/exploring-disease-modification-to-change-the-future-of-epilepsy"><div class="Block_article-cover__vLhzO spinner"><img alt="article-block" loading="lazy" decoding="async" data-nimg="fill" style="position:absolute;height:100%;width:100%;left:0;top:0;right:0;bottom:0;color:transparent;background-size:cover;background-position:50% 50%;background-repeat:no-repeat;background-image:url(&quot;data:image/svg+xml;charset=utf-8,%3Csvg xmlns=&#x27;http%3A//www.w3.org/2000/svg&#x27;%3E%3Cimage style=&#x27;filter:blur(20px)&#x27; preserveAspectRatio=&#x27;none&#x27; x=&#x27;0&#x27; y=&#x27;0&#x27; height=&#x27;100%25&#x27; width=&#x27;100%25&#x27; href=&#x27;data:image/gif;base64,R0lGODlhAQABAPAAANzc3P///yH5BAAAAAAALAAAAAABAAEAAAICRAEAOw==&#x27;/%3E%3C/svg%3E&quot;)" sizes="260px" srcSet="https://media.magloft.app/pdf-import/1085/images/img_13-3.jpg?optimizer=image&amp;format=webp&amp;width=16&amp;aspectRatio=1.33 16w, https://media.magloft.app/pdf-import/1085/images/img_13-3.jpg?optimizer=image&amp;format=webp&amp;width=32&amp;aspectRatio=1.33 32w, https://media.magloft.app/pdf-import/1085/images/img_13-3.jpg?optimizer=image&amp;format=webp&amp;width=48&amp;aspectRatio=1.33 48w, https://media.magloft.app/pdf-import/1085/images/img_13-3.jpg?optimizer=image&amp;format=webp&amp;width=54&amp;aspectRatio=1.33 54w, https://media.magloft.app/pdf-import/1085/images/img_13-3.jpg?optimizer=image&amp;format=webp&amp;width=64&amp;aspectRatio=1.33 64w, https://media.magloft.app/pdf-import/1085/images/img_13-3.jpg?optimizer=image&amp;format=webp&amp;width=70&amp;aspectRatio=1.33 70w, https://media.magloft.app/pdf-import/1085/images/img_13-3.jpg?optimizer=image&amp;format=webp&amp;width=82&amp;aspectRatio=1.33 82w, https://media.magloft.app/pdf-import/1085/images/img_13-3.jpg?optimizer=image&amp;format=webp&amp;width=96&amp;aspectRatio=1.33 96w, https://media.magloft.app/pdf-import/1085/images/img_13-3.jpg?optimizer=image&amp;format=webp&amp;width=96&amp;aspectRatio=1.33 96w, https://media.magloft.app/pdf-import/1085/images/img_13-3.jpg?optimizer=image&amp;format=webp&amp;width=110&amp;aspectRatio=1.33 110w, https://media.magloft.app/pdf-import/1085/images/img_13-3.jpg?optimizer=image&amp;format=webp&amp;width=128&amp;aspectRatio=1.33 128w, https://media.magloft.app/pdf-import/1085/images/img_13-3.jpg?optimizer=image&amp;format=webp&amp;width=128&amp;aspectRatio=1.33 128w, https://media.magloft.app/pdf-import/1085/images/img_13-3.jpg?optimizer=image&amp;format=webp&amp;width=138&amp;aspectRatio=1.33 138w, https://media.magloft.app/pdf-import/1085/images/img_13-3.jpg?optimizer=image&amp;format=webp&amp;width=192&amp;aspectRatio=1.33 192w, https://media.magloft.app/pdf-import/1085/images/img_13-3.jpg?optimizer=image&amp;format=webp&amp;width=200&amp;aspectRatio=1.33 200w, https://media.magloft.app/pdf-import/1085/images/img_13-3.jpg?optimizer=image&amp;format=webp&amp;width=252&amp;aspectRatio=1.33 252w, https://media.magloft.app/pdf-import/1085/images/img_13-3.jpg?optimizer=image&amp;format=webp&amp;width=256&amp;aspectRatio=1.33 256w, https://media.magloft.app/pdf-import/1085/images/img_13-3.jpg?optimizer=image&amp;format=webp&amp;width=260&amp;aspectRatio=1.33 260w, https://media.magloft.app/pdf-import/1085/images/img_13-3.jpg?optimizer=image&amp;format=webp&amp;width=298&amp;aspectRatio=1.33 298w, https://media.magloft.app/pdf-import/1085/images/img_13-3.jpg?optimizer=image&amp;format=webp&amp;width=378&amp;aspectRatio=1.33 378w, https://media.magloft.app/pdf-import/1085/images/img_13-3.jpg?optimizer=image&amp;format=webp&amp;width=384&amp;aspectRatio=1.33 384w, https://media.magloft.app/pdf-import/1085/images/img_13-3.jpg?optimizer=image&amp;format=webp&amp;width=384&amp;aspectRatio=1.33 384w, https://media.magloft.app/pdf-import/1085/images/img_13-3.jpg?optimizer=image&amp;format=webp&amp;width=520&amp;aspectRatio=1.33 520w, https://media.magloft.app/pdf-import/1085/images/img_13-3.jpg?optimizer=image&amp;format=webp&amp;width=640&amp;aspectRatio=1.33 640w, https://media.magloft.app/pdf-import/1085/images/img_13-3.jpg?optimizer=image&amp;format=webp&amp;width=756&amp;aspectRatio=1.33 756w, https://media.magloft.app/pdf-import/1085/images/img_13-3.jpg?optimizer=image&amp;format=webp&amp;width=828&amp;aspectRatio=1.33 828w, https://media.magloft.app/pdf-import/1085/images/img_13-3.jpg?optimizer=image&amp;format=webp&amp;width=1080&amp;aspectRatio=1.33 1080w, https://media.magloft.app/pdf-import/1085/images/img_13-3.jpg?optimizer=image&amp;format=webp&amp;width=1200&amp;aspectRatio=1.33 1200w, https://media.magloft.app/pdf-import/1085/images/img_13-3.jpg?optimizer=image&amp;format=webp&amp;width=1920&amp;aspectRatio=1.33 1920w, https://media.magloft.app/pdf-import/1085/images/img_13-3.jpg?optimizer=image&amp;format=webp&amp;width=2048&amp;aspectRatio=1.33 2048w" src="https://media.magloft.app/pdf-import/1085/images/img_13-3.jpg?optimizer=image&amp;format=webp&amp;width=2048&amp;aspectRatio=1.33"/></div><div class="Block_article-contents__M6B6V"><h3>Exploring disease modification to change the future of epilepsy treatment</h3><p>Konrad Werhahn from UCB discusses how disease-modifying solutions may introduce a new era in treatment for epilepsies</p><small></small>  <small>17 July 2024</small></div></a><a class="Block_article-card__mncKE" href="/articles/the-role-of-ai-in-patient-support"><div class="Block_article-cover__vLhzO spinner"><img alt="article-block" loading="lazy" decoding="async" data-nimg="fill" style="position:absolute;height:100%;width:100%;left:0;top:0;right:0;bottom:0;color:transparent;background-size:cover;background-position:50% 50%;background-repeat:no-repeat;background-image:url(&quot;data:image/svg+xml;charset=utf-8,%3Csvg xmlns=&#x27;http%3A//www.w3.org/2000/svg&#x27;%3E%3Cimage style=&#x27;filter:blur(20px)&#x27; preserveAspectRatio=&#x27;none&#x27; x=&#x27;0&#x27; y=&#x27;0&#x27; height=&#x27;100%25&#x27; width=&#x27;100%25&#x27; href=&#x27;data:image/gif;base64,R0lGODlhAQABAPAAANzc3P///yH5BAAAAAAALAAAAAABAAEAAAICRAEAOw==&#x27;/%3E%3C/svg%3E&quot;)" sizes="260px" srcSet="https://media.magloft.app/pdf-import/1085/images/img_16-4.jpg?optimizer=image&amp;format=webp&amp;width=16&amp;aspectRatio=1.33 16w, https://media.magloft.app/pdf-import/1085/images/img_16-4.jpg?optimizer=image&amp;format=webp&amp;width=32&amp;aspectRatio=1.33 32w, https://media.magloft.app/pdf-import/1085/images/img_16-4.jpg?optimizer=image&amp;format=webp&amp;width=48&amp;aspectRatio=1.33 48w, https://media.magloft.app/pdf-import/1085/images/img_16-4.jpg?optimizer=image&amp;format=webp&amp;width=54&amp;aspectRatio=1.33 54w, https://media.magloft.app/pdf-import/1085/images/img_16-4.jpg?optimizer=image&amp;format=webp&amp;width=64&amp;aspectRatio=1.33 64w, https://media.magloft.app/pdf-import/1085/images/img_16-4.jpg?optimizer=image&amp;format=webp&amp;width=70&amp;aspectRatio=1.33 70w, https://media.magloft.app/pdf-import/1085/images/img_16-4.jpg?optimizer=image&amp;format=webp&amp;width=82&amp;aspectRatio=1.33 82w, https://media.magloft.app/pdf-import/1085/images/img_16-4.jpg?optimizer=image&amp;format=webp&amp;width=96&amp;aspectRatio=1.33 96w, https://media.magloft.app/pdf-import/1085/images/img_16-4.jpg?optimizer=image&amp;format=webp&amp;width=96&amp;aspectRatio=1.33 96w, https://media.magloft.app/pdf-import/1085/images/img_16-4.jpg?optimizer=image&amp;format=webp&amp;width=110&amp;aspectRatio=1.33 110w, https://media.magloft.app/pdf-import/1085/images/img_16-4.jpg?optimizer=image&amp;format=webp&amp;width=128&amp;aspectRatio=1.33 128w, https://media.magloft.app/pdf-import/1085/images/img_16-4.jpg?optimizer=image&amp;format=webp&amp;width=128&amp;aspectRatio=1.33 128w, https://media.magloft.app/pdf-import/1085/images/img_16-4.jpg?optimizer=image&amp;format=webp&amp;width=138&amp;aspectRatio=1.33 138w, https://media.magloft.app/pdf-import/1085/images/img_16-4.jpg?optimizer=image&amp;format=webp&amp;width=192&amp;aspectRatio=1.33 192w, https://media.magloft.app/pdf-import/1085/images/img_16-4.jpg?optimizer=image&amp;format=webp&amp;width=200&amp;aspectRatio=1.33 200w, https://media.magloft.app/pdf-import/1085/images/img_16-4.jpg?optimizer=image&amp;format=webp&amp;width=252&amp;aspectRatio=1.33 252w, https://media.magloft.app/pdf-import/1085/images/img_16-4.jpg?optimizer=image&amp;format=webp&amp;width=256&amp;aspectRatio=1.33 256w, https://media.magloft.app/pdf-import/1085/images/img_16-4.jpg?optimizer=image&amp;format=webp&amp;width=260&amp;aspectRatio=1.33 260w, https://media.magloft.app/pdf-import/1085/images/img_16-4.jpg?optimizer=image&amp;format=webp&amp;width=298&amp;aspectRatio=1.33 298w, https://media.magloft.app/pdf-import/1085/images/img_16-4.jpg?optimizer=image&amp;format=webp&amp;width=378&amp;aspectRatio=1.33 378w, https://media.magloft.app/pdf-import/1085/images/img_16-4.jpg?optimizer=image&amp;format=webp&amp;width=384&amp;aspectRatio=1.33 384w, https://media.magloft.app/pdf-import/1085/images/img_16-4.jpg?optimizer=image&amp;format=webp&amp;width=384&amp;aspectRatio=1.33 384w, https://media.magloft.app/pdf-import/1085/images/img_16-4.jpg?optimizer=image&amp;format=webp&amp;width=520&amp;aspectRatio=1.33 520w, https://media.magloft.app/pdf-import/1085/images/img_16-4.jpg?optimizer=image&amp;format=webp&amp;width=640&amp;aspectRatio=1.33 640w, https://media.magloft.app/pdf-import/1085/images/img_16-4.jpg?optimizer=image&amp;format=webp&amp;width=756&amp;aspectRatio=1.33 756w, https://media.magloft.app/pdf-import/1085/images/img_16-4.jpg?optimizer=image&amp;format=webp&amp;width=828&amp;aspectRatio=1.33 828w, https://media.magloft.app/pdf-import/1085/images/img_16-4.jpg?optimizer=image&amp;format=webp&amp;width=1080&amp;aspectRatio=1.33 1080w, https://media.magloft.app/pdf-import/1085/images/img_16-4.jpg?optimizer=image&amp;format=webp&amp;width=1200&amp;aspectRatio=1.33 1200w, https://media.magloft.app/pdf-import/1085/images/img_16-4.jpg?optimizer=image&amp;format=webp&amp;width=1920&amp;aspectRatio=1.33 1920w, https://media.magloft.app/pdf-import/1085/images/img_16-4.jpg?optimizer=image&amp;format=webp&amp;width=2048&amp;aspectRatio=1.33 2048w" src="https://media.magloft.app/pdf-import/1085/images/img_16-4.jpg?optimizer=image&amp;format=webp&amp;width=2048&amp;aspectRatio=1.33"/></div><div class="Block_article-contents__M6B6V"><h3>The role of AI in patient support</h3><p>Rajul Jain from ProPharma considers how AI can be used in patient support, especially considering how it can be used to streamline operations and supplement human expertise</p><small></small>  <small>17 July 2024</small></div></a><a class="Block_article-card__mncKE" href="/articles/20-years-of-egfr-in-nsclc-how-precision-medicine-helps-navigate"><div class="Block_article-cover__vLhzO spinner"><img alt="article-block" loading="lazy" decoding="async" data-nimg="fill" style="position:absolute;height:100%;width:100%;left:0;top:0;right:0;bottom:0;color:transparent;background-size:cover;background-position:50% 50%;background-repeat:no-repeat;background-image:url(&quot;data:image/svg+xml;charset=utf-8,%3Csvg xmlns=&#x27;http%3A//www.w3.org/2000/svg&#x27;%3E%3Cimage style=&#x27;filter:blur(20px)&#x27; preserveAspectRatio=&#x27;none&#x27; x=&#x27;0&#x27; y=&#x27;0&#x27; height=&#x27;100%25&#x27; width=&#x27;100%25&#x27; href=&#x27;data:image/gif;base64,R0lGODlhAQABAPAAANzc3P///yH5BAAAAAAALAAAAAABAAEAAAICRAEAOw==&#x27;/%3E%3C/svg%3E&quot;)" sizes="260px" srcSet="https://media.magloft.app/pdf-import/1071/images/img_14-3.jpg?optimizer=image&amp;format=webp&amp;width=16&amp;aspectRatio=1.33 16w, https://media.magloft.app/pdf-import/1071/images/img_14-3.jpg?optimizer=image&amp;format=webp&amp;width=32&amp;aspectRatio=1.33 32w, https://media.magloft.app/pdf-import/1071/images/img_14-3.jpg?optimizer=image&amp;format=webp&amp;width=48&amp;aspectRatio=1.33 48w, https://media.magloft.app/pdf-import/1071/images/img_14-3.jpg?optimizer=image&amp;format=webp&amp;width=54&amp;aspectRatio=1.33 54w, https://media.magloft.app/pdf-import/1071/images/img_14-3.jpg?optimizer=image&amp;format=webp&amp;width=64&amp;aspectRatio=1.33 64w, https://media.magloft.app/pdf-import/1071/images/img_14-3.jpg?optimizer=image&amp;format=webp&amp;width=70&amp;aspectRatio=1.33 70w, https://media.magloft.app/pdf-import/1071/images/img_14-3.jpg?optimizer=image&amp;format=webp&amp;width=82&amp;aspectRatio=1.33 82w, https://media.magloft.app/pdf-import/1071/images/img_14-3.jpg?optimizer=image&amp;format=webp&amp;width=96&amp;aspectRatio=1.33 96w, https://media.magloft.app/pdf-import/1071/images/img_14-3.jpg?optimizer=image&amp;format=webp&amp;width=96&amp;aspectRatio=1.33 96w, https://media.magloft.app/pdf-import/1071/images/img_14-3.jpg?optimizer=image&amp;format=webp&amp;width=110&amp;aspectRatio=1.33 110w, https://media.magloft.app/pdf-import/1071/images/img_14-3.jpg?optimizer=image&amp;format=webp&amp;width=128&amp;aspectRatio=1.33 128w, https://media.magloft.app/pdf-import/1071/images/img_14-3.jpg?optimizer=image&amp;format=webp&amp;width=128&amp;aspectRatio=1.33 128w, https://media.magloft.app/pdf-import/1071/images/img_14-3.jpg?optimizer=image&amp;format=webp&amp;width=138&amp;aspectRatio=1.33 138w, https://media.magloft.app/pdf-import/1071/images/img_14-3.jpg?optimizer=image&amp;format=webp&amp;width=192&amp;aspectRatio=1.33 192w, https://media.magloft.app/pdf-import/1071/images/img_14-3.jpg?optimizer=image&amp;format=webp&amp;width=200&amp;aspectRatio=1.33 200w, https://media.magloft.app/pdf-import/1071/images/img_14-3.jpg?optimizer=image&amp;format=webp&amp;width=252&amp;aspectRatio=1.33 252w, https://media.magloft.app/pdf-import/1071/images/img_14-3.jpg?optimizer=image&amp;format=webp&amp;width=256&amp;aspectRatio=1.33 256w, https://media.magloft.app/pdf-import/1071/images/img_14-3.jpg?optimizer=image&amp;format=webp&amp;width=260&amp;aspectRatio=1.33 260w, https://media.magloft.app/pdf-import/1071/images/img_14-3.jpg?optimizer=image&amp;format=webp&amp;width=298&amp;aspectRatio=1.33 298w, https://media.magloft.app/pdf-import/1071/images/img_14-3.jpg?optimizer=image&amp;format=webp&amp;width=378&amp;aspectRatio=1.33 378w, https://media.magloft.app/pdf-import/1071/images/img_14-3.jpg?optimizer=image&amp;format=webp&amp;width=384&amp;aspectRatio=1.33 384w, https://media.magloft.app/pdf-import/1071/images/img_14-3.jpg?optimizer=image&amp;format=webp&amp;width=384&amp;aspectRatio=1.33 384w, https://media.magloft.app/pdf-import/1071/images/img_14-3.jpg?optimizer=image&amp;format=webp&amp;width=520&amp;aspectRatio=1.33 520w, https://media.magloft.app/pdf-import/1071/images/img_14-3.jpg?optimizer=image&amp;format=webp&amp;width=640&amp;aspectRatio=1.33 640w, https://media.magloft.app/pdf-import/1071/images/img_14-3.jpg?optimizer=image&amp;format=webp&amp;width=756&amp;aspectRatio=1.33 756w, https://media.magloft.app/pdf-import/1071/images/img_14-3.jpg?optimizer=image&amp;format=webp&amp;width=828&amp;aspectRatio=1.33 828w, https://media.magloft.app/pdf-import/1071/images/img_14-3.jpg?optimizer=image&amp;format=webp&amp;width=1080&amp;aspectRatio=1.33 1080w, https://media.magloft.app/pdf-import/1071/images/img_14-3.jpg?optimizer=image&amp;format=webp&amp;width=1200&amp;aspectRatio=1.33 1200w, https://media.magloft.app/pdf-import/1071/images/img_14-3.jpg?optimizer=image&amp;format=webp&amp;width=1920&amp;aspectRatio=1.33 1920w, https://media.magloft.app/pdf-import/1071/images/img_14-3.jpg?optimizer=image&amp;format=webp&amp;width=2048&amp;aspectRatio=1.33 2048w" src="https://media.magloft.app/pdf-import/1071/images/img_14-3.jpg?optimizer=image&amp;format=webp&amp;width=2048&amp;aspectRatio=1.33"/></div><div class="Block_article-contents__M6B6V"><h3>20 years of EGFR in NSCLC: how precision medicine helps navigate lung cancer challenges</h3><p>Henar Hevia at Johnson &amp; Johnson considers the progress that has been made in lung cancer treatment since the discovery of EGFR, including the evolving treatment paradigm, the role of precision medicine in treatment decision-making and quality of life for patients receiving targeted treatments</p><small></small>  <small>4 June 2024</small></div></a><a class="Block_article-card__mncKE" href="/articles/paediatric-clinical-trials-for-obesity-treatment"><div class="Block_article-cover__vLhzO spinner"><img alt="article-block" loading="lazy" decoding="async" data-nimg="fill" style="position:absolute;height:100%;width:100%;left:0;top:0;right:0;bottom:0;color:transparent;background-size:cover;background-position:50% 50%;background-repeat:no-repeat;background-image:url(&quot;data:image/svg+xml;charset=utf-8,%3Csvg xmlns=&#x27;http%3A//www.w3.org/2000/svg&#x27;%3E%3Cimage style=&#x27;filter:blur(20px)&#x27; preserveAspectRatio=&#x27;none&#x27; x=&#x27;0&#x27; y=&#x27;0&#x27; height=&#x27;100%25&#x27; width=&#x27;100%25&#x27; href=&#x27;data:image/gif;base64,R0lGODlhAQABAPAAANzc3P///yH5BAAAAAAALAAAAAABAAEAAAICRAEAOw==&#x27;/%3E%3C/svg%3E&quot;)" sizes="260px" srcSet="https://media.magloft.app/pdf-import/1071/images/img_16-2.jpg?optimizer=image&amp;format=webp&amp;width=16&amp;aspectRatio=1.33 16w, https://media.magloft.app/pdf-import/1071/images/img_16-2.jpg?optimizer=image&amp;format=webp&amp;width=32&amp;aspectRatio=1.33 32w, https://media.magloft.app/pdf-import/1071/images/img_16-2.jpg?optimizer=image&amp;format=webp&amp;width=48&amp;aspectRatio=1.33 48w, https://media.magloft.app/pdf-import/1071/images/img_16-2.jpg?optimizer=image&amp;format=webp&amp;width=54&amp;aspectRatio=1.33 54w, https://media.magloft.app/pdf-import/1071/images/img_16-2.jpg?optimizer=image&amp;format=webp&amp;width=64&amp;aspectRatio=1.33 64w, https://media.magloft.app/pdf-import/1071/images/img_16-2.jpg?optimizer=image&amp;format=webp&amp;width=70&amp;aspectRatio=1.33 70w, https://media.magloft.app/pdf-import/1071/images/img_16-2.jpg?optimizer=image&amp;format=webp&amp;width=82&amp;aspectRatio=1.33 82w, https://media.magloft.app/pdf-import/1071/images/img_16-2.jpg?optimizer=image&amp;format=webp&amp;width=96&amp;aspectRatio=1.33 96w, https://media.magloft.app/pdf-import/1071/images/img_16-2.jpg?optimizer=image&amp;format=webp&amp;width=96&amp;aspectRatio=1.33 96w, https://media.magloft.app/pdf-import/1071/images/img_16-2.jpg?optimizer=image&amp;format=webp&amp;width=110&amp;aspectRatio=1.33 110w, https://media.magloft.app/pdf-import/1071/images/img_16-2.jpg?optimizer=image&amp;format=webp&amp;width=128&amp;aspectRatio=1.33 128w, https://media.magloft.app/pdf-import/1071/images/img_16-2.jpg?optimizer=image&amp;format=webp&amp;width=128&amp;aspectRatio=1.33 128w, https://media.magloft.app/pdf-import/1071/images/img_16-2.jpg?optimizer=image&amp;format=webp&amp;width=138&amp;aspectRatio=1.33 138w, https://media.magloft.app/pdf-import/1071/images/img_16-2.jpg?optimizer=image&amp;format=webp&amp;width=192&amp;aspectRatio=1.33 192w, https://media.magloft.app/pdf-import/1071/images/img_16-2.jpg?optimizer=image&amp;format=webp&amp;width=200&amp;aspectRatio=1.33 200w, https://media.magloft.app/pdf-import/1071/images/img_16-2.jpg?optimizer=image&amp;format=webp&amp;width=252&amp;aspectRatio=1.33 252w, https://media.magloft.app/pdf-import/1071/images/img_16-2.jpg?optimizer=image&amp;format=webp&amp;width=256&amp;aspectRatio=1.33 256w, https://media.magloft.app/pdf-import/1071/images/img_16-2.jpg?optimizer=image&amp;format=webp&amp;width=260&amp;aspectRatio=1.33 260w, https://media.magloft.app/pdf-import/1071/images/img_16-2.jpg?optimizer=image&amp;format=webp&amp;width=298&amp;aspectRatio=1.33 298w, https://media.magloft.app/pdf-import/1071/images/img_16-2.jpg?optimizer=image&amp;format=webp&amp;width=378&amp;aspectRatio=1.33 378w, https://media.magloft.app/pdf-import/1071/images/img_16-2.jpg?optimizer=image&amp;format=webp&amp;width=384&amp;aspectRatio=1.33 384w, https://media.magloft.app/pdf-import/1071/images/img_16-2.jpg?optimizer=image&amp;format=webp&amp;width=384&amp;aspectRatio=1.33 384w, https://media.magloft.app/pdf-import/1071/images/img_16-2.jpg?optimizer=image&amp;format=webp&amp;width=520&amp;aspectRatio=1.33 520w, https://media.magloft.app/pdf-import/1071/images/img_16-2.jpg?optimizer=image&amp;format=webp&amp;width=640&amp;aspectRatio=1.33 640w, https://media.magloft.app/pdf-import/1071/images/img_16-2.jpg?optimizer=image&amp;format=webp&amp;width=756&amp;aspectRatio=1.33 756w, https://media.magloft.app/pdf-import/1071/images/img_16-2.jpg?optimizer=image&amp;format=webp&amp;width=828&amp;aspectRatio=1.33 828w, https://media.magloft.app/pdf-import/1071/images/img_16-2.jpg?optimizer=image&amp;format=webp&amp;width=1080&amp;aspectRatio=1.33 1080w, https://media.magloft.app/pdf-import/1071/images/img_16-2.jpg?optimizer=image&amp;format=webp&amp;width=1200&amp;aspectRatio=1.33 1200w, https://media.magloft.app/pdf-import/1071/images/img_16-2.jpg?optimizer=image&amp;format=webp&amp;width=1920&amp;aspectRatio=1.33 1920w, https://media.magloft.app/pdf-import/1071/images/img_16-2.jpg?optimizer=image&amp;format=webp&amp;width=2048&amp;aspectRatio=1.33 2048w" src="https://media.magloft.app/pdf-import/1071/images/img_16-2.jpg?optimizer=image&amp;format=webp&amp;width=2048&amp;aspectRatio=1.33"/></div><div class="Block_article-contents__M6B6V"><h3>Paediatric clinical trials for obesity treatment</h3><p>Alan Baldridge and Heather Peterson from ICON consider the prevalence of paediatric obesity and assess clinical trials of its treatments</p><small></small>  <small>4 June 2024</small></div></a><a class="Block_article-card__mncKE" href="/articles/epilepsy-and-brain-health-a-call-for-global-action-and-unity"><div class="Block_article-cover__vLhzO spinner"><img alt="article-block" loading="lazy" decoding="async" data-nimg="fill" style="position:absolute;height:100%;width:100%;left:0;top:0;right:0;bottom:0;color:transparent;background-size:cover;background-position:50% 50%;background-repeat:no-repeat;background-image:url(&quot;data:image/svg+xml;charset=utf-8,%3Csvg xmlns=&#x27;http%3A//www.w3.org/2000/svg&#x27;%3E%3Cimage style=&#x27;filter:blur(20px)&#x27; preserveAspectRatio=&#x27;none&#x27; x=&#x27;0&#x27; y=&#x27;0&#x27; height=&#x27;100%25&#x27; width=&#x27;100%25&#x27; href=&#x27;data:image/gif;base64,R0lGODlhAQABAPAAANzc3P///yH5BAAAAAAALAAAAAABAAEAAAICRAEAOw==&#x27;/%3E%3C/svg%3E&quot;)" sizes="260px" srcSet="https://media.magloft.app/pwa-664/article/image/c761b8da-dcc1-4126-820a-cfcd83c479a6.png?optimizer=image&amp;format=webp&amp;width=16&amp;aspectRatio=1.33 16w, https://media.magloft.app/pwa-664/article/image/c761b8da-dcc1-4126-820a-cfcd83c479a6.png?optimizer=image&amp;format=webp&amp;width=32&amp;aspectRatio=1.33 32w, https://media.magloft.app/pwa-664/article/image/c761b8da-dcc1-4126-820a-cfcd83c479a6.png?optimizer=image&amp;format=webp&amp;width=48&amp;aspectRatio=1.33 48w, https://media.magloft.app/pwa-664/article/image/c761b8da-dcc1-4126-820a-cfcd83c479a6.png?optimizer=image&amp;format=webp&amp;width=54&amp;aspectRatio=1.33 54w, https://media.magloft.app/pwa-664/article/image/c761b8da-dcc1-4126-820a-cfcd83c479a6.png?optimizer=image&amp;format=webp&amp;width=64&amp;aspectRatio=1.33 64w, https://media.magloft.app/pwa-664/article/image/c761b8da-dcc1-4126-820a-cfcd83c479a6.png?optimizer=image&amp;format=webp&amp;width=70&amp;aspectRatio=1.33 70w, https://media.magloft.app/pwa-664/article/image/c761b8da-dcc1-4126-820a-cfcd83c479a6.png?optimizer=image&amp;format=webp&amp;width=82&amp;aspectRatio=1.33 82w, https://media.magloft.app/pwa-664/article/image/c761b8da-dcc1-4126-820a-cfcd83c479a6.png?optimizer=image&amp;format=webp&amp;width=96&amp;aspectRatio=1.33 96w, https://media.magloft.app/pwa-664/article/image/c761b8da-dcc1-4126-820a-cfcd83c479a6.png?optimizer=image&amp;format=webp&amp;width=96&amp;aspectRatio=1.33 96w, https://media.magloft.app/pwa-664/article/image/c761b8da-dcc1-4126-820a-cfcd83c479a6.png?optimizer=image&amp;format=webp&amp;width=110&amp;aspectRatio=1.33 110w, https://media.magloft.app/pwa-664/article/image/c761b8da-dcc1-4126-820a-cfcd83c479a6.png?optimizer=image&amp;format=webp&amp;width=128&amp;aspectRatio=1.33 128w, https://media.magloft.app/pwa-664/article/image/c761b8da-dcc1-4126-820a-cfcd83c479a6.png?optimizer=image&amp;format=webp&amp;width=128&amp;aspectRatio=1.33 128w, https://media.magloft.app/pwa-664/article/image/c761b8da-dcc1-4126-820a-cfcd83c479a6.png?optimizer=image&amp;format=webp&amp;width=138&amp;aspectRatio=1.33 138w, https://media.magloft.app/pwa-664/article/image/c761b8da-dcc1-4126-820a-cfcd83c479a6.png?optimizer=image&amp;format=webp&amp;width=192&amp;aspectRatio=1.33 192w, https://media.magloft.app/pwa-664/article/image/c761b8da-dcc1-4126-820a-cfcd83c479a6.png?optimizer=image&amp;format=webp&amp;width=200&amp;aspectRatio=1.33 200w, https://media.magloft.app/pwa-664/article/image/c761b8da-dcc1-4126-820a-cfcd83c479a6.png?optimizer=image&amp;format=webp&amp;width=252&amp;aspectRatio=1.33 252w, https://media.magloft.app/pwa-664/article/image/c761b8da-dcc1-4126-820a-cfcd83c479a6.png?optimizer=image&amp;format=webp&amp;width=256&amp;aspectRatio=1.33 256w, https://media.magloft.app/pwa-664/article/image/c761b8da-dcc1-4126-820a-cfcd83c479a6.png?optimizer=image&amp;format=webp&amp;width=260&amp;aspectRatio=1.33 260w, https://media.magloft.app/pwa-664/article/image/c761b8da-dcc1-4126-820a-cfcd83c479a6.png?optimizer=image&amp;format=webp&amp;width=298&amp;aspectRatio=1.33 298w, https://media.magloft.app/pwa-664/article/image/c761b8da-dcc1-4126-820a-cfcd83c479a6.png?optimizer=image&amp;format=webp&amp;width=378&amp;aspectRatio=1.33 378w, https://media.magloft.app/pwa-664/article/image/c761b8da-dcc1-4126-820a-cfcd83c479a6.png?optimizer=image&amp;format=webp&amp;width=384&amp;aspectRatio=1.33 384w, https://media.magloft.app/pwa-664/article/image/c761b8da-dcc1-4126-820a-cfcd83c479a6.png?optimizer=image&amp;format=webp&amp;width=384&amp;aspectRatio=1.33 384w, https://media.magloft.app/pwa-664/article/image/c761b8da-dcc1-4126-820a-cfcd83c479a6.png?optimizer=image&amp;format=webp&amp;width=520&amp;aspectRatio=1.33 520w, https://media.magloft.app/pwa-664/article/image/c761b8da-dcc1-4126-820a-cfcd83c479a6.png?optimizer=image&amp;format=webp&amp;width=640&amp;aspectRatio=1.33 640w, https://media.magloft.app/pwa-664/article/image/c761b8da-dcc1-4126-820a-cfcd83c479a6.png?optimizer=image&amp;format=webp&amp;width=756&amp;aspectRatio=1.33 756w, https://media.magloft.app/pwa-664/article/image/c761b8da-dcc1-4126-820a-cfcd83c479a6.png?optimizer=image&amp;format=webp&amp;width=828&amp;aspectRatio=1.33 828w, https://media.magloft.app/pwa-664/article/image/c761b8da-dcc1-4126-820a-cfcd83c479a6.png?optimizer=image&amp;format=webp&amp;width=1080&amp;aspectRatio=1.33 1080w, https://media.magloft.app/pwa-664/article/image/c761b8da-dcc1-4126-820a-cfcd83c479a6.png?optimizer=image&amp;format=webp&amp;width=1200&amp;aspectRatio=1.33 1200w, https://media.magloft.app/pwa-664/article/image/c761b8da-dcc1-4126-820a-cfcd83c479a6.png?optimizer=image&amp;format=webp&amp;width=1920&amp;aspectRatio=1.33 1920w, https://media.magloft.app/pwa-664/article/image/c761b8da-dcc1-4126-820a-cfcd83c479a6.png?optimizer=image&amp;format=webp&amp;width=2048&amp;aspectRatio=1.33 2048w" src="https://media.magloft.app/pwa-664/article/image/c761b8da-dcc1-4126-820a-cfcd83c479a6.png?optimizer=image&amp;format=webp&amp;width=2048&amp;aspectRatio=1.33"/></div><div class="Block_article-contents__M6B6V"><h3>Epilepsy and brain health: a call for global action and unity</h3><p>Rafal Kaminski from Angelini Pharma tells Pharmafocus about the global challenge of epilepsy as well as how his company is striving to bridge the gaps in epilepsy treatment</p><small></small>  <small>28 April 2024</small></div></a></div></div><div id="article-category-block" class="Block_block__MHhr4" style="background-color:transparent"><div style="height:auto" class="BlockHeader_block-header__JmokO"><div class="BlockHeader_container-title__l5lHB"><h2 style="border-bottom-color:#F90505">UK News</h2></div><a style="color:#F90505" href="/categories/uk-pharma-news"><span>view more</span><div class="Icon_nav-arrow-right__JFm_F Icon_icon__t_YgI icon" style="background-color:#F90505;min-width:24px"></div></a></div><div class="Block_article-layout__527Uy Block_variant-c__AkeuK"><a class="Block_article-card__mncKE" href="/articles/clue-points-launches-medical-safety-review-msr-software-for-c"><div class="Block_article-cover__vLhzO"><img alt="article-category" loading="lazy" decoding="async" data-nimg="fill" style="position:absolute;height:100%;width:100%;left:0;top:0;right:0;bottom:0;color:transparent;background-size:cover;background-position:50% 50%;background-repeat:no-repeat;background-image:url(&quot;data:image/svg+xml;charset=utf-8,%3Csvg xmlns=&#x27;http%3A//www.w3.org/2000/svg&#x27;%3E%3Cimage style=&#x27;filter:blur(20px)&#x27; preserveAspectRatio=&#x27;none&#x27; x=&#x27;0&#x27; y=&#x27;0&#x27; height=&#x27;100%25&#x27; width=&#x27;100%25&#x27; href=&#x27;data:image/gif;base64,R0lGODlhAQABAPAAANzc3P///yH5BAAAAAAALAAAAAABAAEAAAICRAEAOw==&#x27;/%3E%3C/svg%3E&quot;)" sizes="70px" srcSet="https://media.magloft.app/pdf-import/1125/images/img_6-1.jpg?optimizer=image&amp;format=webp&amp;width=16&amp;aspectRatio=1.33 16w, https://media.magloft.app/pdf-import/1125/images/img_6-1.jpg?optimizer=image&amp;format=webp&amp;width=32&amp;aspectRatio=1.33 32w, https://media.magloft.app/pdf-import/1125/images/img_6-1.jpg?optimizer=image&amp;format=webp&amp;width=48&amp;aspectRatio=1.33 48w, https://media.magloft.app/pdf-import/1125/images/img_6-1.jpg?optimizer=image&amp;format=webp&amp;width=54&amp;aspectRatio=1.33 54w, https://media.magloft.app/pdf-import/1125/images/img_6-1.jpg?optimizer=image&amp;format=webp&amp;width=64&amp;aspectRatio=1.33 64w, https://media.magloft.app/pdf-import/1125/images/img_6-1.jpg?optimizer=image&amp;format=webp&amp;width=70&amp;aspectRatio=1.33 70w, https://media.magloft.app/pdf-import/1125/images/img_6-1.jpg?optimizer=image&amp;format=webp&amp;width=82&amp;aspectRatio=1.33 82w, https://media.magloft.app/pdf-import/1125/images/img_6-1.jpg?optimizer=image&amp;format=webp&amp;width=96&amp;aspectRatio=1.33 96w, https://media.magloft.app/pdf-import/1125/images/img_6-1.jpg?optimizer=image&amp;format=webp&amp;width=96&amp;aspectRatio=1.33 96w, https://media.magloft.app/pdf-import/1125/images/img_6-1.jpg?optimizer=image&amp;format=webp&amp;width=110&amp;aspectRatio=1.33 110w, https://media.magloft.app/pdf-import/1125/images/img_6-1.jpg?optimizer=image&amp;format=webp&amp;width=128&amp;aspectRatio=1.33 128w, https://media.magloft.app/pdf-import/1125/images/img_6-1.jpg?optimizer=image&amp;format=webp&amp;width=128&amp;aspectRatio=1.33 128w, https://media.magloft.app/pdf-import/1125/images/img_6-1.jpg?optimizer=image&amp;format=webp&amp;width=138&amp;aspectRatio=1.33 138w, https://media.magloft.app/pdf-import/1125/images/img_6-1.jpg?optimizer=image&amp;format=webp&amp;width=192&amp;aspectRatio=1.33 192w, https://media.magloft.app/pdf-import/1125/images/img_6-1.jpg?optimizer=image&amp;format=webp&amp;width=200&amp;aspectRatio=1.33 200w, https://media.magloft.app/pdf-import/1125/images/img_6-1.jpg?optimizer=image&amp;format=webp&amp;width=252&amp;aspectRatio=1.33 252w, https://media.magloft.app/pdf-import/1125/images/img_6-1.jpg?optimizer=image&amp;format=webp&amp;width=256&amp;aspectRatio=1.33 256w, https://media.magloft.app/pdf-import/1125/images/img_6-1.jpg?optimizer=image&amp;format=webp&amp;width=260&amp;aspectRatio=1.33 260w, https://media.magloft.app/pdf-import/1125/images/img_6-1.jpg?optimizer=image&amp;format=webp&amp;width=298&amp;aspectRatio=1.33 298w, https://media.magloft.app/pdf-import/1125/images/img_6-1.jpg?optimizer=image&amp;format=webp&amp;width=378&amp;aspectRatio=1.33 378w, https://media.magloft.app/pdf-import/1125/images/img_6-1.jpg?optimizer=image&amp;format=webp&amp;width=384&amp;aspectRatio=1.33 384w, https://media.magloft.app/pdf-import/1125/images/img_6-1.jpg?optimizer=image&amp;format=webp&amp;width=384&amp;aspectRatio=1.33 384w, https://media.magloft.app/pdf-import/1125/images/img_6-1.jpg?optimizer=image&amp;format=webp&amp;width=520&amp;aspectRatio=1.33 520w, https://media.magloft.app/pdf-import/1125/images/img_6-1.jpg?optimizer=image&amp;format=webp&amp;width=640&amp;aspectRatio=1.33 640w, https://media.magloft.app/pdf-import/1125/images/img_6-1.jpg?optimizer=image&amp;format=webp&amp;width=756&amp;aspectRatio=1.33 756w, https://media.magloft.app/pdf-import/1125/images/img_6-1.jpg?optimizer=image&amp;format=webp&amp;width=828&amp;aspectRatio=1.33 828w, https://media.magloft.app/pdf-import/1125/images/img_6-1.jpg?optimizer=image&amp;format=webp&amp;width=1080&amp;aspectRatio=1.33 1080w, https://media.magloft.app/pdf-import/1125/images/img_6-1.jpg?optimizer=image&amp;format=webp&amp;width=1200&amp;aspectRatio=1.33 1200w, https://media.magloft.app/pdf-import/1125/images/img_6-1.jpg?optimizer=image&amp;format=webp&amp;width=1920&amp;aspectRatio=1.33 1920w, https://media.magloft.app/pdf-import/1125/images/img_6-1.jpg?optimizer=image&amp;format=webp&amp;width=2048&amp;aspectRatio=1.33 2048w" src="https://media.magloft.app/pdf-import/1125/images/img_6-1.jpg?optimizer=image&amp;format=webp&amp;width=2048&amp;aspectRatio=1.33"/></div><div class="Block_article-contents__M6B6V"><h3>CluePoints launches Medical &amp; Safety Review (MSR) software</h3><p>Risk-based quality management (RBQM) and data quality oversight software company Cluepoints launches its latest application, the medical &amp; safety review (MSR), to simplify and streamline the medical analysis of study data through user-friendly dashboards, data manipulation and cleaning, query management and full transparency over the data history.</p></div></a><a class="Block_article-card__mncKE" href="/articles/next-generation-sequencing-partnership-announced-between-angle-p"><div class="Block_article-cover__vLhzO"><img alt="article-category" loading="lazy" decoding="async" data-nimg="fill" style="position:absolute;height:100%;width:100%;left:0;top:0;right:0;bottom:0;color:transparent;background-size:cover;background-position:50% 50%;background-repeat:no-repeat;background-image:url(&quot;data:image/svg+xml;charset=utf-8,%3Csvg xmlns=&#x27;http%3A//www.w3.org/2000/svg&#x27;%3E%3Cimage style=&#x27;filter:blur(20px)&#x27; preserveAspectRatio=&#x27;none&#x27; x=&#x27;0&#x27; y=&#x27;0&#x27; height=&#x27;100%25&#x27; width=&#x27;100%25&#x27; href=&#x27;data:image/gif;base64,R0lGODlhAQABAPAAANzc3P///yH5BAAAAAAALAAAAAABAAEAAAICRAEAOw==&#x27;/%3E%3C/svg%3E&quot;)" sizes="70px" srcSet="https://media.magloft.app/pdf-import/1125/images/img_10-2.jpg?optimizer=image&amp;format=webp&amp;width=16&amp;aspectRatio=1.33 16w, https://media.magloft.app/pdf-import/1125/images/img_10-2.jpg?optimizer=image&amp;format=webp&amp;width=32&amp;aspectRatio=1.33 32w, https://media.magloft.app/pdf-import/1125/images/img_10-2.jpg?optimizer=image&amp;format=webp&amp;width=48&amp;aspectRatio=1.33 48w, https://media.magloft.app/pdf-import/1125/images/img_10-2.jpg?optimizer=image&amp;format=webp&amp;width=54&amp;aspectRatio=1.33 54w, https://media.magloft.app/pdf-import/1125/images/img_10-2.jpg?optimizer=image&amp;format=webp&amp;width=64&amp;aspectRatio=1.33 64w, https://media.magloft.app/pdf-import/1125/images/img_10-2.jpg?optimizer=image&amp;format=webp&amp;width=70&amp;aspectRatio=1.33 70w, https://media.magloft.app/pdf-import/1125/images/img_10-2.jpg?optimizer=image&amp;format=webp&amp;width=82&amp;aspectRatio=1.33 82w, https://media.magloft.app/pdf-import/1125/images/img_10-2.jpg?optimizer=image&amp;format=webp&amp;width=96&amp;aspectRatio=1.33 96w, https://media.magloft.app/pdf-import/1125/images/img_10-2.jpg?optimizer=image&amp;format=webp&amp;width=96&amp;aspectRatio=1.33 96w, https://media.magloft.app/pdf-import/1125/images/img_10-2.jpg?optimizer=image&amp;format=webp&amp;width=110&amp;aspectRatio=1.33 110w, https://media.magloft.app/pdf-import/1125/images/img_10-2.jpg?optimizer=image&amp;format=webp&amp;width=128&amp;aspectRatio=1.33 128w, https://media.magloft.app/pdf-import/1125/images/img_10-2.jpg?optimizer=image&amp;format=webp&amp;width=128&amp;aspectRatio=1.33 128w, https://media.magloft.app/pdf-import/1125/images/img_10-2.jpg?optimizer=image&amp;format=webp&amp;width=138&amp;aspectRatio=1.33 138w, https://media.magloft.app/pdf-import/1125/images/img_10-2.jpg?optimizer=image&amp;format=webp&amp;width=192&amp;aspectRatio=1.33 192w, https://media.magloft.app/pdf-import/1125/images/img_10-2.jpg?optimizer=image&amp;format=webp&amp;width=200&amp;aspectRatio=1.33 200w, https://media.magloft.app/pdf-import/1125/images/img_10-2.jpg?optimizer=image&amp;format=webp&amp;width=252&amp;aspectRatio=1.33 252w, https://media.magloft.app/pdf-import/1125/images/img_10-2.jpg?optimizer=image&amp;format=webp&amp;width=256&amp;aspectRatio=1.33 256w, https://media.magloft.app/pdf-import/1125/images/img_10-2.jpg?optimizer=image&amp;format=webp&amp;width=260&amp;aspectRatio=1.33 260w, https://media.magloft.app/pdf-import/1125/images/img_10-2.jpg?optimizer=image&amp;format=webp&amp;width=298&amp;aspectRatio=1.33 298w, https://media.magloft.app/pdf-import/1125/images/img_10-2.jpg?optimizer=image&amp;format=webp&amp;width=378&amp;aspectRatio=1.33 378w, https://media.magloft.app/pdf-import/1125/images/img_10-2.jpg?optimizer=image&amp;format=webp&amp;width=384&amp;aspectRatio=1.33 384w, https://media.magloft.app/pdf-import/1125/images/img_10-2.jpg?optimizer=image&amp;format=webp&amp;width=384&amp;aspectRatio=1.33 384w, https://media.magloft.app/pdf-import/1125/images/img_10-2.jpg?optimizer=image&amp;format=webp&amp;width=520&amp;aspectRatio=1.33 520w, https://media.magloft.app/pdf-import/1125/images/img_10-2.jpg?optimizer=image&amp;format=webp&amp;width=640&amp;aspectRatio=1.33 640w, https://media.magloft.app/pdf-import/1125/images/img_10-2.jpg?optimizer=image&amp;format=webp&amp;width=756&amp;aspectRatio=1.33 756w, https://media.magloft.app/pdf-import/1125/images/img_10-2.jpg?optimizer=image&amp;format=webp&amp;width=828&amp;aspectRatio=1.33 828w, https://media.magloft.app/pdf-import/1125/images/img_10-2.jpg?optimizer=image&amp;format=webp&amp;width=1080&amp;aspectRatio=1.33 1080w, https://media.magloft.app/pdf-import/1125/images/img_10-2.jpg?optimizer=image&amp;format=webp&amp;width=1200&amp;aspectRatio=1.33 1200w, https://media.magloft.app/pdf-import/1125/images/img_10-2.jpg?optimizer=image&amp;format=webp&amp;width=1920&amp;aspectRatio=1.33 1920w, https://media.magloft.app/pdf-import/1125/images/img_10-2.jpg?optimizer=image&amp;format=webp&amp;width=2048&amp;aspectRatio=1.33 2048w" src="https://media.magloft.app/pdf-import/1125/images/img_10-2.jpg?optimizer=image&amp;format=webp&amp;width=2048&amp;aspectRatio=1.33"/></div><div class="Block_article-contents__M6B6V"><h3>Next-generation sequencing partnership announced between ANGLE plc and NuProbe</h3><p>Liquid biopsy company ANGLE plc has announced a partnership with NuProbe, a genomics and molecular diagnostics company, to utilise the latter’s pan-cancer next-generation sequencing (NGS) panel.</p></div></a><a class="Block_article-card__mncKE" href="/articles/fda-approves-first-drug-in-50-years-for-treatment-of-schizophren"><div class="Block_article-cover__vLhzO"><img alt="article-category" loading="lazy" decoding="async" data-nimg="fill" style="position:absolute;height:100%;width:100%;left:0;top:0;right:0;bottom:0;color:transparent;background-size:cover;background-position:50% 50%;background-repeat:no-repeat;background-image:url(&quot;data:image/svg+xml;charset=utf-8,%3Csvg xmlns=&#x27;http%3A//www.w3.org/2000/svg&#x27;%3E%3Cimage style=&#x27;filter:blur(20px)&#x27; preserveAspectRatio=&#x27;none&#x27; x=&#x27;0&#x27; y=&#x27;0&#x27; height=&#x27;100%25&#x27; width=&#x27;100%25&#x27; href=&#x27;data:image/gif;base64,R0lGODlhAQABAPAAANzc3P///yH5BAAAAAAALAAAAAABAAEAAAICRAEAOw==&#x27;/%3E%3C/svg%3E&quot;)" sizes="70px" srcSet="https://media.magloft.app/pdf-import/1125/images/img_1-1.jpg?optimizer=image&amp;format=webp&amp;width=16&amp;aspectRatio=1.33 16w, https://media.magloft.app/pdf-import/1125/images/img_1-1.jpg?optimizer=image&amp;format=webp&amp;width=32&amp;aspectRatio=1.33 32w, https://media.magloft.app/pdf-import/1125/images/img_1-1.jpg?optimizer=image&amp;format=webp&amp;width=48&amp;aspectRatio=1.33 48w, https://media.magloft.app/pdf-import/1125/images/img_1-1.jpg?optimizer=image&amp;format=webp&amp;width=54&amp;aspectRatio=1.33 54w, https://media.magloft.app/pdf-import/1125/images/img_1-1.jpg?optimizer=image&amp;format=webp&amp;width=64&amp;aspectRatio=1.33 64w, https://media.magloft.app/pdf-import/1125/images/img_1-1.jpg?optimizer=image&amp;format=webp&amp;width=70&amp;aspectRatio=1.33 70w, https://media.magloft.app/pdf-import/1125/images/img_1-1.jpg?optimizer=image&amp;format=webp&amp;width=82&amp;aspectRatio=1.33 82w, https://media.magloft.app/pdf-import/1125/images/img_1-1.jpg?optimizer=image&amp;format=webp&amp;width=96&amp;aspectRatio=1.33 96w, https://media.magloft.app/pdf-import/1125/images/img_1-1.jpg?optimizer=image&amp;format=webp&amp;width=96&amp;aspectRatio=1.33 96w, https://media.magloft.app/pdf-import/1125/images/img_1-1.jpg?optimizer=image&amp;format=webp&amp;width=110&amp;aspectRatio=1.33 110w, https://media.magloft.app/pdf-import/1125/images/img_1-1.jpg?optimizer=image&amp;format=webp&amp;width=128&amp;aspectRatio=1.33 128w, https://media.magloft.app/pdf-import/1125/images/img_1-1.jpg?optimizer=image&amp;format=webp&amp;width=128&amp;aspectRatio=1.33 128w, https://media.magloft.app/pdf-import/1125/images/img_1-1.jpg?optimizer=image&amp;format=webp&amp;width=138&amp;aspectRatio=1.33 138w, https://media.magloft.app/pdf-import/1125/images/img_1-1.jpg?optimizer=image&amp;format=webp&amp;width=192&amp;aspectRatio=1.33 192w, https://media.magloft.app/pdf-import/1125/images/img_1-1.jpg?optimizer=image&amp;format=webp&amp;width=200&amp;aspectRatio=1.33 200w, https://media.magloft.app/pdf-import/1125/images/img_1-1.jpg?optimizer=image&amp;format=webp&amp;width=252&amp;aspectRatio=1.33 252w, https://media.magloft.app/pdf-import/1125/images/img_1-1.jpg?optimizer=image&amp;format=webp&amp;width=256&amp;aspectRatio=1.33 256w, https://media.magloft.app/pdf-import/1125/images/img_1-1.jpg?optimizer=image&amp;format=webp&amp;width=260&amp;aspectRatio=1.33 260w, https://media.magloft.app/pdf-import/1125/images/img_1-1.jpg?optimizer=image&amp;format=webp&amp;width=298&amp;aspectRatio=1.33 298w, https://media.magloft.app/pdf-import/1125/images/img_1-1.jpg?optimizer=image&amp;format=webp&amp;width=378&amp;aspectRatio=1.33 378w, https://media.magloft.app/pdf-import/1125/images/img_1-1.jpg?optimizer=image&amp;format=webp&amp;width=384&amp;aspectRatio=1.33 384w, https://media.magloft.app/pdf-import/1125/images/img_1-1.jpg?optimizer=image&amp;format=webp&amp;width=384&amp;aspectRatio=1.33 384w, https://media.magloft.app/pdf-import/1125/images/img_1-1.jpg?optimizer=image&amp;format=webp&amp;width=520&amp;aspectRatio=1.33 520w, https://media.magloft.app/pdf-import/1125/images/img_1-1.jpg?optimizer=image&amp;format=webp&amp;width=640&amp;aspectRatio=1.33 640w, https://media.magloft.app/pdf-import/1125/images/img_1-1.jpg?optimizer=image&amp;format=webp&amp;width=756&amp;aspectRatio=1.33 756w, https://media.magloft.app/pdf-import/1125/images/img_1-1.jpg?optimizer=image&amp;format=webp&amp;width=828&amp;aspectRatio=1.33 828w, https://media.magloft.app/pdf-import/1125/images/img_1-1.jpg?optimizer=image&amp;format=webp&amp;width=1080&amp;aspectRatio=1.33 1080w, https://media.magloft.app/pdf-import/1125/images/img_1-1.jpg?optimizer=image&amp;format=webp&amp;width=1200&amp;aspectRatio=1.33 1200w, https://media.magloft.app/pdf-import/1125/images/img_1-1.jpg?optimizer=image&amp;format=webp&amp;width=1920&amp;aspectRatio=1.33 1920w, https://media.magloft.app/pdf-import/1125/images/img_1-1.jpg?optimizer=image&amp;format=webp&amp;width=2048&amp;aspectRatio=1.33 2048w" src="https://media.magloft.app/pdf-import/1125/images/img_1-1.jpg?optimizer=image&amp;format=webp&amp;width=2048&amp;aspectRatio=1.33"/></div><div class="Block_article-contents__M6B6V"><h3>FDA approves first drug in 50 years for treatment of schizophrenia in adults</h3><p>Earlier this September, the US Food and Drug Administration (FDA) granted approval for PureTech Health’s Karxt for the treatment of schizophrenia in adults, triggering royalty payments of $29m to PureTech. It will be the first approved mechanism by the FDAfor schizophrenia in over 50 years.</p></div></a><a class="Block_article-card__mncKE" href="/articles/research-collaboration-between-fda-and-owlstone-medical-set-to-s"><div class="Block_article-cover__vLhzO"><img alt="article-category" loading="lazy" decoding="async" data-nimg="fill" style="position:absolute;height:100%;width:100%;left:0;top:0;right:0;bottom:0;color:transparent;background-size:cover;background-position:50% 50%;background-repeat:no-repeat;background-image:url(&quot;data:image/svg+xml;charset=utf-8,%3Csvg xmlns=&#x27;http%3A//www.w3.org/2000/svg&#x27;%3E%3Cimage style=&#x27;filter:blur(20px)&#x27; preserveAspectRatio=&#x27;none&#x27; x=&#x27;0&#x27; y=&#x27;0&#x27; height=&#x27;100%25&#x27; width=&#x27;100%25&#x27; href=&#x27;data:image/gif;base64,R0lGODlhAQABAPAAANzc3P///yH5BAAAAAAALAAAAAABAAEAAAICRAEAOw==&#x27;/%3E%3C/svg%3E&quot;)" sizes="70px" srcSet="https://media.magloft.app/pdf-import/1125/images/img_2-3.jpg?optimizer=image&amp;format=webp&amp;width=16&amp;aspectRatio=1.33 16w, https://media.magloft.app/pdf-import/1125/images/img_2-3.jpg?optimizer=image&amp;format=webp&amp;width=32&amp;aspectRatio=1.33 32w, https://media.magloft.app/pdf-import/1125/images/img_2-3.jpg?optimizer=image&amp;format=webp&amp;width=48&amp;aspectRatio=1.33 48w, https://media.magloft.app/pdf-import/1125/images/img_2-3.jpg?optimizer=image&amp;format=webp&amp;width=54&amp;aspectRatio=1.33 54w, https://media.magloft.app/pdf-import/1125/images/img_2-3.jpg?optimizer=image&amp;format=webp&amp;width=64&amp;aspectRatio=1.33 64w, https://media.magloft.app/pdf-import/1125/images/img_2-3.jpg?optimizer=image&amp;format=webp&amp;width=70&amp;aspectRatio=1.33 70w, https://media.magloft.app/pdf-import/1125/images/img_2-3.jpg?optimizer=image&amp;format=webp&amp;width=82&amp;aspectRatio=1.33 82w, https://media.magloft.app/pdf-import/1125/images/img_2-3.jpg?optimizer=image&amp;format=webp&amp;width=96&amp;aspectRatio=1.33 96w, https://media.magloft.app/pdf-import/1125/images/img_2-3.jpg?optimizer=image&amp;format=webp&amp;width=96&amp;aspectRatio=1.33 96w, https://media.magloft.app/pdf-import/1125/images/img_2-3.jpg?optimizer=image&amp;format=webp&amp;width=110&amp;aspectRatio=1.33 110w, https://media.magloft.app/pdf-import/1125/images/img_2-3.jpg?optimizer=image&amp;format=webp&amp;width=128&amp;aspectRatio=1.33 128w, https://media.magloft.app/pdf-import/1125/images/img_2-3.jpg?optimizer=image&amp;format=webp&amp;width=128&amp;aspectRatio=1.33 128w, https://media.magloft.app/pdf-import/1125/images/img_2-3.jpg?optimizer=image&amp;format=webp&amp;width=138&amp;aspectRatio=1.33 138w, https://media.magloft.app/pdf-import/1125/images/img_2-3.jpg?optimizer=image&amp;format=webp&amp;width=192&amp;aspectRatio=1.33 192w, https://media.magloft.app/pdf-import/1125/images/img_2-3.jpg?optimizer=image&amp;format=webp&amp;width=200&amp;aspectRatio=1.33 200w, https://media.magloft.app/pdf-import/1125/images/img_2-3.jpg?optimizer=image&amp;format=webp&amp;width=252&amp;aspectRatio=1.33 252w, https://media.magloft.app/pdf-import/1125/images/img_2-3.jpg?optimizer=image&amp;format=webp&amp;width=256&amp;aspectRatio=1.33 256w, https://media.magloft.app/pdf-import/1125/images/img_2-3.jpg?optimizer=image&amp;format=webp&amp;width=260&amp;aspectRatio=1.33 260w, https://media.magloft.app/pdf-import/1125/images/img_2-3.jpg?optimizer=image&amp;format=webp&amp;width=298&amp;aspectRatio=1.33 298w, https://media.magloft.app/pdf-import/1125/images/img_2-3.jpg?optimizer=image&amp;format=webp&amp;width=378&amp;aspectRatio=1.33 378w, https://media.magloft.app/pdf-import/1125/images/img_2-3.jpg?optimizer=image&amp;format=webp&amp;width=384&amp;aspectRatio=1.33 384w, https://media.magloft.app/pdf-import/1125/images/img_2-3.jpg?optimizer=image&amp;format=webp&amp;width=384&amp;aspectRatio=1.33 384w, https://media.magloft.app/pdf-import/1125/images/img_2-3.jpg?optimizer=image&amp;format=webp&amp;width=520&amp;aspectRatio=1.33 520w, https://media.magloft.app/pdf-import/1125/images/img_2-3.jpg?optimizer=image&amp;format=webp&amp;width=640&amp;aspectRatio=1.33 640w, https://media.magloft.app/pdf-import/1125/images/img_2-3.jpg?optimizer=image&amp;format=webp&amp;width=756&amp;aspectRatio=1.33 756w, https://media.magloft.app/pdf-import/1125/images/img_2-3.jpg?optimizer=image&amp;format=webp&amp;width=828&amp;aspectRatio=1.33 828w, https://media.magloft.app/pdf-import/1125/images/img_2-3.jpg?optimizer=image&amp;format=webp&amp;width=1080&amp;aspectRatio=1.33 1080w, https://media.magloft.app/pdf-import/1125/images/img_2-3.jpg?optimizer=image&amp;format=webp&amp;width=1200&amp;aspectRatio=1.33 1200w, https://media.magloft.app/pdf-import/1125/images/img_2-3.jpg?optimizer=image&amp;format=webp&amp;width=1920&amp;aspectRatio=1.33 1920w, https://media.magloft.app/pdf-import/1125/images/img_2-3.jpg?optimizer=image&amp;format=webp&amp;width=2048&amp;aspectRatio=1.33 2048w" src="https://media.magloft.app/pdf-import/1125/images/img_2-3.jpg?optimizer=image&amp;format=webp&amp;width=2048&amp;aspectRatio=1.33"/></div><div class="Block_article-contents__M6B6V"><h3>Research collaboration between FDA and Owlstone Medical set to see improvements in breath biopsies</h3><p>Owlstone Medical has entered into a research collaboration with the US Food and Drug administration’s (FDA) centre for devices and radiological health to develop methods for the confident identification of individual chemicals in the composure of breath.</p></div></a><a class="Block_article-card__mncKE" href="/articles/first-nasal-spray-for-treatment-of-anaphylaxis-approved-by-fda"><div class="Block_article-cover__vLhzO"><img alt="article-category" loading="lazy" decoding="async" data-nimg="fill" style="position:absolute;height:100%;width:100%;left:0;top:0;right:0;bottom:0;color:transparent;background-size:cover;background-position:50% 50%;background-repeat:no-repeat;background-image:url(&quot;data:image/svg+xml;charset=utf-8,%3Csvg xmlns=&#x27;http%3A//www.w3.org/2000/svg&#x27;%3E%3Cimage style=&#x27;filter:blur(20px)&#x27; preserveAspectRatio=&#x27;none&#x27; x=&#x27;0&#x27; y=&#x27;0&#x27; height=&#x27;100%25&#x27; width=&#x27;100%25&#x27; href=&#x27;data:image/gif;base64,R0lGODlhAQABAPAAANzc3P///yH5BAAAAAAALAAAAAABAAEAAAICRAEAOw==&#x27;/%3E%3C/svg%3E&quot;)" sizes="70px" srcSet="https://media.magloft.app/pdf-import/1110/images/img_1-1.jpg?optimizer=image&amp;format=webp&amp;width=16&amp;aspectRatio=1.33 16w, https://media.magloft.app/pdf-import/1110/images/img_1-1.jpg?optimizer=image&amp;format=webp&amp;width=32&amp;aspectRatio=1.33 32w, https://media.magloft.app/pdf-import/1110/images/img_1-1.jpg?optimizer=image&amp;format=webp&amp;width=48&amp;aspectRatio=1.33 48w, https://media.magloft.app/pdf-import/1110/images/img_1-1.jpg?optimizer=image&amp;format=webp&amp;width=54&amp;aspectRatio=1.33 54w, https://media.magloft.app/pdf-import/1110/images/img_1-1.jpg?optimizer=image&amp;format=webp&amp;width=64&amp;aspectRatio=1.33 64w, https://media.magloft.app/pdf-import/1110/images/img_1-1.jpg?optimizer=image&amp;format=webp&amp;width=70&amp;aspectRatio=1.33 70w, https://media.magloft.app/pdf-import/1110/images/img_1-1.jpg?optimizer=image&amp;format=webp&amp;width=82&amp;aspectRatio=1.33 82w, https://media.magloft.app/pdf-import/1110/images/img_1-1.jpg?optimizer=image&amp;format=webp&amp;width=96&amp;aspectRatio=1.33 96w, https://media.magloft.app/pdf-import/1110/images/img_1-1.jpg?optimizer=image&amp;format=webp&amp;width=96&amp;aspectRatio=1.33 96w, https://media.magloft.app/pdf-import/1110/images/img_1-1.jpg?optimizer=image&amp;format=webp&amp;width=110&amp;aspectRatio=1.33 110w, https://media.magloft.app/pdf-import/1110/images/img_1-1.jpg?optimizer=image&amp;format=webp&amp;width=128&amp;aspectRatio=1.33 128w, https://media.magloft.app/pdf-import/1110/images/img_1-1.jpg?optimizer=image&amp;format=webp&amp;width=128&amp;aspectRatio=1.33 128w, https://media.magloft.app/pdf-import/1110/images/img_1-1.jpg?optimizer=image&amp;format=webp&amp;width=138&amp;aspectRatio=1.33 138w, https://media.magloft.app/pdf-import/1110/images/img_1-1.jpg?optimizer=image&amp;format=webp&amp;width=192&amp;aspectRatio=1.33 192w, https://media.magloft.app/pdf-import/1110/images/img_1-1.jpg?optimizer=image&amp;format=webp&amp;width=200&amp;aspectRatio=1.33 200w, https://media.magloft.app/pdf-import/1110/images/img_1-1.jpg?optimizer=image&amp;format=webp&amp;width=252&amp;aspectRatio=1.33 252w, https://media.magloft.app/pdf-import/1110/images/img_1-1.jpg?optimizer=image&amp;format=webp&amp;width=256&amp;aspectRatio=1.33 256w, https://media.magloft.app/pdf-import/1110/images/img_1-1.jpg?optimizer=image&amp;format=webp&amp;width=260&amp;aspectRatio=1.33 260w, https://media.magloft.app/pdf-import/1110/images/img_1-1.jpg?optimizer=image&amp;format=webp&amp;width=298&amp;aspectRatio=1.33 298w, https://media.magloft.app/pdf-import/1110/images/img_1-1.jpg?optimizer=image&amp;format=webp&amp;width=378&amp;aspectRatio=1.33 378w, https://media.magloft.app/pdf-import/1110/images/img_1-1.jpg?optimizer=image&amp;format=webp&amp;width=384&amp;aspectRatio=1.33 384w, https://media.magloft.app/pdf-import/1110/images/img_1-1.jpg?optimizer=image&amp;format=webp&amp;width=384&amp;aspectRatio=1.33 384w, https://media.magloft.app/pdf-import/1110/images/img_1-1.jpg?optimizer=image&amp;format=webp&amp;width=520&amp;aspectRatio=1.33 520w, https://media.magloft.app/pdf-import/1110/images/img_1-1.jpg?optimizer=image&amp;format=webp&amp;width=640&amp;aspectRatio=1.33 640w, https://media.magloft.app/pdf-import/1110/images/img_1-1.jpg?optimizer=image&amp;format=webp&amp;width=756&amp;aspectRatio=1.33 756w, https://media.magloft.app/pdf-import/1110/images/img_1-1.jpg?optimizer=image&amp;format=webp&amp;width=828&amp;aspectRatio=1.33 828w, https://media.magloft.app/pdf-import/1110/images/img_1-1.jpg?optimizer=image&amp;format=webp&amp;width=1080&amp;aspectRatio=1.33 1080w, https://media.magloft.app/pdf-import/1110/images/img_1-1.jpg?optimizer=image&amp;format=webp&amp;width=1200&amp;aspectRatio=1.33 1200w, https://media.magloft.app/pdf-import/1110/images/img_1-1.jpg?optimizer=image&amp;format=webp&amp;width=1920&amp;aspectRatio=1.33 1920w, https://media.magloft.app/pdf-import/1110/images/img_1-1.jpg?optimizer=image&amp;format=webp&amp;width=2048&amp;aspectRatio=1.33 2048w" src="https://media.magloft.app/pdf-import/1110/images/img_1-1.jpg?optimizer=image&amp;format=webp&amp;width=2048&amp;aspectRatio=1.33"/></div><div class="Block_article-contents__M6B6V"><h3>First nasal spray for treatment of anaphylaxis approved by FDA</h3><p>Ars pharmaceuticals has been granted approval by the us food and drug administration (fda) for their epinephrine nasal spray, neffy, to be used as treatment of type 1 allergic reactions including anaphylaxis.</p></div></a><a class="Block_article-card__mncKE" href="/articles/novo-holdings-invests-in-oxford-nanopore-technologies"><div class="Block_article-cover__vLhzO"><img alt="article-category" loading="lazy" decoding="async" data-nimg="fill" style="position:absolute;height:100%;width:100%;left:0;top:0;right:0;bottom:0;color:transparent;background-size:cover;background-position:50% 50%;background-repeat:no-repeat;background-image:url(&quot;data:image/svg+xml;charset=utf-8,%3Csvg xmlns=&#x27;http%3A//www.w3.org/2000/svg&#x27;%3E%3Cimage style=&#x27;filter:blur(20px)&#x27; preserveAspectRatio=&#x27;none&#x27; x=&#x27;0&#x27; y=&#x27;0&#x27; height=&#x27;100%25&#x27; width=&#x27;100%25&#x27; href=&#x27;data:image/gif;base64,R0lGODlhAQABAPAAANzc3P///yH5BAAAAAAALAAAAAABAAEAAAICRAEAOw==&#x27;/%3E%3C/svg%3E&quot;)" sizes="70px" srcSet="https://media.magloft.app/pdf-import/1110/images/img_4-1.jpg?optimizer=image&amp;format=webp&amp;width=16&amp;aspectRatio=1.33 16w, https://media.magloft.app/pdf-import/1110/images/img_4-1.jpg?optimizer=image&amp;format=webp&amp;width=32&amp;aspectRatio=1.33 32w, https://media.magloft.app/pdf-import/1110/images/img_4-1.jpg?optimizer=image&amp;format=webp&amp;width=48&amp;aspectRatio=1.33 48w, https://media.magloft.app/pdf-import/1110/images/img_4-1.jpg?optimizer=image&amp;format=webp&amp;width=54&amp;aspectRatio=1.33 54w, https://media.magloft.app/pdf-import/1110/images/img_4-1.jpg?optimizer=image&amp;format=webp&amp;width=64&amp;aspectRatio=1.33 64w, https://media.magloft.app/pdf-import/1110/images/img_4-1.jpg?optimizer=image&amp;format=webp&amp;width=70&amp;aspectRatio=1.33 70w, https://media.magloft.app/pdf-import/1110/images/img_4-1.jpg?optimizer=image&amp;format=webp&amp;width=82&amp;aspectRatio=1.33 82w, https://media.magloft.app/pdf-import/1110/images/img_4-1.jpg?optimizer=image&amp;format=webp&amp;width=96&amp;aspectRatio=1.33 96w, https://media.magloft.app/pdf-import/1110/images/img_4-1.jpg?optimizer=image&amp;format=webp&amp;width=96&amp;aspectRatio=1.33 96w, https://media.magloft.app/pdf-import/1110/images/img_4-1.jpg?optimizer=image&amp;format=webp&amp;width=110&amp;aspectRatio=1.33 110w, https://media.magloft.app/pdf-import/1110/images/img_4-1.jpg?optimizer=image&amp;format=webp&amp;width=128&amp;aspectRatio=1.33 128w, https://media.magloft.app/pdf-import/1110/images/img_4-1.jpg?optimizer=image&amp;format=webp&amp;width=128&amp;aspectRatio=1.33 128w, https://media.magloft.app/pdf-import/1110/images/img_4-1.jpg?optimizer=image&amp;format=webp&amp;width=138&amp;aspectRatio=1.33 138w, https://media.magloft.app/pdf-import/1110/images/img_4-1.jpg?optimizer=image&amp;format=webp&amp;width=192&amp;aspectRatio=1.33 192w, https://media.magloft.app/pdf-import/1110/images/img_4-1.jpg?optimizer=image&amp;format=webp&amp;width=200&amp;aspectRatio=1.33 200w, https://media.magloft.app/pdf-import/1110/images/img_4-1.jpg?optimizer=image&amp;format=webp&amp;width=252&amp;aspectRatio=1.33 252w, https://media.magloft.app/pdf-import/1110/images/img_4-1.jpg?optimizer=image&amp;format=webp&amp;width=256&amp;aspectRatio=1.33 256w, https://media.magloft.app/pdf-import/1110/images/img_4-1.jpg?optimizer=image&amp;format=webp&amp;width=260&amp;aspectRatio=1.33 260w, https://media.magloft.app/pdf-import/1110/images/img_4-1.jpg?optimizer=image&amp;format=webp&amp;width=298&amp;aspectRatio=1.33 298w, https://media.magloft.app/pdf-import/1110/images/img_4-1.jpg?optimizer=image&amp;format=webp&amp;width=378&amp;aspectRatio=1.33 378w, https://media.magloft.app/pdf-import/1110/images/img_4-1.jpg?optimizer=image&amp;format=webp&amp;width=384&amp;aspectRatio=1.33 384w, https://media.magloft.app/pdf-import/1110/images/img_4-1.jpg?optimizer=image&amp;format=webp&amp;width=384&amp;aspectRatio=1.33 384w, https://media.magloft.app/pdf-import/1110/images/img_4-1.jpg?optimizer=image&amp;format=webp&amp;width=520&amp;aspectRatio=1.33 520w, https://media.magloft.app/pdf-import/1110/images/img_4-1.jpg?optimizer=image&amp;format=webp&amp;width=640&amp;aspectRatio=1.33 640w, https://media.magloft.app/pdf-import/1110/images/img_4-1.jpg?optimizer=image&amp;format=webp&amp;width=756&amp;aspectRatio=1.33 756w, https://media.magloft.app/pdf-import/1110/images/img_4-1.jpg?optimizer=image&amp;format=webp&amp;width=828&amp;aspectRatio=1.33 828w, https://media.magloft.app/pdf-import/1110/images/img_4-1.jpg?optimizer=image&amp;format=webp&amp;width=1080&amp;aspectRatio=1.33 1080w, https://media.magloft.app/pdf-import/1110/images/img_4-1.jpg?optimizer=image&amp;format=webp&amp;width=1200&amp;aspectRatio=1.33 1200w, https://media.magloft.app/pdf-import/1110/images/img_4-1.jpg?optimizer=image&amp;format=webp&amp;width=1920&amp;aspectRatio=1.33 1920w, https://media.magloft.app/pdf-import/1110/images/img_4-1.jpg?optimizer=image&amp;format=webp&amp;width=2048&amp;aspectRatio=1.33 2048w" src="https://media.magloft.app/pdf-import/1110/images/img_4-1.jpg?optimizer=image&amp;format=webp&amp;width=2048&amp;aspectRatio=1.33"/></div><div class="Block_article-contents__M6B6V"><h3>Novo Holdings invests in Oxford Nanopore Technologies</h3><p>Leading life science investor novo holdings has announced a £50m investment in oxford nanopore technologies. Oxford nanopore technologies is a leading uk-listed company currently specialising in a new generation of molecular sensing technology based on nanopores.</p></div></a><a class="Block_article-card__mncKE" href="/articles/cresset-collaborates-with-enamine-to-enable-the-design-of-new-ta"><div class="Block_article-cover__vLhzO"><img alt="article-category" loading="lazy" decoding="async" data-nimg="fill" style="position:absolute;height:100%;width:100%;left:0;top:0;right:0;bottom:0;color:transparent;background-size:cover;background-position:50% 50%;background-repeat:no-repeat;background-image:url(&quot;data:image/svg+xml;charset=utf-8,%3Csvg xmlns=&#x27;http%3A//www.w3.org/2000/svg&#x27;%3E%3Cimage style=&#x27;filter:blur(20px)&#x27; preserveAspectRatio=&#x27;none&#x27; x=&#x27;0&#x27; y=&#x27;0&#x27; height=&#x27;100%25&#x27; width=&#x27;100%25&#x27; href=&#x27;data:image/gif;base64,R0lGODlhAQABAPAAANzc3P///yH5BAAAAAAALAAAAAABAAEAAAICRAEAOw==&#x27;/%3E%3C/svg%3E&quot;)" sizes="70px" srcSet="https://media.magloft.app/pdf-import/1110/images/img_4-2.jpg?optimizer=image&amp;format=webp&amp;width=16&amp;aspectRatio=1.33 16w, https://media.magloft.app/pdf-import/1110/images/img_4-2.jpg?optimizer=image&amp;format=webp&amp;width=32&amp;aspectRatio=1.33 32w, https://media.magloft.app/pdf-import/1110/images/img_4-2.jpg?optimizer=image&amp;format=webp&amp;width=48&amp;aspectRatio=1.33 48w, https://media.magloft.app/pdf-import/1110/images/img_4-2.jpg?optimizer=image&amp;format=webp&amp;width=54&amp;aspectRatio=1.33 54w, https://media.magloft.app/pdf-import/1110/images/img_4-2.jpg?optimizer=image&amp;format=webp&amp;width=64&amp;aspectRatio=1.33 64w, https://media.magloft.app/pdf-import/1110/images/img_4-2.jpg?optimizer=image&amp;format=webp&amp;width=70&amp;aspectRatio=1.33 70w, https://media.magloft.app/pdf-import/1110/images/img_4-2.jpg?optimizer=image&amp;format=webp&amp;width=82&amp;aspectRatio=1.33 82w, https://media.magloft.app/pdf-import/1110/images/img_4-2.jpg?optimizer=image&amp;format=webp&amp;width=96&amp;aspectRatio=1.33 96w, https://media.magloft.app/pdf-import/1110/images/img_4-2.jpg?optimizer=image&amp;format=webp&amp;width=96&amp;aspectRatio=1.33 96w, https://media.magloft.app/pdf-import/1110/images/img_4-2.jpg?optimizer=image&amp;format=webp&amp;width=110&amp;aspectRatio=1.33 110w, https://media.magloft.app/pdf-import/1110/images/img_4-2.jpg?optimizer=image&amp;format=webp&amp;width=128&amp;aspectRatio=1.33 128w, https://media.magloft.app/pdf-import/1110/images/img_4-2.jpg?optimizer=image&amp;format=webp&amp;width=128&amp;aspectRatio=1.33 128w, https://media.magloft.app/pdf-import/1110/images/img_4-2.jpg?optimizer=image&amp;format=webp&amp;width=138&amp;aspectRatio=1.33 138w, https://media.magloft.app/pdf-import/1110/images/img_4-2.jpg?optimizer=image&amp;format=webp&amp;width=192&amp;aspectRatio=1.33 192w, https://media.magloft.app/pdf-import/1110/images/img_4-2.jpg?optimizer=image&amp;format=webp&amp;width=200&amp;aspectRatio=1.33 200w, https://media.magloft.app/pdf-import/1110/images/img_4-2.jpg?optimizer=image&amp;format=webp&amp;width=252&amp;aspectRatio=1.33 252w, https://media.magloft.app/pdf-import/1110/images/img_4-2.jpg?optimizer=image&amp;format=webp&amp;width=256&amp;aspectRatio=1.33 256w, https://media.magloft.app/pdf-import/1110/images/img_4-2.jpg?optimizer=image&amp;format=webp&amp;width=260&amp;aspectRatio=1.33 260w, https://media.magloft.app/pdf-import/1110/images/img_4-2.jpg?optimizer=image&amp;format=webp&amp;width=298&amp;aspectRatio=1.33 298w, https://media.magloft.app/pdf-import/1110/images/img_4-2.jpg?optimizer=image&amp;format=webp&amp;width=378&amp;aspectRatio=1.33 378w, https://media.magloft.app/pdf-import/1110/images/img_4-2.jpg?optimizer=image&amp;format=webp&amp;width=384&amp;aspectRatio=1.33 384w, https://media.magloft.app/pdf-import/1110/images/img_4-2.jpg?optimizer=image&amp;format=webp&amp;width=384&amp;aspectRatio=1.33 384w, https://media.magloft.app/pdf-import/1110/images/img_4-2.jpg?optimizer=image&amp;format=webp&amp;width=520&amp;aspectRatio=1.33 520w, https://media.magloft.app/pdf-import/1110/images/img_4-2.jpg?optimizer=image&amp;format=webp&amp;width=640&amp;aspectRatio=1.33 640w, https://media.magloft.app/pdf-import/1110/images/img_4-2.jpg?optimizer=image&amp;format=webp&amp;width=756&amp;aspectRatio=1.33 756w, https://media.magloft.app/pdf-import/1110/images/img_4-2.jpg?optimizer=image&amp;format=webp&amp;width=828&amp;aspectRatio=1.33 828w, https://media.magloft.app/pdf-import/1110/images/img_4-2.jpg?optimizer=image&amp;format=webp&amp;width=1080&amp;aspectRatio=1.33 1080w, https://media.magloft.app/pdf-import/1110/images/img_4-2.jpg?optimizer=image&amp;format=webp&amp;width=1200&amp;aspectRatio=1.33 1200w, https://media.magloft.app/pdf-import/1110/images/img_4-2.jpg?optimizer=image&amp;format=webp&amp;width=1920&amp;aspectRatio=1.33 1920w, https://media.magloft.app/pdf-import/1110/images/img_4-2.jpg?optimizer=image&amp;format=webp&amp;width=2048&amp;aspectRatio=1.33 2048w" src="https://media.magloft.app/pdf-import/1110/images/img_4-2.jpg?optimizer=image&amp;format=webp&amp;width=2048&amp;aspectRatio=1.33"/></div><div class="Block_article-contents__M6B6V"><h3>Cresset collaborates with Enamine to enable the design of new targeted protein degraders</h3><p>Drug discovery company Cresset has announced the extension of its global collaboration with chemical and biological contract research organisation (cro) Enamine.</p></div></a><a class="Block_article-card__mncKE" href="/articles/first-oral-treatment-for-hormone-sensitive-prostate-cancer-recom"><div class="Block_article-cover__vLhzO"><img alt="article-category" loading="lazy" decoding="async" data-nimg="fill" style="position:absolute;height:100%;width:100%;left:0;top:0;right:0;bottom:0;color:transparent;background-size:cover;background-position:50% 50%;background-repeat:no-repeat;background-image:url(&quot;data:image/svg+xml;charset=utf-8,%3Csvg xmlns=&#x27;http%3A//www.w3.org/2000/svg&#x27;%3E%3Cimage style=&#x27;filter:blur(20px)&#x27; preserveAspectRatio=&#x27;none&#x27; x=&#x27;0&#x27; y=&#x27;0&#x27; height=&#x27;100%25&#x27; width=&#x27;100%25&#x27; href=&#x27;data:image/gif;base64,R0lGODlhAQABAPAAANzc3P///yH5BAAAAAAALAAAAAABAAEAAAICRAEAOw==&#x27;/%3E%3C/svg%3E&quot;)" sizes="70px" srcSet="https://media.magloft.app/pdf-import/1110/images/pages/pg-005.jpg?optimizer=image&amp;format=webp&amp;width=16&amp;aspectRatio=1.33 16w, https://media.magloft.app/pdf-import/1110/images/pages/pg-005.jpg?optimizer=image&amp;format=webp&amp;width=32&amp;aspectRatio=1.33 32w, https://media.magloft.app/pdf-import/1110/images/pages/pg-005.jpg?optimizer=image&amp;format=webp&amp;width=48&amp;aspectRatio=1.33 48w, https://media.magloft.app/pdf-import/1110/images/pages/pg-005.jpg?optimizer=image&amp;format=webp&amp;width=54&amp;aspectRatio=1.33 54w, https://media.magloft.app/pdf-import/1110/images/pages/pg-005.jpg?optimizer=image&amp;format=webp&amp;width=64&amp;aspectRatio=1.33 64w, https://media.magloft.app/pdf-import/1110/images/pages/pg-005.jpg?optimizer=image&amp;format=webp&amp;width=70&amp;aspectRatio=1.33 70w, https://media.magloft.app/pdf-import/1110/images/pages/pg-005.jpg?optimizer=image&amp;format=webp&amp;width=82&amp;aspectRatio=1.33 82w, https://media.magloft.app/pdf-import/1110/images/pages/pg-005.jpg?optimizer=image&amp;format=webp&amp;width=96&amp;aspectRatio=1.33 96w, https://media.magloft.app/pdf-import/1110/images/pages/pg-005.jpg?optimizer=image&amp;format=webp&amp;width=96&amp;aspectRatio=1.33 96w, https://media.magloft.app/pdf-import/1110/images/pages/pg-005.jpg?optimizer=image&amp;format=webp&amp;width=110&amp;aspectRatio=1.33 110w, https://media.magloft.app/pdf-import/1110/images/pages/pg-005.jpg?optimizer=image&amp;format=webp&amp;width=128&amp;aspectRatio=1.33 128w, https://media.magloft.app/pdf-import/1110/images/pages/pg-005.jpg?optimizer=image&amp;format=webp&amp;width=128&amp;aspectRatio=1.33 128w, https://media.magloft.app/pdf-import/1110/images/pages/pg-005.jpg?optimizer=image&amp;format=webp&amp;width=138&amp;aspectRatio=1.33 138w, https://media.magloft.app/pdf-import/1110/images/pages/pg-005.jpg?optimizer=image&amp;format=webp&amp;width=192&amp;aspectRatio=1.33 192w, https://media.magloft.app/pdf-import/1110/images/pages/pg-005.jpg?optimizer=image&amp;format=webp&amp;width=200&amp;aspectRatio=1.33 200w, https://media.magloft.app/pdf-import/1110/images/pages/pg-005.jpg?optimizer=image&amp;format=webp&amp;width=252&amp;aspectRatio=1.33 252w, https://media.magloft.app/pdf-import/1110/images/pages/pg-005.jpg?optimizer=image&amp;format=webp&amp;width=256&amp;aspectRatio=1.33 256w, https://media.magloft.app/pdf-import/1110/images/pages/pg-005.jpg?optimizer=image&amp;format=webp&amp;width=260&amp;aspectRatio=1.33 260w, https://media.magloft.app/pdf-import/1110/images/pages/pg-005.jpg?optimizer=image&amp;format=webp&amp;width=298&amp;aspectRatio=1.33 298w, https://media.magloft.app/pdf-import/1110/images/pages/pg-005.jpg?optimizer=image&amp;format=webp&amp;width=378&amp;aspectRatio=1.33 378w, https://media.magloft.app/pdf-import/1110/images/pages/pg-005.jpg?optimizer=image&amp;format=webp&amp;width=384&amp;aspectRatio=1.33 384w, https://media.magloft.app/pdf-import/1110/images/pages/pg-005.jpg?optimizer=image&amp;format=webp&amp;width=384&amp;aspectRatio=1.33 384w, https://media.magloft.app/pdf-import/1110/images/pages/pg-005.jpg?optimizer=image&amp;format=webp&amp;width=520&amp;aspectRatio=1.33 520w, https://media.magloft.app/pdf-import/1110/images/pages/pg-005.jpg?optimizer=image&amp;format=webp&amp;width=640&amp;aspectRatio=1.33 640w, https://media.magloft.app/pdf-import/1110/images/pages/pg-005.jpg?optimizer=image&amp;format=webp&amp;width=756&amp;aspectRatio=1.33 756w, https://media.magloft.app/pdf-import/1110/images/pages/pg-005.jpg?optimizer=image&amp;format=webp&amp;width=828&amp;aspectRatio=1.33 828w, https://media.magloft.app/pdf-import/1110/images/pages/pg-005.jpg?optimizer=image&amp;format=webp&amp;width=1080&amp;aspectRatio=1.33 1080w, https://media.magloft.app/pdf-import/1110/images/pages/pg-005.jpg?optimizer=image&amp;format=webp&amp;width=1200&amp;aspectRatio=1.33 1200w, https://media.magloft.app/pdf-import/1110/images/pages/pg-005.jpg?optimizer=image&amp;format=webp&amp;width=1920&amp;aspectRatio=1.33 1920w, https://media.magloft.app/pdf-import/1110/images/pages/pg-005.jpg?optimizer=image&amp;format=webp&amp;width=2048&amp;aspectRatio=1.33 2048w" src="https://media.magloft.app/pdf-import/1110/images/pages/pg-005.jpg?optimizer=image&amp;format=webp&amp;width=2048&amp;aspectRatio=1.33"/></div><div class="Block_article-contents__M6B6V"><h3>First oral treatment for hormone-sensitive prostate cancer recommended by NICE</h3><p>Accord healthcare have recently announced that NICE have recommended the first oral androgen deprivation therapy (adt) treatment for hormone-sensitive prostate cancer. Prostate cancer is the most common cancer in men across the uk.</p></div></a><a class="Block_article-card__mncKE" href="/articles/verisense-announce-opening-of-digital-biobank"><div class="Block_article-cover__vLhzO"><img alt="article-category" loading="lazy" decoding="async" data-nimg="fill" style="position:absolute;height:100%;width:100%;left:0;top:0;right:0;bottom:0;color:transparent;background-size:cover;background-position:50% 50%;background-repeat:no-repeat;background-image:url(&quot;data:image/svg+xml;charset=utf-8,%3Csvg xmlns=&#x27;http%3A//www.w3.org/2000/svg&#x27;%3E%3Cimage style=&#x27;filter:blur(20px)&#x27; preserveAspectRatio=&#x27;none&#x27; x=&#x27;0&#x27; y=&#x27;0&#x27; height=&#x27;100%25&#x27; width=&#x27;100%25&#x27; href=&#x27;data:image/gif;base64,R0lGODlhAQABAPAAANzc3P///yH5BAAAAAAALAAAAAABAAEAAAICRAEAOw==&#x27;/%3E%3C/svg%3E&quot;)" sizes="70px" srcSet="https://media.magloft.app/pdf-import/1110/images/img_5-1.jpg?optimizer=image&amp;format=webp&amp;width=16&amp;aspectRatio=1.33 16w, https://media.magloft.app/pdf-import/1110/images/img_5-1.jpg?optimizer=image&amp;format=webp&amp;width=32&amp;aspectRatio=1.33 32w, https://media.magloft.app/pdf-import/1110/images/img_5-1.jpg?optimizer=image&amp;format=webp&amp;width=48&amp;aspectRatio=1.33 48w, https://media.magloft.app/pdf-import/1110/images/img_5-1.jpg?optimizer=image&amp;format=webp&amp;width=54&amp;aspectRatio=1.33 54w, https://media.magloft.app/pdf-import/1110/images/img_5-1.jpg?optimizer=image&amp;format=webp&amp;width=64&amp;aspectRatio=1.33 64w, https://media.magloft.app/pdf-import/1110/images/img_5-1.jpg?optimizer=image&amp;format=webp&amp;width=70&amp;aspectRatio=1.33 70w, https://media.magloft.app/pdf-import/1110/images/img_5-1.jpg?optimizer=image&amp;format=webp&amp;width=82&amp;aspectRatio=1.33 82w, https://media.magloft.app/pdf-import/1110/images/img_5-1.jpg?optimizer=image&amp;format=webp&amp;width=96&amp;aspectRatio=1.33 96w, https://media.magloft.app/pdf-import/1110/images/img_5-1.jpg?optimizer=image&amp;format=webp&amp;width=96&amp;aspectRatio=1.33 96w, https://media.magloft.app/pdf-import/1110/images/img_5-1.jpg?optimizer=image&amp;format=webp&amp;width=110&amp;aspectRatio=1.33 110w, https://media.magloft.app/pdf-import/1110/images/img_5-1.jpg?optimizer=image&amp;format=webp&amp;width=128&amp;aspectRatio=1.33 128w, https://media.magloft.app/pdf-import/1110/images/img_5-1.jpg?optimizer=image&amp;format=webp&amp;width=128&amp;aspectRatio=1.33 128w, https://media.magloft.app/pdf-import/1110/images/img_5-1.jpg?optimizer=image&amp;format=webp&amp;width=138&amp;aspectRatio=1.33 138w, https://media.magloft.app/pdf-import/1110/images/img_5-1.jpg?optimizer=image&amp;format=webp&amp;width=192&amp;aspectRatio=1.33 192w, https://media.magloft.app/pdf-import/1110/images/img_5-1.jpg?optimizer=image&amp;format=webp&amp;width=200&amp;aspectRatio=1.33 200w, https://media.magloft.app/pdf-import/1110/images/img_5-1.jpg?optimizer=image&amp;format=webp&amp;width=252&amp;aspectRatio=1.33 252w, https://media.magloft.app/pdf-import/1110/images/img_5-1.jpg?optimizer=image&amp;format=webp&amp;width=256&amp;aspectRatio=1.33 256w, https://media.magloft.app/pdf-import/1110/images/img_5-1.jpg?optimizer=image&amp;format=webp&amp;width=260&amp;aspectRatio=1.33 260w, https://media.magloft.app/pdf-import/1110/images/img_5-1.jpg?optimizer=image&amp;format=webp&amp;width=298&amp;aspectRatio=1.33 298w, https://media.magloft.app/pdf-import/1110/images/img_5-1.jpg?optimizer=image&amp;format=webp&amp;width=378&amp;aspectRatio=1.33 378w, https://media.magloft.app/pdf-import/1110/images/img_5-1.jpg?optimizer=image&amp;format=webp&amp;width=384&amp;aspectRatio=1.33 384w, https://media.magloft.app/pdf-import/1110/images/img_5-1.jpg?optimizer=image&amp;format=webp&amp;width=384&amp;aspectRatio=1.33 384w, https://media.magloft.app/pdf-import/1110/images/img_5-1.jpg?optimizer=image&amp;format=webp&amp;width=520&amp;aspectRatio=1.33 520w, https://media.magloft.app/pdf-import/1110/images/img_5-1.jpg?optimizer=image&amp;format=webp&amp;width=640&amp;aspectRatio=1.33 640w, https://media.magloft.app/pdf-import/1110/images/img_5-1.jpg?optimizer=image&amp;format=webp&amp;width=756&amp;aspectRatio=1.33 756w, https://media.magloft.app/pdf-import/1110/images/img_5-1.jpg?optimizer=image&amp;format=webp&amp;width=828&amp;aspectRatio=1.33 828w, https://media.magloft.app/pdf-import/1110/images/img_5-1.jpg?optimizer=image&amp;format=webp&amp;width=1080&amp;aspectRatio=1.33 1080w, https://media.magloft.app/pdf-import/1110/images/img_5-1.jpg?optimizer=image&amp;format=webp&amp;width=1200&amp;aspectRatio=1.33 1200w, https://media.magloft.app/pdf-import/1110/images/img_5-1.jpg?optimizer=image&amp;format=webp&amp;width=1920&amp;aspectRatio=1.33 1920w, https://media.magloft.app/pdf-import/1110/images/img_5-1.jpg?optimizer=image&amp;format=webp&amp;width=2048&amp;aspectRatio=1.33 2048w" src="https://media.magloft.app/pdf-import/1110/images/img_5-1.jpg?optimizer=image&amp;format=webp&amp;width=2048&amp;aspectRatio=1.33"/></div><div class="Block_article-contents__M6B6V"><h3>Verisense announce opening of Digital Biobank</h3><p>This month, Verisense have announced that their digital biobank, with data from over one million people, is open for business.</p></div></a><a class="Block_article-card__mncKE" href="/articles/positive-results-announced-for-levicept-s-moderate-to-severe-ost"><div class="Block_article-cover__vLhzO"><img alt="article-category" loading="lazy" decoding="async" data-nimg="fill" style="position:absolute;height:100%;width:100%;left:0;top:0;right:0;bottom:0;color:transparent;background-size:cover;background-position:50% 50%;background-repeat:no-repeat;background-image:url(&quot;data:image/svg+xml;charset=utf-8,%3Csvg xmlns=&#x27;http%3A//www.w3.org/2000/svg&#x27;%3E%3Cimage style=&#x27;filter:blur(20px)&#x27; preserveAspectRatio=&#x27;none&#x27; x=&#x27;0&#x27; y=&#x27;0&#x27; height=&#x27;100%25&#x27; width=&#x27;100%25&#x27; href=&#x27;data:image/gif;base64,R0lGODlhAQABAPAAANzc3P///yH5BAAAAAAALAAAAAABAAEAAAICRAEAOw==&#x27;/%3E%3C/svg%3E&quot;)" sizes="70px" srcSet="https://media.magloft.app/pdf-import/1110/images/img_6-1.jpg?optimizer=image&amp;format=webp&amp;width=16&amp;aspectRatio=1.33 16w, https://media.magloft.app/pdf-import/1110/images/img_6-1.jpg?optimizer=image&amp;format=webp&amp;width=32&amp;aspectRatio=1.33 32w, https://media.magloft.app/pdf-import/1110/images/img_6-1.jpg?optimizer=image&amp;format=webp&amp;width=48&amp;aspectRatio=1.33 48w, https://media.magloft.app/pdf-import/1110/images/img_6-1.jpg?optimizer=image&amp;format=webp&amp;width=54&amp;aspectRatio=1.33 54w, https://media.magloft.app/pdf-import/1110/images/img_6-1.jpg?optimizer=image&amp;format=webp&amp;width=64&amp;aspectRatio=1.33 64w, https://media.magloft.app/pdf-import/1110/images/img_6-1.jpg?optimizer=image&amp;format=webp&amp;width=70&amp;aspectRatio=1.33 70w, https://media.magloft.app/pdf-import/1110/images/img_6-1.jpg?optimizer=image&amp;format=webp&amp;width=82&amp;aspectRatio=1.33 82w, https://media.magloft.app/pdf-import/1110/images/img_6-1.jpg?optimizer=image&amp;format=webp&amp;width=96&amp;aspectRatio=1.33 96w, https://media.magloft.app/pdf-import/1110/images/img_6-1.jpg?optimizer=image&amp;format=webp&amp;width=96&amp;aspectRatio=1.33 96w, https://media.magloft.app/pdf-import/1110/images/img_6-1.jpg?optimizer=image&amp;format=webp&amp;width=110&amp;aspectRatio=1.33 110w, https://media.magloft.app/pdf-import/1110/images/img_6-1.jpg?optimizer=image&amp;format=webp&amp;width=128&amp;aspectRatio=1.33 128w, https://media.magloft.app/pdf-import/1110/images/img_6-1.jpg?optimizer=image&amp;format=webp&amp;width=128&amp;aspectRatio=1.33 128w, https://media.magloft.app/pdf-import/1110/images/img_6-1.jpg?optimizer=image&amp;format=webp&amp;width=138&amp;aspectRatio=1.33 138w, https://media.magloft.app/pdf-import/1110/images/img_6-1.jpg?optimizer=image&amp;format=webp&amp;width=192&amp;aspectRatio=1.33 192w, https://media.magloft.app/pdf-import/1110/images/img_6-1.jpg?optimizer=image&amp;format=webp&amp;width=200&amp;aspectRatio=1.33 200w, https://media.magloft.app/pdf-import/1110/images/img_6-1.jpg?optimizer=image&amp;format=webp&amp;width=252&amp;aspectRatio=1.33 252w, https://media.magloft.app/pdf-import/1110/images/img_6-1.jpg?optimizer=image&amp;format=webp&amp;width=256&amp;aspectRatio=1.33 256w, https://media.magloft.app/pdf-import/1110/images/img_6-1.jpg?optimizer=image&amp;format=webp&amp;width=260&amp;aspectRatio=1.33 260w, https://media.magloft.app/pdf-import/1110/images/img_6-1.jpg?optimizer=image&amp;format=webp&amp;width=298&amp;aspectRatio=1.33 298w, https://media.magloft.app/pdf-import/1110/images/img_6-1.jpg?optimizer=image&amp;format=webp&amp;width=378&amp;aspectRatio=1.33 378w, https://media.magloft.app/pdf-import/1110/images/img_6-1.jpg?optimizer=image&amp;format=webp&amp;width=384&amp;aspectRatio=1.33 384w, https://media.magloft.app/pdf-import/1110/images/img_6-1.jpg?optimizer=image&amp;format=webp&amp;width=384&amp;aspectRatio=1.33 384w, https://media.magloft.app/pdf-import/1110/images/img_6-1.jpg?optimizer=image&amp;format=webp&amp;width=520&amp;aspectRatio=1.33 520w, https://media.magloft.app/pdf-import/1110/images/img_6-1.jpg?optimizer=image&amp;format=webp&amp;width=640&amp;aspectRatio=1.33 640w, https://media.magloft.app/pdf-import/1110/images/img_6-1.jpg?optimizer=image&amp;format=webp&amp;width=756&amp;aspectRatio=1.33 756w, https://media.magloft.app/pdf-import/1110/images/img_6-1.jpg?optimizer=image&amp;format=webp&amp;width=828&amp;aspectRatio=1.33 828w, https://media.magloft.app/pdf-import/1110/images/img_6-1.jpg?optimizer=image&amp;format=webp&amp;width=1080&amp;aspectRatio=1.33 1080w, https://media.magloft.app/pdf-import/1110/images/img_6-1.jpg?optimizer=image&amp;format=webp&amp;width=1200&amp;aspectRatio=1.33 1200w, https://media.magloft.app/pdf-import/1110/images/img_6-1.jpg?optimizer=image&amp;format=webp&amp;width=1920&amp;aspectRatio=1.33 1920w, https://media.magloft.app/pdf-import/1110/images/img_6-1.jpg?optimizer=image&amp;format=webp&amp;width=2048&amp;aspectRatio=1.33 2048w" src="https://media.magloft.app/pdf-import/1110/images/img_6-1.jpg?optimizer=image&amp;format=webp&amp;width=2048&amp;aspectRatio=1.33"/></div><div class="Block_article-contents__M6B6V"><h3>Positive results announced for Levicept’s moderate-to-severe osteoarthritis treatment</h3><p>Biotechnology company Levicept has announced positive results from its phase 2 trial into levi-04 for the treatment of osteoarthritis.</p></div></a><a class="Block_article-card__mncKE" href="/articles/calliditas-therapeutics-announces-positive-phase-2b-data-in-prim"><div class="Block_article-cover__vLhzO"><img alt="article-category" loading="lazy" decoding="async" data-nimg="fill" style="position:absolute;height:100%;width:100%;left:0;top:0;right:0;bottom:0;color:transparent;background-size:cover;background-position:50% 50%;background-repeat:no-repeat;background-image:url(&quot;data:image/svg+xml;charset=utf-8,%3Csvg xmlns=&#x27;http%3A//www.w3.org/2000/svg&#x27;%3E%3Cimage style=&#x27;filter:blur(20px)&#x27; preserveAspectRatio=&#x27;none&#x27; x=&#x27;0&#x27; y=&#x27;0&#x27; height=&#x27;100%25&#x27; width=&#x27;100%25&#x27; href=&#x27;data:image/gif;base64,R0lGODlhAQABAPAAANzc3P///yH5BAAAAAAALAAAAAABAAEAAAICRAEAOw==&#x27;/%3E%3C/svg%3E&quot;)" sizes="70px" srcSet="https://media.magloft.app/pdf-import/1110/images/pages/pg-007.jpg?optimizer=image&amp;format=webp&amp;width=16&amp;aspectRatio=1.33 16w, https://media.magloft.app/pdf-import/1110/images/pages/pg-007.jpg?optimizer=image&amp;format=webp&amp;width=32&amp;aspectRatio=1.33 32w, https://media.magloft.app/pdf-import/1110/images/pages/pg-007.jpg?optimizer=image&amp;format=webp&amp;width=48&amp;aspectRatio=1.33 48w, https://media.magloft.app/pdf-import/1110/images/pages/pg-007.jpg?optimizer=image&amp;format=webp&amp;width=54&amp;aspectRatio=1.33 54w, https://media.magloft.app/pdf-import/1110/images/pages/pg-007.jpg?optimizer=image&amp;format=webp&amp;width=64&amp;aspectRatio=1.33 64w, https://media.magloft.app/pdf-import/1110/images/pages/pg-007.jpg?optimizer=image&amp;format=webp&amp;width=70&amp;aspectRatio=1.33 70w, https://media.magloft.app/pdf-import/1110/images/pages/pg-007.jpg?optimizer=image&amp;format=webp&amp;width=82&amp;aspectRatio=1.33 82w, https://media.magloft.app/pdf-import/1110/images/pages/pg-007.jpg?optimizer=image&amp;format=webp&amp;width=96&amp;aspectRatio=1.33 96w, https://media.magloft.app/pdf-import/1110/images/pages/pg-007.jpg?optimizer=image&amp;format=webp&amp;width=96&amp;aspectRatio=1.33 96w, https://media.magloft.app/pdf-import/1110/images/pages/pg-007.jpg?optimizer=image&amp;format=webp&amp;width=110&amp;aspectRatio=1.33 110w, https://media.magloft.app/pdf-import/1110/images/pages/pg-007.jpg?optimizer=image&amp;format=webp&amp;width=128&amp;aspectRatio=1.33 128w, https://media.magloft.app/pdf-import/1110/images/pages/pg-007.jpg?optimizer=image&amp;format=webp&amp;width=128&amp;aspectRatio=1.33 128w, https://media.magloft.app/pdf-import/1110/images/pages/pg-007.jpg?optimizer=image&amp;format=webp&amp;width=138&amp;aspectRatio=1.33 138w, https://media.magloft.app/pdf-import/1110/images/pages/pg-007.jpg?optimizer=image&amp;format=webp&amp;width=192&amp;aspectRatio=1.33 192w, https://media.magloft.app/pdf-import/1110/images/pages/pg-007.jpg?optimizer=image&amp;format=webp&amp;width=200&amp;aspectRatio=1.33 200w, https://media.magloft.app/pdf-import/1110/images/pages/pg-007.jpg?optimizer=image&amp;format=webp&amp;width=252&amp;aspectRatio=1.33 252w, https://media.magloft.app/pdf-import/1110/images/pages/pg-007.jpg?optimizer=image&amp;format=webp&amp;width=256&amp;aspectRatio=1.33 256w, https://media.magloft.app/pdf-import/1110/images/pages/pg-007.jpg?optimizer=image&amp;format=webp&amp;width=260&amp;aspectRatio=1.33 260w, https://media.magloft.app/pdf-import/1110/images/pages/pg-007.jpg?optimizer=image&amp;format=webp&amp;width=298&amp;aspectRatio=1.33 298w, https://media.magloft.app/pdf-import/1110/images/pages/pg-007.jpg?optimizer=image&amp;format=webp&amp;width=378&amp;aspectRatio=1.33 378w, https://media.magloft.app/pdf-import/1110/images/pages/pg-007.jpg?optimizer=image&amp;format=webp&amp;width=384&amp;aspectRatio=1.33 384w, https://media.magloft.app/pdf-import/1110/images/pages/pg-007.jpg?optimizer=image&amp;format=webp&amp;width=384&amp;aspectRatio=1.33 384w, https://media.magloft.app/pdf-import/1110/images/pages/pg-007.jpg?optimizer=image&amp;format=webp&amp;width=520&amp;aspectRatio=1.33 520w, https://media.magloft.app/pdf-import/1110/images/pages/pg-007.jpg?optimizer=image&amp;format=webp&amp;width=640&amp;aspectRatio=1.33 640w, https://media.magloft.app/pdf-import/1110/images/pages/pg-007.jpg?optimizer=image&amp;format=webp&amp;width=756&amp;aspectRatio=1.33 756w, https://media.magloft.app/pdf-import/1110/images/pages/pg-007.jpg?optimizer=image&amp;format=webp&amp;width=828&amp;aspectRatio=1.33 828w, https://media.magloft.app/pdf-import/1110/images/pages/pg-007.jpg?optimizer=image&amp;format=webp&amp;width=1080&amp;aspectRatio=1.33 1080w, https://media.magloft.app/pdf-import/1110/images/pages/pg-007.jpg?optimizer=image&amp;format=webp&amp;width=1200&amp;aspectRatio=1.33 1200w, https://media.magloft.app/pdf-import/1110/images/pages/pg-007.jpg?optimizer=image&amp;format=webp&amp;width=1920&amp;aspectRatio=1.33 1920w, https://media.magloft.app/pdf-import/1110/images/pages/pg-007.jpg?optimizer=image&amp;format=webp&amp;width=2048&amp;aspectRatio=1.33 2048w" src="https://media.magloft.app/pdf-import/1110/images/pages/pg-007.jpg?optimizer=image&amp;format=webp&amp;width=2048&amp;aspectRatio=1.33"/></div><div class="Block_article-contents__M6B6V"><h3>Calliditas Therapeutics announces positive phase 2b data in Primary Biliary Cholangitis trial</h3><p>Calliditas therapeutics ab has recently announced that the phase 2b transform trial met its primary endpoint. The trial showed statistically significant improvement in alkaline phosphatase (alp) for both doses tested versus placebo. the trial evaluated setanaxib, a nox enzyme inhibitor, in patients with primary biliary cholangitis (pbc) and elevated liver stiffness.</p></div></a><a class="Block_article-card__mncKE" href="/articles/chmp-gives-positive-opinion-for-merck-s-keytruda-for-unresectabl"><div class="Block_article-cover__vLhzO"><img alt="article-category" loading="lazy" decoding="async" data-nimg="fill" style="position:absolute;height:100%;width:100%;left:0;top:0;right:0;bottom:0;color:transparent;background-size:cover;background-position:50% 50%;background-repeat:no-repeat;background-image:url(&quot;data:image/svg+xml;charset=utf-8,%3Csvg xmlns=&#x27;http%3A//www.w3.org/2000/svg&#x27;%3E%3Cimage style=&#x27;filter:blur(20px)&#x27; preserveAspectRatio=&#x27;none&#x27; x=&#x27;0&#x27; y=&#x27;0&#x27; height=&#x27;100%25&#x27; width=&#x27;100%25&#x27; href=&#x27;data:image/gif;base64,R0lGODlhAQABAPAAANzc3P///yH5BAAAAAAALAAAAAABAAEAAAICRAEAOw==&#x27;/%3E%3C/svg%3E&quot;)" sizes="70px" srcSet="https://media.magloft.app/pdf-import/1110/images/img_7-1.jpg?optimizer=image&amp;format=webp&amp;width=16&amp;aspectRatio=1.33 16w, https://media.magloft.app/pdf-import/1110/images/img_7-1.jpg?optimizer=image&amp;format=webp&amp;width=32&amp;aspectRatio=1.33 32w, https://media.magloft.app/pdf-import/1110/images/img_7-1.jpg?optimizer=image&amp;format=webp&amp;width=48&amp;aspectRatio=1.33 48w, https://media.magloft.app/pdf-import/1110/images/img_7-1.jpg?optimizer=image&amp;format=webp&amp;width=54&amp;aspectRatio=1.33 54w, https://media.magloft.app/pdf-import/1110/images/img_7-1.jpg?optimizer=image&amp;format=webp&amp;width=64&amp;aspectRatio=1.33 64w, https://media.magloft.app/pdf-import/1110/images/img_7-1.jpg?optimizer=image&amp;format=webp&amp;width=70&amp;aspectRatio=1.33 70w, https://media.magloft.app/pdf-import/1110/images/img_7-1.jpg?optimizer=image&amp;format=webp&amp;width=82&amp;aspectRatio=1.33 82w, https://media.magloft.app/pdf-import/1110/images/img_7-1.jpg?optimizer=image&amp;format=webp&amp;width=96&amp;aspectRatio=1.33 96w, https://media.magloft.app/pdf-import/1110/images/img_7-1.jpg?optimizer=image&amp;format=webp&amp;width=96&amp;aspectRatio=1.33 96w, https://media.magloft.app/pdf-import/1110/images/img_7-1.jpg?optimizer=image&amp;format=webp&amp;width=110&amp;aspectRatio=1.33 110w, https://media.magloft.app/pdf-import/1110/images/img_7-1.jpg?optimizer=image&amp;format=webp&amp;width=128&amp;aspectRatio=1.33 128w, https://media.magloft.app/pdf-import/1110/images/img_7-1.jpg?optimizer=image&amp;format=webp&amp;width=128&amp;aspectRatio=1.33 128w, https://media.magloft.app/pdf-import/1110/images/img_7-1.jpg?optimizer=image&amp;format=webp&amp;width=138&amp;aspectRatio=1.33 138w, https://media.magloft.app/pdf-import/1110/images/img_7-1.jpg?optimizer=image&amp;format=webp&amp;width=192&amp;aspectRatio=1.33 192w, https://media.magloft.app/pdf-import/1110/images/img_7-1.jpg?optimizer=image&amp;format=webp&amp;width=200&amp;aspectRatio=1.33 200w, https://media.magloft.app/pdf-import/1110/images/img_7-1.jpg?optimizer=image&amp;format=webp&amp;width=252&amp;aspectRatio=1.33 252w, https://media.magloft.app/pdf-import/1110/images/img_7-1.jpg?optimizer=image&amp;format=webp&amp;width=256&amp;aspectRatio=1.33 256w, https://media.magloft.app/pdf-import/1110/images/img_7-1.jpg?optimizer=image&amp;format=webp&amp;width=260&amp;aspectRatio=1.33 260w, https://media.magloft.app/pdf-import/1110/images/img_7-1.jpg?optimizer=image&amp;format=webp&amp;width=298&amp;aspectRatio=1.33 298w, https://media.magloft.app/pdf-import/1110/images/img_7-1.jpg?optimizer=image&amp;format=webp&amp;width=378&amp;aspectRatio=1.33 378w, https://media.magloft.app/pdf-import/1110/images/img_7-1.jpg?optimizer=image&amp;format=webp&amp;width=384&amp;aspectRatio=1.33 384w, https://media.magloft.app/pdf-import/1110/images/img_7-1.jpg?optimizer=image&amp;format=webp&amp;width=384&amp;aspectRatio=1.33 384w, https://media.magloft.app/pdf-import/1110/images/img_7-1.jpg?optimizer=image&amp;format=webp&amp;width=520&amp;aspectRatio=1.33 520w, https://media.magloft.app/pdf-import/1110/images/img_7-1.jpg?optimizer=image&amp;format=webp&amp;width=640&amp;aspectRatio=1.33 640w, https://media.magloft.app/pdf-import/1110/images/img_7-1.jpg?optimizer=image&amp;format=webp&amp;width=756&amp;aspectRatio=1.33 756w, https://media.magloft.app/pdf-import/1110/images/img_7-1.jpg?optimizer=image&amp;format=webp&amp;width=828&amp;aspectRatio=1.33 828w, https://media.magloft.app/pdf-import/1110/images/img_7-1.jpg?optimizer=image&amp;format=webp&amp;width=1080&amp;aspectRatio=1.33 1080w, https://media.magloft.app/pdf-import/1110/images/img_7-1.jpg?optimizer=image&amp;format=webp&amp;width=1200&amp;aspectRatio=1.33 1200w, https://media.magloft.app/pdf-import/1110/images/img_7-1.jpg?optimizer=image&amp;format=webp&amp;width=1920&amp;aspectRatio=1.33 1920w, https://media.magloft.app/pdf-import/1110/images/img_7-1.jpg?optimizer=image&amp;format=webp&amp;width=2048&amp;aspectRatio=1.33 2048w" src="https://media.magloft.app/pdf-import/1110/images/img_7-1.jpg?optimizer=image&amp;format=webp&amp;width=2048&amp;aspectRatio=1.33"/></div><div class="Block_article-contents__M6B6V"><h3>CHMP gives positive opinion for Merck’s KEYTRUDA for unresectable or metastatic urothelial carcinoma</h3><p>Merck (known as MSDoutside of the US and Canada) has announced that its anti-pd-1 therapy, in combination with padcev (enfortuman vedotin-ejfv), has received a positive opinion from the European Medicines Agency (EMA)</p></div></a><a class="Block_article-card__mncKE" href="/articles/clinical-trials-for-personalised-cancer-vaccine-used-to-tackle-a"><div class="Block_article-cover__vLhzO"><img alt="article-category" loading="lazy" decoding="async" data-nimg="fill" style="position:absolute;height:100%;width:100%;left:0;top:0;right:0;bottom:0;color:transparent;background-size:cover;background-position:50% 50%;background-repeat:no-repeat;background-image:url(&quot;data:image/svg+xml;charset=utf-8,%3Csvg xmlns=&#x27;http%3A//www.w3.org/2000/svg&#x27;%3E%3Cimage style=&#x27;filter:blur(20px)&#x27; preserveAspectRatio=&#x27;none&#x27; x=&#x27;0&#x27; y=&#x27;0&#x27; height=&#x27;100%25&#x27; width=&#x27;100%25&#x27; href=&#x27;data:image/gif;base64,R0lGODlhAQABAPAAANzc3P///yH5BAAAAAAALAAAAAABAAEAAAICRAEAOw==&#x27;/%3E%3C/svg%3E&quot;)" sizes="70px" srcSet="https://media.magloft.app/pdf-import/1110/images/img_6-2.jpg?optimizer=image&amp;format=webp&amp;width=16&amp;aspectRatio=1.33 16w, https://media.magloft.app/pdf-import/1110/images/img_6-2.jpg?optimizer=image&amp;format=webp&amp;width=32&amp;aspectRatio=1.33 32w, https://media.magloft.app/pdf-import/1110/images/img_6-2.jpg?optimizer=image&amp;format=webp&amp;width=48&amp;aspectRatio=1.33 48w, https://media.magloft.app/pdf-import/1110/images/img_6-2.jpg?optimizer=image&amp;format=webp&amp;width=54&amp;aspectRatio=1.33 54w, https://media.magloft.app/pdf-import/1110/images/img_6-2.jpg?optimizer=image&amp;format=webp&amp;width=64&amp;aspectRatio=1.33 64w, https://media.magloft.app/pdf-import/1110/images/img_6-2.jpg?optimizer=image&amp;format=webp&amp;width=70&amp;aspectRatio=1.33 70w, https://media.magloft.app/pdf-import/1110/images/img_6-2.jpg?optimizer=image&amp;format=webp&amp;width=82&amp;aspectRatio=1.33 82w, https://media.magloft.app/pdf-import/1110/images/img_6-2.jpg?optimizer=image&amp;format=webp&amp;width=96&amp;aspectRatio=1.33 96w, https://media.magloft.app/pdf-import/1110/images/img_6-2.jpg?optimizer=image&amp;format=webp&amp;width=96&amp;aspectRatio=1.33 96w, https://media.magloft.app/pdf-import/1110/images/img_6-2.jpg?optimizer=image&amp;format=webp&amp;width=110&amp;aspectRatio=1.33 110w, https://media.magloft.app/pdf-import/1110/images/img_6-2.jpg?optimizer=image&amp;format=webp&amp;width=128&amp;aspectRatio=1.33 128w, https://media.magloft.app/pdf-import/1110/images/img_6-2.jpg?optimizer=image&amp;format=webp&amp;width=128&amp;aspectRatio=1.33 128w, https://media.magloft.app/pdf-import/1110/images/img_6-2.jpg?optimizer=image&amp;format=webp&amp;width=138&amp;aspectRatio=1.33 138w, https://media.magloft.app/pdf-import/1110/images/img_6-2.jpg?optimizer=image&amp;format=webp&amp;width=192&amp;aspectRatio=1.33 192w, https://media.magloft.app/pdf-import/1110/images/img_6-2.jpg?optimizer=image&amp;format=webp&amp;width=200&amp;aspectRatio=1.33 200w, https://media.magloft.app/pdf-import/1110/images/img_6-2.jpg?optimizer=image&amp;format=webp&amp;width=252&amp;aspectRatio=1.33 252w, https://media.magloft.app/pdf-import/1110/images/img_6-2.jpg?optimizer=image&amp;format=webp&amp;width=256&amp;aspectRatio=1.33 256w, https://media.magloft.app/pdf-import/1110/images/img_6-2.jpg?optimizer=image&amp;format=webp&amp;width=260&amp;aspectRatio=1.33 260w, https://media.magloft.app/pdf-import/1110/images/img_6-2.jpg?optimizer=image&amp;format=webp&amp;width=298&amp;aspectRatio=1.33 298w, https://media.magloft.app/pdf-import/1110/images/img_6-2.jpg?optimizer=image&amp;format=webp&amp;width=378&amp;aspectRatio=1.33 378w, https://media.magloft.app/pdf-import/1110/images/img_6-2.jpg?optimizer=image&amp;format=webp&amp;width=384&amp;aspectRatio=1.33 384w, https://media.magloft.app/pdf-import/1110/images/img_6-2.jpg?optimizer=image&amp;format=webp&amp;width=384&amp;aspectRatio=1.33 384w, https://media.magloft.app/pdf-import/1110/images/img_6-2.jpg?optimizer=image&amp;format=webp&amp;width=520&amp;aspectRatio=1.33 520w, https://media.magloft.app/pdf-import/1110/images/img_6-2.jpg?optimizer=image&amp;format=webp&amp;width=640&amp;aspectRatio=1.33 640w, https://media.magloft.app/pdf-import/1110/images/img_6-2.jpg?optimizer=image&amp;format=webp&amp;width=756&amp;aspectRatio=1.33 756w, https://media.magloft.app/pdf-import/1110/images/img_6-2.jpg?optimizer=image&amp;format=webp&amp;width=828&amp;aspectRatio=1.33 828w, https://media.magloft.app/pdf-import/1110/images/img_6-2.jpg?optimizer=image&amp;format=webp&amp;width=1080&amp;aspectRatio=1.33 1080w, https://media.magloft.app/pdf-import/1110/images/img_6-2.jpg?optimizer=image&amp;format=webp&amp;width=1200&amp;aspectRatio=1.33 1200w, https://media.magloft.app/pdf-import/1110/images/img_6-2.jpg?optimizer=image&amp;format=webp&amp;width=1920&amp;aspectRatio=1.33 1920w, https://media.magloft.app/pdf-import/1110/images/img_6-2.jpg?optimizer=image&amp;format=webp&amp;width=2048&amp;aspectRatio=1.33 2048w" src="https://media.magloft.app/pdf-import/1110/images/img_6-2.jpg?optimizer=image&amp;format=webp&amp;width=2048&amp;aspectRatio=1.33"/></div><div class="Block_article-contents__M6B6V"><h3>Clinical trials for personalised cancer vaccine used to tackle aggressive brain tumours in young</h3><p>Researchers at the UCLA Health jonsson comprehensive cancer center have announced that they are launching a first-of-its-kind clinical trial to evaluate the safety and effectiveness of a cancer vaccine. The vaccine targets h3 g34-mutant diffuse hemispheric glioma, an aggressive brain tumour typically found in adolescents and young people.</p></div></a><a class="Block_article-card__mncKE" href="/articles/the-national-institute-for-health-and-care-excellence-announce-t"><div class="Block_article-cover__vLhzO"><img alt="article-category" loading="lazy" decoding="async" data-nimg="fill" style="position:absolute;height:100%;width:100%;left:0;top:0;right:0;bottom:0;color:transparent;background-size:cover;background-position:50% 50%;background-repeat:no-repeat;background-image:url(&quot;data:image/svg+xml;charset=utf-8,%3Csvg xmlns=&#x27;http%3A//www.w3.org/2000/svg&#x27;%3E%3Cimage style=&#x27;filter:blur(20px)&#x27; preserveAspectRatio=&#x27;none&#x27; x=&#x27;0&#x27; y=&#x27;0&#x27; height=&#x27;100%25&#x27; width=&#x27;100%25&#x27; href=&#x27;data:image/gif;base64,R0lGODlhAQABAPAAANzc3P///yH5BAAAAAAALAAAAAABAAEAAAICRAEAOw==&#x27;/%3E%3C/svg%3E&quot;)" sizes="70px" srcSet="https://media.magloft.app/pdf-import/1110/images/pages/pg-008.jpg?optimizer=image&amp;format=webp&amp;width=16&amp;aspectRatio=1.33 16w, https://media.magloft.app/pdf-import/1110/images/pages/pg-008.jpg?optimizer=image&amp;format=webp&amp;width=32&amp;aspectRatio=1.33 32w, https://media.magloft.app/pdf-import/1110/images/pages/pg-008.jpg?optimizer=image&amp;format=webp&amp;width=48&amp;aspectRatio=1.33 48w, https://media.magloft.app/pdf-import/1110/images/pages/pg-008.jpg?optimizer=image&amp;format=webp&amp;width=54&amp;aspectRatio=1.33 54w, https://media.magloft.app/pdf-import/1110/images/pages/pg-008.jpg?optimizer=image&amp;format=webp&amp;width=64&amp;aspectRatio=1.33 64w, https://media.magloft.app/pdf-import/1110/images/pages/pg-008.jpg?optimizer=image&amp;format=webp&amp;width=70&amp;aspectRatio=1.33 70w, https://media.magloft.app/pdf-import/1110/images/pages/pg-008.jpg?optimizer=image&amp;format=webp&amp;width=82&amp;aspectRatio=1.33 82w, https://media.magloft.app/pdf-import/1110/images/pages/pg-008.jpg?optimizer=image&amp;format=webp&amp;width=96&amp;aspectRatio=1.33 96w, https://media.magloft.app/pdf-import/1110/images/pages/pg-008.jpg?optimizer=image&amp;format=webp&amp;width=96&amp;aspectRatio=1.33 96w, https://media.magloft.app/pdf-import/1110/images/pages/pg-008.jpg?optimizer=image&amp;format=webp&amp;width=110&amp;aspectRatio=1.33 110w, https://media.magloft.app/pdf-import/1110/images/pages/pg-008.jpg?optimizer=image&amp;format=webp&amp;width=128&amp;aspectRatio=1.33 128w, https://media.magloft.app/pdf-import/1110/images/pages/pg-008.jpg?optimizer=image&amp;format=webp&amp;width=128&amp;aspectRatio=1.33 128w, https://media.magloft.app/pdf-import/1110/images/pages/pg-008.jpg?optimizer=image&amp;format=webp&amp;width=138&amp;aspectRatio=1.33 138w, https://media.magloft.app/pdf-import/1110/images/pages/pg-008.jpg?optimizer=image&amp;format=webp&amp;width=192&amp;aspectRatio=1.33 192w, https://media.magloft.app/pdf-import/1110/images/pages/pg-008.jpg?optimizer=image&amp;format=webp&amp;width=200&amp;aspectRatio=1.33 200w, https://media.magloft.app/pdf-import/1110/images/pages/pg-008.jpg?optimizer=image&amp;format=webp&amp;width=252&amp;aspectRatio=1.33 252w, https://media.magloft.app/pdf-import/1110/images/pages/pg-008.jpg?optimizer=image&amp;format=webp&amp;width=256&amp;aspectRatio=1.33 256w, https://media.magloft.app/pdf-import/1110/images/pages/pg-008.jpg?optimizer=image&amp;format=webp&amp;width=260&amp;aspectRatio=1.33 260w, https://media.magloft.app/pdf-import/1110/images/pages/pg-008.jpg?optimizer=image&amp;format=webp&amp;width=298&amp;aspectRatio=1.33 298w, https://media.magloft.app/pdf-import/1110/images/pages/pg-008.jpg?optimizer=image&amp;format=webp&amp;width=378&amp;aspectRatio=1.33 378w, https://media.magloft.app/pdf-import/1110/images/pages/pg-008.jpg?optimizer=image&amp;format=webp&amp;width=384&amp;aspectRatio=1.33 384w, https://media.magloft.app/pdf-import/1110/images/pages/pg-008.jpg?optimizer=image&amp;format=webp&amp;width=384&amp;aspectRatio=1.33 384w, https://media.magloft.app/pdf-import/1110/images/pages/pg-008.jpg?optimizer=image&amp;format=webp&amp;width=520&amp;aspectRatio=1.33 520w, https://media.magloft.app/pdf-import/1110/images/pages/pg-008.jpg?optimizer=image&amp;format=webp&amp;width=640&amp;aspectRatio=1.33 640w, https://media.magloft.app/pdf-import/1110/images/pages/pg-008.jpg?optimizer=image&amp;format=webp&amp;width=756&amp;aspectRatio=1.33 756w, https://media.magloft.app/pdf-import/1110/images/pages/pg-008.jpg?optimizer=image&amp;format=webp&amp;width=828&amp;aspectRatio=1.33 828w, https://media.magloft.app/pdf-import/1110/images/pages/pg-008.jpg?optimizer=image&amp;format=webp&amp;width=1080&amp;aspectRatio=1.33 1080w, https://media.magloft.app/pdf-import/1110/images/pages/pg-008.jpg?optimizer=image&amp;format=webp&amp;width=1200&amp;aspectRatio=1.33 1200w, https://media.magloft.app/pdf-import/1110/images/pages/pg-008.jpg?optimizer=image&amp;format=webp&amp;width=1920&amp;aspectRatio=1.33 1920w, https://media.magloft.app/pdf-import/1110/images/pages/pg-008.jpg?optimizer=image&amp;format=webp&amp;width=2048&amp;aspectRatio=1.33 2048w" src="https://media.magloft.app/pdf-import/1110/images/pages/pg-008.jpg?optimizer=image&amp;format=webp&amp;width=2048&amp;aspectRatio=1.33"/></div><div class="Block_article-contents__M6B6V"><h3>The National Institute for Health and Care Excellence announce technology appraisal guidance</h3><p>The National Institute for Health and Care excellence (NICE) have recommended adult patients in England or Wales with moderately or severely active ulcerative colitis (uc) who have not responded well to or cannot tolerate conventional or biological therapy including a tumour necrosis factor (tnf) alpha inhibitor the option of skyrizi (risankizumab).</p></div></a><a class="Block_article-card__mncKE" href="/articles/european-commission-approves-combination-chemotherapy-for-treatm"><div class="Block_article-cover__vLhzO"><img alt="article-category" loading="lazy" decoding="async" data-nimg="fill" style="position:absolute;height:100%;width:100%;left:0;top:0;right:0;bottom:0;color:transparent;background-size:cover;background-position:50% 50%;background-repeat:no-repeat;background-image:url(&quot;data:image/svg+xml;charset=utf-8,%3Csvg xmlns=&#x27;http%3A//www.w3.org/2000/svg&#x27;%3E%3Cimage style=&#x27;filter:blur(20px)&#x27; preserveAspectRatio=&#x27;none&#x27; x=&#x27;0&#x27; y=&#x27;0&#x27; height=&#x27;100%25&#x27; width=&#x27;100%25&#x27; href=&#x27;data:image/gif;base64,R0lGODlhAQABAPAAANzc3P///yH5BAAAAAAALAAAAAABAAEAAAICRAEAOw==&#x27;/%3E%3C/svg%3E&quot;)" sizes="70px" srcSet="https://media.magloft.app/pdf-import/1110/images/pages/pg-009.jpg?optimizer=image&amp;format=webp&amp;width=16&amp;aspectRatio=1.33 16w, https://media.magloft.app/pdf-import/1110/images/pages/pg-009.jpg?optimizer=image&amp;format=webp&amp;width=32&amp;aspectRatio=1.33 32w, https://media.magloft.app/pdf-import/1110/images/pages/pg-009.jpg?optimizer=image&amp;format=webp&amp;width=48&amp;aspectRatio=1.33 48w, https://media.magloft.app/pdf-import/1110/images/pages/pg-009.jpg?optimizer=image&amp;format=webp&amp;width=54&amp;aspectRatio=1.33 54w, https://media.magloft.app/pdf-import/1110/images/pages/pg-009.jpg?optimizer=image&amp;format=webp&amp;width=64&amp;aspectRatio=1.33 64w, https://media.magloft.app/pdf-import/1110/images/pages/pg-009.jpg?optimizer=image&amp;format=webp&amp;width=70&amp;aspectRatio=1.33 70w, https://media.magloft.app/pdf-import/1110/images/pages/pg-009.jpg?optimizer=image&amp;format=webp&amp;width=82&amp;aspectRatio=1.33 82w, https://media.magloft.app/pdf-import/1110/images/pages/pg-009.jpg?optimizer=image&amp;format=webp&amp;width=96&amp;aspectRatio=1.33 96w, https://media.magloft.app/pdf-import/1110/images/pages/pg-009.jpg?optimizer=image&amp;format=webp&amp;width=96&amp;aspectRatio=1.33 96w, https://media.magloft.app/pdf-import/1110/images/pages/pg-009.jpg?optimizer=image&amp;format=webp&amp;width=110&amp;aspectRatio=1.33 110w, https://media.magloft.app/pdf-import/1110/images/pages/pg-009.jpg?optimizer=image&amp;format=webp&amp;width=128&amp;aspectRatio=1.33 128w, https://media.magloft.app/pdf-import/1110/images/pages/pg-009.jpg?optimizer=image&amp;format=webp&amp;width=128&amp;aspectRatio=1.33 128w, https://media.magloft.app/pdf-import/1110/images/pages/pg-009.jpg?optimizer=image&amp;format=webp&amp;width=138&amp;aspectRatio=1.33 138w, https://media.magloft.app/pdf-import/1110/images/pages/pg-009.jpg?optimizer=image&amp;format=webp&amp;width=192&amp;aspectRatio=1.33 192w, https://media.magloft.app/pdf-import/1110/images/pages/pg-009.jpg?optimizer=image&amp;format=webp&amp;width=200&amp;aspectRatio=1.33 200w, https://media.magloft.app/pdf-import/1110/images/pages/pg-009.jpg?optimizer=image&amp;format=webp&amp;width=252&amp;aspectRatio=1.33 252w, https://media.magloft.app/pdf-import/1110/images/pages/pg-009.jpg?optimizer=image&amp;format=webp&amp;width=256&amp;aspectRatio=1.33 256w, https://media.magloft.app/pdf-import/1110/images/pages/pg-009.jpg?optimizer=image&amp;format=webp&amp;width=260&amp;aspectRatio=1.33 260w, https://media.magloft.app/pdf-import/1110/images/pages/pg-009.jpg?optimizer=image&amp;format=webp&amp;width=298&amp;aspectRatio=1.33 298w, https://media.magloft.app/pdf-import/1110/images/pages/pg-009.jpg?optimizer=image&amp;format=webp&amp;width=378&amp;aspectRatio=1.33 378w, https://media.magloft.app/pdf-import/1110/images/pages/pg-009.jpg?optimizer=image&amp;format=webp&amp;width=384&amp;aspectRatio=1.33 384w, https://media.magloft.app/pdf-import/1110/images/pages/pg-009.jpg?optimizer=image&amp;format=webp&amp;width=384&amp;aspectRatio=1.33 384w, https://media.magloft.app/pdf-import/1110/images/pages/pg-009.jpg?optimizer=image&amp;format=webp&amp;width=520&amp;aspectRatio=1.33 520w, https://media.magloft.app/pdf-import/1110/images/pages/pg-009.jpg?optimizer=image&amp;format=webp&amp;width=640&amp;aspectRatio=1.33 640w, https://media.magloft.app/pdf-import/1110/images/pages/pg-009.jpg?optimizer=image&amp;format=webp&amp;width=756&amp;aspectRatio=1.33 756w, https://media.magloft.app/pdf-import/1110/images/pages/pg-009.jpg?optimizer=image&amp;format=webp&amp;width=828&amp;aspectRatio=1.33 828w, https://media.magloft.app/pdf-import/1110/images/pages/pg-009.jpg?optimizer=image&amp;format=webp&amp;width=1080&amp;aspectRatio=1.33 1080w, https://media.magloft.app/pdf-import/1110/images/pages/pg-009.jpg?optimizer=image&amp;format=webp&amp;width=1200&amp;aspectRatio=1.33 1200w, https://media.magloft.app/pdf-import/1110/images/pages/pg-009.jpg?optimizer=image&amp;format=webp&amp;width=1920&amp;aspectRatio=1.33 1920w, https://media.magloft.app/pdf-import/1110/images/pages/pg-009.jpg?optimizer=image&amp;format=webp&amp;width=2048&amp;aspectRatio=1.33 2048w" src="https://media.magloft.app/pdf-import/1110/images/pages/pg-009.jpg?optimizer=image&amp;format=webp&amp;width=2048&amp;aspectRatio=1.33"/></div><div class="Block_article-contents__M6B6V"><h3>European Commission approves combination chemotherapy for treatment of advanced EGFR-mutated</h3><p>This month, Janssen-Cilag international, part of johnson &amp; johnson (j&amp;j) has announced that the European Commission (EC) has approved a combined treatment of rybrevant (amivantamab) and chemotherapy (carboplatin and pemerexed) for the treatment of non-small cell lung cancer (nsclc) with an epidermal growth factor receptor (EGFR).</p></div></a><a class="Block_article-card__mncKE" href="/articles/eisai-and-eco-navi-sta-enter-dementia-collaboration"><div class="Block_article-cover__vLhzO"><img alt="article-category" loading="lazy" decoding="async" data-nimg="fill" style="position:absolute;height:100%;width:100%;left:0;top:0;right:0;bottom:0;color:transparent;background-size:cover;background-position:50% 50%;background-repeat:no-repeat;background-image:url(&quot;data:image/svg+xml;charset=utf-8,%3Csvg xmlns=&#x27;http%3A//www.w3.org/2000/svg&#x27;%3E%3Cimage style=&#x27;filter:blur(20px)&#x27; preserveAspectRatio=&#x27;none&#x27; x=&#x27;0&#x27; y=&#x27;0&#x27; height=&#x27;100%25&#x27; width=&#x27;100%25&#x27; href=&#x27;data:image/gif;base64,R0lGODlhAQABAPAAANzc3P///yH5BAAAAAAALAAAAAABAAEAAAICRAEAOw==&#x27;/%3E%3C/svg%3E&quot;)" sizes="70px" srcSet="https://media.magloft.app/pdf-import/1110/images/img_10-2.jpg?optimizer=image&amp;format=webp&amp;width=16&amp;aspectRatio=1.33 16w, https://media.magloft.app/pdf-import/1110/images/img_10-2.jpg?optimizer=image&amp;format=webp&amp;width=32&amp;aspectRatio=1.33 32w, https://media.magloft.app/pdf-import/1110/images/img_10-2.jpg?optimizer=image&amp;format=webp&amp;width=48&amp;aspectRatio=1.33 48w, https://media.magloft.app/pdf-import/1110/images/img_10-2.jpg?optimizer=image&amp;format=webp&amp;width=54&amp;aspectRatio=1.33 54w, https://media.magloft.app/pdf-import/1110/images/img_10-2.jpg?optimizer=image&amp;format=webp&amp;width=64&amp;aspectRatio=1.33 64w, https://media.magloft.app/pdf-import/1110/images/img_10-2.jpg?optimizer=image&amp;format=webp&amp;width=70&amp;aspectRatio=1.33 70w, https://media.magloft.app/pdf-import/1110/images/img_10-2.jpg?optimizer=image&amp;format=webp&amp;width=82&amp;aspectRatio=1.33 82w, https://media.magloft.app/pdf-import/1110/images/img_10-2.jpg?optimizer=image&amp;format=webp&amp;width=96&amp;aspectRatio=1.33 96w, https://media.magloft.app/pdf-import/1110/images/img_10-2.jpg?optimizer=image&amp;format=webp&amp;width=96&amp;aspectRatio=1.33 96w, https://media.magloft.app/pdf-import/1110/images/img_10-2.jpg?optimizer=image&amp;format=webp&amp;width=110&amp;aspectRatio=1.33 110w, https://media.magloft.app/pdf-import/1110/images/img_10-2.jpg?optimizer=image&amp;format=webp&amp;width=128&amp;aspectRatio=1.33 128w, https://media.magloft.app/pdf-import/1110/images/img_10-2.jpg?optimizer=image&amp;format=webp&amp;width=128&amp;aspectRatio=1.33 128w, https://media.magloft.app/pdf-import/1110/images/img_10-2.jpg?optimizer=image&amp;format=webp&amp;width=138&amp;aspectRatio=1.33 138w, https://media.magloft.app/pdf-import/1110/images/img_10-2.jpg?optimizer=image&amp;format=webp&amp;width=192&amp;aspectRatio=1.33 192w, https://media.magloft.app/pdf-import/1110/images/img_10-2.jpg?optimizer=image&amp;format=webp&amp;width=200&amp;aspectRatio=1.33 200w, https://media.magloft.app/pdf-import/1110/images/img_10-2.jpg?optimizer=image&amp;format=webp&amp;width=252&amp;aspectRatio=1.33 252w, https://media.magloft.app/pdf-import/1110/images/img_10-2.jpg?optimizer=image&amp;format=webp&amp;width=256&amp;aspectRatio=1.33 256w, https://media.magloft.app/pdf-import/1110/images/img_10-2.jpg?optimizer=image&amp;format=webp&amp;width=260&amp;aspectRatio=1.33 260w, https://media.magloft.app/pdf-import/1110/images/img_10-2.jpg?optimizer=image&amp;format=webp&amp;width=298&amp;aspectRatio=1.33 298w, https://media.magloft.app/pdf-import/1110/images/img_10-2.jpg?optimizer=image&amp;format=webp&amp;width=378&amp;aspectRatio=1.33 378w, https://media.magloft.app/pdf-import/1110/images/img_10-2.jpg?optimizer=image&amp;format=webp&amp;width=384&amp;aspectRatio=1.33 384w, https://media.magloft.app/pdf-import/1110/images/img_10-2.jpg?optimizer=image&amp;format=webp&amp;width=384&amp;aspectRatio=1.33 384w, https://media.magloft.app/pdf-import/1110/images/img_10-2.jpg?optimizer=image&amp;format=webp&amp;width=520&amp;aspectRatio=1.33 520w, https://media.magloft.app/pdf-import/1110/images/img_10-2.jpg?optimizer=image&amp;format=webp&amp;width=640&amp;aspectRatio=1.33 640w, https://media.magloft.app/pdf-import/1110/images/img_10-2.jpg?optimizer=image&amp;format=webp&amp;width=756&amp;aspectRatio=1.33 756w, https://media.magloft.app/pdf-import/1110/images/img_10-2.jpg?optimizer=image&amp;format=webp&amp;width=828&amp;aspectRatio=1.33 828w, https://media.magloft.app/pdf-import/1110/images/img_10-2.jpg?optimizer=image&amp;format=webp&amp;width=1080&amp;aspectRatio=1.33 1080w, https://media.magloft.app/pdf-import/1110/images/img_10-2.jpg?optimizer=image&amp;format=webp&amp;width=1200&amp;aspectRatio=1.33 1200w, https://media.magloft.app/pdf-import/1110/images/img_10-2.jpg?optimizer=image&amp;format=webp&amp;width=1920&amp;aspectRatio=1.33 1920w, https://media.magloft.app/pdf-import/1110/images/img_10-2.jpg?optimizer=image&amp;format=webp&amp;width=2048&amp;aspectRatio=1.33 2048w" src="https://media.magloft.app/pdf-import/1110/images/img_10-2.jpg?optimizer=image&amp;format=webp&amp;width=2048&amp;aspectRatio=1.33"/></div><div class="Block_article-contents__M6B6V"><h3>Eisai and EcoNaviSta enter dementia collaboration</h3><p>Eisai and Econavista have announced that they have entered into a business alliance agreement, initiating their collaboration intended to build an ecosystem in the field of dementia.</p></div></a></div></div><div id="article-category-block" class="Block_block__MHhr4" style="background-color:transparent"><div style="height:auto" class="BlockHeader_block-header__JmokO"><div class="BlockHeader_container-title__l5lHB"><h2 style="border-bottom-color:#2873B0">Global News</h2></div><a style="color:#2873B0" href="/categories/approvals"><span>view more</span><div class="Icon_nav-arrow-right__JFm_F Icon_icon__t_YgI icon" style="background-color:#2873B0;min-width:24px"></div></a></div><div class="Block_article-layout__527Uy Block_variant-c__AkeuK"><a class="Block_article-card__mncKE" href="/articles/nice-gives-positive-recommendation-for-santen-s-roclanda-e19d"><div class="Block_article-cover__vLhzO"><img alt="article-category" loading="lazy" decoding="async" data-nimg="fill" style="position:absolute;height:100%;width:100%;left:0;top:0;right:0;bottom:0;color:transparent;background-size:cover;background-position:50% 50%;background-repeat:no-repeat;background-image:url(&quot;data:image/svg+xml;charset=utf-8,%3Csvg xmlns=&#x27;http%3A//www.w3.org/2000/svg&#x27;%3E%3Cimage style=&#x27;filter:blur(20px)&#x27; preserveAspectRatio=&#x27;none&#x27; x=&#x27;0&#x27; y=&#x27;0&#x27; height=&#x27;100%25&#x27; width=&#x27;100%25&#x27; href=&#x27;data:image/gif;base64,R0lGODlhAQABAPAAANzc3P///yH5BAAAAAAALAAAAAABAAEAAAICRAEAOw==&#x27;/%3E%3C/svg%3E&quot;)" sizes="70px" srcSet="https://media.magloft.app/pdf-import/1144/images/pages/pg-012.jpg?optimizer=image&amp;format=webp&amp;width=16&amp;aspectRatio=1.33 16w, https://media.magloft.app/pdf-import/1144/images/pages/pg-012.jpg?optimizer=image&amp;format=webp&amp;width=32&amp;aspectRatio=1.33 32w, https://media.magloft.app/pdf-import/1144/images/pages/pg-012.jpg?optimizer=image&amp;format=webp&amp;width=48&amp;aspectRatio=1.33 48w, https://media.magloft.app/pdf-import/1144/images/pages/pg-012.jpg?optimizer=image&amp;format=webp&amp;width=54&amp;aspectRatio=1.33 54w, https://media.magloft.app/pdf-import/1144/images/pages/pg-012.jpg?optimizer=image&amp;format=webp&amp;width=64&amp;aspectRatio=1.33 64w, https://media.magloft.app/pdf-import/1144/images/pages/pg-012.jpg?optimizer=image&amp;format=webp&amp;width=70&amp;aspectRatio=1.33 70w, https://media.magloft.app/pdf-import/1144/images/pages/pg-012.jpg?optimizer=image&amp;format=webp&amp;width=82&amp;aspectRatio=1.33 82w, https://media.magloft.app/pdf-import/1144/images/pages/pg-012.jpg?optimizer=image&amp;format=webp&amp;width=96&amp;aspectRatio=1.33 96w, https://media.magloft.app/pdf-import/1144/images/pages/pg-012.jpg?optimizer=image&amp;format=webp&amp;width=96&amp;aspectRatio=1.33 96w, https://media.magloft.app/pdf-import/1144/images/pages/pg-012.jpg?optimizer=image&amp;format=webp&amp;width=110&amp;aspectRatio=1.33 110w, https://media.magloft.app/pdf-import/1144/images/pages/pg-012.jpg?optimizer=image&amp;format=webp&amp;width=128&amp;aspectRatio=1.33 128w, https://media.magloft.app/pdf-import/1144/images/pages/pg-012.jpg?optimizer=image&amp;format=webp&amp;width=128&amp;aspectRatio=1.33 128w, https://media.magloft.app/pdf-import/1144/images/pages/pg-012.jpg?optimizer=image&amp;format=webp&amp;width=138&amp;aspectRatio=1.33 138w, https://media.magloft.app/pdf-import/1144/images/pages/pg-012.jpg?optimizer=image&amp;format=webp&amp;width=192&amp;aspectRatio=1.33 192w, https://media.magloft.app/pdf-import/1144/images/pages/pg-012.jpg?optimizer=image&amp;format=webp&amp;width=200&amp;aspectRatio=1.33 200w, https://media.magloft.app/pdf-import/1144/images/pages/pg-012.jpg?optimizer=image&amp;format=webp&amp;width=252&amp;aspectRatio=1.33 252w, https://media.magloft.app/pdf-import/1144/images/pages/pg-012.jpg?optimizer=image&amp;format=webp&amp;width=256&amp;aspectRatio=1.33 256w, https://media.magloft.app/pdf-import/1144/images/pages/pg-012.jpg?optimizer=image&amp;format=webp&amp;width=260&amp;aspectRatio=1.33 260w, https://media.magloft.app/pdf-import/1144/images/pages/pg-012.jpg?optimizer=image&amp;format=webp&amp;width=298&amp;aspectRatio=1.33 298w, https://media.magloft.app/pdf-import/1144/images/pages/pg-012.jpg?optimizer=image&amp;format=webp&amp;width=378&amp;aspectRatio=1.33 378w, https://media.magloft.app/pdf-import/1144/images/pages/pg-012.jpg?optimizer=image&amp;format=webp&amp;width=384&amp;aspectRatio=1.33 384w, https://media.magloft.app/pdf-import/1144/images/pages/pg-012.jpg?optimizer=image&amp;format=webp&amp;width=384&amp;aspectRatio=1.33 384w, https://media.magloft.app/pdf-import/1144/images/pages/pg-012.jpg?optimizer=image&amp;format=webp&amp;width=520&amp;aspectRatio=1.33 520w, https://media.magloft.app/pdf-import/1144/images/pages/pg-012.jpg?optimizer=image&amp;format=webp&amp;width=640&amp;aspectRatio=1.33 640w, https://media.magloft.app/pdf-import/1144/images/pages/pg-012.jpg?optimizer=image&amp;format=webp&amp;width=756&amp;aspectRatio=1.33 756w, https://media.magloft.app/pdf-import/1144/images/pages/pg-012.jpg?optimizer=image&amp;format=webp&amp;width=828&amp;aspectRatio=1.33 828w, https://media.magloft.app/pdf-import/1144/images/pages/pg-012.jpg?optimizer=image&amp;format=webp&amp;width=1080&amp;aspectRatio=1.33 1080w, https://media.magloft.app/pdf-import/1144/images/pages/pg-012.jpg?optimizer=image&amp;format=webp&amp;width=1200&amp;aspectRatio=1.33 1200w, https://media.magloft.app/pdf-import/1144/images/pages/pg-012.jpg?optimizer=image&amp;format=webp&amp;width=1920&amp;aspectRatio=1.33 1920w, https://media.magloft.app/pdf-import/1144/images/pages/pg-012.jpg?optimizer=image&amp;format=webp&amp;width=2048&amp;aspectRatio=1.33 2048w" src="https://media.magloft.app/pdf-import/1144/images/pages/pg-012.jpg?optimizer=image&amp;format=webp&amp;width=2048&amp;aspectRatio=1.33"/></div><div class="Block_article-contents__M6B6V"><h3>NICE gives positive recommendation for Santen’s Roclanda</h3><p>The National Institute for Health and Care Excellence (NICE) has given a positive recommendation for Santen’s Roclanda (netarsudil 0.02% and latanoprost 0.005%) as an option for patients suffering from primary open-angle glaucoma (poag) or ocular hypertension.</p></div></a><a class="Block_article-card__mncKE" href="/articles/chmp-adopts-positive-opinion-for-new-breast-cancer-drug-kisqual-db01"><div class="Block_article-cover__vLhzO"><img alt="article-category" loading="lazy" decoding="async" data-nimg="fill" style="position:absolute;height:100%;width:100%;left:0;top:0;right:0;bottom:0;color:transparent;background-size:cover;background-position:50% 50%;background-repeat:no-repeat;background-image:url(&quot;data:image/svg+xml;charset=utf-8,%3Csvg xmlns=&#x27;http%3A//www.w3.org/2000/svg&#x27;%3E%3Cimage style=&#x27;filter:blur(20px)&#x27; preserveAspectRatio=&#x27;none&#x27; x=&#x27;0&#x27; y=&#x27;0&#x27; height=&#x27;100%25&#x27; width=&#x27;100%25&#x27; href=&#x27;data:image/gif;base64,R0lGODlhAQABAPAAANzc3P///yH5BAAAAAAALAAAAAABAAEAAAICRAEAOw==&#x27;/%3E%3C/svg%3E&quot;)" sizes="70px" srcSet="https://media.magloft.app/pdf-import/1144/images/img_12-1.jpg?optimizer=image&amp;format=webp&amp;width=16&amp;aspectRatio=1.33 16w, https://media.magloft.app/pdf-import/1144/images/img_12-1.jpg?optimizer=image&amp;format=webp&amp;width=32&amp;aspectRatio=1.33 32w, https://media.magloft.app/pdf-import/1144/images/img_12-1.jpg?optimizer=image&amp;format=webp&amp;width=48&amp;aspectRatio=1.33 48w, https://media.magloft.app/pdf-import/1144/images/img_12-1.jpg?optimizer=image&amp;format=webp&amp;width=54&amp;aspectRatio=1.33 54w, https://media.magloft.app/pdf-import/1144/images/img_12-1.jpg?optimizer=image&amp;format=webp&amp;width=64&amp;aspectRatio=1.33 64w, https://media.magloft.app/pdf-import/1144/images/img_12-1.jpg?optimizer=image&amp;format=webp&amp;width=70&amp;aspectRatio=1.33 70w, https://media.magloft.app/pdf-import/1144/images/img_12-1.jpg?optimizer=image&amp;format=webp&amp;width=82&amp;aspectRatio=1.33 82w, https://media.magloft.app/pdf-import/1144/images/img_12-1.jpg?optimizer=image&amp;format=webp&amp;width=96&amp;aspectRatio=1.33 96w, https://media.magloft.app/pdf-import/1144/images/img_12-1.jpg?optimizer=image&amp;format=webp&amp;width=96&amp;aspectRatio=1.33 96w, https://media.magloft.app/pdf-import/1144/images/img_12-1.jpg?optimizer=image&amp;format=webp&amp;width=110&amp;aspectRatio=1.33 110w, https://media.magloft.app/pdf-import/1144/images/img_12-1.jpg?optimizer=image&amp;format=webp&amp;width=128&amp;aspectRatio=1.33 128w, https://media.magloft.app/pdf-import/1144/images/img_12-1.jpg?optimizer=image&amp;format=webp&amp;width=128&amp;aspectRatio=1.33 128w, https://media.magloft.app/pdf-import/1144/images/img_12-1.jpg?optimizer=image&amp;format=webp&amp;width=138&amp;aspectRatio=1.33 138w, https://media.magloft.app/pdf-import/1144/images/img_12-1.jpg?optimizer=image&amp;format=webp&amp;width=192&amp;aspectRatio=1.33 192w, https://media.magloft.app/pdf-import/1144/images/img_12-1.jpg?optimizer=image&amp;format=webp&amp;width=200&amp;aspectRatio=1.33 200w, https://media.magloft.app/pdf-import/1144/images/img_12-1.jpg?optimizer=image&amp;format=webp&amp;width=252&amp;aspectRatio=1.33 252w, https://media.magloft.app/pdf-import/1144/images/img_12-1.jpg?optimizer=image&amp;format=webp&amp;width=256&amp;aspectRatio=1.33 256w, https://media.magloft.app/pdf-import/1144/images/img_12-1.jpg?optimizer=image&amp;format=webp&amp;width=260&amp;aspectRatio=1.33 260w, https://media.magloft.app/pdf-import/1144/images/img_12-1.jpg?optimizer=image&amp;format=webp&amp;width=298&amp;aspectRatio=1.33 298w, https://media.magloft.app/pdf-import/1144/images/img_12-1.jpg?optimizer=image&amp;format=webp&amp;width=378&amp;aspectRatio=1.33 378w, https://media.magloft.app/pdf-import/1144/images/img_12-1.jpg?optimizer=image&amp;format=webp&amp;width=384&amp;aspectRatio=1.33 384w, https://media.magloft.app/pdf-import/1144/images/img_12-1.jpg?optimizer=image&amp;format=webp&amp;width=384&amp;aspectRatio=1.33 384w, https://media.magloft.app/pdf-import/1144/images/img_12-1.jpg?optimizer=image&amp;format=webp&amp;width=520&amp;aspectRatio=1.33 520w, https://media.magloft.app/pdf-import/1144/images/img_12-1.jpg?optimizer=image&amp;format=webp&amp;width=640&amp;aspectRatio=1.33 640w, https://media.magloft.app/pdf-import/1144/images/img_12-1.jpg?optimizer=image&amp;format=webp&amp;width=756&amp;aspectRatio=1.33 756w, https://media.magloft.app/pdf-import/1144/images/img_12-1.jpg?optimizer=image&amp;format=webp&amp;width=828&amp;aspectRatio=1.33 828w, https://media.magloft.app/pdf-import/1144/images/img_12-1.jpg?optimizer=image&amp;format=webp&amp;width=1080&amp;aspectRatio=1.33 1080w, https://media.magloft.app/pdf-import/1144/images/img_12-1.jpg?optimizer=image&amp;format=webp&amp;width=1200&amp;aspectRatio=1.33 1200w, https://media.magloft.app/pdf-import/1144/images/img_12-1.jpg?optimizer=image&amp;format=webp&amp;width=1920&amp;aspectRatio=1.33 1920w, https://media.magloft.app/pdf-import/1144/images/img_12-1.jpg?optimizer=image&amp;format=webp&amp;width=2048&amp;aspectRatio=1.33 2048w" src="https://media.magloft.app/pdf-import/1144/images/img_12-1.jpg?optimizer=image&amp;format=webp&amp;width=2048&amp;aspectRatio=1.33"/></div><div class="Block_article-contents__M6B6V"><h3>CHMP adopts positive opinion for new breast cancer drug, Kisquali, from Novartis</h3><p>Last month, the Committee for Medicinal Products for Human Use (CHMP), which is part of the European Medicines Agency (EMA) announced that it has adopted a positive opinion for Novartis’ Kisquali (ribociclib) as an adjuvant in the treatment of adults with hormone receptor-positive/human epidermal growth factor 2negative (hr+/her2-) early breast cancer (ebc).</p></div></a><a class="Block_article-card__mncKE" href="/articles/eplontersen-recommended-for-eu-approval-by-chmp-for-treatment-of-aaa6"><div class="Block_article-cover__vLhzO"><img alt="article-category" loading="lazy" decoding="async" data-nimg="fill" style="position:absolute;height:100%;width:100%;left:0;top:0;right:0;bottom:0;color:transparent;background-size:cover;background-position:50% 50%;background-repeat:no-repeat;background-image:url(&quot;data:image/svg+xml;charset=utf-8,%3Csvg xmlns=&#x27;http%3A//www.w3.org/2000/svg&#x27;%3E%3Cimage style=&#x27;filter:blur(20px)&#x27; preserveAspectRatio=&#x27;none&#x27; x=&#x27;0&#x27; y=&#x27;0&#x27; height=&#x27;100%25&#x27; width=&#x27;100%25&#x27; href=&#x27;data:image/gif;base64,R0lGODlhAQABAPAAANzc3P///yH5BAAAAAAALAAAAAABAAEAAAICRAEAOw==&#x27;/%3E%3C/svg%3E&quot;)" sizes="70px" srcSet="https://media.magloft.app/pdf-import/1144/images/img_13-1.jpg?optimizer=image&amp;format=webp&amp;width=16&amp;aspectRatio=1.33 16w, https://media.magloft.app/pdf-import/1144/images/img_13-1.jpg?optimizer=image&amp;format=webp&amp;width=32&amp;aspectRatio=1.33 32w, https://media.magloft.app/pdf-import/1144/images/img_13-1.jpg?optimizer=image&amp;format=webp&amp;width=48&amp;aspectRatio=1.33 48w, https://media.magloft.app/pdf-import/1144/images/img_13-1.jpg?optimizer=image&amp;format=webp&amp;width=54&amp;aspectRatio=1.33 54w, https://media.magloft.app/pdf-import/1144/images/img_13-1.jpg?optimizer=image&amp;format=webp&amp;width=64&amp;aspectRatio=1.33 64w, https://media.magloft.app/pdf-import/1144/images/img_13-1.jpg?optimizer=image&amp;format=webp&amp;width=70&amp;aspectRatio=1.33 70w, https://media.magloft.app/pdf-import/1144/images/img_13-1.jpg?optimizer=image&amp;format=webp&amp;width=82&amp;aspectRatio=1.33 82w, https://media.magloft.app/pdf-import/1144/images/img_13-1.jpg?optimizer=image&amp;format=webp&amp;width=96&amp;aspectRatio=1.33 96w, https://media.magloft.app/pdf-import/1144/images/img_13-1.jpg?optimizer=image&amp;format=webp&amp;width=96&amp;aspectRatio=1.33 96w, https://media.magloft.app/pdf-import/1144/images/img_13-1.jpg?optimizer=image&amp;format=webp&amp;width=110&amp;aspectRatio=1.33 110w, https://media.magloft.app/pdf-import/1144/images/img_13-1.jpg?optimizer=image&amp;format=webp&amp;width=128&amp;aspectRatio=1.33 128w, https://media.magloft.app/pdf-import/1144/images/img_13-1.jpg?optimizer=image&amp;format=webp&amp;width=128&amp;aspectRatio=1.33 128w, https://media.magloft.app/pdf-import/1144/images/img_13-1.jpg?optimizer=image&amp;format=webp&amp;width=138&amp;aspectRatio=1.33 138w, https://media.magloft.app/pdf-import/1144/images/img_13-1.jpg?optimizer=image&amp;format=webp&amp;width=192&amp;aspectRatio=1.33 192w, https://media.magloft.app/pdf-import/1144/images/img_13-1.jpg?optimizer=image&amp;format=webp&amp;width=200&amp;aspectRatio=1.33 200w, https://media.magloft.app/pdf-import/1144/images/img_13-1.jpg?optimizer=image&amp;format=webp&amp;width=252&amp;aspectRatio=1.33 252w, https://media.magloft.app/pdf-import/1144/images/img_13-1.jpg?optimizer=image&amp;format=webp&amp;width=256&amp;aspectRatio=1.33 256w, https://media.magloft.app/pdf-import/1144/images/img_13-1.jpg?optimizer=image&amp;format=webp&amp;width=260&amp;aspectRatio=1.33 260w, https://media.magloft.app/pdf-import/1144/images/img_13-1.jpg?optimizer=image&amp;format=webp&amp;width=298&amp;aspectRatio=1.33 298w, https://media.magloft.app/pdf-import/1144/images/img_13-1.jpg?optimizer=image&amp;format=webp&amp;width=378&amp;aspectRatio=1.33 378w, https://media.magloft.app/pdf-import/1144/images/img_13-1.jpg?optimizer=image&amp;format=webp&amp;width=384&amp;aspectRatio=1.33 384w, https://media.magloft.app/pdf-import/1144/images/img_13-1.jpg?optimizer=image&amp;format=webp&amp;width=384&amp;aspectRatio=1.33 384w, https://media.magloft.app/pdf-import/1144/images/img_13-1.jpg?optimizer=image&amp;format=webp&amp;width=520&amp;aspectRatio=1.33 520w, https://media.magloft.app/pdf-import/1144/images/img_13-1.jpg?optimizer=image&amp;format=webp&amp;width=640&amp;aspectRatio=1.33 640w, https://media.magloft.app/pdf-import/1144/images/img_13-1.jpg?optimizer=image&amp;format=webp&amp;width=756&amp;aspectRatio=1.33 756w, https://media.magloft.app/pdf-import/1144/images/img_13-1.jpg?optimizer=image&amp;format=webp&amp;width=828&amp;aspectRatio=1.33 828w, https://media.magloft.app/pdf-import/1144/images/img_13-1.jpg?optimizer=image&amp;format=webp&amp;width=1080&amp;aspectRatio=1.33 1080w, https://media.magloft.app/pdf-import/1144/images/img_13-1.jpg?optimizer=image&amp;format=webp&amp;width=1200&amp;aspectRatio=1.33 1200w, https://media.magloft.app/pdf-import/1144/images/img_13-1.jpg?optimizer=image&amp;format=webp&amp;width=1920&amp;aspectRatio=1.33 1920w, https://media.magloft.app/pdf-import/1144/images/img_13-1.jpg?optimizer=image&amp;format=webp&amp;width=2048&amp;aspectRatio=1.33 2048w" src="https://media.magloft.app/pdf-import/1144/images/img_13-1.jpg?optimizer=image&amp;format=webp&amp;width=2048&amp;aspectRatio=1.33"/></div><div class="Block_article-contents__M6B6V"><h3>Eplontersen recommended for EU approval by CHMP for hereditary transthyretin-mediated amyloidosis</h3><p>Wainzua (Eplotersen), produced by AstraZeneca and Ionis, has been recommended for approval in the EU by the European Medicines Agency’s (EMA’s) Committee for Medicinal Products for Human Use (CHMP). The drug will be used as a treatment for hereditary transthyretin-mediated amyloidosis in adult patients who have stage 1 or 2 polyneuropathy (commonly referred to as hattr-pn or attrv-pn).</p></div></a><a class="Block_article-card__mncKE" href="/articles/cytex-ortho-receives-fda-greenlight-for-clinical-trials-into-join-f46a"><div class="Block_article-cover__vLhzO"><img alt="article-category" loading="lazy" decoding="async" data-nimg="fill" style="position:absolute;height:100%;width:100%;left:0;top:0;right:0;bottom:0;color:transparent;background-size:cover;background-position:50% 50%;background-repeat:no-repeat;background-image:url(&quot;data:image/svg+xml;charset=utf-8,%3Csvg xmlns=&#x27;http%3A//www.w3.org/2000/svg&#x27;%3E%3Cimage style=&#x27;filter:blur(20px)&#x27; preserveAspectRatio=&#x27;none&#x27; x=&#x27;0&#x27; y=&#x27;0&#x27; height=&#x27;100%25&#x27; width=&#x27;100%25&#x27; href=&#x27;data:image/gif;base64,R0lGODlhAQABAPAAANzc3P///yH5BAAAAAAALAAAAAABAAEAAAICRAEAOw==&#x27;/%3E%3C/svg%3E&quot;)" sizes="70px" srcSet="https://media.magloft.app/pdf-import/1144/images/img_13-2.jpg?optimizer=image&amp;format=webp&amp;width=16&amp;aspectRatio=1.33 16w, https://media.magloft.app/pdf-import/1144/images/img_13-2.jpg?optimizer=image&amp;format=webp&amp;width=32&amp;aspectRatio=1.33 32w, https://media.magloft.app/pdf-import/1144/images/img_13-2.jpg?optimizer=image&amp;format=webp&amp;width=48&amp;aspectRatio=1.33 48w, https://media.magloft.app/pdf-import/1144/images/img_13-2.jpg?optimizer=image&amp;format=webp&amp;width=54&amp;aspectRatio=1.33 54w, https://media.magloft.app/pdf-import/1144/images/img_13-2.jpg?optimizer=image&amp;format=webp&amp;width=64&amp;aspectRatio=1.33 64w, https://media.magloft.app/pdf-import/1144/images/img_13-2.jpg?optimizer=image&amp;format=webp&amp;width=70&amp;aspectRatio=1.33 70w, https://media.magloft.app/pdf-import/1144/images/img_13-2.jpg?optimizer=image&amp;format=webp&amp;width=82&amp;aspectRatio=1.33 82w, https://media.magloft.app/pdf-import/1144/images/img_13-2.jpg?optimizer=image&amp;format=webp&amp;width=96&amp;aspectRatio=1.33 96w, https://media.magloft.app/pdf-import/1144/images/img_13-2.jpg?optimizer=image&amp;format=webp&amp;width=96&amp;aspectRatio=1.33 96w, https://media.magloft.app/pdf-import/1144/images/img_13-2.jpg?optimizer=image&amp;format=webp&amp;width=110&amp;aspectRatio=1.33 110w, https://media.magloft.app/pdf-import/1144/images/img_13-2.jpg?optimizer=image&amp;format=webp&amp;width=128&amp;aspectRatio=1.33 128w, https://media.magloft.app/pdf-import/1144/images/img_13-2.jpg?optimizer=image&amp;format=webp&amp;width=128&amp;aspectRatio=1.33 128w, https://media.magloft.app/pdf-import/1144/images/img_13-2.jpg?optimizer=image&amp;format=webp&amp;width=138&amp;aspectRatio=1.33 138w, https://media.magloft.app/pdf-import/1144/images/img_13-2.jpg?optimizer=image&amp;format=webp&amp;width=192&amp;aspectRatio=1.33 192w, https://media.magloft.app/pdf-import/1144/images/img_13-2.jpg?optimizer=image&amp;format=webp&amp;width=200&amp;aspectRatio=1.33 200w, https://media.magloft.app/pdf-import/1144/images/img_13-2.jpg?optimizer=image&amp;format=webp&amp;width=252&amp;aspectRatio=1.33 252w, https://media.magloft.app/pdf-import/1144/images/img_13-2.jpg?optimizer=image&amp;format=webp&amp;width=256&amp;aspectRatio=1.33 256w, https://media.magloft.app/pdf-import/1144/images/img_13-2.jpg?optimizer=image&amp;format=webp&amp;width=260&amp;aspectRatio=1.33 260w, https://media.magloft.app/pdf-import/1144/images/img_13-2.jpg?optimizer=image&amp;format=webp&amp;width=298&amp;aspectRatio=1.33 298w, https://media.magloft.app/pdf-import/1144/images/img_13-2.jpg?optimizer=image&amp;format=webp&amp;width=378&amp;aspectRatio=1.33 378w, https://media.magloft.app/pdf-import/1144/images/img_13-2.jpg?optimizer=image&amp;format=webp&amp;width=384&amp;aspectRatio=1.33 384w, https://media.magloft.app/pdf-import/1144/images/img_13-2.jpg?optimizer=image&amp;format=webp&amp;width=384&amp;aspectRatio=1.33 384w, https://media.magloft.app/pdf-import/1144/images/img_13-2.jpg?optimizer=image&amp;format=webp&amp;width=520&amp;aspectRatio=1.33 520w, https://media.magloft.app/pdf-import/1144/images/img_13-2.jpg?optimizer=image&amp;format=webp&amp;width=640&amp;aspectRatio=1.33 640w, https://media.magloft.app/pdf-import/1144/images/img_13-2.jpg?optimizer=image&amp;format=webp&amp;width=756&amp;aspectRatio=1.33 756w, https://media.magloft.app/pdf-import/1144/images/img_13-2.jpg?optimizer=image&amp;format=webp&amp;width=828&amp;aspectRatio=1.33 828w, https://media.magloft.app/pdf-import/1144/images/img_13-2.jpg?optimizer=image&amp;format=webp&amp;width=1080&amp;aspectRatio=1.33 1080w, https://media.magloft.app/pdf-import/1144/images/img_13-2.jpg?optimizer=image&amp;format=webp&amp;width=1200&amp;aspectRatio=1.33 1200w, https://media.magloft.app/pdf-import/1144/images/img_13-2.jpg?optimizer=image&amp;format=webp&amp;width=1920&amp;aspectRatio=1.33 1920w, https://media.magloft.app/pdf-import/1144/images/img_13-2.jpg?optimizer=image&amp;format=webp&amp;width=2048&amp;aspectRatio=1.33 2048w" src="https://media.magloft.app/pdf-import/1144/images/img_13-2.jpg?optimizer=image&amp;format=webp&amp;width=2048&amp;aspectRatio=1.33"/></div><div class="Block_article-contents__M6B6V"><h3>CytexOrtho receives FDA greenlight for clinical trials into joint repair technology</h3><p>Clinical stage medical device company CytexOrtho has announced approval from the US Food and Drug Administration (FDA) for its planned phase 1 clinical trial into orthopaedic joint preservation and repair.</p></div></a><a class="Block_article-card__mncKE" href="/articles/survey-from-roche-finds-worryingly-low-understandings-about-hpv"><div class="Block_article-cover__vLhzO"><img alt="article-category" loading="lazy" decoding="async" data-nimg="fill" style="position:absolute;height:100%;width:100%;left:0;top:0;right:0;bottom:0;color:transparent;background-size:cover;background-position:50% 50%;background-repeat:no-repeat;background-image:url(&quot;data:image/svg+xml;charset=utf-8,%3Csvg xmlns=&#x27;http%3A//www.w3.org/2000/svg&#x27;%3E%3Cimage style=&#x27;filter:blur(20px)&#x27; preserveAspectRatio=&#x27;none&#x27; x=&#x27;0&#x27; y=&#x27;0&#x27; height=&#x27;100%25&#x27; width=&#x27;100%25&#x27; href=&#x27;data:image/gif;base64,R0lGODlhAQABAPAAANzc3P///yH5BAAAAAAALAAAAAABAAEAAAICRAEAOw==&#x27;/%3E%3C/svg%3E&quot;)" sizes="70px" srcSet="https://media.magloft.app/pdf-import/1144/images/img_1-1.jpg?optimizer=image&amp;format=webp&amp;width=16&amp;aspectRatio=1.33 16w, https://media.magloft.app/pdf-import/1144/images/img_1-1.jpg?optimizer=image&amp;format=webp&amp;width=32&amp;aspectRatio=1.33 32w, https://media.magloft.app/pdf-import/1144/images/img_1-1.jpg?optimizer=image&amp;format=webp&amp;width=48&amp;aspectRatio=1.33 48w, https://media.magloft.app/pdf-import/1144/images/img_1-1.jpg?optimizer=image&amp;format=webp&amp;width=54&amp;aspectRatio=1.33 54w, https://media.magloft.app/pdf-import/1144/images/img_1-1.jpg?optimizer=image&amp;format=webp&amp;width=64&amp;aspectRatio=1.33 64w, https://media.magloft.app/pdf-import/1144/images/img_1-1.jpg?optimizer=image&amp;format=webp&amp;width=70&amp;aspectRatio=1.33 70w, https://media.magloft.app/pdf-import/1144/images/img_1-1.jpg?optimizer=image&amp;format=webp&amp;width=82&amp;aspectRatio=1.33 82w, https://media.magloft.app/pdf-import/1144/images/img_1-1.jpg?optimizer=image&amp;format=webp&amp;width=96&amp;aspectRatio=1.33 96w, https://media.magloft.app/pdf-import/1144/images/img_1-1.jpg?optimizer=image&amp;format=webp&amp;width=96&amp;aspectRatio=1.33 96w, https://media.magloft.app/pdf-import/1144/images/img_1-1.jpg?optimizer=image&amp;format=webp&amp;width=110&amp;aspectRatio=1.33 110w, https://media.magloft.app/pdf-import/1144/images/img_1-1.jpg?optimizer=image&amp;format=webp&amp;width=128&amp;aspectRatio=1.33 128w, https://media.magloft.app/pdf-import/1144/images/img_1-1.jpg?optimizer=image&amp;format=webp&amp;width=128&amp;aspectRatio=1.33 128w, https://media.magloft.app/pdf-import/1144/images/img_1-1.jpg?optimizer=image&amp;format=webp&amp;width=138&amp;aspectRatio=1.33 138w, https://media.magloft.app/pdf-import/1144/images/img_1-1.jpg?optimizer=image&amp;format=webp&amp;width=192&amp;aspectRatio=1.33 192w, https://media.magloft.app/pdf-import/1144/images/img_1-1.jpg?optimizer=image&amp;format=webp&amp;width=200&amp;aspectRatio=1.33 200w, https://media.magloft.app/pdf-import/1144/images/img_1-1.jpg?optimizer=image&amp;format=webp&amp;width=252&amp;aspectRatio=1.33 252w, https://media.magloft.app/pdf-import/1144/images/img_1-1.jpg?optimizer=image&amp;format=webp&amp;width=256&amp;aspectRatio=1.33 256w, https://media.magloft.app/pdf-import/1144/images/img_1-1.jpg?optimizer=image&amp;format=webp&amp;width=260&amp;aspectRatio=1.33 260w, https://media.magloft.app/pdf-import/1144/images/img_1-1.jpg?optimizer=image&amp;format=webp&amp;width=298&amp;aspectRatio=1.33 298w, https://media.magloft.app/pdf-import/1144/images/img_1-1.jpg?optimizer=image&amp;format=webp&amp;width=378&amp;aspectRatio=1.33 378w, https://media.magloft.app/pdf-import/1144/images/img_1-1.jpg?optimizer=image&amp;format=webp&amp;width=384&amp;aspectRatio=1.33 384w, https://media.magloft.app/pdf-import/1144/images/img_1-1.jpg?optimizer=image&amp;format=webp&amp;width=384&amp;aspectRatio=1.33 384w, https://media.magloft.app/pdf-import/1144/images/img_1-1.jpg?optimizer=image&amp;format=webp&amp;width=520&amp;aspectRatio=1.33 520w, https://media.magloft.app/pdf-import/1144/images/img_1-1.jpg?optimizer=image&amp;format=webp&amp;width=640&amp;aspectRatio=1.33 640w, https://media.magloft.app/pdf-import/1144/images/img_1-1.jpg?optimizer=image&amp;format=webp&amp;width=756&amp;aspectRatio=1.33 756w, https://media.magloft.app/pdf-import/1144/images/img_1-1.jpg?optimizer=image&amp;format=webp&amp;width=828&amp;aspectRatio=1.33 828w, https://media.magloft.app/pdf-import/1144/images/img_1-1.jpg?optimizer=image&amp;format=webp&amp;width=1080&amp;aspectRatio=1.33 1080w, https://media.magloft.app/pdf-import/1144/images/img_1-1.jpg?optimizer=image&amp;format=webp&amp;width=1200&amp;aspectRatio=1.33 1200w, https://media.magloft.app/pdf-import/1144/images/img_1-1.jpg?optimizer=image&amp;format=webp&amp;width=1920&amp;aspectRatio=1.33 1920w, https://media.magloft.app/pdf-import/1144/images/img_1-1.jpg?optimizer=image&amp;format=webp&amp;width=2048&amp;aspectRatio=1.33 2048w" src="https://media.magloft.app/pdf-import/1144/images/img_1-1.jpg?optimizer=image&amp;format=webp&amp;width=2048&amp;aspectRatio=1.33"/></div><div class="Block_article-contents__M6B6V"><h3>Survey from Roche finds worryingly low understandings about HPV and cervical cancer</h3><p>Questioning almost 9,000 participants across 12 countries in Latin America and Europe, the research revealed significant knowledge gaps surrounding human papillomavirus (HPV) and highlighted several significant barriers preventing women from screening for it.</p></div></a><a class="Block_article-card__mncKE" href="/articles/best-in-class-ai-model-from-bioptimus-integrated-into-proscia-s"><div class="Block_article-cover__vLhzO"><img alt="article-category" loading="lazy" decoding="async" data-nimg="fill" style="position:absolute;height:100%;width:100%;left:0;top:0;right:0;bottom:0;color:transparent;background-size:cover;background-position:50% 50%;background-repeat:no-repeat;background-image:url(&quot;data:image/svg+xml;charset=utf-8,%3Csvg xmlns=&#x27;http%3A//www.w3.org/2000/svg&#x27;%3E%3Cimage style=&#x27;filter:blur(20px)&#x27; preserveAspectRatio=&#x27;none&#x27; x=&#x27;0&#x27; y=&#x27;0&#x27; height=&#x27;100%25&#x27; width=&#x27;100%25&#x27; href=&#x27;data:image/gif;base64,R0lGODlhAQABAPAAANzc3P///yH5BAAAAAAALAAAAAABAAEAAAICRAEAOw==&#x27;/%3E%3C/svg%3E&quot;)" sizes="70px" srcSet="https://media.magloft.app/pdf-import/1144/images/img_2-4.jpg?optimizer=image&amp;format=webp&amp;width=16&amp;aspectRatio=1.33 16w, https://media.magloft.app/pdf-import/1144/images/img_2-4.jpg?optimizer=image&amp;format=webp&amp;width=32&amp;aspectRatio=1.33 32w, https://media.magloft.app/pdf-import/1144/images/img_2-4.jpg?optimizer=image&amp;format=webp&amp;width=48&amp;aspectRatio=1.33 48w, https://media.magloft.app/pdf-import/1144/images/img_2-4.jpg?optimizer=image&amp;format=webp&amp;width=54&amp;aspectRatio=1.33 54w, https://media.magloft.app/pdf-import/1144/images/img_2-4.jpg?optimizer=image&amp;format=webp&amp;width=64&amp;aspectRatio=1.33 64w, https://media.magloft.app/pdf-import/1144/images/img_2-4.jpg?optimizer=image&amp;format=webp&amp;width=70&amp;aspectRatio=1.33 70w, https://media.magloft.app/pdf-import/1144/images/img_2-4.jpg?optimizer=image&amp;format=webp&amp;width=82&amp;aspectRatio=1.33 82w, https://media.magloft.app/pdf-import/1144/images/img_2-4.jpg?optimizer=image&amp;format=webp&amp;width=96&amp;aspectRatio=1.33 96w, https://media.magloft.app/pdf-import/1144/images/img_2-4.jpg?optimizer=image&amp;format=webp&amp;width=96&amp;aspectRatio=1.33 96w, https://media.magloft.app/pdf-import/1144/images/img_2-4.jpg?optimizer=image&amp;format=webp&amp;width=110&amp;aspectRatio=1.33 110w, https://media.magloft.app/pdf-import/1144/images/img_2-4.jpg?optimizer=image&amp;format=webp&amp;width=128&amp;aspectRatio=1.33 128w, https://media.magloft.app/pdf-import/1144/images/img_2-4.jpg?optimizer=image&amp;format=webp&amp;width=128&amp;aspectRatio=1.33 128w, https://media.magloft.app/pdf-import/1144/images/img_2-4.jpg?optimizer=image&amp;format=webp&amp;width=138&amp;aspectRatio=1.33 138w, https://media.magloft.app/pdf-import/1144/images/img_2-4.jpg?optimizer=image&amp;format=webp&amp;width=192&amp;aspectRatio=1.33 192w, https://media.magloft.app/pdf-import/1144/images/img_2-4.jpg?optimizer=image&amp;format=webp&amp;width=200&amp;aspectRatio=1.33 200w, https://media.magloft.app/pdf-import/1144/images/img_2-4.jpg?optimizer=image&amp;format=webp&amp;width=252&amp;aspectRatio=1.33 252w, https://media.magloft.app/pdf-import/1144/images/img_2-4.jpg?optimizer=image&amp;format=webp&amp;width=256&amp;aspectRatio=1.33 256w, https://media.magloft.app/pdf-import/1144/images/img_2-4.jpg?optimizer=image&amp;format=webp&amp;width=260&amp;aspectRatio=1.33 260w, https://media.magloft.app/pdf-import/1144/images/img_2-4.jpg?optimizer=image&amp;format=webp&amp;width=298&amp;aspectRatio=1.33 298w, https://media.magloft.app/pdf-import/1144/images/img_2-4.jpg?optimizer=image&amp;format=webp&amp;width=378&amp;aspectRatio=1.33 378w, https://media.magloft.app/pdf-import/1144/images/img_2-4.jpg?optimizer=image&amp;format=webp&amp;width=384&amp;aspectRatio=1.33 384w, https://media.magloft.app/pdf-import/1144/images/img_2-4.jpg?optimizer=image&amp;format=webp&amp;width=384&amp;aspectRatio=1.33 384w, https://media.magloft.app/pdf-import/1144/images/img_2-4.jpg?optimizer=image&amp;format=webp&amp;width=520&amp;aspectRatio=1.33 520w, https://media.magloft.app/pdf-import/1144/images/img_2-4.jpg?optimizer=image&amp;format=webp&amp;width=640&amp;aspectRatio=1.33 640w, https://media.magloft.app/pdf-import/1144/images/img_2-4.jpg?optimizer=image&amp;format=webp&amp;width=756&amp;aspectRatio=1.33 756w, https://media.magloft.app/pdf-import/1144/images/img_2-4.jpg?optimizer=image&amp;format=webp&amp;width=828&amp;aspectRatio=1.33 828w, https://media.magloft.app/pdf-import/1144/images/img_2-4.jpg?optimizer=image&amp;format=webp&amp;width=1080&amp;aspectRatio=1.33 1080w, https://media.magloft.app/pdf-import/1144/images/img_2-4.jpg?optimizer=image&amp;format=webp&amp;width=1200&amp;aspectRatio=1.33 1200w, https://media.magloft.app/pdf-import/1144/images/img_2-4.jpg?optimizer=image&amp;format=webp&amp;width=1920&amp;aspectRatio=1.33 1920w, https://media.magloft.app/pdf-import/1144/images/img_2-4.jpg?optimizer=image&amp;format=webp&amp;width=2048&amp;aspectRatio=1.33 2048w" src="https://media.magloft.app/pdf-import/1144/images/img_2-4.jpg?optimizer=image&amp;format=webp&amp;width=2048&amp;aspectRatio=1.33"/></div><div class="Block_article-contents__M6B6V"><h3>Best-in-class AI model from Bioptimus integrated into Proscia’s leading software platform</h3><p>French start-up Bioptimus has announced that its H-optimus-o biology reference artificial intelligence (AI) foundation model has been wholly integrated into Proscia’s Concentriq Embeddings software platform, with the aim of enabling quicker and more efficient breakthroughs in AI development for therapeutic research.</p></div></a><a class="Block_article-card__mncKE" href="/articles/hiv-vaccine-candidate-successfully-optimised-for-industrial-prod"><div class="Block_article-cover__vLhzO"><img alt="article-category" loading="lazy" decoding="async" data-nimg="fill" style="position:absolute;height:100%;width:100%;left:0;top:0;right:0;bottom:0;color:transparent;background-size:cover;background-position:50% 50%;background-repeat:no-repeat;background-image:url(&quot;data:image/svg+xml;charset=utf-8,%3Csvg xmlns=&#x27;http%3A//www.w3.org/2000/svg&#x27;%3E%3Cimage style=&#x27;filter:blur(20px)&#x27; preserveAspectRatio=&#x27;none&#x27; x=&#x27;0&#x27; y=&#x27;0&#x27; height=&#x27;100%25&#x27; width=&#x27;100%25&#x27; href=&#x27;data:image/gif;base64,R0lGODlhAQABAPAAANzc3P///yH5BAAAAAAALAAAAAABAAEAAAICRAEAOw==&#x27;/%3E%3C/svg%3E&quot;)" sizes="70px" srcSet="https://media.magloft.app/pdf-import/1144/images/img_5-2.jpg?optimizer=image&amp;format=webp&amp;width=16&amp;aspectRatio=1.33 16w, https://media.magloft.app/pdf-import/1144/images/img_5-2.jpg?optimizer=image&amp;format=webp&amp;width=32&amp;aspectRatio=1.33 32w, https://media.magloft.app/pdf-import/1144/images/img_5-2.jpg?optimizer=image&amp;format=webp&amp;width=48&amp;aspectRatio=1.33 48w, https://media.magloft.app/pdf-import/1144/images/img_5-2.jpg?optimizer=image&amp;format=webp&amp;width=54&amp;aspectRatio=1.33 54w, https://media.magloft.app/pdf-import/1144/images/img_5-2.jpg?optimizer=image&amp;format=webp&amp;width=64&amp;aspectRatio=1.33 64w, https://media.magloft.app/pdf-import/1144/images/img_5-2.jpg?optimizer=image&amp;format=webp&amp;width=70&amp;aspectRatio=1.33 70w, https://media.magloft.app/pdf-import/1144/images/img_5-2.jpg?optimizer=image&amp;format=webp&amp;width=82&amp;aspectRatio=1.33 82w, https://media.magloft.app/pdf-import/1144/images/img_5-2.jpg?optimizer=image&amp;format=webp&amp;width=96&amp;aspectRatio=1.33 96w, https://media.magloft.app/pdf-import/1144/images/img_5-2.jpg?optimizer=image&amp;format=webp&amp;width=96&amp;aspectRatio=1.33 96w, https://media.magloft.app/pdf-import/1144/images/img_5-2.jpg?optimizer=image&amp;format=webp&amp;width=110&amp;aspectRatio=1.33 110w, https://media.magloft.app/pdf-import/1144/images/img_5-2.jpg?optimizer=image&amp;format=webp&amp;width=128&amp;aspectRatio=1.33 128w, https://media.magloft.app/pdf-import/1144/images/img_5-2.jpg?optimizer=image&amp;format=webp&amp;width=128&amp;aspectRatio=1.33 128w, https://media.magloft.app/pdf-import/1144/images/img_5-2.jpg?optimizer=image&amp;format=webp&amp;width=138&amp;aspectRatio=1.33 138w, https://media.magloft.app/pdf-import/1144/images/img_5-2.jpg?optimizer=image&amp;format=webp&amp;width=192&amp;aspectRatio=1.33 192w, https://media.magloft.app/pdf-import/1144/images/img_5-2.jpg?optimizer=image&amp;format=webp&amp;width=200&amp;aspectRatio=1.33 200w, https://media.magloft.app/pdf-import/1144/images/img_5-2.jpg?optimizer=image&amp;format=webp&amp;width=252&amp;aspectRatio=1.33 252w, https://media.magloft.app/pdf-import/1144/images/img_5-2.jpg?optimizer=image&amp;format=webp&amp;width=256&amp;aspectRatio=1.33 256w, https://media.magloft.app/pdf-import/1144/images/img_5-2.jpg?optimizer=image&amp;format=webp&amp;width=260&amp;aspectRatio=1.33 260w, https://media.magloft.app/pdf-import/1144/images/img_5-2.jpg?optimizer=image&amp;format=webp&amp;width=298&amp;aspectRatio=1.33 298w, https://media.magloft.app/pdf-import/1144/images/img_5-2.jpg?optimizer=image&amp;format=webp&amp;width=378&amp;aspectRatio=1.33 378w, https://media.magloft.app/pdf-import/1144/images/img_5-2.jpg?optimizer=image&amp;format=webp&amp;width=384&amp;aspectRatio=1.33 384w, https://media.magloft.app/pdf-import/1144/images/img_5-2.jpg?optimizer=image&amp;format=webp&amp;width=384&amp;aspectRatio=1.33 384w, https://media.magloft.app/pdf-import/1144/images/img_5-2.jpg?optimizer=image&amp;format=webp&amp;width=520&amp;aspectRatio=1.33 520w, https://media.magloft.app/pdf-import/1144/images/img_5-2.jpg?optimizer=image&amp;format=webp&amp;width=640&amp;aspectRatio=1.33 640w, https://media.magloft.app/pdf-import/1144/images/img_5-2.jpg?optimizer=image&amp;format=webp&amp;width=756&amp;aspectRatio=1.33 756w, https://media.magloft.app/pdf-import/1144/images/img_5-2.jpg?optimizer=image&amp;format=webp&amp;width=828&amp;aspectRatio=1.33 828w, https://media.magloft.app/pdf-import/1144/images/img_5-2.jpg?optimizer=image&amp;format=webp&amp;width=1080&amp;aspectRatio=1.33 1080w, https://media.magloft.app/pdf-import/1144/images/img_5-2.jpg?optimizer=image&amp;format=webp&amp;width=1200&amp;aspectRatio=1.33 1200w, https://media.magloft.app/pdf-import/1144/images/img_5-2.jpg?optimizer=image&amp;format=webp&amp;width=1920&amp;aspectRatio=1.33 1920w, https://media.magloft.app/pdf-import/1144/images/img_5-2.jpg?optimizer=image&amp;format=webp&amp;width=2048&amp;aspectRatio=1.33 2048w" src="https://media.magloft.app/pdf-import/1144/images/img_5-2.jpg?optimizer=image&amp;format=webp&amp;width=2048&amp;aspectRatio=1.33"/></div><div class="Block_article-contents__M6B6V"><h3>HIV vaccine candidate successfully optimised for industrial production</h3><p>Sumagen Canada Inc, a biotech company based in both South Korea and Canada has partnered with CDMO Naobios to industrialise Sumagen’s human immunodeficiency virus (HIV)-1 vaccine candidate (SAV0001) at bench scale.</p></div></a><a class="Block_article-card__mncKE" href="/articles/aravax-successfully-recruits-for-phase-3-peanut-allergy-treatmen"><div class="Block_article-cover__vLhzO"><img alt="article-category" loading="lazy" decoding="async" data-nimg="fill" style="position:absolute;height:100%;width:100%;left:0;top:0;right:0;bottom:0;color:transparent;background-size:cover;background-position:50% 50%;background-repeat:no-repeat;background-image:url(&quot;data:image/svg+xml;charset=utf-8,%3Csvg xmlns=&#x27;http%3A//www.w3.org/2000/svg&#x27;%3E%3Cimage style=&#x27;filter:blur(20px)&#x27; preserveAspectRatio=&#x27;none&#x27; x=&#x27;0&#x27; y=&#x27;0&#x27; height=&#x27;100%25&#x27; width=&#x27;100%25&#x27; href=&#x27;data:image/gif;base64,R0lGODlhAQABAPAAANzc3P///yH5BAAAAAAALAAAAAABAAEAAAICRAEAOw==&#x27;/%3E%3C/svg%3E&quot;)" sizes="70px" srcSet="https://media.magloft.app/pdf-import/1144/images/img_10-1.jpg?optimizer=image&amp;format=webp&amp;width=16&amp;aspectRatio=1.33 16w, https://media.magloft.app/pdf-import/1144/images/img_10-1.jpg?optimizer=image&amp;format=webp&amp;width=32&amp;aspectRatio=1.33 32w, https://media.magloft.app/pdf-import/1144/images/img_10-1.jpg?optimizer=image&amp;format=webp&amp;width=48&amp;aspectRatio=1.33 48w, https://media.magloft.app/pdf-import/1144/images/img_10-1.jpg?optimizer=image&amp;format=webp&amp;width=54&amp;aspectRatio=1.33 54w, https://media.magloft.app/pdf-import/1144/images/img_10-1.jpg?optimizer=image&amp;format=webp&amp;width=64&amp;aspectRatio=1.33 64w, https://media.magloft.app/pdf-import/1144/images/img_10-1.jpg?optimizer=image&amp;format=webp&amp;width=70&amp;aspectRatio=1.33 70w, https://media.magloft.app/pdf-import/1144/images/img_10-1.jpg?optimizer=image&amp;format=webp&amp;width=82&amp;aspectRatio=1.33 82w, https://media.magloft.app/pdf-import/1144/images/img_10-1.jpg?optimizer=image&amp;format=webp&amp;width=96&amp;aspectRatio=1.33 96w, https://media.magloft.app/pdf-import/1144/images/img_10-1.jpg?optimizer=image&amp;format=webp&amp;width=96&amp;aspectRatio=1.33 96w, https://media.magloft.app/pdf-import/1144/images/img_10-1.jpg?optimizer=image&amp;format=webp&amp;width=110&amp;aspectRatio=1.33 110w, https://media.magloft.app/pdf-import/1144/images/img_10-1.jpg?optimizer=image&amp;format=webp&amp;width=128&amp;aspectRatio=1.33 128w, https://media.magloft.app/pdf-import/1144/images/img_10-1.jpg?optimizer=image&amp;format=webp&amp;width=128&amp;aspectRatio=1.33 128w, https://media.magloft.app/pdf-import/1144/images/img_10-1.jpg?optimizer=image&amp;format=webp&amp;width=138&amp;aspectRatio=1.33 138w, https://media.magloft.app/pdf-import/1144/images/img_10-1.jpg?optimizer=image&amp;format=webp&amp;width=192&amp;aspectRatio=1.33 192w, https://media.magloft.app/pdf-import/1144/images/img_10-1.jpg?optimizer=image&amp;format=webp&amp;width=200&amp;aspectRatio=1.33 200w, https://media.magloft.app/pdf-import/1144/images/img_10-1.jpg?optimizer=image&amp;format=webp&amp;width=252&amp;aspectRatio=1.33 252w, https://media.magloft.app/pdf-import/1144/images/img_10-1.jpg?optimizer=image&amp;format=webp&amp;width=256&amp;aspectRatio=1.33 256w, https://media.magloft.app/pdf-import/1144/images/img_10-1.jpg?optimizer=image&amp;format=webp&amp;width=260&amp;aspectRatio=1.33 260w, https://media.magloft.app/pdf-import/1144/images/img_10-1.jpg?optimizer=image&amp;format=webp&amp;width=298&amp;aspectRatio=1.33 298w, https://media.magloft.app/pdf-import/1144/images/img_10-1.jpg?optimizer=image&amp;format=webp&amp;width=378&amp;aspectRatio=1.33 378w, https://media.magloft.app/pdf-import/1144/images/img_10-1.jpg?optimizer=image&amp;format=webp&amp;width=384&amp;aspectRatio=1.33 384w, https://media.magloft.app/pdf-import/1144/images/img_10-1.jpg?optimizer=image&amp;format=webp&amp;width=384&amp;aspectRatio=1.33 384w, https://media.magloft.app/pdf-import/1144/images/img_10-1.jpg?optimizer=image&amp;format=webp&amp;width=520&amp;aspectRatio=1.33 520w, https://media.magloft.app/pdf-import/1144/images/img_10-1.jpg?optimizer=image&amp;format=webp&amp;width=640&amp;aspectRatio=1.33 640w, https://media.magloft.app/pdf-import/1144/images/img_10-1.jpg?optimizer=image&amp;format=webp&amp;width=756&amp;aspectRatio=1.33 756w, https://media.magloft.app/pdf-import/1144/images/img_10-1.jpg?optimizer=image&amp;format=webp&amp;width=828&amp;aspectRatio=1.33 828w, https://media.magloft.app/pdf-import/1144/images/img_10-1.jpg?optimizer=image&amp;format=webp&amp;width=1080&amp;aspectRatio=1.33 1080w, https://media.magloft.app/pdf-import/1144/images/img_10-1.jpg?optimizer=image&amp;format=webp&amp;width=1200&amp;aspectRatio=1.33 1200w, https://media.magloft.app/pdf-import/1144/images/img_10-1.jpg?optimizer=image&amp;format=webp&amp;width=1920&amp;aspectRatio=1.33 1920w, https://media.magloft.app/pdf-import/1144/images/img_10-1.jpg?optimizer=image&amp;format=webp&amp;width=2048&amp;aspectRatio=1.33 2048w" src="https://media.magloft.app/pdf-import/1144/images/img_10-1.jpg?optimizer=image&amp;format=webp&amp;width=2048&amp;aspectRatio=1.33"/></div><div class="Block_article-contents__M6B6V"><h3>Aravax successfully recruits for phase 3 peanut allergy treatment study</h3><p>Clinical-stage biotech company Aravax has announced that it has completed phase 2 recruitment for its precision therapy (pvx108) study, which investigates treatment of peanut allergies.</p></div></a><a class="Block_article-card__mncKE" href="/articles/headlands-research-opens-new-clinical-trials-site-in-el-paso-te"><div class="Block_article-cover__vLhzO"><img alt="article-category" loading="lazy" decoding="async" data-nimg="fill" style="position:absolute;height:100%;width:100%;left:0;top:0;right:0;bottom:0;color:transparent;background-size:cover;background-position:50% 50%;background-repeat:no-repeat;background-image:url(&quot;data:image/svg+xml;charset=utf-8,%3Csvg xmlns=&#x27;http%3A//www.w3.org/2000/svg&#x27;%3E%3Cimage style=&#x27;filter:blur(20px)&#x27; preserveAspectRatio=&#x27;none&#x27; x=&#x27;0&#x27; y=&#x27;0&#x27; height=&#x27;100%25&#x27; width=&#x27;100%25&#x27; href=&#x27;data:image/gif;base64,R0lGODlhAQABAPAAANzc3P///yH5BAAAAAAALAAAAAABAAEAAAICRAEAOw==&#x27;/%3E%3C/svg%3E&quot;)" sizes="70px" srcSet="https://media.magloft.app/pdf-import/1125/images/img_6-2.jpg?optimizer=image&amp;format=webp&amp;width=16&amp;aspectRatio=1.33 16w, https://media.magloft.app/pdf-import/1125/images/img_6-2.jpg?optimizer=image&amp;format=webp&amp;width=32&amp;aspectRatio=1.33 32w, https://media.magloft.app/pdf-import/1125/images/img_6-2.jpg?optimizer=image&amp;format=webp&amp;width=48&amp;aspectRatio=1.33 48w, https://media.magloft.app/pdf-import/1125/images/img_6-2.jpg?optimizer=image&amp;format=webp&amp;width=54&amp;aspectRatio=1.33 54w, https://media.magloft.app/pdf-import/1125/images/img_6-2.jpg?optimizer=image&amp;format=webp&amp;width=64&amp;aspectRatio=1.33 64w, https://media.magloft.app/pdf-import/1125/images/img_6-2.jpg?optimizer=image&amp;format=webp&amp;width=70&amp;aspectRatio=1.33 70w, https://media.magloft.app/pdf-import/1125/images/img_6-2.jpg?optimizer=image&amp;format=webp&amp;width=82&amp;aspectRatio=1.33 82w, https://media.magloft.app/pdf-import/1125/images/img_6-2.jpg?optimizer=image&amp;format=webp&amp;width=96&amp;aspectRatio=1.33 96w, https://media.magloft.app/pdf-import/1125/images/img_6-2.jpg?optimizer=image&amp;format=webp&amp;width=96&amp;aspectRatio=1.33 96w, https://media.magloft.app/pdf-import/1125/images/img_6-2.jpg?optimizer=image&amp;format=webp&amp;width=110&amp;aspectRatio=1.33 110w, https://media.magloft.app/pdf-import/1125/images/img_6-2.jpg?optimizer=image&amp;format=webp&amp;width=128&amp;aspectRatio=1.33 128w, https://media.magloft.app/pdf-import/1125/images/img_6-2.jpg?optimizer=image&amp;format=webp&amp;width=128&amp;aspectRatio=1.33 128w, https://media.magloft.app/pdf-import/1125/images/img_6-2.jpg?optimizer=image&amp;format=webp&amp;width=138&amp;aspectRatio=1.33 138w, https://media.magloft.app/pdf-import/1125/images/img_6-2.jpg?optimizer=image&amp;format=webp&amp;width=192&amp;aspectRatio=1.33 192w, https://media.magloft.app/pdf-import/1125/images/img_6-2.jpg?optimizer=image&amp;format=webp&amp;width=200&amp;aspectRatio=1.33 200w, https://media.magloft.app/pdf-import/1125/images/img_6-2.jpg?optimizer=image&amp;format=webp&amp;width=252&amp;aspectRatio=1.33 252w, https://media.magloft.app/pdf-import/1125/images/img_6-2.jpg?optimizer=image&amp;format=webp&amp;width=256&amp;aspectRatio=1.33 256w, https://media.magloft.app/pdf-import/1125/images/img_6-2.jpg?optimizer=image&amp;format=webp&amp;width=260&amp;aspectRatio=1.33 260w, https://media.magloft.app/pdf-import/1125/images/img_6-2.jpg?optimizer=image&amp;format=webp&amp;width=298&amp;aspectRatio=1.33 298w, https://media.magloft.app/pdf-import/1125/images/img_6-2.jpg?optimizer=image&amp;format=webp&amp;width=378&amp;aspectRatio=1.33 378w, https://media.magloft.app/pdf-import/1125/images/img_6-2.jpg?optimizer=image&amp;format=webp&amp;width=384&amp;aspectRatio=1.33 384w, https://media.magloft.app/pdf-import/1125/images/img_6-2.jpg?optimizer=image&amp;format=webp&amp;width=384&amp;aspectRatio=1.33 384w, https://media.magloft.app/pdf-import/1125/images/img_6-2.jpg?optimizer=image&amp;format=webp&amp;width=520&amp;aspectRatio=1.33 520w, https://media.magloft.app/pdf-import/1125/images/img_6-2.jpg?optimizer=image&amp;format=webp&amp;width=640&amp;aspectRatio=1.33 640w, https://media.magloft.app/pdf-import/1125/images/img_6-2.jpg?optimizer=image&amp;format=webp&amp;width=756&amp;aspectRatio=1.33 756w, https://media.magloft.app/pdf-import/1125/images/img_6-2.jpg?optimizer=image&amp;format=webp&amp;width=828&amp;aspectRatio=1.33 828w, https://media.magloft.app/pdf-import/1125/images/img_6-2.jpg?optimizer=image&amp;format=webp&amp;width=1080&amp;aspectRatio=1.33 1080w, https://media.magloft.app/pdf-import/1125/images/img_6-2.jpg?optimizer=image&amp;format=webp&amp;width=1200&amp;aspectRatio=1.33 1200w, https://media.magloft.app/pdf-import/1125/images/img_6-2.jpg?optimizer=image&amp;format=webp&amp;width=1920&amp;aspectRatio=1.33 1920w, https://media.magloft.app/pdf-import/1125/images/img_6-2.jpg?optimizer=image&amp;format=webp&amp;width=2048&amp;aspectRatio=1.33 2048w" src="https://media.magloft.app/pdf-import/1125/images/img_6-2.jpg?optimizer=image&amp;format=webp&amp;width=2048&amp;aspectRatio=1.33"/></div><div class="Block_article-contents__M6B6V"><h3>Headlands Research opens new clinical trials site in El Paso, Texas, to serve Hispanic population</h3><p>Headlands Research, a multinational network of clinical research sites, has launched a new clinical trials site in El Paso, Texas, US.</p></div></a><a class="Block_article-card__mncKE" href="/articles/biologic-medicine-dupixent-approved-by-fda-for-copd-patients-in"><div class="Block_article-cover__vLhzO"><img alt="article-category" loading="lazy" decoding="async" data-nimg="fill" style="position:absolute;height:100%;width:100%;left:0;top:0;right:0;bottom:0;color:transparent;background-size:cover;background-position:50% 50%;background-repeat:no-repeat;background-image:url(&quot;data:image/svg+xml;charset=utf-8,%3Csvg xmlns=&#x27;http%3A//www.w3.org/2000/svg&#x27;%3E%3Cimage style=&#x27;filter:blur(20px)&#x27; preserveAspectRatio=&#x27;none&#x27; x=&#x27;0&#x27; y=&#x27;0&#x27; height=&#x27;100%25&#x27; width=&#x27;100%25&#x27; href=&#x27;data:image/gif;base64,R0lGODlhAQABAPAAANzc3P///yH5BAAAAAAALAAAAAABAAEAAAICRAEAOw==&#x27;/%3E%3C/svg%3E&quot;)" sizes="70px" srcSet="https://media.magloft.app/pdf-import/1125/images/img_8-1.jpg?optimizer=image&amp;format=webp&amp;width=16&amp;aspectRatio=1.33 16w, https://media.magloft.app/pdf-import/1125/images/img_8-1.jpg?optimizer=image&amp;format=webp&amp;width=32&amp;aspectRatio=1.33 32w, https://media.magloft.app/pdf-import/1125/images/img_8-1.jpg?optimizer=image&amp;format=webp&amp;width=48&amp;aspectRatio=1.33 48w, https://media.magloft.app/pdf-import/1125/images/img_8-1.jpg?optimizer=image&amp;format=webp&amp;width=54&amp;aspectRatio=1.33 54w, https://media.magloft.app/pdf-import/1125/images/img_8-1.jpg?optimizer=image&amp;format=webp&amp;width=64&amp;aspectRatio=1.33 64w, https://media.magloft.app/pdf-import/1125/images/img_8-1.jpg?optimizer=image&amp;format=webp&amp;width=70&amp;aspectRatio=1.33 70w, https://media.magloft.app/pdf-import/1125/images/img_8-1.jpg?optimizer=image&amp;format=webp&amp;width=82&amp;aspectRatio=1.33 82w, https://media.magloft.app/pdf-import/1125/images/img_8-1.jpg?optimizer=image&amp;format=webp&amp;width=96&amp;aspectRatio=1.33 96w, https://media.magloft.app/pdf-import/1125/images/img_8-1.jpg?optimizer=image&amp;format=webp&amp;width=96&amp;aspectRatio=1.33 96w, https://media.magloft.app/pdf-import/1125/images/img_8-1.jpg?optimizer=image&amp;format=webp&amp;width=110&amp;aspectRatio=1.33 110w, https://media.magloft.app/pdf-import/1125/images/img_8-1.jpg?optimizer=image&amp;format=webp&amp;width=128&amp;aspectRatio=1.33 128w, https://media.magloft.app/pdf-import/1125/images/img_8-1.jpg?optimizer=image&amp;format=webp&amp;width=128&amp;aspectRatio=1.33 128w, https://media.magloft.app/pdf-import/1125/images/img_8-1.jpg?optimizer=image&amp;format=webp&amp;width=138&amp;aspectRatio=1.33 138w, https://media.magloft.app/pdf-import/1125/images/img_8-1.jpg?optimizer=image&amp;format=webp&amp;width=192&amp;aspectRatio=1.33 192w, https://media.magloft.app/pdf-import/1125/images/img_8-1.jpg?optimizer=image&amp;format=webp&amp;width=200&amp;aspectRatio=1.33 200w, https://media.magloft.app/pdf-import/1125/images/img_8-1.jpg?optimizer=image&amp;format=webp&amp;width=252&amp;aspectRatio=1.33 252w, https://media.magloft.app/pdf-import/1125/images/img_8-1.jpg?optimizer=image&amp;format=webp&amp;width=256&amp;aspectRatio=1.33 256w, https://media.magloft.app/pdf-import/1125/images/img_8-1.jpg?optimizer=image&amp;format=webp&amp;width=260&amp;aspectRatio=1.33 260w, https://media.magloft.app/pdf-import/1125/images/img_8-1.jpg?optimizer=image&amp;format=webp&amp;width=298&amp;aspectRatio=1.33 298w, https://media.magloft.app/pdf-import/1125/images/img_8-1.jpg?optimizer=image&amp;format=webp&amp;width=378&amp;aspectRatio=1.33 378w, https://media.magloft.app/pdf-import/1125/images/img_8-1.jpg?optimizer=image&amp;format=webp&amp;width=384&amp;aspectRatio=1.33 384w, https://media.magloft.app/pdf-import/1125/images/img_8-1.jpg?optimizer=image&amp;format=webp&amp;width=384&amp;aspectRatio=1.33 384w, https://media.magloft.app/pdf-import/1125/images/img_8-1.jpg?optimizer=image&amp;format=webp&amp;width=520&amp;aspectRatio=1.33 520w, https://media.magloft.app/pdf-import/1125/images/img_8-1.jpg?optimizer=image&amp;format=webp&amp;width=640&amp;aspectRatio=1.33 640w, https://media.magloft.app/pdf-import/1125/images/img_8-1.jpg?optimizer=image&amp;format=webp&amp;width=756&amp;aspectRatio=1.33 756w, https://media.magloft.app/pdf-import/1125/images/img_8-1.jpg?optimizer=image&amp;format=webp&amp;width=828&amp;aspectRatio=1.33 828w, https://media.magloft.app/pdf-import/1125/images/img_8-1.jpg?optimizer=image&amp;format=webp&amp;width=1080&amp;aspectRatio=1.33 1080w, https://media.magloft.app/pdf-import/1125/images/img_8-1.jpg?optimizer=image&amp;format=webp&amp;width=1200&amp;aspectRatio=1.33 1200w, https://media.magloft.app/pdf-import/1125/images/img_8-1.jpg?optimizer=image&amp;format=webp&amp;width=1920&amp;aspectRatio=1.33 1920w, https://media.magloft.app/pdf-import/1125/images/img_8-1.jpg?optimizer=image&amp;format=webp&amp;width=2048&amp;aspectRatio=1.33 2048w" src="https://media.magloft.app/pdf-import/1125/images/img_8-1.jpg?optimizer=image&amp;format=webp&amp;width=2048&amp;aspectRatio=1.33"/></div><div class="Block_article-contents__M6B6V"><h3>Biologic medicine Dupixent approved by FDA for COPD patients in the US</h3><p>The US Food and Drug Administration has approved Sanofi’s Dupixent as an add-on maintenance treatment for adults with inadequately controlled chronic obstructive pulmonary disease (COPD) and an eosinophilic phenotype.</p></div></a><a class="Block_article-card__mncKE" href="/articles/tiziana-life-sciences-awarded-4m-grant-by-nih-to-study-anti-cd3"><div class="Block_article-cover__vLhzO"><img alt="article-category" loading="lazy" decoding="async" data-nimg="fill" style="position:absolute;height:100%;width:100%;left:0;top:0;right:0;bottom:0;color:transparent;background-size:cover;background-position:50% 50%;background-repeat:no-repeat;background-image:url(&quot;data:image/svg+xml;charset=utf-8,%3Csvg xmlns=&#x27;http%3A//www.w3.org/2000/svg&#x27;%3E%3Cimage style=&#x27;filter:blur(20px)&#x27; preserveAspectRatio=&#x27;none&#x27; x=&#x27;0&#x27; y=&#x27;0&#x27; height=&#x27;100%25&#x27; width=&#x27;100%25&#x27; href=&#x27;data:image/gif;base64,R0lGODlhAQABAPAAANzc3P///yH5BAAAAAAALAAAAAABAAEAAAICRAEAOw==&#x27;/%3E%3C/svg%3E&quot;)" sizes="70px" srcSet="https://media.magloft.app/pdf-import/1125/images/img_7-1.jpg?optimizer=image&amp;format=webp&amp;width=16&amp;aspectRatio=1.33 16w, https://media.magloft.app/pdf-import/1125/images/img_7-1.jpg?optimizer=image&amp;format=webp&amp;width=32&amp;aspectRatio=1.33 32w, https://media.magloft.app/pdf-import/1125/images/img_7-1.jpg?optimizer=image&amp;format=webp&amp;width=48&amp;aspectRatio=1.33 48w, https://media.magloft.app/pdf-import/1125/images/img_7-1.jpg?optimizer=image&amp;format=webp&amp;width=54&amp;aspectRatio=1.33 54w, https://media.magloft.app/pdf-import/1125/images/img_7-1.jpg?optimizer=image&amp;format=webp&amp;width=64&amp;aspectRatio=1.33 64w, https://media.magloft.app/pdf-import/1125/images/img_7-1.jpg?optimizer=image&amp;format=webp&amp;width=70&amp;aspectRatio=1.33 70w, https://media.magloft.app/pdf-import/1125/images/img_7-1.jpg?optimizer=image&amp;format=webp&amp;width=82&amp;aspectRatio=1.33 82w, https://media.magloft.app/pdf-import/1125/images/img_7-1.jpg?optimizer=image&amp;format=webp&amp;width=96&amp;aspectRatio=1.33 96w, https://media.magloft.app/pdf-import/1125/images/img_7-1.jpg?optimizer=image&amp;format=webp&amp;width=96&amp;aspectRatio=1.33 96w, https://media.magloft.app/pdf-import/1125/images/img_7-1.jpg?optimizer=image&amp;format=webp&amp;width=110&amp;aspectRatio=1.33 110w, https://media.magloft.app/pdf-import/1125/images/img_7-1.jpg?optimizer=image&amp;format=webp&amp;width=128&amp;aspectRatio=1.33 128w, https://media.magloft.app/pdf-import/1125/images/img_7-1.jpg?optimizer=image&amp;format=webp&amp;width=128&amp;aspectRatio=1.33 128w, https://media.magloft.app/pdf-import/1125/images/img_7-1.jpg?optimizer=image&amp;format=webp&amp;width=138&amp;aspectRatio=1.33 138w, https://media.magloft.app/pdf-import/1125/images/img_7-1.jpg?optimizer=image&amp;format=webp&amp;width=192&amp;aspectRatio=1.33 192w, https://media.magloft.app/pdf-import/1125/images/img_7-1.jpg?optimizer=image&amp;format=webp&amp;width=200&amp;aspectRatio=1.33 200w, https://media.magloft.app/pdf-import/1125/images/img_7-1.jpg?optimizer=image&amp;format=webp&amp;width=252&amp;aspectRatio=1.33 252w, https://media.magloft.app/pdf-import/1125/images/img_7-1.jpg?optimizer=image&amp;format=webp&amp;width=256&amp;aspectRatio=1.33 256w, https://media.magloft.app/pdf-import/1125/images/img_7-1.jpg?optimizer=image&amp;format=webp&amp;width=260&amp;aspectRatio=1.33 260w, https://media.magloft.app/pdf-import/1125/images/img_7-1.jpg?optimizer=image&amp;format=webp&amp;width=298&amp;aspectRatio=1.33 298w, https://media.magloft.app/pdf-import/1125/images/img_7-1.jpg?optimizer=image&amp;format=webp&amp;width=378&amp;aspectRatio=1.33 378w, https://media.magloft.app/pdf-import/1125/images/img_7-1.jpg?optimizer=image&amp;format=webp&amp;width=384&amp;aspectRatio=1.33 384w, https://media.magloft.app/pdf-import/1125/images/img_7-1.jpg?optimizer=image&amp;format=webp&amp;width=384&amp;aspectRatio=1.33 384w, https://media.magloft.app/pdf-import/1125/images/img_7-1.jpg?optimizer=image&amp;format=webp&amp;width=520&amp;aspectRatio=1.33 520w, https://media.magloft.app/pdf-import/1125/images/img_7-1.jpg?optimizer=image&amp;format=webp&amp;width=640&amp;aspectRatio=1.33 640w, https://media.magloft.app/pdf-import/1125/images/img_7-1.jpg?optimizer=image&amp;format=webp&amp;width=756&amp;aspectRatio=1.33 756w, https://media.magloft.app/pdf-import/1125/images/img_7-1.jpg?optimizer=image&amp;format=webp&amp;width=828&amp;aspectRatio=1.33 828w, https://media.magloft.app/pdf-import/1125/images/img_7-1.jpg?optimizer=image&amp;format=webp&amp;width=1080&amp;aspectRatio=1.33 1080w, https://media.magloft.app/pdf-import/1125/images/img_7-1.jpg?optimizer=image&amp;format=webp&amp;width=1200&amp;aspectRatio=1.33 1200w, https://media.magloft.app/pdf-import/1125/images/img_7-1.jpg?optimizer=image&amp;format=webp&amp;width=1920&amp;aspectRatio=1.33 1920w, https://media.magloft.app/pdf-import/1125/images/img_7-1.jpg?optimizer=image&amp;format=webp&amp;width=2048&amp;aspectRatio=1.33 2048w" src="https://media.magloft.app/pdf-import/1125/images/img_7-1.jpg?optimizer=image&amp;format=webp&amp;width=2048&amp;aspectRatio=1.33"/></div><div class="Block_article-contents__M6B6V"><h3>Tiziana Life Sciences awarded $4m grant by NIH to study anti-CD3 in Alzheimer’s disease</h3><p>Tiziana Life Sciences, a biotechnology company developing immunomodulation therapies, announced that the National Institutes of Health (NIH),&#x27;s National Institute on Aging has awarded a $4m grant to Dr Howard Weiner as principal investigator at Brigham and Women’s Hospital to be the key research site to study nasal anti-cd3 for the treatment of alzheimer’s disease (ad).</p></div></a><a class="Block_article-card__mncKE" href="/articles/european-commission-approves-astellas-pharma-s-gej-adenocarcinom"><div class="Block_article-cover__vLhzO"><img alt="article-category" loading="lazy" decoding="async" data-nimg="fill" style="position:absolute;height:100%;width:100%;left:0;top:0;right:0;bottom:0;color:transparent;background-size:cover;background-position:50% 50%;background-repeat:no-repeat;background-image:url(&quot;data:image/svg+xml;charset=utf-8,%3Csvg xmlns=&#x27;http%3A//www.w3.org/2000/svg&#x27;%3E%3Cimage style=&#x27;filter:blur(20px)&#x27; preserveAspectRatio=&#x27;none&#x27; x=&#x27;0&#x27; y=&#x27;0&#x27; height=&#x27;100%25&#x27; width=&#x27;100%25&#x27; href=&#x27;data:image/gif;base64,R0lGODlhAQABAPAAANzc3P///yH5BAAAAAAALAAAAAABAAEAAAICRAEAOw==&#x27;/%3E%3C/svg%3E&quot;)" sizes="70px" srcSet="https://media.magloft.app/pdf-import/1125/images/pages/pg-008.jpg?optimizer=image&amp;format=webp&amp;width=16&amp;aspectRatio=1.33 16w, https://media.magloft.app/pdf-import/1125/images/pages/pg-008.jpg?optimizer=image&amp;format=webp&amp;width=32&amp;aspectRatio=1.33 32w, https://media.magloft.app/pdf-import/1125/images/pages/pg-008.jpg?optimizer=image&amp;format=webp&amp;width=48&amp;aspectRatio=1.33 48w, https://media.magloft.app/pdf-import/1125/images/pages/pg-008.jpg?optimizer=image&amp;format=webp&amp;width=54&amp;aspectRatio=1.33 54w, https://media.magloft.app/pdf-import/1125/images/pages/pg-008.jpg?optimizer=image&amp;format=webp&amp;width=64&amp;aspectRatio=1.33 64w, https://media.magloft.app/pdf-import/1125/images/pages/pg-008.jpg?optimizer=image&amp;format=webp&amp;width=70&amp;aspectRatio=1.33 70w, https://media.magloft.app/pdf-import/1125/images/pages/pg-008.jpg?optimizer=image&amp;format=webp&amp;width=82&amp;aspectRatio=1.33 82w, https://media.magloft.app/pdf-import/1125/images/pages/pg-008.jpg?optimizer=image&amp;format=webp&amp;width=96&amp;aspectRatio=1.33 96w, https://media.magloft.app/pdf-import/1125/images/pages/pg-008.jpg?optimizer=image&amp;format=webp&amp;width=96&amp;aspectRatio=1.33 96w, https://media.magloft.app/pdf-import/1125/images/pages/pg-008.jpg?optimizer=image&amp;format=webp&amp;width=110&amp;aspectRatio=1.33 110w, https://media.magloft.app/pdf-import/1125/images/pages/pg-008.jpg?optimizer=image&amp;format=webp&amp;width=128&amp;aspectRatio=1.33 128w, https://media.magloft.app/pdf-import/1125/images/pages/pg-008.jpg?optimizer=image&amp;format=webp&amp;width=128&amp;aspectRatio=1.33 128w, https://media.magloft.app/pdf-import/1125/images/pages/pg-008.jpg?optimizer=image&amp;format=webp&amp;width=138&amp;aspectRatio=1.33 138w, https://media.magloft.app/pdf-import/1125/images/pages/pg-008.jpg?optimizer=image&amp;format=webp&amp;width=192&amp;aspectRatio=1.33 192w, https://media.magloft.app/pdf-import/1125/images/pages/pg-008.jpg?optimizer=image&amp;format=webp&amp;width=200&amp;aspectRatio=1.33 200w, https://media.magloft.app/pdf-import/1125/images/pages/pg-008.jpg?optimizer=image&amp;format=webp&amp;width=252&amp;aspectRatio=1.33 252w, https://media.magloft.app/pdf-import/1125/images/pages/pg-008.jpg?optimizer=image&amp;format=webp&amp;width=256&amp;aspectRatio=1.33 256w, https://media.magloft.app/pdf-import/1125/images/pages/pg-008.jpg?optimizer=image&amp;format=webp&amp;width=260&amp;aspectRatio=1.33 260w, https://media.magloft.app/pdf-import/1125/images/pages/pg-008.jpg?optimizer=image&amp;format=webp&amp;width=298&amp;aspectRatio=1.33 298w, https://media.magloft.app/pdf-import/1125/images/pages/pg-008.jpg?optimizer=image&amp;format=webp&amp;width=378&amp;aspectRatio=1.33 378w, https://media.magloft.app/pdf-import/1125/images/pages/pg-008.jpg?optimizer=image&amp;format=webp&amp;width=384&amp;aspectRatio=1.33 384w, https://media.magloft.app/pdf-import/1125/images/pages/pg-008.jpg?optimizer=image&amp;format=webp&amp;width=384&amp;aspectRatio=1.33 384w, https://media.magloft.app/pdf-import/1125/images/pages/pg-008.jpg?optimizer=image&amp;format=webp&amp;width=520&amp;aspectRatio=1.33 520w, https://media.magloft.app/pdf-import/1125/images/pages/pg-008.jpg?optimizer=image&amp;format=webp&amp;width=640&amp;aspectRatio=1.33 640w, https://media.magloft.app/pdf-import/1125/images/pages/pg-008.jpg?optimizer=image&amp;format=webp&amp;width=756&amp;aspectRatio=1.33 756w, https://media.magloft.app/pdf-import/1125/images/pages/pg-008.jpg?optimizer=image&amp;format=webp&amp;width=828&amp;aspectRatio=1.33 828w, https://media.magloft.app/pdf-import/1125/images/pages/pg-008.jpg?optimizer=image&amp;format=webp&amp;width=1080&amp;aspectRatio=1.33 1080w, https://media.magloft.app/pdf-import/1125/images/pages/pg-008.jpg?optimizer=image&amp;format=webp&amp;width=1200&amp;aspectRatio=1.33 1200w, https://media.magloft.app/pdf-import/1125/images/pages/pg-008.jpg?optimizer=image&amp;format=webp&amp;width=1920&amp;aspectRatio=1.33 1920w, https://media.magloft.app/pdf-import/1125/images/pages/pg-008.jpg?optimizer=image&amp;format=webp&amp;width=2048&amp;aspectRatio=1.33 2048w" src="https://media.magloft.app/pdf-import/1125/images/pages/pg-008.jpg?optimizer=image&amp;format=webp&amp;width=2048&amp;aspectRatio=1.33"/></div><div class="Block_article-contents__M6B6V"><h3>European Commission approves Astellas Pharma’s GEJ adenocarcinoma treatment</h3><p>The European Commission (EC) has approved Astellas Pharma’s vyloy (zolbetuximab) in combination with fluoropyrimidine and platinum-containing chemotherapy as a treatment for adult patients with locally advanced unresectable or metastatic human epidermal growth factor receptor 2 (HER2)negative gastric or gastro-oesophageal junction (GEJ) adenocarcinoma whose tumours are claudin (CLDN) 18.2 positive.</p></div></a><a class="Block_article-card__mncKE" href="/articles/ministry-of-health-labour-and-welfare-of-japan-approves-new-dru"><div class="Block_article-cover__vLhzO"><img alt="article-category" loading="lazy" decoding="async" data-nimg="fill" style="position:absolute;height:100%;width:100%;left:0;top:0;right:0;bottom:0;color:transparent;background-size:cover;background-position:50% 50%;background-repeat:no-repeat;background-image:url(&quot;data:image/svg+xml;charset=utf-8,%3Csvg xmlns=&#x27;http%3A//www.w3.org/2000/svg&#x27;%3E%3Cimage style=&#x27;filter:blur(20px)&#x27; preserveAspectRatio=&#x27;none&#x27; x=&#x27;0&#x27; y=&#x27;0&#x27; height=&#x27;100%25&#x27; width=&#x27;100%25&#x27; href=&#x27;data:image/gif;base64,R0lGODlhAQABAPAAANzc3P///yH5BAAAAAAALAAAAAABAAEAAAICRAEAOw==&#x27;/%3E%3C/svg%3E&quot;)" sizes="70px" srcSet="https://media.magloft.app/pdf-import/1125/images/img_9-2.jpg?optimizer=image&amp;format=webp&amp;width=16&amp;aspectRatio=1.33 16w, https://media.magloft.app/pdf-import/1125/images/img_9-2.jpg?optimizer=image&amp;format=webp&amp;width=32&amp;aspectRatio=1.33 32w, https://media.magloft.app/pdf-import/1125/images/img_9-2.jpg?optimizer=image&amp;format=webp&amp;width=48&amp;aspectRatio=1.33 48w, https://media.magloft.app/pdf-import/1125/images/img_9-2.jpg?optimizer=image&amp;format=webp&amp;width=54&amp;aspectRatio=1.33 54w, https://media.magloft.app/pdf-import/1125/images/img_9-2.jpg?optimizer=image&amp;format=webp&amp;width=64&amp;aspectRatio=1.33 64w, https://media.magloft.app/pdf-import/1125/images/img_9-2.jpg?optimizer=image&amp;format=webp&amp;width=70&amp;aspectRatio=1.33 70w, https://media.magloft.app/pdf-import/1125/images/img_9-2.jpg?optimizer=image&amp;format=webp&amp;width=82&amp;aspectRatio=1.33 82w, https://media.magloft.app/pdf-import/1125/images/img_9-2.jpg?optimizer=image&amp;format=webp&amp;width=96&amp;aspectRatio=1.33 96w, https://media.magloft.app/pdf-import/1125/images/img_9-2.jpg?optimizer=image&amp;format=webp&amp;width=96&amp;aspectRatio=1.33 96w, https://media.magloft.app/pdf-import/1125/images/img_9-2.jpg?optimizer=image&amp;format=webp&amp;width=110&amp;aspectRatio=1.33 110w, https://media.magloft.app/pdf-import/1125/images/img_9-2.jpg?optimizer=image&amp;format=webp&amp;width=128&amp;aspectRatio=1.33 128w, https://media.magloft.app/pdf-import/1125/images/img_9-2.jpg?optimizer=image&amp;format=webp&amp;width=128&amp;aspectRatio=1.33 128w, https://media.magloft.app/pdf-import/1125/images/img_9-2.jpg?optimizer=image&amp;format=webp&amp;width=138&amp;aspectRatio=1.33 138w, https://media.magloft.app/pdf-import/1125/images/img_9-2.jpg?optimizer=image&amp;format=webp&amp;width=192&amp;aspectRatio=1.33 192w, https://media.magloft.app/pdf-import/1125/images/img_9-2.jpg?optimizer=image&amp;format=webp&amp;width=200&amp;aspectRatio=1.33 200w, https://media.magloft.app/pdf-import/1125/images/img_9-2.jpg?optimizer=image&amp;format=webp&amp;width=252&amp;aspectRatio=1.33 252w, https://media.magloft.app/pdf-import/1125/images/img_9-2.jpg?optimizer=image&amp;format=webp&amp;width=256&amp;aspectRatio=1.33 256w, https://media.magloft.app/pdf-import/1125/images/img_9-2.jpg?optimizer=image&amp;format=webp&amp;width=260&amp;aspectRatio=1.33 260w, https://media.magloft.app/pdf-import/1125/images/img_9-2.jpg?optimizer=image&amp;format=webp&amp;width=298&amp;aspectRatio=1.33 298w, https://media.magloft.app/pdf-import/1125/images/img_9-2.jpg?optimizer=image&amp;format=webp&amp;width=378&amp;aspectRatio=1.33 378w, https://media.magloft.app/pdf-import/1125/images/img_9-2.jpg?optimizer=image&amp;format=webp&amp;width=384&amp;aspectRatio=1.33 384w, https://media.magloft.app/pdf-import/1125/images/img_9-2.jpg?optimizer=image&amp;format=webp&amp;width=384&amp;aspectRatio=1.33 384w, https://media.magloft.app/pdf-import/1125/images/img_9-2.jpg?optimizer=image&amp;format=webp&amp;width=520&amp;aspectRatio=1.33 520w, https://media.magloft.app/pdf-import/1125/images/img_9-2.jpg?optimizer=image&amp;format=webp&amp;width=640&amp;aspectRatio=1.33 640w, https://media.magloft.app/pdf-import/1125/images/img_9-2.jpg?optimizer=image&amp;format=webp&amp;width=756&amp;aspectRatio=1.33 756w, https://media.magloft.app/pdf-import/1125/images/img_9-2.jpg?optimizer=image&amp;format=webp&amp;width=828&amp;aspectRatio=1.33 828w, https://media.magloft.app/pdf-import/1125/images/img_9-2.jpg?optimizer=image&amp;format=webp&amp;width=1080&amp;aspectRatio=1.33 1080w, https://media.magloft.app/pdf-import/1125/images/img_9-2.jpg?optimizer=image&amp;format=webp&amp;width=1200&amp;aspectRatio=1.33 1200w, https://media.magloft.app/pdf-import/1125/images/img_9-2.jpg?optimizer=image&amp;format=webp&amp;width=1920&amp;aspectRatio=1.33 1920w, https://media.magloft.app/pdf-import/1125/images/img_9-2.jpg?optimizer=image&amp;format=webp&amp;width=2048&amp;aspectRatio=1.33 2048w" src="https://media.magloft.app/pdf-import/1125/images/img_9-2.jpg?optimizer=image&amp;format=webp&amp;width=2048&amp;aspectRatio=1.33"/></div><div class="Block_article-contents__M6B6V"><h3>Ministry of Health, Labour and Welfare of Japan approves new drug for early Alzheimer’s disease</h3><p>The Ministry of Health, Labour and Welfare Japan has approved treatment for Eli Lilly’s KINSULA, indicated for adult patients with early symptomatic Alzheimer’s disease (AD). This also includes patients with mild dementia stage AD, and mild cognitive impairment.</p></div></a><a class="Block_article-card__mncKE" href="/articles/new-collaboration-agreement-announced-between-emih-association-a"><div class="Block_article-cover__vLhzO"><img alt="article-category" loading="lazy" decoding="async" data-nimg="fill" style="position:absolute;height:100%;width:100%;left:0;top:0;right:0;bottom:0;color:transparent;background-size:cover;background-position:50% 50%;background-repeat:no-repeat;background-image:url(&quot;data:image/svg+xml;charset=utf-8,%3Csvg xmlns=&#x27;http%3A//www.w3.org/2000/svg&#x27;%3E%3Cimage style=&#x27;filter:blur(20px)&#x27; preserveAspectRatio=&#x27;none&#x27; x=&#x27;0&#x27; y=&#x27;0&#x27; height=&#x27;100%25&#x27; width=&#x27;100%25&#x27; href=&#x27;data:image/gif;base64,R0lGODlhAQABAPAAANzc3P///yH5BAAAAAAALAAAAAABAAEAAAICRAEAOw==&#x27;/%3E%3C/svg%3E&quot;)" sizes="70px" srcSet="https://media.magloft.app/pdf-import/1125/images/img_10-1.jpg?optimizer=image&amp;format=webp&amp;width=16&amp;aspectRatio=1.33 16w, https://media.magloft.app/pdf-import/1125/images/img_10-1.jpg?optimizer=image&amp;format=webp&amp;width=32&amp;aspectRatio=1.33 32w, https://media.magloft.app/pdf-import/1125/images/img_10-1.jpg?optimizer=image&amp;format=webp&amp;width=48&amp;aspectRatio=1.33 48w, https://media.magloft.app/pdf-import/1125/images/img_10-1.jpg?optimizer=image&amp;format=webp&amp;width=54&amp;aspectRatio=1.33 54w, https://media.magloft.app/pdf-import/1125/images/img_10-1.jpg?optimizer=image&amp;format=webp&amp;width=64&amp;aspectRatio=1.33 64w, https://media.magloft.app/pdf-import/1125/images/img_10-1.jpg?optimizer=image&amp;format=webp&amp;width=70&amp;aspectRatio=1.33 70w, https://media.magloft.app/pdf-import/1125/images/img_10-1.jpg?optimizer=image&amp;format=webp&amp;width=82&amp;aspectRatio=1.33 82w, https://media.magloft.app/pdf-import/1125/images/img_10-1.jpg?optimizer=image&amp;format=webp&amp;width=96&amp;aspectRatio=1.33 96w, https://media.magloft.app/pdf-import/1125/images/img_10-1.jpg?optimizer=image&amp;format=webp&amp;width=96&amp;aspectRatio=1.33 96w, https://media.magloft.app/pdf-import/1125/images/img_10-1.jpg?optimizer=image&amp;format=webp&amp;width=110&amp;aspectRatio=1.33 110w, https://media.magloft.app/pdf-import/1125/images/img_10-1.jpg?optimizer=image&amp;format=webp&amp;width=128&amp;aspectRatio=1.33 128w, https://media.magloft.app/pdf-import/1125/images/img_10-1.jpg?optimizer=image&amp;format=webp&amp;width=128&amp;aspectRatio=1.33 128w, https://media.magloft.app/pdf-import/1125/images/img_10-1.jpg?optimizer=image&amp;format=webp&amp;width=138&amp;aspectRatio=1.33 138w, https://media.magloft.app/pdf-import/1125/images/img_10-1.jpg?optimizer=image&amp;format=webp&amp;width=192&amp;aspectRatio=1.33 192w, https://media.magloft.app/pdf-import/1125/images/img_10-1.jpg?optimizer=image&amp;format=webp&amp;width=200&amp;aspectRatio=1.33 200w, https://media.magloft.app/pdf-import/1125/images/img_10-1.jpg?optimizer=image&amp;format=webp&amp;width=252&amp;aspectRatio=1.33 252w, https://media.magloft.app/pdf-import/1125/images/img_10-1.jpg?optimizer=image&amp;format=webp&amp;width=256&amp;aspectRatio=1.33 256w, https://media.magloft.app/pdf-import/1125/images/img_10-1.jpg?optimizer=image&amp;format=webp&amp;width=260&amp;aspectRatio=1.33 260w, https://media.magloft.app/pdf-import/1125/images/img_10-1.jpg?optimizer=image&amp;format=webp&amp;width=298&amp;aspectRatio=1.33 298w, https://media.magloft.app/pdf-import/1125/images/img_10-1.jpg?optimizer=image&amp;format=webp&amp;width=378&amp;aspectRatio=1.33 378w, https://media.magloft.app/pdf-import/1125/images/img_10-1.jpg?optimizer=image&amp;format=webp&amp;width=384&amp;aspectRatio=1.33 384w, https://media.magloft.app/pdf-import/1125/images/img_10-1.jpg?optimizer=image&amp;format=webp&amp;width=384&amp;aspectRatio=1.33 384w, https://media.magloft.app/pdf-import/1125/images/img_10-1.jpg?optimizer=image&amp;format=webp&amp;width=520&amp;aspectRatio=1.33 520w, https://media.magloft.app/pdf-import/1125/images/img_10-1.jpg?optimizer=image&amp;format=webp&amp;width=640&amp;aspectRatio=1.33 640w, https://media.magloft.app/pdf-import/1125/images/img_10-1.jpg?optimizer=image&amp;format=webp&amp;width=756&amp;aspectRatio=1.33 756w, https://media.magloft.app/pdf-import/1125/images/img_10-1.jpg?optimizer=image&amp;format=webp&amp;width=828&amp;aspectRatio=1.33 828w, https://media.magloft.app/pdf-import/1125/images/img_10-1.jpg?optimizer=image&amp;format=webp&amp;width=1080&amp;aspectRatio=1.33 1080w, https://media.magloft.app/pdf-import/1125/images/img_10-1.jpg?optimizer=image&amp;format=webp&amp;width=1200&amp;aspectRatio=1.33 1200w, https://media.magloft.app/pdf-import/1125/images/img_10-1.jpg?optimizer=image&amp;format=webp&amp;width=1920&amp;aspectRatio=1.33 1920w, https://media.magloft.app/pdf-import/1125/images/img_10-1.jpg?optimizer=image&amp;format=webp&amp;width=2048&amp;aspectRatio=1.33 2048w" src="https://media.magloft.app/pdf-import/1125/images/img_10-1.jpg?optimizer=image&amp;format=webp&amp;width=2048&amp;aspectRatio=1.33"/></div><div class="Block_article-contents__M6B6V"><h3>New collaboration agreement announced between EMIH association and the MTIG</h3><p>The European Microbiome Innovation for Health (EMIH) association and the Microbiome Therapeutics Innovation Group (MTIG) have announced a new collaborative agreement. The agreement seeks to advance microbiome drug development by improving collaboration between the two microbiome focused coalitions. </p></div></a><a class="Block_article-card__mncKE" href="/articles/fda-approves-first-drug-in-50-years-for-treatment-of-schizophren"><div class="Block_article-cover__vLhzO"><img alt="article-category" loading="lazy" decoding="async" data-nimg="fill" style="position:absolute;height:100%;width:100%;left:0;top:0;right:0;bottom:0;color:transparent;background-size:cover;background-position:50% 50%;background-repeat:no-repeat;background-image:url(&quot;data:image/svg+xml;charset=utf-8,%3Csvg xmlns=&#x27;http%3A//www.w3.org/2000/svg&#x27;%3E%3Cimage style=&#x27;filter:blur(20px)&#x27; preserveAspectRatio=&#x27;none&#x27; x=&#x27;0&#x27; y=&#x27;0&#x27; height=&#x27;100%25&#x27; width=&#x27;100%25&#x27; href=&#x27;data:image/gif;base64,R0lGODlhAQABAPAAANzc3P///yH5BAAAAAAALAAAAAABAAEAAAICRAEAOw==&#x27;/%3E%3C/svg%3E&quot;)" sizes="70px" srcSet="https://media.magloft.app/pdf-import/1125/images/img_1-1.jpg?optimizer=image&amp;format=webp&amp;width=16&amp;aspectRatio=1.33 16w, https://media.magloft.app/pdf-import/1125/images/img_1-1.jpg?optimizer=image&amp;format=webp&amp;width=32&amp;aspectRatio=1.33 32w, https://media.magloft.app/pdf-import/1125/images/img_1-1.jpg?optimizer=image&amp;format=webp&amp;width=48&amp;aspectRatio=1.33 48w, https://media.magloft.app/pdf-import/1125/images/img_1-1.jpg?optimizer=image&amp;format=webp&amp;width=54&amp;aspectRatio=1.33 54w, https://media.magloft.app/pdf-import/1125/images/img_1-1.jpg?optimizer=image&amp;format=webp&amp;width=64&amp;aspectRatio=1.33 64w, https://media.magloft.app/pdf-import/1125/images/img_1-1.jpg?optimizer=image&amp;format=webp&amp;width=70&amp;aspectRatio=1.33 70w, https://media.magloft.app/pdf-import/1125/images/img_1-1.jpg?optimizer=image&amp;format=webp&amp;width=82&amp;aspectRatio=1.33 82w, https://media.magloft.app/pdf-import/1125/images/img_1-1.jpg?optimizer=image&amp;format=webp&amp;width=96&amp;aspectRatio=1.33 96w, https://media.magloft.app/pdf-import/1125/images/img_1-1.jpg?optimizer=image&amp;format=webp&amp;width=96&amp;aspectRatio=1.33 96w, https://media.magloft.app/pdf-import/1125/images/img_1-1.jpg?optimizer=image&amp;format=webp&amp;width=110&amp;aspectRatio=1.33 110w, https://media.magloft.app/pdf-import/1125/images/img_1-1.jpg?optimizer=image&amp;format=webp&amp;width=128&amp;aspectRatio=1.33 128w, https://media.magloft.app/pdf-import/1125/images/img_1-1.jpg?optimizer=image&amp;format=webp&amp;width=128&amp;aspectRatio=1.33 128w, https://media.magloft.app/pdf-import/1125/images/img_1-1.jpg?optimizer=image&amp;format=webp&amp;width=138&amp;aspectRatio=1.33 138w, https://media.magloft.app/pdf-import/1125/images/img_1-1.jpg?optimizer=image&amp;format=webp&amp;width=192&amp;aspectRatio=1.33 192w, https://media.magloft.app/pdf-import/1125/images/img_1-1.jpg?optimizer=image&amp;format=webp&amp;width=200&amp;aspectRatio=1.33 200w, https://media.magloft.app/pdf-import/1125/images/img_1-1.jpg?optimizer=image&amp;format=webp&amp;width=252&amp;aspectRatio=1.33 252w, https://media.magloft.app/pdf-import/1125/images/img_1-1.jpg?optimizer=image&amp;format=webp&amp;width=256&amp;aspectRatio=1.33 256w, https://media.magloft.app/pdf-import/1125/images/img_1-1.jpg?optimizer=image&amp;format=webp&amp;width=260&amp;aspectRatio=1.33 260w, https://media.magloft.app/pdf-import/1125/images/img_1-1.jpg?optimizer=image&amp;format=webp&amp;width=298&amp;aspectRatio=1.33 298w, https://media.magloft.app/pdf-import/1125/images/img_1-1.jpg?optimizer=image&amp;format=webp&amp;width=378&amp;aspectRatio=1.33 378w, https://media.magloft.app/pdf-import/1125/images/img_1-1.jpg?optimizer=image&amp;format=webp&amp;width=384&amp;aspectRatio=1.33 384w, https://media.magloft.app/pdf-import/1125/images/img_1-1.jpg?optimizer=image&amp;format=webp&amp;width=384&amp;aspectRatio=1.33 384w, https://media.magloft.app/pdf-import/1125/images/img_1-1.jpg?optimizer=image&amp;format=webp&amp;width=520&amp;aspectRatio=1.33 520w, https://media.magloft.app/pdf-import/1125/images/img_1-1.jpg?optimizer=image&amp;format=webp&amp;width=640&amp;aspectRatio=1.33 640w, https://media.magloft.app/pdf-import/1125/images/img_1-1.jpg?optimizer=image&amp;format=webp&amp;width=756&amp;aspectRatio=1.33 756w, https://media.magloft.app/pdf-import/1125/images/img_1-1.jpg?optimizer=image&amp;format=webp&amp;width=828&amp;aspectRatio=1.33 828w, https://media.magloft.app/pdf-import/1125/images/img_1-1.jpg?optimizer=image&amp;format=webp&amp;width=1080&amp;aspectRatio=1.33 1080w, https://media.magloft.app/pdf-import/1125/images/img_1-1.jpg?optimizer=image&amp;format=webp&amp;width=1200&amp;aspectRatio=1.33 1200w, https://media.magloft.app/pdf-import/1125/images/img_1-1.jpg?optimizer=image&amp;format=webp&amp;width=1920&amp;aspectRatio=1.33 1920w, https://media.magloft.app/pdf-import/1125/images/img_1-1.jpg?optimizer=image&amp;format=webp&amp;width=2048&amp;aspectRatio=1.33 2048w" src="https://media.magloft.app/pdf-import/1125/images/img_1-1.jpg?optimizer=image&amp;format=webp&amp;width=2048&amp;aspectRatio=1.33"/></div><div class="Block_article-contents__M6B6V"><h3>FDA approves first drug in 50 years for treatment of schizophrenia in adults</h3><p>Earlier this September, the US Food and Drug Administration (FDA) granted approval for PureTech Health’s Karxt for the treatment of schizophrenia in adults, triggering royalty payments of $29m to PureTech. It will be the first approved mechanism by the FDAfor schizophrenia in over 50 years.</p></div></a><a class="Block_article-card__mncKE" href="/articles/third-application-for-orion-s-prostate-cancer-drug-submitted-by"><div class="Block_article-cover__vLhzO"><img alt="article-category" loading="lazy" decoding="async" data-nimg="fill" style="position:absolute;height:100%;width:100%;left:0;top:0;right:0;bottom:0;color:transparent;background-size:cover;background-position:50% 50%;background-repeat:no-repeat;background-image:url(&quot;data:image/svg+xml;charset=utf-8,%3Csvg xmlns=&#x27;http%3A//www.w3.org/2000/svg&#x27;%3E%3Cimage style=&#x27;filter:blur(20px)&#x27; preserveAspectRatio=&#x27;none&#x27; x=&#x27;0&#x27; y=&#x27;0&#x27; height=&#x27;100%25&#x27; width=&#x27;100%25&#x27; href=&#x27;data:image/gif;base64,R0lGODlhAQABAPAAANzc3P///yH5BAAAAAAALAAAAAABAAEAAAICRAEAOw==&#x27;/%3E%3C/svg%3E&quot;)" sizes="70px" srcSet="https://media.magloft.app/pdf-import/1125/images/pages/pg-004.jpg?optimizer=image&amp;format=webp&amp;width=16&amp;aspectRatio=1.33 16w, https://media.magloft.app/pdf-import/1125/images/pages/pg-004.jpg?optimizer=image&amp;format=webp&amp;width=32&amp;aspectRatio=1.33 32w, https://media.magloft.app/pdf-import/1125/images/pages/pg-004.jpg?optimizer=image&amp;format=webp&amp;width=48&amp;aspectRatio=1.33 48w, https://media.magloft.app/pdf-import/1125/images/pages/pg-004.jpg?optimizer=image&amp;format=webp&amp;width=54&amp;aspectRatio=1.33 54w, https://media.magloft.app/pdf-import/1125/images/pages/pg-004.jpg?optimizer=image&amp;format=webp&amp;width=64&amp;aspectRatio=1.33 64w, https://media.magloft.app/pdf-import/1125/images/pages/pg-004.jpg?optimizer=image&amp;format=webp&amp;width=70&amp;aspectRatio=1.33 70w, https://media.magloft.app/pdf-import/1125/images/pages/pg-004.jpg?optimizer=image&amp;format=webp&amp;width=82&amp;aspectRatio=1.33 82w, https://media.magloft.app/pdf-import/1125/images/pages/pg-004.jpg?optimizer=image&amp;format=webp&amp;width=96&amp;aspectRatio=1.33 96w, https://media.magloft.app/pdf-import/1125/images/pages/pg-004.jpg?optimizer=image&amp;format=webp&amp;width=96&amp;aspectRatio=1.33 96w, https://media.magloft.app/pdf-import/1125/images/pages/pg-004.jpg?optimizer=image&amp;format=webp&amp;width=110&amp;aspectRatio=1.33 110w, https://media.magloft.app/pdf-import/1125/images/pages/pg-004.jpg?optimizer=image&amp;format=webp&amp;width=128&amp;aspectRatio=1.33 128w, https://media.magloft.app/pdf-import/1125/images/pages/pg-004.jpg?optimizer=image&amp;format=webp&amp;width=128&amp;aspectRatio=1.33 128w, https://media.magloft.app/pdf-import/1125/images/pages/pg-004.jpg?optimizer=image&amp;format=webp&amp;width=138&amp;aspectRatio=1.33 138w, https://media.magloft.app/pdf-import/1125/images/pages/pg-004.jpg?optimizer=image&amp;format=webp&amp;width=192&amp;aspectRatio=1.33 192w, https://media.magloft.app/pdf-import/1125/images/pages/pg-004.jpg?optimizer=image&amp;format=webp&amp;width=200&amp;aspectRatio=1.33 200w, https://media.magloft.app/pdf-import/1125/images/pages/pg-004.jpg?optimizer=image&amp;format=webp&amp;width=252&amp;aspectRatio=1.33 252w, https://media.magloft.app/pdf-import/1125/images/pages/pg-004.jpg?optimizer=image&amp;format=webp&amp;width=256&amp;aspectRatio=1.33 256w, https://media.magloft.app/pdf-import/1125/images/pages/pg-004.jpg?optimizer=image&amp;format=webp&amp;width=260&amp;aspectRatio=1.33 260w, https://media.magloft.app/pdf-import/1125/images/pages/pg-004.jpg?optimizer=image&amp;format=webp&amp;width=298&amp;aspectRatio=1.33 298w, https://media.magloft.app/pdf-import/1125/images/pages/pg-004.jpg?optimizer=image&amp;format=webp&amp;width=378&amp;aspectRatio=1.33 378w, https://media.magloft.app/pdf-import/1125/images/pages/pg-004.jpg?optimizer=image&amp;format=webp&amp;width=384&amp;aspectRatio=1.33 384w, https://media.magloft.app/pdf-import/1125/images/pages/pg-004.jpg?optimizer=image&amp;format=webp&amp;width=384&amp;aspectRatio=1.33 384w, https://media.magloft.app/pdf-import/1125/images/pages/pg-004.jpg?optimizer=image&amp;format=webp&amp;width=520&amp;aspectRatio=1.33 520w, https://media.magloft.app/pdf-import/1125/images/pages/pg-004.jpg?optimizer=image&amp;format=webp&amp;width=640&amp;aspectRatio=1.33 640w, https://media.magloft.app/pdf-import/1125/images/pages/pg-004.jpg?optimizer=image&amp;format=webp&amp;width=756&amp;aspectRatio=1.33 756w, https://media.magloft.app/pdf-import/1125/images/pages/pg-004.jpg?optimizer=image&amp;format=webp&amp;width=828&amp;aspectRatio=1.33 828w, https://media.magloft.app/pdf-import/1125/images/pages/pg-004.jpg?optimizer=image&amp;format=webp&amp;width=1080&amp;aspectRatio=1.33 1080w, https://media.magloft.app/pdf-import/1125/images/pages/pg-004.jpg?optimizer=image&amp;format=webp&amp;width=1200&amp;aspectRatio=1.33 1200w, https://media.magloft.app/pdf-import/1125/images/pages/pg-004.jpg?optimizer=image&amp;format=webp&amp;width=1920&amp;aspectRatio=1.33 1920w, https://media.magloft.app/pdf-import/1125/images/pages/pg-004.jpg?optimizer=image&amp;format=webp&amp;width=2048&amp;aspectRatio=1.33 2048w" src="https://media.magloft.app/pdf-import/1125/images/pages/pg-004.jpg?optimizer=image&amp;format=webp&amp;width=2048&amp;aspectRatio=1.33"/></div><div class="Block_article-contents__M6B6V"><h3>Third application for Orion’s prostate cancer drug submitted by partner Bayer</h3><p>Finnish pharmaceutical company Orion has announced that its partner Bayer is applying for a third application of its prostate cancer drug, darolutamide, in the US.</p></div></a></div></div><div class="AdvertisementBlock_advertisement-block__8EDkY AdvertisementBlock_placeholder__jhbpI"><div class="AdvertisementBlock_placeholder-inner__UakOd spinner"></div></div><div id="article-category-block" class="Block_block__MHhr4" style="background-color:transparent"><div style="height:auto" class="BlockHeader_block-header__JmokO"><div class="BlockHeader_container-title__l5lHB"><h2 style="border-bottom-color:#2873B0">European News</h2></div><a style="color:#2873B0" href="/categories/general-news"><span>view more</span><div class="Icon_nav-arrow-right__JFm_F Icon_icon__t_YgI icon" style="background-color:#2873B0;min-width:24px"></div></a></div><div class="Block_article-layout__527Uy Block_variant-c__AkeuK"><a class="Block_article-card__mncKE" href="/articles/survey-from-roche-finds-worryingly-low-understandings-about-hpv-a2ec"><div class="Block_article-cover__vLhzO"><img alt="article-category" loading="lazy" decoding="async" data-nimg="fill" style="position:absolute;height:100%;width:100%;left:0;top:0;right:0;bottom:0;color:transparent;background-size:cover;background-position:50% 50%;background-repeat:no-repeat;background-image:url(&quot;data:image/svg+xml;charset=utf-8,%3Csvg xmlns=&#x27;http%3A//www.w3.org/2000/svg&#x27;%3E%3Cimage style=&#x27;filter:blur(20px)&#x27; preserveAspectRatio=&#x27;none&#x27; x=&#x27;0&#x27; y=&#x27;0&#x27; height=&#x27;100%25&#x27; width=&#x27;100%25&#x27; href=&#x27;data:image/gif;base64,R0lGODlhAQABAPAAANzc3P///yH5BAAAAAAALAAAAAABAAEAAAICRAEAOw==&#x27;/%3E%3C/svg%3E&quot;)" sizes="70px" srcSet="https://media.magloft.app/pdf-import/1144/images/img_1-1.jpg?optimizer=image&amp;format=webp&amp;width=16&amp;aspectRatio=1.33 16w, https://media.magloft.app/pdf-import/1144/images/img_1-1.jpg?optimizer=image&amp;format=webp&amp;width=32&amp;aspectRatio=1.33 32w, https://media.magloft.app/pdf-import/1144/images/img_1-1.jpg?optimizer=image&amp;format=webp&amp;width=48&amp;aspectRatio=1.33 48w, https://media.magloft.app/pdf-import/1144/images/img_1-1.jpg?optimizer=image&amp;format=webp&amp;width=54&amp;aspectRatio=1.33 54w, https://media.magloft.app/pdf-import/1144/images/img_1-1.jpg?optimizer=image&amp;format=webp&amp;width=64&amp;aspectRatio=1.33 64w, https://media.magloft.app/pdf-import/1144/images/img_1-1.jpg?optimizer=image&amp;format=webp&amp;width=70&amp;aspectRatio=1.33 70w, https://media.magloft.app/pdf-import/1144/images/img_1-1.jpg?optimizer=image&amp;format=webp&amp;width=82&amp;aspectRatio=1.33 82w, https://media.magloft.app/pdf-import/1144/images/img_1-1.jpg?optimizer=image&amp;format=webp&amp;width=96&amp;aspectRatio=1.33 96w, https://media.magloft.app/pdf-import/1144/images/img_1-1.jpg?optimizer=image&amp;format=webp&amp;width=96&amp;aspectRatio=1.33 96w, https://media.magloft.app/pdf-import/1144/images/img_1-1.jpg?optimizer=image&amp;format=webp&amp;width=110&amp;aspectRatio=1.33 110w, https://media.magloft.app/pdf-import/1144/images/img_1-1.jpg?optimizer=image&amp;format=webp&amp;width=128&amp;aspectRatio=1.33 128w, https://media.magloft.app/pdf-import/1144/images/img_1-1.jpg?optimizer=image&amp;format=webp&amp;width=128&amp;aspectRatio=1.33 128w, https://media.magloft.app/pdf-import/1144/images/img_1-1.jpg?optimizer=image&amp;format=webp&amp;width=138&amp;aspectRatio=1.33 138w, https://media.magloft.app/pdf-import/1144/images/img_1-1.jpg?optimizer=image&amp;format=webp&amp;width=192&amp;aspectRatio=1.33 192w, https://media.magloft.app/pdf-import/1144/images/img_1-1.jpg?optimizer=image&amp;format=webp&amp;width=200&amp;aspectRatio=1.33 200w, https://media.magloft.app/pdf-import/1144/images/img_1-1.jpg?optimizer=image&amp;format=webp&amp;width=252&amp;aspectRatio=1.33 252w, https://media.magloft.app/pdf-import/1144/images/img_1-1.jpg?optimizer=image&amp;format=webp&amp;width=256&amp;aspectRatio=1.33 256w, https://media.magloft.app/pdf-import/1144/images/img_1-1.jpg?optimizer=image&amp;format=webp&amp;width=260&amp;aspectRatio=1.33 260w, https://media.magloft.app/pdf-import/1144/images/img_1-1.jpg?optimizer=image&amp;format=webp&amp;width=298&amp;aspectRatio=1.33 298w, https://media.magloft.app/pdf-import/1144/images/img_1-1.jpg?optimizer=image&amp;format=webp&amp;width=378&amp;aspectRatio=1.33 378w, https://media.magloft.app/pdf-import/1144/images/img_1-1.jpg?optimizer=image&amp;format=webp&amp;width=384&amp;aspectRatio=1.33 384w, https://media.magloft.app/pdf-import/1144/images/img_1-1.jpg?optimizer=image&amp;format=webp&amp;width=384&amp;aspectRatio=1.33 384w, https://media.magloft.app/pdf-import/1144/images/img_1-1.jpg?optimizer=image&amp;format=webp&amp;width=520&amp;aspectRatio=1.33 520w, https://media.magloft.app/pdf-import/1144/images/img_1-1.jpg?optimizer=image&amp;format=webp&amp;width=640&amp;aspectRatio=1.33 640w, https://media.magloft.app/pdf-import/1144/images/img_1-1.jpg?optimizer=image&amp;format=webp&amp;width=756&amp;aspectRatio=1.33 756w, https://media.magloft.app/pdf-import/1144/images/img_1-1.jpg?optimizer=image&amp;format=webp&amp;width=828&amp;aspectRatio=1.33 828w, https://media.magloft.app/pdf-import/1144/images/img_1-1.jpg?optimizer=image&amp;format=webp&amp;width=1080&amp;aspectRatio=1.33 1080w, https://media.magloft.app/pdf-import/1144/images/img_1-1.jpg?optimizer=image&amp;format=webp&amp;width=1200&amp;aspectRatio=1.33 1200w, https://media.magloft.app/pdf-import/1144/images/img_1-1.jpg?optimizer=image&amp;format=webp&amp;width=1920&amp;aspectRatio=1.33 1920w, https://media.magloft.app/pdf-import/1144/images/img_1-1.jpg?optimizer=image&amp;format=webp&amp;width=2048&amp;aspectRatio=1.33 2048w" src="https://media.magloft.app/pdf-import/1144/images/img_1-1.jpg?optimizer=image&amp;format=webp&amp;width=2048&amp;aspectRatio=1.33"/></div><div class="Block_article-contents__M6B6V"><h3>Survey from Roche finds worryingly low understandings about HPV and cervical cancer</h3><p>Questioning almost 9,000 participants across 12 countries in Latin America and Europe, the research revealed significant knowledge gaps surrounding human papillomavirus (HPV) and highlighted several significant barriers preventing women from screening for it.</p></div></a><a class="Block_article-card__mncKE" href="/articles/best-in-class-ai-model-from-bioptimus-integrated-into-proscia-s-5dd5"><div class="Block_article-cover__vLhzO"><img alt="article-category" loading="lazy" decoding="async" data-nimg="fill" style="position:absolute;height:100%;width:100%;left:0;top:0;right:0;bottom:0;color:transparent;background-size:cover;background-position:50% 50%;background-repeat:no-repeat;background-image:url(&quot;data:image/svg+xml;charset=utf-8,%3Csvg xmlns=&#x27;http%3A//www.w3.org/2000/svg&#x27;%3E%3Cimage style=&#x27;filter:blur(20px)&#x27; preserveAspectRatio=&#x27;none&#x27; x=&#x27;0&#x27; y=&#x27;0&#x27; height=&#x27;100%25&#x27; width=&#x27;100%25&#x27; href=&#x27;data:image/gif;base64,R0lGODlhAQABAPAAANzc3P///yH5BAAAAAAALAAAAAABAAEAAAICRAEAOw==&#x27;/%3E%3C/svg%3E&quot;)" sizes="70px" srcSet="https://media.magloft.app/pdf-import/1144/images/img_2-4.jpg?optimizer=image&amp;format=webp&amp;width=16&amp;aspectRatio=1.33 16w, https://media.magloft.app/pdf-import/1144/images/img_2-4.jpg?optimizer=image&amp;format=webp&amp;width=32&amp;aspectRatio=1.33 32w, https://media.magloft.app/pdf-import/1144/images/img_2-4.jpg?optimizer=image&amp;format=webp&amp;width=48&amp;aspectRatio=1.33 48w, https://media.magloft.app/pdf-import/1144/images/img_2-4.jpg?optimizer=image&amp;format=webp&amp;width=54&amp;aspectRatio=1.33 54w, https://media.magloft.app/pdf-import/1144/images/img_2-4.jpg?optimizer=image&amp;format=webp&amp;width=64&amp;aspectRatio=1.33 64w, https://media.magloft.app/pdf-import/1144/images/img_2-4.jpg?optimizer=image&amp;format=webp&amp;width=70&amp;aspectRatio=1.33 70w, https://media.magloft.app/pdf-import/1144/images/img_2-4.jpg?optimizer=image&amp;format=webp&amp;width=82&amp;aspectRatio=1.33 82w, https://media.magloft.app/pdf-import/1144/images/img_2-4.jpg?optimizer=image&amp;format=webp&amp;width=96&amp;aspectRatio=1.33 96w, https://media.magloft.app/pdf-import/1144/images/img_2-4.jpg?optimizer=image&amp;format=webp&amp;width=96&amp;aspectRatio=1.33 96w, https://media.magloft.app/pdf-import/1144/images/img_2-4.jpg?optimizer=image&amp;format=webp&amp;width=110&amp;aspectRatio=1.33 110w, https://media.magloft.app/pdf-import/1144/images/img_2-4.jpg?optimizer=image&amp;format=webp&amp;width=128&amp;aspectRatio=1.33 128w, https://media.magloft.app/pdf-import/1144/images/img_2-4.jpg?optimizer=image&amp;format=webp&amp;width=128&amp;aspectRatio=1.33 128w, https://media.magloft.app/pdf-import/1144/images/img_2-4.jpg?optimizer=image&amp;format=webp&amp;width=138&amp;aspectRatio=1.33 138w, https://media.magloft.app/pdf-import/1144/images/img_2-4.jpg?optimizer=image&amp;format=webp&amp;width=192&amp;aspectRatio=1.33 192w, https://media.magloft.app/pdf-import/1144/images/img_2-4.jpg?optimizer=image&amp;format=webp&amp;width=200&amp;aspectRatio=1.33 200w, https://media.magloft.app/pdf-import/1144/images/img_2-4.jpg?optimizer=image&amp;format=webp&amp;width=252&amp;aspectRatio=1.33 252w, https://media.magloft.app/pdf-import/1144/images/img_2-4.jpg?optimizer=image&amp;format=webp&amp;width=256&amp;aspectRatio=1.33 256w, https://media.magloft.app/pdf-import/1144/images/img_2-4.jpg?optimizer=image&amp;format=webp&amp;width=260&amp;aspectRatio=1.33 260w, https://media.magloft.app/pdf-import/1144/images/img_2-4.jpg?optimizer=image&amp;format=webp&amp;width=298&amp;aspectRatio=1.33 298w, https://media.magloft.app/pdf-import/1144/images/img_2-4.jpg?optimizer=image&amp;format=webp&amp;width=378&amp;aspectRatio=1.33 378w, https://media.magloft.app/pdf-import/1144/images/img_2-4.jpg?optimizer=image&amp;format=webp&amp;width=384&amp;aspectRatio=1.33 384w, https://media.magloft.app/pdf-import/1144/images/img_2-4.jpg?optimizer=image&amp;format=webp&amp;width=384&amp;aspectRatio=1.33 384w, https://media.magloft.app/pdf-import/1144/images/img_2-4.jpg?optimizer=image&amp;format=webp&amp;width=520&amp;aspectRatio=1.33 520w, https://media.magloft.app/pdf-import/1144/images/img_2-4.jpg?optimizer=image&amp;format=webp&amp;width=640&amp;aspectRatio=1.33 640w, https://media.magloft.app/pdf-import/1144/images/img_2-4.jpg?optimizer=image&amp;format=webp&amp;width=756&amp;aspectRatio=1.33 756w, https://media.magloft.app/pdf-import/1144/images/img_2-4.jpg?optimizer=image&amp;format=webp&amp;width=828&amp;aspectRatio=1.33 828w, https://media.magloft.app/pdf-import/1144/images/img_2-4.jpg?optimizer=image&amp;format=webp&amp;width=1080&amp;aspectRatio=1.33 1080w, https://media.magloft.app/pdf-import/1144/images/img_2-4.jpg?optimizer=image&amp;format=webp&amp;width=1200&amp;aspectRatio=1.33 1200w, https://media.magloft.app/pdf-import/1144/images/img_2-4.jpg?optimizer=image&amp;format=webp&amp;width=1920&amp;aspectRatio=1.33 1920w, https://media.magloft.app/pdf-import/1144/images/img_2-4.jpg?optimizer=image&amp;format=webp&amp;width=2048&amp;aspectRatio=1.33 2048w" src="https://media.magloft.app/pdf-import/1144/images/img_2-4.jpg?optimizer=image&amp;format=webp&amp;width=2048&amp;aspectRatio=1.33"/></div><div class="Block_article-contents__M6B6V"><h3>Best-in-class AI model from Bioptimus integrated into Proscia’s leading software platform</h3><p>French start-up Bioptimus has announced that its H-optimus-o biology reference artificial intelligence (AI) foundation model has been wholly integrated into Proscia’s Concentriq embeddings software platform, with the aim of enabling quicker and more efficient breakthroughs in ai development for therapeutic research.</p></div></a><a class="Block_article-card__mncKE" href="/articles/almirall-s-immunoskin-event-returns-for-a-third-year-discussing-cab8"><div class="Block_article-cover__vLhzO"><img alt="article-category" loading="lazy" decoding="async" data-nimg="fill" style="position:absolute;height:100%;width:100%;left:0;top:0;right:0;bottom:0;color:transparent;background-size:cover;background-position:50% 50%;background-repeat:no-repeat;background-image:url(&quot;data:image/svg+xml;charset=utf-8,%3Csvg xmlns=&#x27;http%3A//www.w3.org/2000/svg&#x27;%3E%3Cimage style=&#x27;filter:blur(20px)&#x27; preserveAspectRatio=&#x27;none&#x27; x=&#x27;0&#x27; y=&#x27;0&#x27; height=&#x27;100%25&#x27; width=&#x27;100%25&#x27; href=&#x27;data:image/gif;base64,R0lGODlhAQABAPAAANzc3P///yH5BAAAAAAALAAAAAABAAEAAAICRAEAOw==&#x27;/%3E%3C/svg%3E&quot;)" sizes="70px" srcSet="https://media.magloft.app/pdf-import/1144/images/img_4-1.jpg?optimizer=image&amp;format=webp&amp;width=16&amp;aspectRatio=1.33 16w, https://media.magloft.app/pdf-import/1144/images/img_4-1.jpg?optimizer=image&amp;format=webp&amp;width=32&amp;aspectRatio=1.33 32w, https://media.magloft.app/pdf-import/1144/images/img_4-1.jpg?optimizer=image&amp;format=webp&amp;width=48&amp;aspectRatio=1.33 48w, https://media.magloft.app/pdf-import/1144/images/img_4-1.jpg?optimizer=image&amp;format=webp&amp;width=54&amp;aspectRatio=1.33 54w, https://media.magloft.app/pdf-import/1144/images/img_4-1.jpg?optimizer=image&amp;format=webp&amp;width=64&amp;aspectRatio=1.33 64w, https://media.magloft.app/pdf-import/1144/images/img_4-1.jpg?optimizer=image&amp;format=webp&amp;width=70&amp;aspectRatio=1.33 70w, https://media.magloft.app/pdf-import/1144/images/img_4-1.jpg?optimizer=image&amp;format=webp&amp;width=82&amp;aspectRatio=1.33 82w, https://media.magloft.app/pdf-import/1144/images/img_4-1.jpg?optimizer=image&amp;format=webp&amp;width=96&amp;aspectRatio=1.33 96w, https://media.magloft.app/pdf-import/1144/images/img_4-1.jpg?optimizer=image&amp;format=webp&amp;width=96&amp;aspectRatio=1.33 96w, https://media.magloft.app/pdf-import/1144/images/img_4-1.jpg?optimizer=image&amp;format=webp&amp;width=110&amp;aspectRatio=1.33 110w, https://media.magloft.app/pdf-import/1144/images/img_4-1.jpg?optimizer=image&amp;format=webp&amp;width=128&amp;aspectRatio=1.33 128w, https://media.magloft.app/pdf-import/1144/images/img_4-1.jpg?optimizer=image&amp;format=webp&amp;width=128&amp;aspectRatio=1.33 128w, https://media.magloft.app/pdf-import/1144/images/img_4-1.jpg?optimizer=image&amp;format=webp&amp;width=138&amp;aspectRatio=1.33 138w, https://media.magloft.app/pdf-import/1144/images/img_4-1.jpg?optimizer=image&amp;format=webp&amp;width=192&amp;aspectRatio=1.33 192w, https://media.magloft.app/pdf-import/1144/images/img_4-1.jpg?optimizer=image&amp;format=webp&amp;width=200&amp;aspectRatio=1.33 200w, https://media.magloft.app/pdf-import/1144/images/img_4-1.jpg?optimizer=image&amp;format=webp&amp;width=252&amp;aspectRatio=1.33 252w, https://media.magloft.app/pdf-import/1144/images/img_4-1.jpg?optimizer=image&amp;format=webp&amp;width=256&amp;aspectRatio=1.33 256w, https://media.magloft.app/pdf-import/1144/images/img_4-1.jpg?optimizer=image&amp;format=webp&amp;width=260&amp;aspectRatio=1.33 260w, https://media.magloft.app/pdf-import/1144/images/img_4-1.jpg?optimizer=image&amp;format=webp&amp;width=298&amp;aspectRatio=1.33 298w, https://media.magloft.app/pdf-import/1144/images/img_4-1.jpg?optimizer=image&amp;format=webp&amp;width=378&amp;aspectRatio=1.33 378w, https://media.magloft.app/pdf-import/1144/images/img_4-1.jpg?optimizer=image&amp;format=webp&amp;width=384&amp;aspectRatio=1.33 384w, https://media.magloft.app/pdf-import/1144/images/img_4-1.jpg?optimizer=image&amp;format=webp&amp;width=384&amp;aspectRatio=1.33 384w, https://media.magloft.app/pdf-import/1144/images/img_4-1.jpg?optimizer=image&amp;format=webp&amp;width=520&amp;aspectRatio=1.33 520w, https://media.magloft.app/pdf-import/1144/images/img_4-1.jpg?optimizer=image&amp;format=webp&amp;width=640&amp;aspectRatio=1.33 640w, https://media.magloft.app/pdf-import/1144/images/img_4-1.jpg?optimizer=image&amp;format=webp&amp;width=756&amp;aspectRatio=1.33 756w, https://media.magloft.app/pdf-import/1144/images/img_4-1.jpg?optimizer=image&amp;format=webp&amp;width=828&amp;aspectRatio=1.33 828w, https://media.magloft.app/pdf-import/1144/images/img_4-1.jpg?optimizer=image&amp;format=webp&amp;width=1080&amp;aspectRatio=1.33 1080w, https://media.magloft.app/pdf-import/1144/images/img_4-1.jpg?optimizer=image&amp;format=webp&amp;width=1200&amp;aspectRatio=1.33 1200w, https://media.magloft.app/pdf-import/1144/images/img_4-1.jpg?optimizer=image&amp;format=webp&amp;width=1920&amp;aspectRatio=1.33 1920w, https://media.magloft.app/pdf-import/1144/images/img_4-1.jpg?optimizer=image&amp;format=webp&amp;width=2048&amp;aspectRatio=1.33 2048w" src="https://media.magloft.app/pdf-import/1144/images/img_4-1.jpg?optimizer=image&amp;format=webp&amp;width=2048&amp;aspectRatio=1.33"/></div><div class="Block_article-contents__M6B6V"><h3>Almirall’s Immunoskin event returns for a third year, discussing medical dermatology advances</h3><p>Hosted again in Barcelona, Spain, the Immunoskin conference ran from 26-27 October and brought together leading experts in dermatological conditions and treatments.</p></div></a><a class="Block_article-card__mncKE" href="/articles/eco-vadis-platinum-medal-given-to-liveo-research-s-singapore-phar-2ff8"><div class="Block_article-cover__vLhzO"><img alt="article-category" loading="lazy" decoding="async" data-nimg="fill" style="position:absolute;height:100%;width:100%;left:0;top:0;right:0;bottom:0;color:transparent;background-size:cover;background-position:50% 50%;background-repeat:no-repeat;background-image:url(&quot;data:image/svg+xml;charset=utf-8,%3Csvg xmlns=&#x27;http%3A//www.w3.org/2000/svg&#x27;%3E%3Cimage style=&#x27;filter:blur(20px)&#x27; preserveAspectRatio=&#x27;none&#x27; x=&#x27;0&#x27; y=&#x27;0&#x27; height=&#x27;100%25&#x27; width=&#x27;100%25&#x27; href=&#x27;data:image/gif;base64,R0lGODlhAQABAPAAANzc3P///yH5BAAAAAAALAAAAAABAAEAAAICRAEAOw==&#x27;/%3E%3C/svg%3E&quot;)" sizes="70px" srcSet="https://media.magloft.app/pdf-import/1144/images/img_4-2.jpg?optimizer=image&amp;format=webp&amp;width=16&amp;aspectRatio=1.33 16w, https://media.magloft.app/pdf-import/1144/images/img_4-2.jpg?optimizer=image&amp;format=webp&amp;width=32&amp;aspectRatio=1.33 32w, https://media.magloft.app/pdf-import/1144/images/img_4-2.jpg?optimizer=image&amp;format=webp&amp;width=48&amp;aspectRatio=1.33 48w, https://media.magloft.app/pdf-import/1144/images/img_4-2.jpg?optimizer=image&amp;format=webp&amp;width=54&amp;aspectRatio=1.33 54w, https://media.magloft.app/pdf-import/1144/images/img_4-2.jpg?optimizer=image&amp;format=webp&amp;width=64&amp;aspectRatio=1.33 64w, https://media.magloft.app/pdf-import/1144/images/img_4-2.jpg?optimizer=image&amp;format=webp&amp;width=70&amp;aspectRatio=1.33 70w, https://media.magloft.app/pdf-import/1144/images/img_4-2.jpg?optimizer=image&amp;format=webp&amp;width=82&amp;aspectRatio=1.33 82w, https://media.magloft.app/pdf-import/1144/images/img_4-2.jpg?optimizer=image&amp;format=webp&amp;width=96&amp;aspectRatio=1.33 96w, https://media.magloft.app/pdf-import/1144/images/img_4-2.jpg?optimizer=image&amp;format=webp&amp;width=96&amp;aspectRatio=1.33 96w, https://media.magloft.app/pdf-import/1144/images/img_4-2.jpg?optimizer=image&amp;format=webp&amp;width=110&amp;aspectRatio=1.33 110w, https://media.magloft.app/pdf-import/1144/images/img_4-2.jpg?optimizer=image&amp;format=webp&amp;width=128&amp;aspectRatio=1.33 128w, https://media.magloft.app/pdf-import/1144/images/img_4-2.jpg?optimizer=image&amp;format=webp&amp;width=128&amp;aspectRatio=1.33 128w, https://media.magloft.app/pdf-import/1144/images/img_4-2.jpg?optimizer=image&amp;format=webp&amp;width=138&amp;aspectRatio=1.33 138w, https://media.magloft.app/pdf-import/1144/images/img_4-2.jpg?optimizer=image&amp;format=webp&amp;width=192&amp;aspectRatio=1.33 192w, https://media.magloft.app/pdf-import/1144/images/img_4-2.jpg?optimizer=image&amp;format=webp&amp;width=200&amp;aspectRatio=1.33 200w, https://media.magloft.app/pdf-import/1144/images/img_4-2.jpg?optimizer=image&amp;format=webp&amp;width=252&amp;aspectRatio=1.33 252w, https://media.magloft.app/pdf-import/1144/images/img_4-2.jpg?optimizer=image&amp;format=webp&amp;width=256&amp;aspectRatio=1.33 256w, https://media.magloft.app/pdf-import/1144/images/img_4-2.jpg?optimizer=image&amp;format=webp&amp;width=260&amp;aspectRatio=1.33 260w, https://media.magloft.app/pdf-import/1144/images/img_4-2.jpg?optimizer=image&amp;format=webp&amp;width=298&amp;aspectRatio=1.33 298w, https://media.magloft.app/pdf-import/1144/images/img_4-2.jpg?optimizer=image&amp;format=webp&amp;width=378&amp;aspectRatio=1.33 378w, https://media.magloft.app/pdf-import/1144/images/img_4-2.jpg?optimizer=image&amp;format=webp&amp;width=384&amp;aspectRatio=1.33 384w, https://media.magloft.app/pdf-import/1144/images/img_4-2.jpg?optimizer=image&amp;format=webp&amp;width=384&amp;aspectRatio=1.33 384w, https://media.magloft.app/pdf-import/1144/images/img_4-2.jpg?optimizer=image&amp;format=webp&amp;width=520&amp;aspectRatio=1.33 520w, https://media.magloft.app/pdf-import/1144/images/img_4-2.jpg?optimizer=image&amp;format=webp&amp;width=640&amp;aspectRatio=1.33 640w, https://media.magloft.app/pdf-import/1144/images/img_4-2.jpg?optimizer=image&amp;format=webp&amp;width=756&amp;aspectRatio=1.33 756w, https://media.magloft.app/pdf-import/1144/images/img_4-2.jpg?optimizer=image&amp;format=webp&amp;width=828&amp;aspectRatio=1.33 828w, https://media.magloft.app/pdf-import/1144/images/img_4-2.jpg?optimizer=image&amp;format=webp&amp;width=1080&amp;aspectRatio=1.33 1080w, https://media.magloft.app/pdf-import/1144/images/img_4-2.jpg?optimizer=image&amp;format=webp&amp;width=1200&amp;aspectRatio=1.33 1200w, https://media.magloft.app/pdf-import/1144/images/img_4-2.jpg?optimizer=image&amp;format=webp&amp;width=1920&amp;aspectRatio=1.33 1920w, https://media.magloft.app/pdf-import/1144/images/img_4-2.jpg?optimizer=image&amp;format=webp&amp;width=2048&amp;aspectRatio=1.33 2048w" src="https://media.magloft.app/pdf-import/1144/images/img_4-2.jpg?optimizer=image&amp;format=webp&amp;width=2048&amp;aspectRatio=1.33"/></div><div class="Block_article-contents__M6B6V"><h3>EcoVadis Platinum medal given to Liveo Research’s Singapore pharma packaging site</h3><p>Liveo Research, a leading primary packaging manufacturer, has had the EcoVadis rating of its Singapore site increased from gold to platinum. This means that the pharma packaging site is now rated in the top 1% of the 100,000 companies evaluated by ecovadis in its annual global surveys.</p></div></a><a class="Block_article-card__mncKE" href="/articles/hutchmed-set-to-receive-20m-in-funding-from-takeda-for-colorect-ebe1"><div class="Block_article-cover__vLhzO"><img alt="article-category" loading="lazy" decoding="async" data-nimg="fill" style="position:absolute;height:100%;width:100%;left:0;top:0;right:0;bottom:0;color:transparent;background-size:cover;background-position:50% 50%;background-repeat:no-repeat;background-image:url(&quot;data:image/svg+xml;charset=utf-8,%3Csvg xmlns=&#x27;http%3A//www.w3.org/2000/svg&#x27;%3E%3Cimage style=&#x27;filter:blur(20px)&#x27; preserveAspectRatio=&#x27;none&#x27; x=&#x27;0&#x27; y=&#x27;0&#x27; height=&#x27;100%25&#x27; width=&#x27;100%25&#x27; href=&#x27;data:image/gif;base64,R0lGODlhAQABAPAAANzc3P///yH5BAAAAAAALAAAAAABAAEAAAICRAEAOw==&#x27;/%3E%3C/svg%3E&quot;)" sizes="70px" srcSet="https://media.magloft.app/pdf-import/1144/images/img_5-1.jpg?optimizer=image&amp;format=webp&amp;width=16&amp;aspectRatio=1.33 16w, https://media.magloft.app/pdf-import/1144/images/img_5-1.jpg?optimizer=image&amp;format=webp&amp;width=32&amp;aspectRatio=1.33 32w, https://media.magloft.app/pdf-import/1144/images/img_5-1.jpg?optimizer=image&amp;format=webp&amp;width=48&amp;aspectRatio=1.33 48w, https://media.magloft.app/pdf-import/1144/images/img_5-1.jpg?optimizer=image&amp;format=webp&amp;width=54&amp;aspectRatio=1.33 54w, https://media.magloft.app/pdf-import/1144/images/img_5-1.jpg?optimizer=image&amp;format=webp&amp;width=64&amp;aspectRatio=1.33 64w, https://media.magloft.app/pdf-import/1144/images/img_5-1.jpg?optimizer=image&amp;format=webp&amp;width=70&amp;aspectRatio=1.33 70w, https://media.magloft.app/pdf-import/1144/images/img_5-1.jpg?optimizer=image&amp;format=webp&amp;width=82&amp;aspectRatio=1.33 82w, https://media.magloft.app/pdf-import/1144/images/img_5-1.jpg?optimizer=image&amp;format=webp&amp;width=96&amp;aspectRatio=1.33 96w, https://media.magloft.app/pdf-import/1144/images/img_5-1.jpg?optimizer=image&amp;format=webp&amp;width=96&amp;aspectRatio=1.33 96w, https://media.magloft.app/pdf-import/1144/images/img_5-1.jpg?optimizer=image&amp;format=webp&amp;width=110&amp;aspectRatio=1.33 110w, https://media.magloft.app/pdf-import/1144/images/img_5-1.jpg?optimizer=image&amp;format=webp&amp;width=128&amp;aspectRatio=1.33 128w, https://media.magloft.app/pdf-import/1144/images/img_5-1.jpg?optimizer=image&amp;format=webp&amp;width=128&amp;aspectRatio=1.33 128w, https://media.magloft.app/pdf-import/1144/images/img_5-1.jpg?optimizer=image&amp;format=webp&amp;width=138&amp;aspectRatio=1.33 138w, https://media.magloft.app/pdf-import/1144/images/img_5-1.jpg?optimizer=image&amp;format=webp&amp;width=192&amp;aspectRatio=1.33 192w, https://media.magloft.app/pdf-import/1144/images/img_5-1.jpg?optimizer=image&amp;format=webp&amp;width=200&amp;aspectRatio=1.33 200w, https://media.magloft.app/pdf-import/1144/images/img_5-1.jpg?optimizer=image&amp;format=webp&amp;width=252&amp;aspectRatio=1.33 252w, https://media.magloft.app/pdf-import/1144/images/img_5-1.jpg?optimizer=image&amp;format=webp&amp;width=256&amp;aspectRatio=1.33 256w, https://media.magloft.app/pdf-import/1144/images/img_5-1.jpg?optimizer=image&amp;format=webp&amp;width=260&amp;aspectRatio=1.33 260w, https://media.magloft.app/pdf-import/1144/images/img_5-1.jpg?optimizer=image&amp;format=webp&amp;width=298&amp;aspectRatio=1.33 298w, https://media.magloft.app/pdf-import/1144/images/img_5-1.jpg?optimizer=image&amp;format=webp&amp;width=378&amp;aspectRatio=1.33 378w, https://media.magloft.app/pdf-import/1144/images/img_5-1.jpg?optimizer=image&amp;format=webp&amp;width=384&amp;aspectRatio=1.33 384w, https://media.magloft.app/pdf-import/1144/images/img_5-1.jpg?optimizer=image&amp;format=webp&amp;width=384&amp;aspectRatio=1.33 384w, https://media.magloft.app/pdf-import/1144/images/img_5-1.jpg?optimizer=image&amp;format=webp&amp;width=520&amp;aspectRatio=1.33 520w, https://media.magloft.app/pdf-import/1144/images/img_5-1.jpg?optimizer=image&amp;format=webp&amp;width=640&amp;aspectRatio=1.33 640w, https://media.magloft.app/pdf-import/1144/images/img_5-1.jpg?optimizer=image&amp;format=webp&amp;width=756&amp;aspectRatio=1.33 756w, https://media.magloft.app/pdf-import/1144/images/img_5-1.jpg?optimizer=image&amp;format=webp&amp;width=828&amp;aspectRatio=1.33 828w, https://media.magloft.app/pdf-import/1144/images/img_5-1.jpg?optimizer=image&amp;format=webp&amp;width=1080&amp;aspectRatio=1.33 1080w, https://media.magloft.app/pdf-import/1144/images/img_5-1.jpg?optimizer=image&amp;format=webp&amp;width=1200&amp;aspectRatio=1.33 1200w, https://media.magloft.app/pdf-import/1144/images/img_5-1.jpg?optimizer=image&amp;format=webp&amp;width=1920&amp;aspectRatio=1.33 1920w, https://media.magloft.app/pdf-import/1144/images/img_5-1.jpg?optimizer=image&amp;format=webp&amp;width=2048&amp;aspectRatio=1.33 2048w" src="https://media.magloft.app/pdf-import/1144/images/img_5-1.jpg?optimizer=image&amp;format=webp&amp;width=2048&amp;aspectRatio=1.33"/></div><div class="Block_article-contents__M6B6V"><h3>HUTCHMED set to receive $20m in funding from Takeda for colorectal cancer drug sales</h3><p>In late October, HUTCHMED’s partner Takeda will pay a milestone payment of $20m as the result of over $200m worth of sales for Fruzaqla (fruquintinib), which treats metastatic colorectal cancer (CRC).</p></div></a><a class="Block_article-card__mncKE" href="/articles/exhibitor-numbers-for-cphi-india-grow-for-third-year-in-a-row-w-ee82"><div class="Block_article-cover__vLhzO"><img alt="article-category" loading="lazy" decoding="async" data-nimg="fill" style="position:absolute;height:100%;width:100%;left:0;top:0;right:0;bottom:0;color:transparent;background-size:cover;background-position:50% 50%;background-repeat:no-repeat;background-image:url(&quot;data:image/svg+xml;charset=utf-8,%3Csvg xmlns=&#x27;http%3A//www.w3.org/2000/svg&#x27;%3E%3Cimage style=&#x27;filter:blur(20px)&#x27; preserveAspectRatio=&#x27;none&#x27; x=&#x27;0&#x27; y=&#x27;0&#x27; height=&#x27;100%25&#x27; width=&#x27;100%25&#x27; href=&#x27;data:image/gif;base64,R0lGODlhAQABAPAAANzc3P///yH5BAAAAAAALAAAAAABAAEAAAICRAEAOw==&#x27;/%3E%3C/svg%3E&quot;)" sizes="70px" srcSet="https://media.magloft.app/pdf-import/1144/images/img_6-1.jpg?optimizer=image&amp;format=webp&amp;width=16&amp;aspectRatio=1.33 16w, https://media.magloft.app/pdf-import/1144/images/img_6-1.jpg?optimizer=image&amp;format=webp&amp;width=32&amp;aspectRatio=1.33 32w, https://media.magloft.app/pdf-import/1144/images/img_6-1.jpg?optimizer=image&amp;format=webp&amp;width=48&amp;aspectRatio=1.33 48w, https://media.magloft.app/pdf-import/1144/images/img_6-1.jpg?optimizer=image&amp;format=webp&amp;width=54&amp;aspectRatio=1.33 54w, https://media.magloft.app/pdf-import/1144/images/img_6-1.jpg?optimizer=image&amp;format=webp&amp;width=64&amp;aspectRatio=1.33 64w, https://media.magloft.app/pdf-import/1144/images/img_6-1.jpg?optimizer=image&amp;format=webp&amp;width=70&amp;aspectRatio=1.33 70w, https://media.magloft.app/pdf-import/1144/images/img_6-1.jpg?optimizer=image&amp;format=webp&amp;width=82&amp;aspectRatio=1.33 82w, https://media.magloft.app/pdf-import/1144/images/img_6-1.jpg?optimizer=image&amp;format=webp&amp;width=96&amp;aspectRatio=1.33 96w, https://media.magloft.app/pdf-import/1144/images/img_6-1.jpg?optimizer=image&amp;format=webp&amp;width=96&amp;aspectRatio=1.33 96w, https://media.magloft.app/pdf-import/1144/images/img_6-1.jpg?optimizer=image&amp;format=webp&amp;width=110&amp;aspectRatio=1.33 110w, https://media.magloft.app/pdf-import/1144/images/img_6-1.jpg?optimizer=image&amp;format=webp&amp;width=128&amp;aspectRatio=1.33 128w, https://media.magloft.app/pdf-import/1144/images/img_6-1.jpg?optimizer=image&amp;format=webp&amp;width=128&amp;aspectRatio=1.33 128w, https://media.magloft.app/pdf-import/1144/images/img_6-1.jpg?optimizer=image&amp;format=webp&amp;width=138&amp;aspectRatio=1.33 138w, https://media.magloft.app/pdf-import/1144/images/img_6-1.jpg?optimizer=image&amp;format=webp&amp;width=192&amp;aspectRatio=1.33 192w, https://media.magloft.app/pdf-import/1144/images/img_6-1.jpg?optimizer=image&amp;format=webp&amp;width=200&amp;aspectRatio=1.33 200w, https://media.magloft.app/pdf-import/1144/images/img_6-1.jpg?optimizer=image&amp;format=webp&amp;width=252&amp;aspectRatio=1.33 252w, https://media.magloft.app/pdf-import/1144/images/img_6-1.jpg?optimizer=image&amp;format=webp&amp;width=256&amp;aspectRatio=1.33 256w, https://media.magloft.app/pdf-import/1144/images/img_6-1.jpg?optimizer=image&amp;format=webp&amp;width=260&amp;aspectRatio=1.33 260w, https://media.magloft.app/pdf-import/1144/images/img_6-1.jpg?optimizer=image&amp;format=webp&amp;width=298&amp;aspectRatio=1.33 298w, https://media.magloft.app/pdf-import/1144/images/img_6-1.jpg?optimizer=image&amp;format=webp&amp;width=378&amp;aspectRatio=1.33 378w, https://media.magloft.app/pdf-import/1144/images/img_6-1.jpg?optimizer=image&amp;format=webp&amp;width=384&amp;aspectRatio=1.33 384w, https://media.magloft.app/pdf-import/1144/images/img_6-1.jpg?optimizer=image&amp;format=webp&amp;width=384&amp;aspectRatio=1.33 384w, https://media.magloft.app/pdf-import/1144/images/img_6-1.jpg?optimizer=image&amp;format=webp&amp;width=520&amp;aspectRatio=1.33 520w, https://media.magloft.app/pdf-import/1144/images/img_6-1.jpg?optimizer=image&amp;format=webp&amp;width=640&amp;aspectRatio=1.33 640w, https://media.magloft.app/pdf-import/1144/images/img_6-1.jpg?optimizer=image&amp;format=webp&amp;width=756&amp;aspectRatio=1.33 756w, https://media.magloft.app/pdf-import/1144/images/img_6-1.jpg?optimizer=image&amp;format=webp&amp;width=828&amp;aspectRatio=1.33 828w, https://media.magloft.app/pdf-import/1144/images/img_6-1.jpg?optimizer=image&amp;format=webp&amp;width=1080&amp;aspectRatio=1.33 1080w, https://media.magloft.app/pdf-import/1144/images/img_6-1.jpg?optimizer=image&amp;format=webp&amp;width=1200&amp;aspectRatio=1.33 1200w, https://media.magloft.app/pdf-import/1144/images/img_6-1.jpg?optimizer=image&amp;format=webp&amp;width=1920&amp;aspectRatio=1.33 1920w, https://media.magloft.app/pdf-import/1144/images/img_6-1.jpg?optimizer=image&amp;format=webp&amp;width=2048&amp;aspectRatio=1.33 2048w" src="https://media.magloft.app/pdf-import/1144/images/img_6-1.jpg?optimizer=image&amp;format=webp&amp;width=2048&amp;aspectRatio=1.33"/></div><div class="Block_article-contents__M6B6V"><h3>Exhibitor numbers for CPHI India grow for third year in a row, with 50,000 attendees expected</h3><p>Running from 26-28 November 2024, the largest pharma event in India is expected to have a record attendance of delegates from more than 150 countries, with over 2,000 exhibitors also expected.</p></div></a><a class="Block_article-card__mncKE" href="/articles/pac-bio-announces-update-to-sequencing-system-to-bring-down-cost-7ecd"><div class="Block_article-cover__vLhzO"><img alt="article-category" loading="lazy" decoding="async" data-nimg="fill" style="position:absolute;height:100%;width:100%;left:0;top:0;right:0;bottom:0;color:transparent;background-size:cover;background-position:50% 50%;background-repeat:no-repeat;background-image:url(&quot;data:image/svg+xml;charset=utf-8,%3Csvg xmlns=&#x27;http%3A//www.w3.org/2000/svg&#x27;%3E%3Cimage style=&#x27;filter:blur(20px)&#x27; preserveAspectRatio=&#x27;none&#x27; x=&#x27;0&#x27; y=&#x27;0&#x27; height=&#x27;100%25&#x27; width=&#x27;100%25&#x27; href=&#x27;data:image/gif;base64,R0lGODlhAQABAPAAANzc3P///yH5BAAAAAAALAAAAAABAAEAAAICRAEAOw==&#x27;/%3E%3C/svg%3E&quot;)" sizes="70px" srcSet="https://media.magloft.app/pdf-import/1144/images/img_6-2.jpg?optimizer=image&amp;format=webp&amp;width=16&amp;aspectRatio=1.33 16w, https://media.magloft.app/pdf-import/1144/images/img_6-2.jpg?optimizer=image&amp;format=webp&amp;width=32&amp;aspectRatio=1.33 32w, https://media.magloft.app/pdf-import/1144/images/img_6-2.jpg?optimizer=image&amp;format=webp&amp;width=48&amp;aspectRatio=1.33 48w, https://media.magloft.app/pdf-import/1144/images/img_6-2.jpg?optimizer=image&amp;format=webp&amp;width=54&amp;aspectRatio=1.33 54w, https://media.magloft.app/pdf-import/1144/images/img_6-2.jpg?optimizer=image&amp;format=webp&amp;width=64&amp;aspectRatio=1.33 64w, https://media.magloft.app/pdf-import/1144/images/img_6-2.jpg?optimizer=image&amp;format=webp&amp;width=70&amp;aspectRatio=1.33 70w, https://media.magloft.app/pdf-import/1144/images/img_6-2.jpg?optimizer=image&amp;format=webp&amp;width=82&amp;aspectRatio=1.33 82w, https://media.magloft.app/pdf-import/1144/images/img_6-2.jpg?optimizer=image&amp;format=webp&amp;width=96&amp;aspectRatio=1.33 96w, https://media.magloft.app/pdf-import/1144/images/img_6-2.jpg?optimizer=image&amp;format=webp&amp;width=96&amp;aspectRatio=1.33 96w, https://media.magloft.app/pdf-import/1144/images/img_6-2.jpg?optimizer=image&amp;format=webp&amp;width=110&amp;aspectRatio=1.33 110w, https://media.magloft.app/pdf-import/1144/images/img_6-2.jpg?optimizer=image&amp;format=webp&amp;width=128&amp;aspectRatio=1.33 128w, https://media.magloft.app/pdf-import/1144/images/img_6-2.jpg?optimizer=image&amp;format=webp&amp;width=128&amp;aspectRatio=1.33 128w, https://media.magloft.app/pdf-import/1144/images/img_6-2.jpg?optimizer=image&amp;format=webp&amp;width=138&amp;aspectRatio=1.33 138w, https://media.magloft.app/pdf-import/1144/images/img_6-2.jpg?optimizer=image&amp;format=webp&amp;width=192&amp;aspectRatio=1.33 192w, https://media.magloft.app/pdf-import/1144/images/img_6-2.jpg?optimizer=image&amp;format=webp&amp;width=200&amp;aspectRatio=1.33 200w, https://media.magloft.app/pdf-import/1144/images/img_6-2.jpg?optimizer=image&amp;format=webp&amp;width=252&amp;aspectRatio=1.33 252w, https://media.magloft.app/pdf-import/1144/images/img_6-2.jpg?optimizer=image&amp;format=webp&amp;width=256&amp;aspectRatio=1.33 256w, https://media.magloft.app/pdf-import/1144/images/img_6-2.jpg?optimizer=image&amp;format=webp&amp;width=260&amp;aspectRatio=1.33 260w, https://media.magloft.app/pdf-import/1144/images/img_6-2.jpg?optimizer=image&amp;format=webp&amp;width=298&amp;aspectRatio=1.33 298w, https://media.magloft.app/pdf-import/1144/images/img_6-2.jpg?optimizer=image&amp;format=webp&amp;width=378&amp;aspectRatio=1.33 378w, https://media.magloft.app/pdf-import/1144/images/img_6-2.jpg?optimizer=image&amp;format=webp&amp;width=384&amp;aspectRatio=1.33 384w, https://media.magloft.app/pdf-import/1144/images/img_6-2.jpg?optimizer=image&amp;format=webp&amp;width=384&amp;aspectRatio=1.33 384w, https://media.magloft.app/pdf-import/1144/images/img_6-2.jpg?optimizer=image&amp;format=webp&amp;width=520&amp;aspectRatio=1.33 520w, https://media.magloft.app/pdf-import/1144/images/img_6-2.jpg?optimizer=image&amp;format=webp&amp;width=640&amp;aspectRatio=1.33 640w, https://media.magloft.app/pdf-import/1144/images/img_6-2.jpg?optimizer=image&amp;format=webp&amp;width=756&amp;aspectRatio=1.33 756w, https://media.magloft.app/pdf-import/1144/images/img_6-2.jpg?optimizer=image&amp;format=webp&amp;width=828&amp;aspectRatio=1.33 828w, https://media.magloft.app/pdf-import/1144/images/img_6-2.jpg?optimizer=image&amp;format=webp&amp;width=1080&amp;aspectRatio=1.33 1080w, https://media.magloft.app/pdf-import/1144/images/img_6-2.jpg?optimizer=image&amp;format=webp&amp;width=1200&amp;aspectRatio=1.33 1200w, https://media.magloft.app/pdf-import/1144/images/img_6-2.jpg?optimizer=image&amp;format=webp&amp;width=1920&amp;aspectRatio=1.33 1920w, https://media.magloft.app/pdf-import/1144/images/img_6-2.jpg?optimizer=image&amp;format=webp&amp;width=2048&amp;aspectRatio=1.33 2048w" src="https://media.magloft.app/pdf-import/1144/images/img_6-2.jpg?optimizer=image&amp;format=webp&amp;width=2048&amp;aspectRatio=1.33"/></div><div class="Block_article-contents__M6B6V"><h3>PacBio announces update to sequencing system to bring down cost of genome sample to below $500</h3><p>Announced by PacBio, known for developing sequencing solutions, SPRQ has the potential to significantly reduce the cost of sequencing genomes.</p></div></a><a class="Block_article-card__mncKE" href="/articles/hiv-vaccine-candidate-successfully-optimised-for-industrial-prod-07d5"><div class="Block_article-cover__vLhzO"><img alt="article-category" loading="lazy" decoding="async" data-nimg="fill" style="position:absolute;height:100%;width:100%;left:0;top:0;right:0;bottom:0;color:transparent;background-size:cover;background-position:50% 50%;background-repeat:no-repeat;background-image:url(&quot;data:image/svg+xml;charset=utf-8,%3Csvg xmlns=&#x27;http%3A//www.w3.org/2000/svg&#x27;%3E%3Cimage style=&#x27;filter:blur(20px)&#x27; preserveAspectRatio=&#x27;none&#x27; x=&#x27;0&#x27; y=&#x27;0&#x27; height=&#x27;100%25&#x27; width=&#x27;100%25&#x27; href=&#x27;data:image/gif;base64,R0lGODlhAQABAPAAANzc3P///yH5BAAAAAAALAAAAAABAAEAAAICRAEAOw==&#x27;/%3E%3C/svg%3E&quot;)" sizes="70px" srcSet="https://media.magloft.app/pdf-import/1144/images/img_5-2.jpg?optimizer=image&amp;format=webp&amp;width=16&amp;aspectRatio=1.33 16w, https://media.magloft.app/pdf-import/1144/images/img_5-2.jpg?optimizer=image&amp;format=webp&amp;width=32&amp;aspectRatio=1.33 32w, https://media.magloft.app/pdf-import/1144/images/img_5-2.jpg?optimizer=image&amp;format=webp&amp;width=48&amp;aspectRatio=1.33 48w, https://media.magloft.app/pdf-import/1144/images/img_5-2.jpg?optimizer=image&amp;format=webp&amp;width=54&amp;aspectRatio=1.33 54w, https://media.magloft.app/pdf-import/1144/images/img_5-2.jpg?optimizer=image&amp;format=webp&amp;width=64&amp;aspectRatio=1.33 64w, https://media.magloft.app/pdf-import/1144/images/img_5-2.jpg?optimizer=image&amp;format=webp&amp;width=70&amp;aspectRatio=1.33 70w, https://media.magloft.app/pdf-import/1144/images/img_5-2.jpg?optimizer=image&amp;format=webp&amp;width=82&amp;aspectRatio=1.33 82w, https://media.magloft.app/pdf-import/1144/images/img_5-2.jpg?optimizer=image&amp;format=webp&amp;width=96&amp;aspectRatio=1.33 96w, https://media.magloft.app/pdf-import/1144/images/img_5-2.jpg?optimizer=image&amp;format=webp&amp;width=96&amp;aspectRatio=1.33 96w, https://media.magloft.app/pdf-import/1144/images/img_5-2.jpg?optimizer=image&amp;format=webp&amp;width=110&amp;aspectRatio=1.33 110w, https://media.magloft.app/pdf-import/1144/images/img_5-2.jpg?optimizer=image&amp;format=webp&amp;width=128&amp;aspectRatio=1.33 128w, https://media.magloft.app/pdf-import/1144/images/img_5-2.jpg?optimizer=image&amp;format=webp&amp;width=128&amp;aspectRatio=1.33 128w, https://media.magloft.app/pdf-import/1144/images/img_5-2.jpg?optimizer=image&amp;format=webp&amp;width=138&amp;aspectRatio=1.33 138w, https://media.magloft.app/pdf-import/1144/images/img_5-2.jpg?optimizer=image&amp;format=webp&amp;width=192&amp;aspectRatio=1.33 192w, https://media.magloft.app/pdf-import/1144/images/img_5-2.jpg?optimizer=image&amp;format=webp&amp;width=200&amp;aspectRatio=1.33 200w, https://media.magloft.app/pdf-import/1144/images/img_5-2.jpg?optimizer=image&amp;format=webp&amp;width=252&amp;aspectRatio=1.33 252w, https://media.magloft.app/pdf-import/1144/images/img_5-2.jpg?optimizer=image&amp;format=webp&amp;width=256&amp;aspectRatio=1.33 256w, https://media.magloft.app/pdf-import/1144/images/img_5-2.jpg?optimizer=image&amp;format=webp&amp;width=260&amp;aspectRatio=1.33 260w, https://media.magloft.app/pdf-import/1144/images/img_5-2.jpg?optimizer=image&amp;format=webp&amp;width=298&amp;aspectRatio=1.33 298w, https://media.magloft.app/pdf-import/1144/images/img_5-2.jpg?optimizer=image&amp;format=webp&amp;width=378&amp;aspectRatio=1.33 378w, https://media.magloft.app/pdf-import/1144/images/img_5-2.jpg?optimizer=image&amp;format=webp&amp;width=384&amp;aspectRatio=1.33 384w, https://media.magloft.app/pdf-import/1144/images/img_5-2.jpg?optimizer=image&amp;format=webp&amp;width=384&amp;aspectRatio=1.33 384w, https://media.magloft.app/pdf-import/1144/images/img_5-2.jpg?optimizer=image&amp;format=webp&amp;width=520&amp;aspectRatio=1.33 520w, https://media.magloft.app/pdf-import/1144/images/img_5-2.jpg?optimizer=image&amp;format=webp&amp;width=640&amp;aspectRatio=1.33 640w, https://media.magloft.app/pdf-import/1144/images/img_5-2.jpg?optimizer=image&amp;format=webp&amp;width=756&amp;aspectRatio=1.33 756w, https://media.magloft.app/pdf-import/1144/images/img_5-2.jpg?optimizer=image&amp;format=webp&amp;width=828&amp;aspectRatio=1.33 828w, https://media.magloft.app/pdf-import/1144/images/img_5-2.jpg?optimizer=image&amp;format=webp&amp;width=1080&amp;aspectRatio=1.33 1080w, https://media.magloft.app/pdf-import/1144/images/img_5-2.jpg?optimizer=image&amp;format=webp&amp;width=1200&amp;aspectRatio=1.33 1200w, https://media.magloft.app/pdf-import/1144/images/img_5-2.jpg?optimizer=image&amp;format=webp&amp;width=1920&amp;aspectRatio=1.33 1920w, https://media.magloft.app/pdf-import/1144/images/img_5-2.jpg?optimizer=image&amp;format=webp&amp;width=2048&amp;aspectRatio=1.33 2048w" src="https://media.magloft.app/pdf-import/1144/images/img_5-2.jpg?optimizer=image&amp;format=webp&amp;width=2048&amp;aspectRatio=1.33"/></div><div class="Block_article-contents__M6B6V"><h3>HIV vaccine candidate successfully optimised for industrial production</h3><p>Sumagen Canada Inc, a biotech company based in both South Korea and Canada, has partnered with CDMO Naobios to industrialise Sumagen’s human immunodeficiency virus (HIV)-1 vaccine candidate (sav0001) at bench scale.</p></div></a><a class="Block_article-card__mncKE" href="/articles/bayer-and-liveo-research-pair-to-launch-new-sustainable-blister-4a15"><div class="Block_article-cover__vLhzO"><img alt="article-category" loading="lazy" decoding="async" data-nimg="fill" style="position:absolute;height:100%;width:100%;left:0;top:0;right:0;bottom:0;color:transparent;background-size:cover;background-position:50% 50%;background-repeat:no-repeat;background-image:url(&quot;data:image/svg+xml;charset=utf-8,%3Csvg xmlns=&#x27;http%3A//www.w3.org/2000/svg&#x27;%3E%3Cimage style=&#x27;filter:blur(20px)&#x27; preserveAspectRatio=&#x27;none&#x27; x=&#x27;0&#x27; y=&#x27;0&#x27; height=&#x27;100%25&#x27; width=&#x27;100%25&#x27; href=&#x27;data:image/gif;base64,R0lGODlhAQABAPAAANzc3P///yH5BAAAAAAALAAAAAABAAEAAAICRAEAOw==&#x27;/%3E%3C/svg%3E&quot;)" sizes="70px" srcSet="https://media.magloft.app/pdf-import/1144/images/img_7-2.jpg?optimizer=image&amp;format=webp&amp;width=16&amp;aspectRatio=1.33 16w, https://media.magloft.app/pdf-import/1144/images/img_7-2.jpg?optimizer=image&amp;format=webp&amp;width=32&amp;aspectRatio=1.33 32w, https://media.magloft.app/pdf-import/1144/images/img_7-2.jpg?optimizer=image&amp;format=webp&amp;width=48&amp;aspectRatio=1.33 48w, https://media.magloft.app/pdf-import/1144/images/img_7-2.jpg?optimizer=image&amp;format=webp&amp;width=54&amp;aspectRatio=1.33 54w, https://media.magloft.app/pdf-import/1144/images/img_7-2.jpg?optimizer=image&amp;format=webp&amp;width=64&amp;aspectRatio=1.33 64w, https://media.magloft.app/pdf-import/1144/images/img_7-2.jpg?optimizer=image&amp;format=webp&amp;width=70&amp;aspectRatio=1.33 70w, https://media.magloft.app/pdf-import/1144/images/img_7-2.jpg?optimizer=image&amp;format=webp&amp;width=82&amp;aspectRatio=1.33 82w, https://media.magloft.app/pdf-import/1144/images/img_7-2.jpg?optimizer=image&amp;format=webp&amp;width=96&amp;aspectRatio=1.33 96w, https://media.magloft.app/pdf-import/1144/images/img_7-2.jpg?optimizer=image&amp;format=webp&amp;width=96&amp;aspectRatio=1.33 96w, https://media.magloft.app/pdf-import/1144/images/img_7-2.jpg?optimizer=image&amp;format=webp&amp;width=110&amp;aspectRatio=1.33 110w, https://media.magloft.app/pdf-import/1144/images/img_7-2.jpg?optimizer=image&amp;format=webp&amp;width=128&amp;aspectRatio=1.33 128w, https://media.magloft.app/pdf-import/1144/images/img_7-2.jpg?optimizer=image&amp;format=webp&amp;width=128&amp;aspectRatio=1.33 128w, https://media.magloft.app/pdf-import/1144/images/img_7-2.jpg?optimizer=image&amp;format=webp&amp;width=138&amp;aspectRatio=1.33 138w, https://media.magloft.app/pdf-import/1144/images/img_7-2.jpg?optimizer=image&amp;format=webp&amp;width=192&amp;aspectRatio=1.33 192w, https://media.magloft.app/pdf-import/1144/images/img_7-2.jpg?optimizer=image&amp;format=webp&amp;width=200&amp;aspectRatio=1.33 200w, https://media.magloft.app/pdf-import/1144/images/img_7-2.jpg?optimizer=image&amp;format=webp&amp;width=252&amp;aspectRatio=1.33 252w, https://media.magloft.app/pdf-import/1144/images/img_7-2.jpg?optimizer=image&amp;format=webp&amp;width=256&amp;aspectRatio=1.33 256w, https://media.magloft.app/pdf-import/1144/images/img_7-2.jpg?optimizer=image&amp;format=webp&amp;width=260&amp;aspectRatio=1.33 260w, https://media.magloft.app/pdf-import/1144/images/img_7-2.jpg?optimizer=image&amp;format=webp&amp;width=298&amp;aspectRatio=1.33 298w, https://media.magloft.app/pdf-import/1144/images/img_7-2.jpg?optimizer=image&amp;format=webp&amp;width=378&amp;aspectRatio=1.33 378w, https://media.magloft.app/pdf-import/1144/images/img_7-2.jpg?optimizer=image&amp;format=webp&amp;width=384&amp;aspectRatio=1.33 384w, https://media.magloft.app/pdf-import/1144/images/img_7-2.jpg?optimizer=image&amp;format=webp&amp;width=384&amp;aspectRatio=1.33 384w, https://media.magloft.app/pdf-import/1144/images/img_7-2.jpg?optimizer=image&amp;format=webp&amp;width=520&amp;aspectRatio=1.33 520w, https://media.magloft.app/pdf-import/1144/images/img_7-2.jpg?optimizer=image&amp;format=webp&amp;width=640&amp;aspectRatio=1.33 640w, https://media.magloft.app/pdf-import/1144/images/img_7-2.jpg?optimizer=image&amp;format=webp&amp;width=756&amp;aspectRatio=1.33 756w, https://media.magloft.app/pdf-import/1144/images/img_7-2.jpg?optimizer=image&amp;format=webp&amp;width=828&amp;aspectRatio=1.33 828w, https://media.magloft.app/pdf-import/1144/images/img_7-2.jpg?optimizer=image&amp;format=webp&amp;width=1080&amp;aspectRatio=1.33 1080w, https://media.magloft.app/pdf-import/1144/images/img_7-2.jpg?optimizer=image&amp;format=webp&amp;width=1200&amp;aspectRatio=1.33 1200w, https://media.magloft.app/pdf-import/1144/images/img_7-2.jpg?optimizer=image&amp;format=webp&amp;width=1920&amp;aspectRatio=1.33 1920w, https://media.magloft.app/pdf-import/1144/images/img_7-2.jpg?optimizer=image&amp;format=webp&amp;width=2048&amp;aspectRatio=1.33 2048w" src="https://media.magloft.app/pdf-import/1144/images/img_7-2.jpg?optimizer=image&amp;format=webp&amp;width=2048&amp;aspectRatio=1.33"/></div><div class="Block_article-contents__M6B6V"><h3>Bayer and Liveo Research pair to launch new sustainable blister packaging</h3><p>The partnership between the two companies has resulted in the launching of a first-of-its-kind blister packaging, utilising polyethylene terephthalate (PET) instead of the more traditional poly vinyl chloride (PVC).</p></div></a><a class="Block_article-card__mncKE" href="/articles/nrg-therapeutics-secures-funding-for-development-of-treatment-fo-35cf"><div class="Block_article-cover__vLhzO"><img alt="article-category" loading="lazy" decoding="async" data-nimg="fill" style="position:absolute;height:100%;width:100%;left:0;top:0;right:0;bottom:0;color:transparent;background-size:cover;background-position:50% 50%;background-repeat:no-repeat;background-image:url(&quot;data:image/svg+xml;charset=utf-8,%3Csvg xmlns=&#x27;http%3A//www.w3.org/2000/svg&#x27;%3E%3Cimage style=&#x27;filter:blur(20px)&#x27; preserveAspectRatio=&#x27;none&#x27; x=&#x27;0&#x27; y=&#x27;0&#x27; height=&#x27;100%25&#x27; width=&#x27;100%25&#x27; href=&#x27;data:image/gif;base64,R0lGODlhAQABAPAAANzc3P///yH5BAAAAAAALAAAAAABAAEAAAICRAEAOw==&#x27;/%3E%3C/svg%3E&quot;)" sizes="70px" srcSet="https://media.magloft.app/pdf-import/1144/images/img_7-1.jpg?optimizer=image&amp;format=webp&amp;width=16&amp;aspectRatio=1.33 16w, https://media.magloft.app/pdf-import/1144/images/img_7-1.jpg?optimizer=image&amp;format=webp&amp;width=32&amp;aspectRatio=1.33 32w, https://media.magloft.app/pdf-import/1144/images/img_7-1.jpg?optimizer=image&amp;format=webp&amp;width=48&amp;aspectRatio=1.33 48w, https://media.magloft.app/pdf-import/1144/images/img_7-1.jpg?optimizer=image&amp;format=webp&amp;width=54&amp;aspectRatio=1.33 54w, https://media.magloft.app/pdf-import/1144/images/img_7-1.jpg?optimizer=image&amp;format=webp&amp;width=64&amp;aspectRatio=1.33 64w, https://media.magloft.app/pdf-import/1144/images/img_7-1.jpg?optimizer=image&amp;format=webp&amp;width=70&amp;aspectRatio=1.33 70w, https://media.magloft.app/pdf-import/1144/images/img_7-1.jpg?optimizer=image&amp;format=webp&amp;width=82&amp;aspectRatio=1.33 82w, https://media.magloft.app/pdf-import/1144/images/img_7-1.jpg?optimizer=image&amp;format=webp&amp;width=96&amp;aspectRatio=1.33 96w, https://media.magloft.app/pdf-import/1144/images/img_7-1.jpg?optimizer=image&amp;format=webp&amp;width=96&amp;aspectRatio=1.33 96w, https://media.magloft.app/pdf-import/1144/images/img_7-1.jpg?optimizer=image&amp;format=webp&amp;width=110&amp;aspectRatio=1.33 110w, https://media.magloft.app/pdf-import/1144/images/img_7-1.jpg?optimizer=image&amp;format=webp&amp;width=128&amp;aspectRatio=1.33 128w, https://media.magloft.app/pdf-import/1144/images/img_7-1.jpg?optimizer=image&amp;format=webp&amp;width=128&amp;aspectRatio=1.33 128w, https://media.magloft.app/pdf-import/1144/images/img_7-1.jpg?optimizer=image&amp;format=webp&amp;width=138&amp;aspectRatio=1.33 138w, https://media.magloft.app/pdf-import/1144/images/img_7-1.jpg?optimizer=image&amp;format=webp&amp;width=192&amp;aspectRatio=1.33 192w, https://media.magloft.app/pdf-import/1144/images/img_7-1.jpg?optimizer=image&amp;format=webp&amp;width=200&amp;aspectRatio=1.33 200w, https://media.magloft.app/pdf-import/1144/images/img_7-1.jpg?optimizer=image&amp;format=webp&amp;width=252&amp;aspectRatio=1.33 252w, https://media.magloft.app/pdf-import/1144/images/img_7-1.jpg?optimizer=image&amp;format=webp&amp;width=256&amp;aspectRatio=1.33 256w, https://media.magloft.app/pdf-import/1144/images/img_7-1.jpg?optimizer=image&amp;format=webp&amp;width=260&amp;aspectRatio=1.33 260w, https://media.magloft.app/pdf-import/1144/images/img_7-1.jpg?optimizer=image&amp;format=webp&amp;width=298&amp;aspectRatio=1.33 298w, https://media.magloft.app/pdf-import/1144/images/img_7-1.jpg?optimizer=image&amp;format=webp&amp;width=378&amp;aspectRatio=1.33 378w, https://media.magloft.app/pdf-import/1144/images/img_7-1.jpg?optimizer=image&amp;format=webp&amp;width=384&amp;aspectRatio=1.33 384w, https://media.magloft.app/pdf-import/1144/images/img_7-1.jpg?optimizer=image&amp;format=webp&amp;width=384&amp;aspectRatio=1.33 384w, https://media.magloft.app/pdf-import/1144/images/img_7-1.jpg?optimizer=image&amp;format=webp&amp;width=520&amp;aspectRatio=1.33 520w, https://media.magloft.app/pdf-import/1144/images/img_7-1.jpg?optimizer=image&amp;format=webp&amp;width=640&amp;aspectRatio=1.33 640w, https://media.magloft.app/pdf-import/1144/images/img_7-1.jpg?optimizer=image&amp;format=webp&amp;width=756&amp;aspectRatio=1.33 756w, https://media.magloft.app/pdf-import/1144/images/img_7-1.jpg?optimizer=image&amp;format=webp&amp;width=828&amp;aspectRatio=1.33 828w, https://media.magloft.app/pdf-import/1144/images/img_7-1.jpg?optimizer=image&amp;format=webp&amp;width=1080&amp;aspectRatio=1.33 1080w, https://media.magloft.app/pdf-import/1144/images/img_7-1.jpg?optimizer=image&amp;format=webp&amp;width=1200&amp;aspectRatio=1.33 1200w, https://media.magloft.app/pdf-import/1144/images/img_7-1.jpg?optimizer=image&amp;format=webp&amp;width=1920&amp;aspectRatio=1.33 1920w, https://media.magloft.app/pdf-import/1144/images/img_7-1.jpg?optimizer=image&amp;format=webp&amp;width=2048&amp;aspectRatio=1.33 2048w" src="https://media.magloft.app/pdf-import/1144/images/img_7-1.jpg?optimizer=image&amp;format=webp&amp;width=2048&amp;aspectRatio=1.33"/></div><div class="Block_article-contents__M6B6V"><h3>NRG Therapeutics secures funding for development of treatment for neurodegenerative disease</h3><p>NRG Therapeutics has announced that its NRG5051 inhibitor has secured a $5m grant from the Michael J. Fox foundation for Parkinson’s research (MJFF).</p></div></a><a class="Block_article-card__mncKE" href="/articles/pac-bio-announces-update-to-sequencing-system-to-bring-down-cost"><div class="Block_article-cover__vLhzO"><img alt="article-category" loading="lazy" decoding="async" data-nimg="fill" style="position:absolute;height:100%;width:100%;left:0;top:0;right:0;bottom:0;color:transparent;background-size:cover;background-position:50% 50%;background-repeat:no-repeat;background-image:url(&quot;data:image/svg+xml;charset=utf-8,%3Csvg xmlns=&#x27;http%3A//www.w3.org/2000/svg&#x27;%3E%3Cimage style=&#x27;filter:blur(20px)&#x27; preserveAspectRatio=&#x27;none&#x27; x=&#x27;0&#x27; y=&#x27;0&#x27; height=&#x27;100%25&#x27; width=&#x27;100%25&#x27; href=&#x27;data:image/gif;base64,R0lGODlhAQABAPAAANzc3P///yH5BAAAAAAALAAAAAABAAEAAAICRAEAOw==&#x27;/%3E%3C/svg%3E&quot;)" sizes="70px" srcSet="https://media.magloft.app/pdf-import/1144/images/img_6-2.jpg?optimizer=image&amp;format=webp&amp;width=16&amp;aspectRatio=1.33 16w, https://media.magloft.app/pdf-import/1144/images/img_6-2.jpg?optimizer=image&amp;format=webp&amp;width=32&amp;aspectRatio=1.33 32w, https://media.magloft.app/pdf-import/1144/images/img_6-2.jpg?optimizer=image&amp;format=webp&amp;width=48&amp;aspectRatio=1.33 48w, https://media.magloft.app/pdf-import/1144/images/img_6-2.jpg?optimizer=image&amp;format=webp&amp;width=54&amp;aspectRatio=1.33 54w, https://media.magloft.app/pdf-import/1144/images/img_6-2.jpg?optimizer=image&amp;format=webp&amp;width=64&amp;aspectRatio=1.33 64w, https://media.magloft.app/pdf-import/1144/images/img_6-2.jpg?optimizer=image&amp;format=webp&amp;width=70&amp;aspectRatio=1.33 70w, https://media.magloft.app/pdf-import/1144/images/img_6-2.jpg?optimizer=image&amp;format=webp&amp;width=82&amp;aspectRatio=1.33 82w, https://media.magloft.app/pdf-import/1144/images/img_6-2.jpg?optimizer=image&amp;format=webp&amp;width=96&amp;aspectRatio=1.33 96w, https://media.magloft.app/pdf-import/1144/images/img_6-2.jpg?optimizer=image&amp;format=webp&amp;width=96&amp;aspectRatio=1.33 96w, https://media.magloft.app/pdf-import/1144/images/img_6-2.jpg?optimizer=image&amp;format=webp&amp;width=110&amp;aspectRatio=1.33 110w, https://media.magloft.app/pdf-import/1144/images/img_6-2.jpg?optimizer=image&amp;format=webp&amp;width=128&amp;aspectRatio=1.33 128w, https://media.magloft.app/pdf-import/1144/images/img_6-2.jpg?optimizer=image&amp;format=webp&amp;width=128&amp;aspectRatio=1.33 128w, https://media.magloft.app/pdf-import/1144/images/img_6-2.jpg?optimizer=image&amp;format=webp&amp;width=138&amp;aspectRatio=1.33 138w, https://media.magloft.app/pdf-import/1144/images/img_6-2.jpg?optimizer=image&amp;format=webp&amp;width=192&amp;aspectRatio=1.33 192w, https://media.magloft.app/pdf-import/1144/images/img_6-2.jpg?optimizer=image&amp;format=webp&amp;width=200&amp;aspectRatio=1.33 200w, https://media.magloft.app/pdf-import/1144/images/img_6-2.jpg?optimizer=image&amp;format=webp&amp;width=252&amp;aspectRatio=1.33 252w, https://media.magloft.app/pdf-import/1144/images/img_6-2.jpg?optimizer=image&amp;format=webp&amp;width=256&amp;aspectRatio=1.33 256w, https://media.magloft.app/pdf-import/1144/images/img_6-2.jpg?optimizer=image&amp;format=webp&amp;width=260&amp;aspectRatio=1.33 260w, https://media.magloft.app/pdf-import/1144/images/img_6-2.jpg?optimizer=image&amp;format=webp&amp;width=298&amp;aspectRatio=1.33 298w, https://media.magloft.app/pdf-import/1144/images/img_6-2.jpg?optimizer=image&amp;format=webp&amp;width=378&amp;aspectRatio=1.33 378w, https://media.magloft.app/pdf-import/1144/images/img_6-2.jpg?optimizer=image&amp;format=webp&amp;width=384&amp;aspectRatio=1.33 384w, https://media.magloft.app/pdf-import/1144/images/img_6-2.jpg?optimizer=image&amp;format=webp&amp;width=384&amp;aspectRatio=1.33 384w, https://media.magloft.app/pdf-import/1144/images/img_6-2.jpg?optimizer=image&amp;format=webp&amp;width=520&amp;aspectRatio=1.33 520w, https://media.magloft.app/pdf-import/1144/images/img_6-2.jpg?optimizer=image&amp;format=webp&amp;width=640&amp;aspectRatio=1.33 640w, https://media.magloft.app/pdf-import/1144/images/img_6-2.jpg?optimizer=image&amp;format=webp&amp;width=756&amp;aspectRatio=1.33 756w, https://media.magloft.app/pdf-import/1144/images/img_6-2.jpg?optimizer=image&amp;format=webp&amp;width=828&amp;aspectRatio=1.33 828w, https://media.magloft.app/pdf-import/1144/images/img_6-2.jpg?optimizer=image&amp;format=webp&amp;width=1080&amp;aspectRatio=1.33 1080w, https://media.magloft.app/pdf-import/1144/images/img_6-2.jpg?optimizer=image&amp;format=webp&amp;width=1200&amp;aspectRatio=1.33 1200w, https://media.magloft.app/pdf-import/1144/images/img_6-2.jpg?optimizer=image&amp;format=webp&amp;width=1920&amp;aspectRatio=1.33 1920w, https://media.magloft.app/pdf-import/1144/images/img_6-2.jpg?optimizer=image&amp;format=webp&amp;width=2048&amp;aspectRatio=1.33 2048w" src="https://media.magloft.app/pdf-import/1144/images/img_6-2.jpg?optimizer=image&amp;format=webp&amp;width=2048&amp;aspectRatio=1.33"/></div><div class="Block_article-contents__M6B6V"><h3>PacBio announces update to sequencing system to bring down cost of genome sample to below $500</h3><p>Announced by PacBio, known for developing sequencing solutions, SPRQ has the potential to significantly reduce the cost of sequencing genomes.</p></div></a><a class="Block_article-card__mncKE" href="/articles/bayer-and-liveo-research-pair-to-launch-new-sustainable-blister"><div class="Block_article-cover__vLhzO"><img alt="article-category" loading="lazy" decoding="async" data-nimg="fill" style="position:absolute;height:100%;width:100%;left:0;top:0;right:0;bottom:0;color:transparent;background-size:cover;background-position:50% 50%;background-repeat:no-repeat;background-image:url(&quot;data:image/svg+xml;charset=utf-8,%3Csvg xmlns=&#x27;http%3A//www.w3.org/2000/svg&#x27;%3E%3Cimage style=&#x27;filter:blur(20px)&#x27; preserveAspectRatio=&#x27;none&#x27; x=&#x27;0&#x27; y=&#x27;0&#x27; height=&#x27;100%25&#x27; width=&#x27;100%25&#x27; href=&#x27;data:image/gif;base64,R0lGODlhAQABAPAAANzc3P///yH5BAAAAAAALAAAAAABAAEAAAICRAEAOw==&#x27;/%3E%3C/svg%3E&quot;)" sizes="70px" srcSet="https://media.magloft.app/pdf-import/1144/images/img_7-2.jpg?optimizer=image&amp;format=webp&amp;width=16&amp;aspectRatio=1.33 16w, https://media.magloft.app/pdf-import/1144/images/img_7-2.jpg?optimizer=image&amp;format=webp&amp;width=32&amp;aspectRatio=1.33 32w, https://media.magloft.app/pdf-import/1144/images/img_7-2.jpg?optimizer=image&amp;format=webp&amp;width=48&amp;aspectRatio=1.33 48w, https://media.magloft.app/pdf-import/1144/images/img_7-2.jpg?optimizer=image&amp;format=webp&amp;width=54&amp;aspectRatio=1.33 54w, https://media.magloft.app/pdf-import/1144/images/img_7-2.jpg?optimizer=image&amp;format=webp&amp;width=64&amp;aspectRatio=1.33 64w, https://media.magloft.app/pdf-import/1144/images/img_7-2.jpg?optimizer=image&amp;format=webp&amp;width=70&amp;aspectRatio=1.33 70w, https://media.magloft.app/pdf-import/1144/images/img_7-2.jpg?optimizer=image&amp;format=webp&amp;width=82&amp;aspectRatio=1.33 82w, https://media.magloft.app/pdf-import/1144/images/img_7-2.jpg?optimizer=image&amp;format=webp&amp;width=96&amp;aspectRatio=1.33 96w, https://media.magloft.app/pdf-import/1144/images/img_7-2.jpg?optimizer=image&amp;format=webp&amp;width=96&amp;aspectRatio=1.33 96w, https://media.magloft.app/pdf-import/1144/images/img_7-2.jpg?optimizer=image&amp;format=webp&amp;width=110&amp;aspectRatio=1.33 110w, https://media.magloft.app/pdf-import/1144/images/img_7-2.jpg?optimizer=image&amp;format=webp&amp;width=128&amp;aspectRatio=1.33 128w, https://media.magloft.app/pdf-import/1144/images/img_7-2.jpg?optimizer=image&amp;format=webp&amp;width=128&amp;aspectRatio=1.33 128w, https://media.magloft.app/pdf-import/1144/images/img_7-2.jpg?optimizer=image&amp;format=webp&amp;width=138&amp;aspectRatio=1.33 138w, https://media.magloft.app/pdf-import/1144/images/img_7-2.jpg?optimizer=image&amp;format=webp&amp;width=192&amp;aspectRatio=1.33 192w, https://media.magloft.app/pdf-import/1144/images/img_7-2.jpg?optimizer=image&amp;format=webp&amp;width=200&amp;aspectRatio=1.33 200w, https://media.magloft.app/pdf-import/1144/images/img_7-2.jpg?optimizer=image&amp;format=webp&amp;width=252&amp;aspectRatio=1.33 252w, https://media.magloft.app/pdf-import/1144/images/img_7-2.jpg?optimizer=image&amp;format=webp&amp;width=256&amp;aspectRatio=1.33 256w, https://media.magloft.app/pdf-import/1144/images/img_7-2.jpg?optimizer=image&amp;format=webp&amp;width=260&amp;aspectRatio=1.33 260w, https://media.magloft.app/pdf-import/1144/images/img_7-2.jpg?optimizer=image&amp;format=webp&amp;width=298&amp;aspectRatio=1.33 298w, https://media.magloft.app/pdf-import/1144/images/img_7-2.jpg?optimizer=image&amp;format=webp&amp;width=378&amp;aspectRatio=1.33 378w, https://media.magloft.app/pdf-import/1144/images/img_7-2.jpg?optimizer=image&amp;format=webp&amp;width=384&amp;aspectRatio=1.33 384w, https://media.magloft.app/pdf-import/1144/images/img_7-2.jpg?optimizer=image&amp;format=webp&amp;width=384&amp;aspectRatio=1.33 384w, https://media.magloft.app/pdf-import/1144/images/img_7-2.jpg?optimizer=image&amp;format=webp&amp;width=520&amp;aspectRatio=1.33 520w, https://media.magloft.app/pdf-import/1144/images/img_7-2.jpg?optimizer=image&amp;format=webp&amp;width=640&amp;aspectRatio=1.33 640w, https://media.magloft.app/pdf-import/1144/images/img_7-2.jpg?optimizer=image&amp;format=webp&amp;width=756&amp;aspectRatio=1.33 756w, https://media.magloft.app/pdf-import/1144/images/img_7-2.jpg?optimizer=image&amp;format=webp&amp;width=828&amp;aspectRatio=1.33 828w, https://media.magloft.app/pdf-import/1144/images/img_7-2.jpg?optimizer=image&amp;format=webp&amp;width=1080&amp;aspectRatio=1.33 1080w, https://media.magloft.app/pdf-import/1144/images/img_7-2.jpg?optimizer=image&amp;format=webp&amp;width=1200&amp;aspectRatio=1.33 1200w, https://media.magloft.app/pdf-import/1144/images/img_7-2.jpg?optimizer=image&amp;format=webp&amp;width=1920&amp;aspectRatio=1.33 1920w, https://media.magloft.app/pdf-import/1144/images/img_7-2.jpg?optimizer=image&amp;format=webp&amp;width=2048&amp;aspectRatio=1.33 2048w" src="https://media.magloft.app/pdf-import/1144/images/img_7-2.jpg?optimizer=image&amp;format=webp&amp;width=2048&amp;aspectRatio=1.33"/></div><div class="Block_article-contents__M6B6V"><h3>Bayer and Liveo Research pair to launch new sustainable blister packaging</h3><p>The partnership between the two companies has resulted in the launching of a first-of-its-kind blister packaging, utilising polyethylene terephthalate (PET) instead of the more traditional poly vinyl chloride (PVC).</p></div></a><a class="Block_article-card__mncKE" href="/articles/aravax-successfully-recruits-for-phase-3-peanut-allergy-treatmen"><div class="Block_article-cover__vLhzO"><img alt="article-category" loading="lazy" decoding="async" data-nimg="fill" style="position:absolute;height:100%;width:100%;left:0;top:0;right:0;bottom:0;color:transparent;background-size:cover;background-position:50% 50%;background-repeat:no-repeat;background-image:url(&quot;data:image/svg+xml;charset=utf-8,%3Csvg xmlns=&#x27;http%3A//www.w3.org/2000/svg&#x27;%3E%3Cimage style=&#x27;filter:blur(20px)&#x27; preserveAspectRatio=&#x27;none&#x27; x=&#x27;0&#x27; y=&#x27;0&#x27; height=&#x27;100%25&#x27; width=&#x27;100%25&#x27; href=&#x27;data:image/gif;base64,R0lGODlhAQABAPAAANzc3P///yH5BAAAAAAALAAAAAABAAEAAAICRAEAOw==&#x27;/%3E%3C/svg%3E&quot;)" sizes="70px" srcSet="https://media.magloft.app/pdf-import/1144/images/img_10-1.jpg?optimizer=image&amp;format=webp&amp;width=16&amp;aspectRatio=1.33 16w, https://media.magloft.app/pdf-import/1144/images/img_10-1.jpg?optimizer=image&amp;format=webp&amp;width=32&amp;aspectRatio=1.33 32w, https://media.magloft.app/pdf-import/1144/images/img_10-1.jpg?optimizer=image&amp;format=webp&amp;width=48&amp;aspectRatio=1.33 48w, https://media.magloft.app/pdf-import/1144/images/img_10-1.jpg?optimizer=image&amp;format=webp&amp;width=54&amp;aspectRatio=1.33 54w, https://media.magloft.app/pdf-import/1144/images/img_10-1.jpg?optimizer=image&amp;format=webp&amp;width=64&amp;aspectRatio=1.33 64w, https://media.magloft.app/pdf-import/1144/images/img_10-1.jpg?optimizer=image&amp;format=webp&amp;width=70&amp;aspectRatio=1.33 70w, https://media.magloft.app/pdf-import/1144/images/img_10-1.jpg?optimizer=image&amp;format=webp&amp;width=82&amp;aspectRatio=1.33 82w, https://media.magloft.app/pdf-import/1144/images/img_10-1.jpg?optimizer=image&amp;format=webp&amp;width=96&amp;aspectRatio=1.33 96w, https://media.magloft.app/pdf-import/1144/images/img_10-1.jpg?optimizer=image&amp;format=webp&amp;width=96&amp;aspectRatio=1.33 96w, https://media.magloft.app/pdf-import/1144/images/img_10-1.jpg?optimizer=image&amp;format=webp&amp;width=110&amp;aspectRatio=1.33 110w, https://media.magloft.app/pdf-import/1144/images/img_10-1.jpg?optimizer=image&amp;format=webp&amp;width=128&amp;aspectRatio=1.33 128w, https://media.magloft.app/pdf-import/1144/images/img_10-1.jpg?optimizer=image&amp;format=webp&amp;width=128&amp;aspectRatio=1.33 128w, https://media.magloft.app/pdf-import/1144/images/img_10-1.jpg?optimizer=image&amp;format=webp&amp;width=138&amp;aspectRatio=1.33 138w, https://media.magloft.app/pdf-import/1144/images/img_10-1.jpg?optimizer=image&amp;format=webp&amp;width=192&amp;aspectRatio=1.33 192w, https://media.magloft.app/pdf-import/1144/images/img_10-1.jpg?optimizer=image&amp;format=webp&amp;width=200&amp;aspectRatio=1.33 200w, https://media.magloft.app/pdf-import/1144/images/img_10-1.jpg?optimizer=image&amp;format=webp&amp;width=252&amp;aspectRatio=1.33 252w, https://media.magloft.app/pdf-import/1144/images/img_10-1.jpg?optimizer=image&amp;format=webp&amp;width=256&amp;aspectRatio=1.33 256w, https://media.magloft.app/pdf-import/1144/images/img_10-1.jpg?optimizer=image&amp;format=webp&amp;width=260&amp;aspectRatio=1.33 260w, https://media.magloft.app/pdf-import/1144/images/img_10-1.jpg?optimizer=image&amp;format=webp&amp;width=298&amp;aspectRatio=1.33 298w, https://media.magloft.app/pdf-import/1144/images/img_10-1.jpg?optimizer=image&amp;format=webp&amp;width=378&amp;aspectRatio=1.33 378w, https://media.magloft.app/pdf-import/1144/images/img_10-1.jpg?optimizer=image&amp;format=webp&amp;width=384&amp;aspectRatio=1.33 384w, https://media.magloft.app/pdf-import/1144/images/img_10-1.jpg?optimizer=image&amp;format=webp&amp;width=384&amp;aspectRatio=1.33 384w, https://media.magloft.app/pdf-import/1144/images/img_10-1.jpg?optimizer=image&amp;format=webp&amp;width=520&amp;aspectRatio=1.33 520w, https://media.magloft.app/pdf-import/1144/images/img_10-1.jpg?optimizer=image&amp;format=webp&amp;width=640&amp;aspectRatio=1.33 640w, https://media.magloft.app/pdf-import/1144/images/img_10-1.jpg?optimizer=image&amp;format=webp&amp;width=756&amp;aspectRatio=1.33 756w, https://media.magloft.app/pdf-import/1144/images/img_10-1.jpg?optimizer=image&amp;format=webp&amp;width=828&amp;aspectRatio=1.33 828w, https://media.magloft.app/pdf-import/1144/images/img_10-1.jpg?optimizer=image&amp;format=webp&amp;width=1080&amp;aspectRatio=1.33 1080w, https://media.magloft.app/pdf-import/1144/images/img_10-1.jpg?optimizer=image&amp;format=webp&amp;width=1200&amp;aspectRatio=1.33 1200w, https://media.magloft.app/pdf-import/1144/images/img_10-1.jpg?optimizer=image&amp;format=webp&amp;width=1920&amp;aspectRatio=1.33 1920w, https://media.magloft.app/pdf-import/1144/images/img_10-1.jpg?optimizer=image&amp;format=webp&amp;width=2048&amp;aspectRatio=1.33 2048w" src="https://media.magloft.app/pdf-import/1144/images/img_10-1.jpg?optimizer=image&amp;format=webp&amp;width=2048&amp;aspectRatio=1.33"/></div><div class="Block_article-contents__M6B6V"><h3>Aravax successfully recruits for phase 3 peanut allergy treatment study</h3><p>Clinical-stage biotech company Aravax has announced that it has completed phase 2 recruitment for its precision therapy (pvx108) study, which investigates treatment of peanut allergies.</p></div></a><a class="Block_article-card__mncKE" href="/articles/nrg-therapeutics-secures-funding-for-development-of-treatment-fo"><div class="Block_article-cover__vLhzO"><img alt="article-category" loading="lazy" decoding="async" data-nimg="fill" style="position:absolute;height:100%;width:100%;left:0;top:0;right:0;bottom:0;color:transparent;background-size:cover;background-position:50% 50%;background-repeat:no-repeat;background-image:url(&quot;data:image/svg+xml;charset=utf-8,%3Csvg xmlns=&#x27;http%3A//www.w3.org/2000/svg&#x27;%3E%3Cimage style=&#x27;filter:blur(20px)&#x27; preserveAspectRatio=&#x27;none&#x27; x=&#x27;0&#x27; y=&#x27;0&#x27; height=&#x27;100%25&#x27; width=&#x27;100%25&#x27; href=&#x27;data:image/gif;base64,R0lGODlhAQABAPAAANzc3P///yH5BAAAAAAALAAAAAABAAEAAAICRAEAOw==&#x27;/%3E%3C/svg%3E&quot;)" sizes="70px" srcSet="https://media.magloft.app/pdf-import/1144/images/img_7-1.jpg?optimizer=image&amp;format=webp&amp;width=16&amp;aspectRatio=1.33 16w, https://media.magloft.app/pdf-import/1144/images/img_7-1.jpg?optimizer=image&amp;format=webp&amp;width=32&amp;aspectRatio=1.33 32w, https://media.magloft.app/pdf-import/1144/images/img_7-1.jpg?optimizer=image&amp;format=webp&amp;width=48&amp;aspectRatio=1.33 48w, https://media.magloft.app/pdf-import/1144/images/img_7-1.jpg?optimizer=image&amp;format=webp&amp;width=54&amp;aspectRatio=1.33 54w, https://media.magloft.app/pdf-import/1144/images/img_7-1.jpg?optimizer=image&amp;format=webp&amp;width=64&amp;aspectRatio=1.33 64w, https://media.magloft.app/pdf-import/1144/images/img_7-1.jpg?optimizer=image&amp;format=webp&amp;width=70&amp;aspectRatio=1.33 70w, https://media.magloft.app/pdf-import/1144/images/img_7-1.jpg?optimizer=image&amp;format=webp&amp;width=82&amp;aspectRatio=1.33 82w, https://media.magloft.app/pdf-import/1144/images/img_7-1.jpg?optimizer=image&amp;format=webp&amp;width=96&amp;aspectRatio=1.33 96w, https://media.magloft.app/pdf-import/1144/images/img_7-1.jpg?optimizer=image&amp;format=webp&amp;width=96&amp;aspectRatio=1.33 96w, https://media.magloft.app/pdf-import/1144/images/img_7-1.jpg?optimizer=image&amp;format=webp&amp;width=110&amp;aspectRatio=1.33 110w, https://media.magloft.app/pdf-import/1144/images/img_7-1.jpg?optimizer=image&amp;format=webp&amp;width=128&amp;aspectRatio=1.33 128w, https://media.magloft.app/pdf-import/1144/images/img_7-1.jpg?optimizer=image&amp;format=webp&amp;width=128&amp;aspectRatio=1.33 128w, https://media.magloft.app/pdf-import/1144/images/img_7-1.jpg?optimizer=image&amp;format=webp&amp;width=138&amp;aspectRatio=1.33 138w, https://media.magloft.app/pdf-import/1144/images/img_7-1.jpg?optimizer=image&amp;format=webp&amp;width=192&amp;aspectRatio=1.33 192w, https://media.magloft.app/pdf-import/1144/images/img_7-1.jpg?optimizer=image&amp;format=webp&amp;width=200&amp;aspectRatio=1.33 200w, https://media.magloft.app/pdf-import/1144/images/img_7-1.jpg?optimizer=image&amp;format=webp&amp;width=252&amp;aspectRatio=1.33 252w, https://media.magloft.app/pdf-import/1144/images/img_7-1.jpg?optimizer=image&amp;format=webp&amp;width=256&amp;aspectRatio=1.33 256w, https://media.magloft.app/pdf-import/1144/images/img_7-1.jpg?optimizer=image&amp;format=webp&amp;width=260&amp;aspectRatio=1.33 260w, https://media.magloft.app/pdf-import/1144/images/img_7-1.jpg?optimizer=image&amp;format=webp&amp;width=298&amp;aspectRatio=1.33 298w, https://media.magloft.app/pdf-import/1144/images/img_7-1.jpg?optimizer=image&amp;format=webp&amp;width=378&amp;aspectRatio=1.33 378w, https://media.magloft.app/pdf-import/1144/images/img_7-1.jpg?optimizer=image&amp;format=webp&amp;width=384&amp;aspectRatio=1.33 384w, https://media.magloft.app/pdf-import/1144/images/img_7-1.jpg?optimizer=image&amp;format=webp&amp;width=384&amp;aspectRatio=1.33 384w, https://media.magloft.app/pdf-import/1144/images/img_7-1.jpg?optimizer=image&amp;format=webp&amp;width=520&amp;aspectRatio=1.33 520w, https://media.magloft.app/pdf-import/1144/images/img_7-1.jpg?optimizer=image&amp;format=webp&amp;width=640&amp;aspectRatio=1.33 640w, https://media.magloft.app/pdf-import/1144/images/img_7-1.jpg?optimizer=image&amp;format=webp&amp;width=756&amp;aspectRatio=1.33 756w, https://media.magloft.app/pdf-import/1144/images/img_7-1.jpg?optimizer=image&amp;format=webp&amp;width=828&amp;aspectRatio=1.33 828w, https://media.magloft.app/pdf-import/1144/images/img_7-1.jpg?optimizer=image&amp;format=webp&amp;width=1080&amp;aspectRatio=1.33 1080w, https://media.magloft.app/pdf-import/1144/images/img_7-1.jpg?optimizer=image&amp;format=webp&amp;width=1200&amp;aspectRatio=1.33 1200w, https://media.magloft.app/pdf-import/1144/images/img_7-1.jpg?optimizer=image&amp;format=webp&amp;width=1920&amp;aspectRatio=1.33 1920w, https://media.magloft.app/pdf-import/1144/images/img_7-1.jpg?optimizer=image&amp;format=webp&amp;width=2048&amp;aspectRatio=1.33 2048w" src="https://media.magloft.app/pdf-import/1144/images/img_7-1.jpg?optimizer=image&amp;format=webp&amp;width=2048&amp;aspectRatio=1.33"/></div><div class="Block_article-contents__M6B6V"><h3>NRG Therapeutics secures funding for development of treatment for neurodegenerative disease</h3><p>NRG Therapeutics has announced that its NRG5051 inhibitor has secured a $5m grant from the Michael J. Fox Foundation for Parkinson’s Research (MJFF).</p></div></a><a class="Block_article-card__mncKE" href="/articles/chiesi-announces-phase-3-results-from-enzyme-replacement-study"><div class="Block_article-cover__vLhzO"><img alt="article-category" loading="lazy" decoding="async" data-nimg="fill" style="position:absolute;height:100%;width:100%;left:0;top:0;right:0;bottom:0;color:transparent;background-size:cover;background-position:50% 50%;background-repeat:no-repeat;background-image:url(&quot;data:image/svg+xml;charset=utf-8,%3Csvg xmlns=&#x27;http%3A//www.w3.org/2000/svg&#x27;%3E%3Cimage style=&#x27;filter:blur(20px)&#x27; preserveAspectRatio=&#x27;none&#x27; x=&#x27;0&#x27; y=&#x27;0&#x27; height=&#x27;100%25&#x27; width=&#x27;100%25&#x27; href=&#x27;data:image/gif;base64,R0lGODlhAQABAPAAANzc3P///yH5BAAAAAAALAAAAAABAAEAAAICRAEAOw==&#x27;/%3E%3C/svg%3E&quot;)" sizes="70px" srcSet="https://media.magloft.app/pdf-import/1144/images/img_10-2.jpg?optimizer=image&amp;format=webp&amp;width=16&amp;aspectRatio=1.33 16w, https://media.magloft.app/pdf-import/1144/images/img_10-2.jpg?optimizer=image&amp;format=webp&amp;width=32&amp;aspectRatio=1.33 32w, https://media.magloft.app/pdf-import/1144/images/img_10-2.jpg?optimizer=image&amp;format=webp&amp;width=48&amp;aspectRatio=1.33 48w, https://media.magloft.app/pdf-import/1144/images/img_10-2.jpg?optimizer=image&amp;format=webp&amp;width=54&amp;aspectRatio=1.33 54w, https://media.magloft.app/pdf-import/1144/images/img_10-2.jpg?optimizer=image&amp;format=webp&amp;width=64&amp;aspectRatio=1.33 64w, https://media.magloft.app/pdf-import/1144/images/img_10-2.jpg?optimizer=image&amp;format=webp&amp;width=70&amp;aspectRatio=1.33 70w, https://media.magloft.app/pdf-import/1144/images/img_10-2.jpg?optimizer=image&amp;format=webp&amp;width=82&amp;aspectRatio=1.33 82w, https://media.magloft.app/pdf-import/1144/images/img_10-2.jpg?optimizer=image&amp;format=webp&amp;width=96&amp;aspectRatio=1.33 96w, https://media.magloft.app/pdf-import/1144/images/img_10-2.jpg?optimizer=image&amp;format=webp&amp;width=96&amp;aspectRatio=1.33 96w, https://media.magloft.app/pdf-import/1144/images/img_10-2.jpg?optimizer=image&amp;format=webp&amp;width=110&amp;aspectRatio=1.33 110w, https://media.magloft.app/pdf-import/1144/images/img_10-2.jpg?optimizer=image&amp;format=webp&amp;width=128&amp;aspectRatio=1.33 128w, https://media.magloft.app/pdf-import/1144/images/img_10-2.jpg?optimizer=image&amp;format=webp&amp;width=128&amp;aspectRatio=1.33 128w, https://media.magloft.app/pdf-import/1144/images/img_10-2.jpg?optimizer=image&amp;format=webp&amp;width=138&amp;aspectRatio=1.33 138w, https://media.magloft.app/pdf-import/1144/images/img_10-2.jpg?optimizer=image&amp;format=webp&amp;width=192&amp;aspectRatio=1.33 192w, https://media.magloft.app/pdf-import/1144/images/img_10-2.jpg?optimizer=image&amp;format=webp&amp;width=200&amp;aspectRatio=1.33 200w, https://media.magloft.app/pdf-import/1144/images/img_10-2.jpg?optimizer=image&amp;format=webp&amp;width=252&amp;aspectRatio=1.33 252w, https://media.magloft.app/pdf-import/1144/images/img_10-2.jpg?optimizer=image&amp;format=webp&amp;width=256&amp;aspectRatio=1.33 256w, https://media.magloft.app/pdf-import/1144/images/img_10-2.jpg?optimizer=image&amp;format=webp&amp;width=260&amp;aspectRatio=1.33 260w, https://media.magloft.app/pdf-import/1144/images/img_10-2.jpg?optimizer=image&amp;format=webp&amp;width=298&amp;aspectRatio=1.33 298w, https://media.magloft.app/pdf-import/1144/images/img_10-2.jpg?optimizer=image&amp;format=webp&amp;width=378&amp;aspectRatio=1.33 378w, https://media.magloft.app/pdf-import/1144/images/img_10-2.jpg?optimizer=image&amp;format=webp&amp;width=384&amp;aspectRatio=1.33 384w, https://media.magloft.app/pdf-import/1144/images/img_10-2.jpg?optimizer=image&amp;format=webp&amp;width=384&amp;aspectRatio=1.33 384w, https://media.magloft.app/pdf-import/1144/images/img_10-2.jpg?optimizer=image&amp;format=webp&amp;width=520&amp;aspectRatio=1.33 520w, https://media.magloft.app/pdf-import/1144/images/img_10-2.jpg?optimizer=image&amp;format=webp&amp;width=640&amp;aspectRatio=1.33 640w, https://media.magloft.app/pdf-import/1144/images/img_10-2.jpg?optimizer=image&amp;format=webp&amp;width=756&amp;aspectRatio=1.33 756w, https://media.magloft.app/pdf-import/1144/images/img_10-2.jpg?optimizer=image&amp;format=webp&amp;width=828&amp;aspectRatio=1.33 828w, https://media.magloft.app/pdf-import/1144/images/img_10-2.jpg?optimizer=image&amp;format=webp&amp;width=1080&amp;aspectRatio=1.33 1080w, https://media.magloft.app/pdf-import/1144/images/img_10-2.jpg?optimizer=image&amp;format=webp&amp;width=1200&amp;aspectRatio=1.33 1200w, https://media.magloft.app/pdf-import/1144/images/img_10-2.jpg?optimizer=image&amp;format=webp&amp;width=1920&amp;aspectRatio=1.33 1920w, https://media.magloft.app/pdf-import/1144/images/img_10-2.jpg?optimizer=image&amp;format=webp&amp;width=2048&amp;aspectRatio=1.33 2048w" src="https://media.magloft.app/pdf-import/1144/images/img_10-2.jpg?optimizer=image&amp;format=webp&amp;width=2048&amp;aspectRatio=1.33"/></div><div class="Block_article-contents__M6B6V"><h3>Chiesi announces phase 3 results from enzyme-replacement study</h3><p>Chiesi Global Rare Diseases has announced the results from its BRIGHT trial, which evaluates the efficacy of enzyme-replacement therapy drug ELFABRIO at twice the approved dose in patients who have been treated with agalsidase alfa or beta. </p></div></a><a class="Block_article-card__mncKE" href="/articles/valiant-phase-3-trial-results-highlight-potential-treatment-for"><div class="Block_article-cover__vLhzO"><img alt="article-category" loading="lazy" decoding="async" data-nimg="fill" style="position:absolute;height:100%;width:100%;left:0;top:0;right:0;bottom:0;color:transparent;background-size:cover;background-position:50% 50%;background-repeat:no-repeat;background-image:url(&quot;data:image/svg+xml;charset=utf-8,%3Csvg xmlns=&#x27;http%3A//www.w3.org/2000/svg&#x27;%3E%3Cimage style=&#x27;filter:blur(20px)&#x27; preserveAspectRatio=&#x27;none&#x27; x=&#x27;0&#x27; y=&#x27;0&#x27; height=&#x27;100%25&#x27; width=&#x27;100%25&#x27; href=&#x27;data:image/gif;base64,R0lGODlhAQABAPAAANzc3P///yH5BAAAAAAALAAAAAABAAEAAAICRAEAOw==&#x27;/%3E%3C/svg%3E&quot;)" sizes="70px" srcSet="https://media.magloft.app/pdf-import/1144/images/pages/pg-011.jpg?optimizer=image&amp;format=webp&amp;width=16&amp;aspectRatio=1.33 16w, https://media.magloft.app/pdf-import/1144/images/pages/pg-011.jpg?optimizer=image&amp;format=webp&amp;width=32&amp;aspectRatio=1.33 32w, https://media.magloft.app/pdf-import/1144/images/pages/pg-011.jpg?optimizer=image&amp;format=webp&amp;width=48&amp;aspectRatio=1.33 48w, https://media.magloft.app/pdf-import/1144/images/pages/pg-011.jpg?optimizer=image&amp;format=webp&amp;width=54&amp;aspectRatio=1.33 54w, https://media.magloft.app/pdf-import/1144/images/pages/pg-011.jpg?optimizer=image&amp;format=webp&amp;width=64&amp;aspectRatio=1.33 64w, https://media.magloft.app/pdf-import/1144/images/pages/pg-011.jpg?optimizer=image&amp;format=webp&amp;width=70&amp;aspectRatio=1.33 70w, https://media.magloft.app/pdf-import/1144/images/pages/pg-011.jpg?optimizer=image&amp;format=webp&amp;width=82&amp;aspectRatio=1.33 82w, https://media.magloft.app/pdf-import/1144/images/pages/pg-011.jpg?optimizer=image&amp;format=webp&amp;width=96&amp;aspectRatio=1.33 96w, https://media.magloft.app/pdf-import/1144/images/pages/pg-011.jpg?optimizer=image&amp;format=webp&amp;width=96&amp;aspectRatio=1.33 96w, https://media.magloft.app/pdf-import/1144/images/pages/pg-011.jpg?optimizer=image&amp;format=webp&amp;width=110&amp;aspectRatio=1.33 110w, https://media.magloft.app/pdf-import/1144/images/pages/pg-011.jpg?optimizer=image&amp;format=webp&amp;width=128&amp;aspectRatio=1.33 128w, https://media.magloft.app/pdf-import/1144/images/pages/pg-011.jpg?optimizer=image&amp;format=webp&amp;width=128&amp;aspectRatio=1.33 128w, https://media.magloft.app/pdf-import/1144/images/pages/pg-011.jpg?optimizer=image&amp;format=webp&amp;width=138&amp;aspectRatio=1.33 138w, https://media.magloft.app/pdf-import/1144/images/pages/pg-011.jpg?optimizer=image&amp;format=webp&amp;width=192&amp;aspectRatio=1.33 192w, https://media.magloft.app/pdf-import/1144/images/pages/pg-011.jpg?optimizer=image&amp;format=webp&amp;width=200&amp;aspectRatio=1.33 200w, https://media.magloft.app/pdf-import/1144/images/pages/pg-011.jpg?optimizer=image&amp;format=webp&amp;width=252&amp;aspectRatio=1.33 252w, https://media.magloft.app/pdf-import/1144/images/pages/pg-011.jpg?optimizer=image&amp;format=webp&amp;width=256&amp;aspectRatio=1.33 256w, https://media.magloft.app/pdf-import/1144/images/pages/pg-011.jpg?optimizer=image&amp;format=webp&amp;width=260&amp;aspectRatio=1.33 260w, https://media.magloft.app/pdf-import/1144/images/pages/pg-011.jpg?optimizer=image&amp;format=webp&amp;width=298&amp;aspectRatio=1.33 298w, https://media.magloft.app/pdf-import/1144/images/pages/pg-011.jpg?optimizer=image&amp;format=webp&amp;width=378&amp;aspectRatio=1.33 378w, https://media.magloft.app/pdf-import/1144/images/pages/pg-011.jpg?optimizer=image&amp;format=webp&amp;width=384&amp;aspectRatio=1.33 384w, https://media.magloft.app/pdf-import/1144/images/pages/pg-011.jpg?optimizer=image&amp;format=webp&amp;width=384&amp;aspectRatio=1.33 384w, https://media.magloft.app/pdf-import/1144/images/pages/pg-011.jpg?optimizer=image&amp;format=webp&amp;width=520&amp;aspectRatio=1.33 520w, https://media.magloft.app/pdf-import/1144/images/pages/pg-011.jpg?optimizer=image&amp;format=webp&amp;width=640&amp;aspectRatio=1.33 640w, https://media.magloft.app/pdf-import/1144/images/pages/pg-011.jpg?optimizer=image&amp;format=webp&amp;width=756&amp;aspectRatio=1.33 756w, https://media.magloft.app/pdf-import/1144/images/pages/pg-011.jpg?optimizer=image&amp;format=webp&amp;width=828&amp;aspectRatio=1.33 828w, https://media.magloft.app/pdf-import/1144/images/pages/pg-011.jpg?optimizer=image&amp;format=webp&amp;width=1080&amp;aspectRatio=1.33 1080w, https://media.magloft.app/pdf-import/1144/images/pages/pg-011.jpg?optimizer=image&amp;format=webp&amp;width=1200&amp;aspectRatio=1.33 1200w, https://media.magloft.app/pdf-import/1144/images/pages/pg-011.jpg?optimizer=image&amp;format=webp&amp;width=1920&amp;aspectRatio=1.33 1920w, https://media.magloft.app/pdf-import/1144/images/pages/pg-011.jpg?optimizer=image&amp;format=webp&amp;width=2048&amp;aspectRatio=1.33 2048w" src="https://media.magloft.app/pdf-import/1144/images/pages/pg-011.jpg?optimizer=image&amp;format=webp&amp;width=2048&amp;aspectRatio=1.33"/></div><div class="Block_article-contents__M6B6V"><h3>VALIANT phase 3 trial results highlight potential treatment for rare kidney diseases</h3><p>SOBI and Apellis Pharmaceuticals have announced the results from the VALIANT trial, which highlight that systemic pegcetacoplan treatment could benefit patients with c3 glomerulopathy (c3g) and primary immune complex membranoproliferative glomerulonephritis (ic-mpgn).</p></div></a></div></div><div id="block-guide-install" class="Block_block__MHhr4"><div style="height:auto" class="BlockHeader_block-header__JmokO"><div class="BlockHeader_container-title__l5lHB"><h2 style="border-bottom-color:#444558">How to Install</h2></div></div><div class="Block_article-layout__527Uy Block_variant-install-app__u1xN8"></div></div></div><div style="flex:3.5" class="HomeSection_block-layout-column__7m2l1 HomeSection_block-layout-column-shadow__rMmhb"><div class="Block_block__MHhr4"><div style="height:auto" class="_block-header_bbow2_1"><h2 style="border-bottom-color:#2873B0">Latest Editions</h2><a style="color:#2873B0" href="/collections"><span>view more</span><div class="_nav-arrow-right_1lm7t_175 _icon_1lm7t_1 icon" style="background-color:#2873B0;min-width:24px"></div></a></div><div class="_container_w81db_1"><div class="_container_1x9w0_1 _inner_w81db_24"><a class="_card-link_1vglh_1" href="/collections/pharmafocus-november-2024"><div class="_issue-card_1vglh_5 _zoom-on-hover_1vglh_24" style="border-radius:8px"><div class="_cover_1vglh_36 spinner"><div class="_image-container_1vglh_44"><img alt="Pharmafocus November 2024" loading="eager" width="192" height="256" decoding="async" data-nimg="1" style="color:transparent" sizes="256px" srcSet="https://media.magloft.app/pwa-664/pdf-import/cover/2db03f67-b154-4bb4-8f8a-9fd8660f932b.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=16 16w, https://media.magloft.app/pwa-664/pdf-import/cover/2db03f67-b154-4bb4-8f8a-9fd8660f932b.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=32 32w, https://media.magloft.app/pwa-664/pdf-import/cover/2db03f67-b154-4bb4-8f8a-9fd8660f932b.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=48 48w, https://media.magloft.app/pwa-664/pdf-import/cover/2db03f67-b154-4bb4-8f8a-9fd8660f932b.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=54 54w, https://media.magloft.app/pwa-664/pdf-import/cover/2db03f67-b154-4bb4-8f8a-9fd8660f932b.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=64 64w, https://media.magloft.app/pwa-664/pdf-import/cover/2db03f67-b154-4bb4-8f8a-9fd8660f932b.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=70 70w, https://media.magloft.app/pwa-664/pdf-import/cover/2db03f67-b154-4bb4-8f8a-9fd8660f932b.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=82 82w, https://media.magloft.app/pwa-664/pdf-import/cover/2db03f67-b154-4bb4-8f8a-9fd8660f932b.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=96 96w, https://media.magloft.app/pwa-664/pdf-import/cover/2db03f67-b154-4bb4-8f8a-9fd8660f932b.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=96 96w, https://media.magloft.app/pwa-664/pdf-import/cover/2db03f67-b154-4bb4-8f8a-9fd8660f932b.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=110 110w, https://media.magloft.app/pwa-664/pdf-import/cover/2db03f67-b154-4bb4-8f8a-9fd8660f932b.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=128 128w, https://media.magloft.app/pwa-664/pdf-import/cover/2db03f67-b154-4bb4-8f8a-9fd8660f932b.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=128 128w, https://media.magloft.app/pwa-664/pdf-import/cover/2db03f67-b154-4bb4-8f8a-9fd8660f932b.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=138 138w, https://media.magloft.app/pwa-664/pdf-import/cover/2db03f67-b154-4bb4-8f8a-9fd8660f932b.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=192 192w, https://media.magloft.app/pwa-664/pdf-import/cover/2db03f67-b154-4bb4-8f8a-9fd8660f932b.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=200 200w, https://media.magloft.app/pwa-664/pdf-import/cover/2db03f67-b154-4bb4-8f8a-9fd8660f932b.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=252 252w, https://media.magloft.app/pwa-664/pdf-import/cover/2db03f67-b154-4bb4-8f8a-9fd8660f932b.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=256 256w, https://media.magloft.app/pwa-664/pdf-import/cover/2db03f67-b154-4bb4-8f8a-9fd8660f932b.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=260 260w, https://media.magloft.app/pwa-664/pdf-import/cover/2db03f67-b154-4bb4-8f8a-9fd8660f932b.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=298 298w, https://media.magloft.app/pwa-664/pdf-import/cover/2db03f67-b154-4bb4-8f8a-9fd8660f932b.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=378 378w, https://media.magloft.app/pwa-664/pdf-import/cover/2db03f67-b154-4bb4-8f8a-9fd8660f932b.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=384 384w, https://media.magloft.app/pwa-664/pdf-import/cover/2db03f67-b154-4bb4-8f8a-9fd8660f932b.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=384 384w, https://media.magloft.app/pwa-664/pdf-import/cover/2db03f67-b154-4bb4-8f8a-9fd8660f932b.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=520 520w, https://media.magloft.app/pwa-664/pdf-import/cover/2db03f67-b154-4bb4-8f8a-9fd8660f932b.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=640 640w, https://media.magloft.app/pwa-664/pdf-import/cover/2db03f67-b154-4bb4-8f8a-9fd8660f932b.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=756 756w, https://media.magloft.app/pwa-664/pdf-import/cover/2db03f67-b154-4bb4-8f8a-9fd8660f932b.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=828 828w, https://media.magloft.app/pwa-664/pdf-import/cover/2db03f67-b154-4bb4-8f8a-9fd8660f932b.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=1080 1080w, https://media.magloft.app/pwa-664/pdf-import/cover/2db03f67-b154-4bb4-8f8a-9fd8660f932b.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=1200 1200w, https://media.magloft.app/pwa-664/pdf-import/cover/2db03f67-b154-4bb4-8f8a-9fd8660f932b.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=1920 1920w, https://media.magloft.app/pwa-664/pdf-import/cover/2db03f67-b154-4bb4-8f8a-9fd8660f932b.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=2048 2048w" src="https://media.magloft.app/pwa-664/pdf-import/cover/2db03f67-b154-4bb4-8f8a-9fd8660f932b.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=2048"/></div></div><div class="_issue-category-container_1vglh_62"><div class="_issue-category_1vglh_62" style="background-color:#444444">UK News</div></div><div class="_issue-details_1vglh_80"><h3>Pharmafocus November 2024</h3><p>Welcome to Pharmafocus November 2024!</p></div></div></a><a class="_card-link_1vglh_1" href="/collections/pharmafocus-october-2024"><div class="_issue-card_1vglh_5 _zoom-on-hover_1vglh_24" style="border-radius:8px"><div class="_cover_1vglh_36 spinner"><div class="_image-container_1vglh_44"><img alt="Pharmafocus October 2024" loading="eager" width="192" height="256" decoding="async" data-nimg="1" style="color:transparent" sizes="256px" srcSet="https://media.magloft.app/pwa-664/pdf-import/cover/c2153c79-00ca-4630-a0f2-5b8f0b47a8cc.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=16 16w, https://media.magloft.app/pwa-664/pdf-import/cover/c2153c79-00ca-4630-a0f2-5b8f0b47a8cc.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=32 32w, https://media.magloft.app/pwa-664/pdf-import/cover/c2153c79-00ca-4630-a0f2-5b8f0b47a8cc.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=48 48w, https://media.magloft.app/pwa-664/pdf-import/cover/c2153c79-00ca-4630-a0f2-5b8f0b47a8cc.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=54 54w, https://media.magloft.app/pwa-664/pdf-import/cover/c2153c79-00ca-4630-a0f2-5b8f0b47a8cc.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=64 64w, https://media.magloft.app/pwa-664/pdf-import/cover/c2153c79-00ca-4630-a0f2-5b8f0b47a8cc.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=70 70w, https://media.magloft.app/pwa-664/pdf-import/cover/c2153c79-00ca-4630-a0f2-5b8f0b47a8cc.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=82 82w, https://media.magloft.app/pwa-664/pdf-import/cover/c2153c79-00ca-4630-a0f2-5b8f0b47a8cc.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=96 96w, https://media.magloft.app/pwa-664/pdf-import/cover/c2153c79-00ca-4630-a0f2-5b8f0b47a8cc.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=96 96w, https://media.magloft.app/pwa-664/pdf-import/cover/c2153c79-00ca-4630-a0f2-5b8f0b47a8cc.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=110 110w, https://media.magloft.app/pwa-664/pdf-import/cover/c2153c79-00ca-4630-a0f2-5b8f0b47a8cc.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=128 128w, https://media.magloft.app/pwa-664/pdf-import/cover/c2153c79-00ca-4630-a0f2-5b8f0b47a8cc.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=128 128w, https://media.magloft.app/pwa-664/pdf-import/cover/c2153c79-00ca-4630-a0f2-5b8f0b47a8cc.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=138 138w, https://media.magloft.app/pwa-664/pdf-import/cover/c2153c79-00ca-4630-a0f2-5b8f0b47a8cc.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=192 192w, https://media.magloft.app/pwa-664/pdf-import/cover/c2153c79-00ca-4630-a0f2-5b8f0b47a8cc.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=200 200w, https://media.magloft.app/pwa-664/pdf-import/cover/c2153c79-00ca-4630-a0f2-5b8f0b47a8cc.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=252 252w, https://media.magloft.app/pwa-664/pdf-import/cover/c2153c79-00ca-4630-a0f2-5b8f0b47a8cc.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=256 256w, https://media.magloft.app/pwa-664/pdf-import/cover/c2153c79-00ca-4630-a0f2-5b8f0b47a8cc.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=260 260w, https://media.magloft.app/pwa-664/pdf-import/cover/c2153c79-00ca-4630-a0f2-5b8f0b47a8cc.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=298 298w, https://media.magloft.app/pwa-664/pdf-import/cover/c2153c79-00ca-4630-a0f2-5b8f0b47a8cc.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=378 378w, https://media.magloft.app/pwa-664/pdf-import/cover/c2153c79-00ca-4630-a0f2-5b8f0b47a8cc.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=384 384w, https://media.magloft.app/pwa-664/pdf-import/cover/c2153c79-00ca-4630-a0f2-5b8f0b47a8cc.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=384 384w, https://media.magloft.app/pwa-664/pdf-import/cover/c2153c79-00ca-4630-a0f2-5b8f0b47a8cc.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=520 520w, https://media.magloft.app/pwa-664/pdf-import/cover/c2153c79-00ca-4630-a0f2-5b8f0b47a8cc.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=640 640w, https://media.magloft.app/pwa-664/pdf-import/cover/c2153c79-00ca-4630-a0f2-5b8f0b47a8cc.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=756 756w, https://media.magloft.app/pwa-664/pdf-import/cover/c2153c79-00ca-4630-a0f2-5b8f0b47a8cc.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=828 828w, https://media.magloft.app/pwa-664/pdf-import/cover/c2153c79-00ca-4630-a0f2-5b8f0b47a8cc.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=1080 1080w, https://media.magloft.app/pwa-664/pdf-import/cover/c2153c79-00ca-4630-a0f2-5b8f0b47a8cc.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=1200 1200w, https://media.magloft.app/pwa-664/pdf-import/cover/c2153c79-00ca-4630-a0f2-5b8f0b47a8cc.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=1920 1920w, https://media.magloft.app/pwa-664/pdf-import/cover/c2153c79-00ca-4630-a0f2-5b8f0b47a8cc.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=2048 2048w" src="https://media.magloft.app/pwa-664/pdf-import/cover/c2153c79-00ca-4630-a0f2-5b8f0b47a8cc.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=2048"/></div></div><div class="_issue-category-container_1vglh_62"><div class="_issue-category_1vglh_62" style="background-color:#444444">UK News</div></div><div class="_issue-details_1vglh_80"><h3>Pharmafocus October 2024</h3><p>Welcome to the October 2024 edition of Pharmafocus!</p></div></div></a><a class="_card-link_1vglh_1" href="/collections/pharmafocus-september-2024"><div class="_issue-card_1vglh_5 _zoom-on-hover_1vglh_24" style="border-radius:8px"><div class="_cover_1vglh_36 spinner"><div class="_image-container_1vglh_44"><img alt="Pharmafocus September 2024" loading="eager" width="192" height="256" decoding="async" data-nimg="1" style="color:transparent" sizes="256px" srcSet="https://media.magloft.app/pwa-664/issue/cover/8c56ddb8-0110-48f9-9380-d5f8d77b55b7.png?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=16 16w, https://media.magloft.app/pwa-664/issue/cover/8c56ddb8-0110-48f9-9380-d5f8d77b55b7.png?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=32 32w, https://media.magloft.app/pwa-664/issue/cover/8c56ddb8-0110-48f9-9380-d5f8d77b55b7.png?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=48 48w, https://media.magloft.app/pwa-664/issue/cover/8c56ddb8-0110-48f9-9380-d5f8d77b55b7.png?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=54 54w, https://media.magloft.app/pwa-664/issue/cover/8c56ddb8-0110-48f9-9380-d5f8d77b55b7.png?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=64 64w, https://media.magloft.app/pwa-664/issue/cover/8c56ddb8-0110-48f9-9380-d5f8d77b55b7.png?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=70 70w, https://media.magloft.app/pwa-664/issue/cover/8c56ddb8-0110-48f9-9380-d5f8d77b55b7.png?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=82 82w, https://media.magloft.app/pwa-664/issue/cover/8c56ddb8-0110-48f9-9380-d5f8d77b55b7.png?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=96 96w, https://media.magloft.app/pwa-664/issue/cover/8c56ddb8-0110-48f9-9380-d5f8d77b55b7.png?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=96 96w, https://media.magloft.app/pwa-664/issue/cover/8c56ddb8-0110-48f9-9380-d5f8d77b55b7.png?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=110 110w, https://media.magloft.app/pwa-664/issue/cover/8c56ddb8-0110-48f9-9380-d5f8d77b55b7.png?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=128 128w, https://media.magloft.app/pwa-664/issue/cover/8c56ddb8-0110-48f9-9380-d5f8d77b55b7.png?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=128 128w, https://media.magloft.app/pwa-664/issue/cover/8c56ddb8-0110-48f9-9380-d5f8d77b55b7.png?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=138 138w, https://media.magloft.app/pwa-664/issue/cover/8c56ddb8-0110-48f9-9380-d5f8d77b55b7.png?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=192 192w, https://media.magloft.app/pwa-664/issue/cover/8c56ddb8-0110-48f9-9380-d5f8d77b55b7.png?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=200 200w, https://media.magloft.app/pwa-664/issue/cover/8c56ddb8-0110-48f9-9380-d5f8d77b55b7.png?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=252 252w, https://media.magloft.app/pwa-664/issue/cover/8c56ddb8-0110-48f9-9380-d5f8d77b55b7.png?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=256 256w, https://media.magloft.app/pwa-664/issue/cover/8c56ddb8-0110-48f9-9380-d5f8d77b55b7.png?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=260 260w, https://media.magloft.app/pwa-664/issue/cover/8c56ddb8-0110-48f9-9380-d5f8d77b55b7.png?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=298 298w, https://media.magloft.app/pwa-664/issue/cover/8c56ddb8-0110-48f9-9380-d5f8d77b55b7.png?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=378 378w, https://media.magloft.app/pwa-664/issue/cover/8c56ddb8-0110-48f9-9380-d5f8d77b55b7.png?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=384 384w, https://media.magloft.app/pwa-664/issue/cover/8c56ddb8-0110-48f9-9380-d5f8d77b55b7.png?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=384 384w, https://media.magloft.app/pwa-664/issue/cover/8c56ddb8-0110-48f9-9380-d5f8d77b55b7.png?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=520 520w, https://media.magloft.app/pwa-664/issue/cover/8c56ddb8-0110-48f9-9380-d5f8d77b55b7.png?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=640 640w, https://media.magloft.app/pwa-664/issue/cover/8c56ddb8-0110-48f9-9380-d5f8d77b55b7.png?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=756 756w, https://media.magloft.app/pwa-664/issue/cover/8c56ddb8-0110-48f9-9380-d5f8d77b55b7.png?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=828 828w, https://media.magloft.app/pwa-664/issue/cover/8c56ddb8-0110-48f9-9380-d5f8d77b55b7.png?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=1080 1080w, https://media.magloft.app/pwa-664/issue/cover/8c56ddb8-0110-48f9-9380-d5f8d77b55b7.png?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=1200 1200w, https://media.magloft.app/pwa-664/issue/cover/8c56ddb8-0110-48f9-9380-d5f8d77b55b7.png?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=1920 1920w, https://media.magloft.app/pwa-664/issue/cover/8c56ddb8-0110-48f9-9380-d5f8d77b55b7.png?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=2048 2048w" src="https://media.magloft.app/pwa-664/issue/cover/8c56ddb8-0110-48f9-9380-d5f8d77b55b7.png?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=2048"/></div></div><div class="_issue-category-container_1vglh_62"><div class="_issue-category_1vglh_62" style="background-color:#444444">UK News</div></div><div class="_issue-details_1vglh_80"><h3>Pharmafocus September 2024</h3><p>Welcome to the September 2024 issue of Pharmafocus! This issue covers the latest news including new FDA approval for primary biliary cholangitis, NICE recommendations for skyrizi (risankizumab), CHMP opinion on Merck’s KEYTRUDA, as well as articles on precision medicine and oral peptides PLUS what to look out for at this year&#x27;s CPHI in Milan! </p></div></div></a><a class="_card-link_1vglh_1" href="/collections/july-august-2024"><div class="_issue-card_1vglh_5 _zoom-on-hover_1vglh_24" style="border-radius:8px"><div class="_cover_1vglh_36 spinner"><div class="_image-container_1vglh_44"><img alt="Pharmafocus July/August 2024" loading="eager" width="192" height="256" decoding="async" data-nimg="1" style="color:transparent" sizes="256px" srcSet="https://media.magloft.app/pwa-664/pdf-import/cover/4fcbd25a-422f-4623-85da-91f331e9764f.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=16 16w, https://media.magloft.app/pwa-664/pdf-import/cover/4fcbd25a-422f-4623-85da-91f331e9764f.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=32 32w, https://media.magloft.app/pwa-664/pdf-import/cover/4fcbd25a-422f-4623-85da-91f331e9764f.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=48 48w, https://media.magloft.app/pwa-664/pdf-import/cover/4fcbd25a-422f-4623-85da-91f331e9764f.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=54 54w, https://media.magloft.app/pwa-664/pdf-import/cover/4fcbd25a-422f-4623-85da-91f331e9764f.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=64 64w, https://media.magloft.app/pwa-664/pdf-import/cover/4fcbd25a-422f-4623-85da-91f331e9764f.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=70 70w, https://media.magloft.app/pwa-664/pdf-import/cover/4fcbd25a-422f-4623-85da-91f331e9764f.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=82 82w, https://media.magloft.app/pwa-664/pdf-import/cover/4fcbd25a-422f-4623-85da-91f331e9764f.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=96 96w, https://media.magloft.app/pwa-664/pdf-import/cover/4fcbd25a-422f-4623-85da-91f331e9764f.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=96 96w, https://media.magloft.app/pwa-664/pdf-import/cover/4fcbd25a-422f-4623-85da-91f331e9764f.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=110 110w, https://media.magloft.app/pwa-664/pdf-import/cover/4fcbd25a-422f-4623-85da-91f331e9764f.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=128 128w, https://media.magloft.app/pwa-664/pdf-import/cover/4fcbd25a-422f-4623-85da-91f331e9764f.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=128 128w, https://media.magloft.app/pwa-664/pdf-import/cover/4fcbd25a-422f-4623-85da-91f331e9764f.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=138 138w, https://media.magloft.app/pwa-664/pdf-import/cover/4fcbd25a-422f-4623-85da-91f331e9764f.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=192 192w, https://media.magloft.app/pwa-664/pdf-import/cover/4fcbd25a-422f-4623-85da-91f331e9764f.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=200 200w, https://media.magloft.app/pwa-664/pdf-import/cover/4fcbd25a-422f-4623-85da-91f331e9764f.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=252 252w, https://media.magloft.app/pwa-664/pdf-import/cover/4fcbd25a-422f-4623-85da-91f331e9764f.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=256 256w, https://media.magloft.app/pwa-664/pdf-import/cover/4fcbd25a-422f-4623-85da-91f331e9764f.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=260 260w, https://media.magloft.app/pwa-664/pdf-import/cover/4fcbd25a-422f-4623-85da-91f331e9764f.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=298 298w, https://media.magloft.app/pwa-664/pdf-import/cover/4fcbd25a-422f-4623-85da-91f331e9764f.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=378 378w, https://media.magloft.app/pwa-664/pdf-import/cover/4fcbd25a-422f-4623-85da-91f331e9764f.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=384 384w, https://media.magloft.app/pwa-664/pdf-import/cover/4fcbd25a-422f-4623-85da-91f331e9764f.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=384 384w, https://media.magloft.app/pwa-664/pdf-import/cover/4fcbd25a-422f-4623-85da-91f331e9764f.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=520 520w, https://media.magloft.app/pwa-664/pdf-import/cover/4fcbd25a-422f-4623-85da-91f331e9764f.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=640 640w, https://media.magloft.app/pwa-664/pdf-import/cover/4fcbd25a-422f-4623-85da-91f331e9764f.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=756 756w, https://media.magloft.app/pwa-664/pdf-import/cover/4fcbd25a-422f-4623-85da-91f331e9764f.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=828 828w, https://media.magloft.app/pwa-664/pdf-import/cover/4fcbd25a-422f-4623-85da-91f331e9764f.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=1080 1080w, https://media.magloft.app/pwa-664/pdf-import/cover/4fcbd25a-422f-4623-85da-91f331e9764f.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=1200 1200w, https://media.magloft.app/pwa-664/pdf-import/cover/4fcbd25a-422f-4623-85da-91f331e9764f.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=1920 1920w, https://media.magloft.app/pwa-664/pdf-import/cover/4fcbd25a-422f-4623-85da-91f331e9764f.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=2048 2048w" src="https://media.magloft.app/pwa-664/pdf-import/cover/4fcbd25a-422f-4623-85da-91f331e9764f.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=2048"/></div></div><div class="_issue-details_1vglh_80"><h3>Pharmafocus July/August 2024</h3><p>Welcome to the July/August 2024 issue of Pharmafocus! </p></div></div></a><a class="_card-link_1vglh_1" href="/collections/june-2024"><div class="_issue-card_1vglh_5 _zoom-on-hover_1vglh_24" style="border-radius:8px"><div class="_cover_1vglh_36 spinner"><div class="_image-container_1vglh_44"><img alt="Pharmafocus June 2024" loading="eager" width="192" height="256" decoding="async" data-nimg="1" style="color:transparent" sizes="256px" srcSet="https://media.magloft.app/pwa-664/pdf-import/cover/5b3cdd36-9928-4c26-a58f-5688ff552317.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=16 16w, https://media.magloft.app/pwa-664/pdf-import/cover/5b3cdd36-9928-4c26-a58f-5688ff552317.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=32 32w, https://media.magloft.app/pwa-664/pdf-import/cover/5b3cdd36-9928-4c26-a58f-5688ff552317.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=48 48w, https://media.magloft.app/pwa-664/pdf-import/cover/5b3cdd36-9928-4c26-a58f-5688ff552317.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=54 54w, https://media.magloft.app/pwa-664/pdf-import/cover/5b3cdd36-9928-4c26-a58f-5688ff552317.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=64 64w, https://media.magloft.app/pwa-664/pdf-import/cover/5b3cdd36-9928-4c26-a58f-5688ff552317.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=70 70w, https://media.magloft.app/pwa-664/pdf-import/cover/5b3cdd36-9928-4c26-a58f-5688ff552317.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=82 82w, https://media.magloft.app/pwa-664/pdf-import/cover/5b3cdd36-9928-4c26-a58f-5688ff552317.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=96 96w, https://media.magloft.app/pwa-664/pdf-import/cover/5b3cdd36-9928-4c26-a58f-5688ff552317.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=96 96w, https://media.magloft.app/pwa-664/pdf-import/cover/5b3cdd36-9928-4c26-a58f-5688ff552317.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=110 110w, https://media.magloft.app/pwa-664/pdf-import/cover/5b3cdd36-9928-4c26-a58f-5688ff552317.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=128 128w, https://media.magloft.app/pwa-664/pdf-import/cover/5b3cdd36-9928-4c26-a58f-5688ff552317.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=128 128w, https://media.magloft.app/pwa-664/pdf-import/cover/5b3cdd36-9928-4c26-a58f-5688ff552317.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=138 138w, https://media.magloft.app/pwa-664/pdf-import/cover/5b3cdd36-9928-4c26-a58f-5688ff552317.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=192 192w, https://media.magloft.app/pwa-664/pdf-import/cover/5b3cdd36-9928-4c26-a58f-5688ff552317.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=200 200w, https://media.magloft.app/pwa-664/pdf-import/cover/5b3cdd36-9928-4c26-a58f-5688ff552317.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=252 252w, https://media.magloft.app/pwa-664/pdf-import/cover/5b3cdd36-9928-4c26-a58f-5688ff552317.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=256 256w, https://media.magloft.app/pwa-664/pdf-import/cover/5b3cdd36-9928-4c26-a58f-5688ff552317.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=260 260w, https://media.magloft.app/pwa-664/pdf-import/cover/5b3cdd36-9928-4c26-a58f-5688ff552317.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=298 298w, https://media.magloft.app/pwa-664/pdf-import/cover/5b3cdd36-9928-4c26-a58f-5688ff552317.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=378 378w, https://media.magloft.app/pwa-664/pdf-import/cover/5b3cdd36-9928-4c26-a58f-5688ff552317.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=384 384w, https://media.magloft.app/pwa-664/pdf-import/cover/5b3cdd36-9928-4c26-a58f-5688ff552317.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=384 384w, https://media.magloft.app/pwa-664/pdf-import/cover/5b3cdd36-9928-4c26-a58f-5688ff552317.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=520 520w, https://media.magloft.app/pwa-664/pdf-import/cover/5b3cdd36-9928-4c26-a58f-5688ff552317.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=640 640w, https://media.magloft.app/pwa-664/pdf-import/cover/5b3cdd36-9928-4c26-a58f-5688ff552317.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=756 756w, https://media.magloft.app/pwa-664/pdf-import/cover/5b3cdd36-9928-4c26-a58f-5688ff552317.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=828 828w, https://media.magloft.app/pwa-664/pdf-import/cover/5b3cdd36-9928-4c26-a58f-5688ff552317.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=1080 1080w, https://media.magloft.app/pwa-664/pdf-import/cover/5b3cdd36-9928-4c26-a58f-5688ff552317.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=1200 1200w, https://media.magloft.app/pwa-664/pdf-import/cover/5b3cdd36-9928-4c26-a58f-5688ff552317.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=1920 1920w, https://media.magloft.app/pwa-664/pdf-import/cover/5b3cdd36-9928-4c26-a58f-5688ff552317.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=2048 2048w" src="https://media.magloft.app/pwa-664/pdf-import/cover/5b3cdd36-9928-4c26-a58f-5688ff552317.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=2048"/></div></div><div class="_issue-details_1vglh_80"><h3>Pharmafocus June 2024</h3><p>Welcome to the June 2024 issue of Pharmafocus! </p></div></div></a><a class="_card-link_1vglh_1" href="/collections/may-2024"><div class="_issue-card_1vglh_5 _zoom-on-hover_1vglh_24" style="border-radius:8px"><div class="_cover_1vglh_36 spinner"><div class="_image-container_1vglh_44"><img alt="Pharmafocus May 2024" loading="eager" width="192" height="256" decoding="async" data-nimg="1" style="color:transparent" sizes="256px" srcSet="https://media.magloft.app/pwa-664/pdf-import/cover/9d532da4-36c1-4744-a074-cf2bc7a84d89.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=16 16w, https://media.magloft.app/pwa-664/pdf-import/cover/9d532da4-36c1-4744-a074-cf2bc7a84d89.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=32 32w, https://media.magloft.app/pwa-664/pdf-import/cover/9d532da4-36c1-4744-a074-cf2bc7a84d89.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=48 48w, https://media.magloft.app/pwa-664/pdf-import/cover/9d532da4-36c1-4744-a074-cf2bc7a84d89.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=54 54w, https://media.magloft.app/pwa-664/pdf-import/cover/9d532da4-36c1-4744-a074-cf2bc7a84d89.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=64 64w, https://media.magloft.app/pwa-664/pdf-import/cover/9d532da4-36c1-4744-a074-cf2bc7a84d89.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=70 70w, https://media.magloft.app/pwa-664/pdf-import/cover/9d532da4-36c1-4744-a074-cf2bc7a84d89.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=82 82w, https://media.magloft.app/pwa-664/pdf-import/cover/9d532da4-36c1-4744-a074-cf2bc7a84d89.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=96 96w, https://media.magloft.app/pwa-664/pdf-import/cover/9d532da4-36c1-4744-a074-cf2bc7a84d89.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=96 96w, https://media.magloft.app/pwa-664/pdf-import/cover/9d532da4-36c1-4744-a074-cf2bc7a84d89.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=110 110w, https://media.magloft.app/pwa-664/pdf-import/cover/9d532da4-36c1-4744-a074-cf2bc7a84d89.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=128 128w, https://media.magloft.app/pwa-664/pdf-import/cover/9d532da4-36c1-4744-a074-cf2bc7a84d89.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=128 128w, https://media.magloft.app/pwa-664/pdf-import/cover/9d532da4-36c1-4744-a074-cf2bc7a84d89.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=138 138w, https://media.magloft.app/pwa-664/pdf-import/cover/9d532da4-36c1-4744-a074-cf2bc7a84d89.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=192 192w, https://media.magloft.app/pwa-664/pdf-import/cover/9d532da4-36c1-4744-a074-cf2bc7a84d89.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=200 200w, https://media.magloft.app/pwa-664/pdf-import/cover/9d532da4-36c1-4744-a074-cf2bc7a84d89.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=252 252w, https://media.magloft.app/pwa-664/pdf-import/cover/9d532da4-36c1-4744-a074-cf2bc7a84d89.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=256 256w, https://media.magloft.app/pwa-664/pdf-import/cover/9d532da4-36c1-4744-a074-cf2bc7a84d89.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=260 260w, https://media.magloft.app/pwa-664/pdf-import/cover/9d532da4-36c1-4744-a074-cf2bc7a84d89.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=298 298w, https://media.magloft.app/pwa-664/pdf-import/cover/9d532da4-36c1-4744-a074-cf2bc7a84d89.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=378 378w, https://media.magloft.app/pwa-664/pdf-import/cover/9d532da4-36c1-4744-a074-cf2bc7a84d89.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=384 384w, https://media.magloft.app/pwa-664/pdf-import/cover/9d532da4-36c1-4744-a074-cf2bc7a84d89.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=384 384w, https://media.magloft.app/pwa-664/pdf-import/cover/9d532da4-36c1-4744-a074-cf2bc7a84d89.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=520 520w, https://media.magloft.app/pwa-664/pdf-import/cover/9d532da4-36c1-4744-a074-cf2bc7a84d89.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=640 640w, https://media.magloft.app/pwa-664/pdf-import/cover/9d532da4-36c1-4744-a074-cf2bc7a84d89.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=756 756w, https://media.magloft.app/pwa-664/pdf-import/cover/9d532da4-36c1-4744-a074-cf2bc7a84d89.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=828 828w, https://media.magloft.app/pwa-664/pdf-import/cover/9d532da4-36c1-4744-a074-cf2bc7a84d89.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=1080 1080w, https://media.magloft.app/pwa-664/pdf-import/cover/9d532da4-36c1-4744-a074-cf2bc7a84d89.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=1200 1200w, https://media.magloft.app/pwa-664/pdf-import/cover/9d532da4-36c1-4744-a074-cf2bc7a84d89.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=1920 1920w, https://media.magloft.app/pwa-664/pdf-import/cover/9d532da4-36c1-4744-a074-cf2bc7a84d89.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=2048 2048w" src="https://media.magloft.app/pwa-664/pdf-import/cover/9d532da4-36c1-4744-a074-cf2bc7a84d89.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=2048"/></div></div><div class="_issue-details_1vglh_80"><h3>Pharmafocus May 2024</h3><p>Welcome to the May 2024 issue of Pharmafocus! </p></div></div></a><a class="_card-link_1vglh_1" href="/collections/pharmafocus-april-2024"><div class="_issue-card_1vglh_5 _zoom-on-hover_1vglh_24" style="border-radius:8px"><div class="_cover_1vglh_36 spinner"><div class="_image-container_1vglh_44"><img alt="Pharmafocus April 2024" loading="eager" width="192" height="256" decoding="async" data-nimg="1" style="color:transparent" sizes="256px" srcSet="https://media.magloft.app/pwa-664/pdf-import/cover/6ecdf246-7e70-4b93-8ef2-6f0f97071612.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=16 16w, https://media.magloft.app/pwa-664/pdf-import/cover/6ecdf246-7e70-4b93-8ef2-6f0f97071612.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=32 32w, https://media.magloft.app/pwa-664/pdf-import/cover/6ecdf246-7e70-4b93-8ef2-6f0f97071612.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=48 48w, https://media.magloft.app/pwa-664/pdf-import/cover/6ecdf246-7e70-4b93-8ef2-6f0f97071612.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=54 54w, https://media.magloft.app/pwa-664/pdf-import/cover/6ecdf246-7e70-4b93-8ef2-6f0f97071612.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=64 64w, https://media.magloft.app/pwa-664/pdf-import/cover/6ecdf246-7e70-4b93-8ef2-6f0f97071612.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=70 70w, https://media.magloft.app/pwa-664/pdf-import/cover/6ecdf246-7e70-4b93-8ef2-6f0f97071612.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=82 82w, https://media.magloft.app/pwa-664/pdf-import/cover/6ecdf246-7e70-4b93-8ef2-6f0f97071612.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=96 96w, https://media.magloft.app/pwa-664/pdf-import/cover/6ecdf246-7e70-4b93-8ef2-6f0f97071612.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=96 96w, https://media.magloft.app/pwa-664/pdf-import/cover/6ecdf246-7e70-4b93-8ef2-6f0f97071612.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=110 110w, https://media.magloft.app/pwa-664/pdf-import/cover/6ecdf246-7e70-4b93-8ef2-6f0f97071612.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=128 128w, https://media.magloft.app/pwa-664/pdf-import/cover/6ecdf246-7e70-4b93-8ef2-6f0f97071612.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=128 128w, https://media.magloft.app/pwa-664/pdf-import/cover/6ecdf246-7e70-4b93-8ef2-6f0f97071612.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=138 138w, https://media.magloft.app/pwa-664/pdf-import/cover/6ecdf246-7e70-4b93-8ef2-6f0f97071612.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=192 192w, https://media.magloft.app/pwa-664/pdf-import/cover/6ecdf246-7e70-4b93-8ef2-6f0f97071612.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=200 200w, https://media.magloft.app/pwa-664/pdf-import/cover/6ecdf246-7e70-4b93-8ef2-6f0f97071612.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=252 252w, https://media.magloft.app/pwa-664/pdf-import/cover/6ecdf246-7e70-4b93-8ef2-6f0f97071612.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=256 256w, https://media.magloft.app/pwa-664/pdf-import/cover/6ecdf246-7e70-4b93-8ef2-6f0f97071612.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=260 260w, https://media.magloft.app/pwa-664/pdf-import/cover/6ecdf246-7e70-4b93-8ef2-6f0f97071612.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=298 298w, https://media.magloft.app/pwa-664/pdf-import/cover/6ecdf246-7e70-4b93-8ef2-6f0f97071612.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=378 378w, https://media.magloft.app/pwa-664/pdf-import/cover/6ecdf246-7e70-4b93-8ef2-6f0f97071612.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=384 384w, https://media.magloft.app/pwa-664/pdf-import/cover/6ecdf246-7e70-4b93-8ef2-6f0f97071612.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=384 384w, https://media.magloft.app/pwa-664/pdf-import/cover/6ecdf246-7e70-4b93-8ef2-6f0f97071612.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=520 520w, https://media.magloft.app/pwa-664/pdf-import/cover/6ecdf246-7e70-4b93-8ef2-6f0f97071612.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=640 640w, https://media.magloft.app/pwa-664/pdf-import/cover/6ecdf246-7e70-4b93-8ef2-6f0f97071612.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=756 756w, https://media.magloft.app/pwa-664/pdf-import/cover/6ecdf246-7e70-4b93-8ef2-6f0f97071612.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=828 828w, https://media.magloft.app/pwa-664/pdf-import/cover/6ecdf246-7e70-4b93-8ef2-6f0f97071612.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=1080 1080w, https://media.magloft.app/pwa-664/pdf-import/cover/6ecdf246-7e70-4b93-8ef2-6f0f97071612.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=1200 1200w, https://media.magloft.app/pwa-664/pdf-import/cover/6ecdf246-7e70-4b93-8ef2-6f0f97071612.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=1920 1920w, https://media.magloft.app/pwa-664/pdf-import/cover/6ecdf246-7e70-4b93-8ef2-6f0f97071612.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=2048 2048w" src="https://media.magloft.app/pwa-664/pdf-import/cover/6ecdf246-7e70-4b93-8ef2-6f0f97071612.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=2048"/></div></div><div class="_issue-details_1vglh_80"><h3>Pharmafocus April 2024</h3><p>Welcome to the April 2024 issue of Pharmafocus!</p></div></div></a><a class="_card-link_1vglh_1" href="/collections/march-2024"><div class="_issue-card_1vglh_5 _zoom-on-hover_1vglh_24" style="border-radius:8px"><div class="_cover_1vglh_36 spinner"><div class="_image-container_1vglh_44"><img alt="Pharmafocus March 2024" loading="eager" width="192" height="256" decoding="async" data-nimg="1" style="color:transparent" sizes="256px" srcSet="https://media.magloft.app/pwa-664/pdf-import/cover/060712ee-16a6-45f6-9966-46934c008537.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=16 16w, https://media.magloft.app/pwa-664/pdf-import/cover/060712ee-16a6-45f6-9966-46934c008537.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=32 32w, https://media.magloft.app/pwa-664/pdf-import/cover/060712ee-16a6-45f6-9966-46934c008537.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=48 48w, https://media.magloft.app/pwa-664/pdf-import/cover/060712ee-16a6-45f6-9966-46934c008537.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=54 54w, https://media.magloft.app/pwa-664/pdf-import/cover/060712ee-16a6-45f6-9966-46934c008537.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=64 64w, https://media.magloft.app/pwa-664/pdf-import/cover/060712ee-16a6-45f6-9966-46934c008537.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=70 70w, https://media.magloft.app/pwa-664/pdf-import/cover/060712ee-16a6-45f6-9966-46934c008537.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=82 82w, https://media.magloft.app/pwa-664/pdf-import/cover/060712ee-16a6-45f6-9966-46934c008537.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=96 96w, https://media.magloft.app/pwa-664/pdf-import/cover/060712ee-16a6-45f6-9966-46934c008537.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=96 96w, https://media.magloft.app/pwa-664/pdf-import/cover/060712ee-16a6-45f6-9966-46934c008537.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=110 110w, https://media.magloft.app/pwa-664/pdf-import/cover/060712ee-16a6-45f6-9966-46934c008537.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=128 128w, https://media.magloft.app/pwa-664/pdf-import/cover/060712ee-16a6-45f6-9966-46934c008537.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=128 128w, https://media.magloft.app/pwa-664/pdf-import/cover/060712ee-16a6-45f6-9966-46934c008537.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=138 138w, https://media.magloft.app/pwa-664/pdf-import/cover/060712ee-16a6-45f6-9966-46934c008537.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=192 192w, https://media.magloft.app/pwa-664/pdf-import/cover/060712ee-16a6-45f6-9966-46934c008537.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=200 200w, https://media.magloft.app/pwa-664/pdf-import/cover/060712ee-16a6-45f6-9966-46934c008537.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=252 252w, https://media.magloft.app/pwa-664/pdf-import/cover/060712ee-16a6-45f6-9966-46934c008537.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=256 256w, https://media.magloft.app/pwa-664/pdf-import/cover/060712ee-16a6-45f6-9966-46934c008537.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=260 260w, https://media.magloft.app/pwa-664/pdf-import/cover/060712ee-16a6-45f6-9966-46934c008537.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=298 298w, https://media.magloft.app/pwa-664/pdf-import/cover/060712ee-16a6-45f6-9966-46934c008537.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=378 378w, https://media.magloft.app/pwa-664/pdf-import/cover/060712ee-16a6-45f6-9966-46934c008537.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=384 384w, https://media.magloft.app/pwa-664/pdf-import/cover/060712ee-16a6-45f6-9966-46934c008537.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=384 384w, https://media.magloft.app/pwa-664/pdf-import/cover/060712ee-16a6-45f6-9966-46934c008537.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=520 520w, https://media.magloft.app/pwa-664/pdf-import/cover/060712ee-16a6-45f6-9966-46934c008537.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=640 640w, https://media.magloft.app/pwa-664/pdf-import/cover/060712ee-16a6-45f6-9966-46934c008537.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=756 756w, https://media.magloft.app/pwa-664/pdf-import/cover/060712ee-16a6-45f6-9966-46934c008537.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=828 828w, https://media.magloft.app/pwa-664/pdf-import/cover/060712ee-16a6-45f6-9966-46934c008537.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=1080 1080w, https://media.magloft.app/pwa-664/pdf-import/cover/060712ee-16a6-45f6-9966-46934c008537.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=1200 1200w, https://media.magloft.app/pwa-664/pdf-import/cover/060712ee-16a6-45f6-9966-46934c008537.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=1920 1920w, https://media.magloft.app/pwa-664/pdf-import/cover/060712ee-16a6-45f6-9966-46934c008537.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=2048 2048w" src="https://media.magloft.app/pwa-664/pdf-import/cover/060712ee-16a6-45f6-9966-46934c008537.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=2048"/></div></div><div class="_issue-details_1vglh_80"><h3>Pharmafocus March 2024</h3><p>Welcome to the March 2024 issue of Pharmafocus!</p></div></div></a><a class="_card-link_1vglh_1" href="/collections/january-february-2024"><div class="_issue-card_1vglh_5 _zoom-on-hover_1vglh_24" style="border-radius:8px"><div class="_cover_1vglh_36 spinner"><div class="_image-container_1vglh_44"><img alt="Pharmafocus January/February 2024" loading="eager" width="192" height="256" decoding="async" data-nimg="1" style="color:transparent" sizes="256px" srcSet="https://media.magloft.app/pwa-664/pdf-import/cover/c3992244-61cf-4e63-a755-0ae4043f7342.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=16 16w, https://media.magloft.app/pwa-664/pdf-import/cover/c3992244-61cf-4e63-a755-0ae4043f7342.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=32 32w, https://media.magloft.app/pwa-664/pdf-import/cover/c3992244-61cf-4e63-a755-0ae4043f7342.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=48 48w, https://media.magloft.app/pwa-664/pdf-import/cover/c3992244-61cf-4e63-a755-0ae4043f7342.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=54 54w, https://media.magloft.app/pwa-664/pdf-import/cover/c3992244-61cf-4e63-a755-0ae4043f7342.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=64 64w, https://media.magloft.app/pwa-664/pdf-import/cover/c3992244-61cf-4e63-a755-0ae4043f7342.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=70 70w, https://media.magloft.app/pwa-664/pdf-import/cover/c3992244-61cf-4e63-a755-0ae4043f7342.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=82 82w, https://media.magloft.app/pwa-664/pdf-import/cover/c3992244-61cf-4e63-a755-0ae4043f7342.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=96 96w, https://media.magloft.app/pwa-664/pdf-import/cover/c3992244-61cf-4e63-a755-0ae4043f7342.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=96 96w, https://media.magloft.app/pwa-664/pdf-import/cover/c3992244-61cf-4e63-a755-0ae4043f7342.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=110 110w, https://media.magloft.app/pwa-664/pdf-import/cover/c3992244-61cf-4e63-a755-0ae4043f7342.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=128 128w, https://media.magloft.app/pwa-664/pdf-import/cover/c3992244-61cf-4e63-a755-0ae4043f7342.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=128 128w, https://media.magloft.app/pwa-664/pdf-import/cover/c3992244-61cf-4e63-a755-0ae4043f7342.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=138 138w, https://media.magloft.app/pwa-664/pdf-import/cover/c3992244-61cf-4e63-a755-0ae4043f7342.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=192 192w, https://media.magloft.app/pwa-664/pdf-import/cover/c3992244-61cf-4e63-a755-0ae4043f7342.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=200 200w, https://media.magloft.app/pwa-664/pdf-import/cover/c3992244-61cf-4e63-a755-0ae4043f7342.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=252 252w, https://media.magloft.app/pwa-664/pdf-import/cover/c3992244-61cf-4e63-a755-0ae4043f7342.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=256 256w, https://media.magloft.app/pwa-664/pdf-import/cover/c3992244-61cf-4e63-a755-0ae4043f7342.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=260 260w, https://media.magloft.app/pwa-664/pdf-import/cover/c3992244-61cf-4e63-a755-0ae4043f7342.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=298 298w, https://media.magloft.app/pwa-664/pdf-import/cover/c3992244-61cf-4e63-a755-0ae4043f7342.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=378 378w, https://media.magloft.app/pwa-664/pdf-import/cover/c3992244-61cf-4e63-a755-0ae4043f7342.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=384 384w, https://media.magloft.app/pwa-664/pdf-import/cover/c3992244-61cf-4e63-a755-0ae4043f7342.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=384 384w, https://media.magloft.app/pwa-664/pdf-import/cover/c3992244-61cf-4e63-a755-0ae4043f7342.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=520 520w, https://media.magloft.app/pwa-664/pdf-import/cover/c3992244-61cf-4e63-a755-0ae4043f7342.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=640 640w, https://media.magloft.app/pwa-664/pdf-import/cover/c3992244-61cf-4e63-a755-0ae4043f7342.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=756 756w, https://media.magloft.app/pwa-664/pdf-import/cover/c3992244-61cf-4e63-a755-0ae4043f7342.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=828 828w, https://media.magloft.app/pwa-664/pdf-import/cover/c3992244-61cf-4e63-a755-0ae4043f7342.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=1080 1080w, https://media.magloft.app/pwa-664/pdf-import/cover/c3992244-61cf-4e63-a755-0ae4043f7342.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=1200 1200w, https://media.magloft.app/pwa-664/pdf-import/cover/c3992244-61cf-4e63-a755-0ae4043f7342.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=1920 1920w, https://media.magloft.app/pwa-664/pdf-import/cover/c3992244-61cf-4e63-a755-0ae4043f7342.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=2048 2048w" src="https://media.magloft.app/pwa-664/pdf-import/cover/c3992244-61cf-4e63-a755-0ae4043f7342.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=2048"/></div></div><div class="_issue-details_1vglh_80"><h3>Pharmafocus January/February 2024</h3><p>Welcome to the first Pharmafocus of 2024! </p></div></div></a></div></div></div><div class="AdvertisementBlock_advertisement-block__8EDkY AdvertisementBlock_placeholder__jhbpI"><div class="AdvertisementBlock_placeholder-inner__UakOd spinner"></div></div><div class="CtaBlock_cta-block__6Aun8"><a target="_blank" href="https://curwoodcmsltd.formstack.com/forms/samedan"><div class="CtaBlock_block__JFejl" style="background-color:#FB0505"><div class="CtaBlock_contents__9PUnB"><div class="Icon_symbol-gift__5x19_ CtaBlock_pwa-icon__dIO04 Icon_icon__t_YgI icon"></div><div class="CtaBlock_contents-inner__0kAli"><h2>Newsletters</h2><p>Sign up to our newsletters and digital magazines</p></div></div><div class="CtaBlock_footer__OQd0m"><div style="color:#FB0505">Newsletters</div></div></div></a></div><div class="AdvertisementBlock_advertisement-block__8EDkY AdvertisementBlock_placeholder__jhbpI"><div class="AdvertisementBlock_placeholder-inner__UakOd spinner"></div></div><div class="CtaBlock_cta-block__6Aun8"><a target="_blank" href="https://en.calameo.com/subscriptions/6188508"><div class="CtaBlock_block__JFejl" style="background-color:#F90505"><div class="CtaBlock_contents__9PUnB"><div class="Icon_symbol-day__oOa8V CtaBlock_pwa-icon__dIO04 Icon_icon__t_YgI icon"></div><div class="CtaBlock_contents-inner__0kAli"><h2>Pharmafocus Archive</h2><p>Browse older editions</p></div></div><div class="CtaBlock_footer__OQd0m"><div style="color:#F90505">Pharmafocus Archive</div></div></div></a></div><div class="AdvertisementBlock_advertisement-block__8EDkY AdvertisementBlock_placeholder__jhbpI"><div class="AdvertisementBlock_placeholder-inner__UakOd spinner"></div></div><div id="article-category-block" class="Block_block__MHhr4" style="background-color:transparent"><div style="height:auto" class="BlockHeader_block-header__JmokO"><div class="BlockHeader_container-title__l5lHB"><h2 style="border-bottom-color:#F70707">Appointments</h2></div><a style="color:#F70707" href="/categories/appointments"><span>view more</span><div class="Icon_nav-arrow-right__JFm_F Icon_icon__t_YgI icon" style="background-color:#F70707;min-width:24px"></div></a></div><div class="Block_article-layout-flat-list__qmf0L Block_variant-c__AkeuK"><a class="Block_article-card__mncKE" href="/articles/darrin-schellin-appointed-new-ceo-at-pharma-tech-industries-cc9c"><div class="Block_article-cover__vLhzO"><img alt="article-category" loading="lazy" decoding="async" data-nimg="fill" style="position:absolute;height:100%;width:100%;left:0;top:0;right:0;bottom:0;color:transparent;background-size:cover;background-position:50% 50%;background-repeat:no-repeat;background-image:url(&quot;data:image/svg+xml;charset=utf-8,%3Csvg xmlns=&#x27;http%3A//www.w3.org/2000/svg&#x27;%3E%3Cimage style=&#x27;filter:blur(20px)&#x27; preserveAspectRatio=&#x27;none&#x27; x=&#x27;0&#x27; y=&#x27;0&#x27; height=&#x27;100%25&#x27; width=&#x27;100%25&#x27; href=&#x27;data:image/gif;base64,R0lGODlhAQABAPAAANzc3P///yH5BAAAAAAALAAAAAABAAEAAAICRAEAOw==&#x27;/%3E%3C/svg%3E&quot;)" sizes="70px" srcSet="https://media.magloft.app/pdf-import/1144/images/img_16-1.jpg?optimizer=image&amp;format=webp&amp;width=16&amp;aspectRatio=1.33 16w, https://media.magloft.app/pdf-import/1144/images/img_16-1.jpg?optimizer=image&amp;format=webp&amp;width=32&amp;aspectRatio=1.33 32w, https://media.magloft.app/pdf-import/1144/images/img_16-1.jpg?optimizer=image&amp;format=webp&amp;width=48&amp;aspectRatio=1.33 48w, https://media.magloft.app/pdf-import/1144/images/img_16-1.jpg?optimizer=image&amp;format=webp&amp;width=54&amp;aspectRatio=1.33 54w, https://media.magloft.app/pdf-import/1144/images/img_16-1.jpg?optimizer=image&amp;format=webp&amp;width=64&amp;aspectRatio=1.33 64w, https://media.magloft.app/pdf-import/1144/images/img_16-1.jpg?optimizer=image&amp;format=webp&amp;width=70&amp;aspectRatio=1.33 70w, https://media.magloft.app/pdf-import/1144/images/img_16-1.jpg?optimizer=image&amp;format=webp&amp;width=82&amp;aspectRatio=1.33 82w, https://media.magloft.app/pdf-import/1144/images/img_16-1.jpg?optimizer=image&amp;format=webp&amp;width=96&amp;aspectRatio=1.33 96w, https://media.magloft.app/pdf-import/1144/images/img_16-1.jpg?optimizer=image&amp;format=webp&amp;width=96&amp;aspectRatio=1.33 96w, https://media.magloft.app/pdf-import/1144/images/img_16-1.jpg?optimizer=image&amp;format=webp&amp;width=110&amp;aspectRatio=1.33 110w, https://media.magloft.app/pdf-import/1144/images/img_16-1.jpg?optimizer=image&amp;format=webp&amp;width=128&amp;aspectRatio=1.33 128w, https://media.magloft.app/pdf-import/1144/images/img_16-1.jpg?optimizer=image&amp;format=webp&amp;width=128&amp;aspectRatio=1.33 128w, https://media.magloft.app/pdf-import/1144/images/img_16-1.jpg?optimizer=image&amp;format=webp&amp;width=138&amp;aspectRatio=1.33 138w, https://media.magloft.app/pdf-import/1144/images/img_16-1.jpg?optimizer=image&amp;format=webp&amp;width=192&amp;aspectRatio=1.33 192w, https://media.magloft.app/pdf-import/1144/images/img_16-1.jpg?optimizer=image&amp;format=webp&amp;width=200&amp;aspectRatio=1.33 200w, https://media.magloft.app/pdf-import/1144/images/img_16-1.jpg?optimizer=image&amp;format=webp&amp;width=252&amp;aspectRatio=1.33 252w, https://media.magloft.app/pdf-import/1144/images/img_16-1.jpg?optimizer=image&amp;format=webp&amp;width=256&amp;aspectRatio=1.33 256w, https://media.magloft.app/pdf-import/1144/images/img_16-1.jpg?optimizer=image&amp;format=webp&amp;width=260&amp;aspectRatio=1.33 260w, https://media.magloft.app/pdf-import/1144/images/img_16-1.jpg?optimizer=image&amp;format=webp&amp;width=298&amp;aspectRatio=1.33 298w, https://media.magloft.app/pdf-import/1144/images/img_16-1.jpg?optimizer=image&amp;format=webp&amp;width=378&amp;aspectRatio=1.33 378w, https://media.magloft.app/pdf-import/1144/images/img_16-1.jpg?optimizer=image&amp;format=webp&amp;width=384&amp;aspectRatio=1.33 384w, https://media.magloft.app/pdf-import/1144/images/img_16-1.jpg?optimizer=image&amp;format=webp&amp;width=384&amp;aspectRatio=1.33 384w, https://media.magloft.app/pdf-import/1144/images/img_16-1.jpg?optimizer=image&amp;format=webp&amp;width=520&amp;aspectRatio=1.33 520w, https://media.magloft.app/pdf-import/1144/images/img_16-1.jpg?optimizer=image&amp;format=webp&amp;width=640&amp;aspectRatio=1.33 640w, https://media.magloft.app/pdf-import/1144/images/img_16-1.jpg?optimizer=image&amp;format=webp&amp;width=756&amp;aspectRatio=1.33 756w, https://media.magloft.app/pdf-import/1144/images/img_16-1.jpg?optimizer=image&amp;format=webp&amp;width=828&amp;aspectRatio=1.33 828w, https://media.magloft.app/pdf-import/1144/images/img_16-1.jpg?optimizer=image&amp;format=webp&amp;width=1080&amp;aspectRatio=1.33 1080w, https://media.magloft.app/pdf-import/1144/images/img_16-1.jpg?optimizer=image&amp;format=webp&amp;width=1200&amp;aspectRatio=1.33 1200w, https://media.magloft.app/pdf-import/1144/images/img_16-1.jpg?optimizer=image&amp;format=webp&amp;width=1920&amp;aspectRatio=1.33 1920w, https://media.magloft.app/pdf-import/1144/images/img_16-1.jpg?optimizer=image&amp;format=webp&amp;width=2048&amp;aspectRatio=1.33 2048w" src="https://media.magloft.app/pdf-import/1144/images/img_16-1.jpg?optimizer=image&amp;format=webp&amp;width=2048&amp;aspectRatio=1.33"/></div><div class="Block_article-contents__M6B6V"><h3>Darrin Schellin appointed new CEO at Pharma Tech Industries</h3><p>Pharma Tech Industries, a pharmaceutical manufacturing and packaging solutions contractor for wellness products and medical devices, has announced the appointment of its new chief executive officer, Darrin T Schellin.</p></div></a><a class="Block_article-card__mncKE" href="/articles/clue-points-appoint-richard-young-as-chief-strategy-officer-94fe"><div class="Block_article-cover__vLhzO"><img alt="article-category" loading="lazy" decoding="async" data-nimg="fill" style="position:absolute;height:100%;width:100%;left:0;top:0;right:0;bottom:0;color:transparent;background-size:cover;background-position:50% 50%;background-repeat:no-repeat;background-image:url(&quot;data:image/svg+xml;charset=utf-8,%3Csvg xmlns=&#x27;http%3A//www.w3.org/2000/svg&#x27;%3E%3Cimage style=&#x27;filter:blur(20px)&#x27; preserveAspectRatio=&#x27;none&#x27; x=&#x27;0&#x27; y=&#x27;0&#x27; height=&#x27;100%25&#x27; width=&#x27;100%25&#x27; href=&#x27;data:image/gif;base64,R0lGODlhAQABAPAAANzc3P///yH5BAAAAAAALAAAAAABAAEAAAICRAEAOw==&#x27;/%3E%3C/svg%3E&quot;)" sizes="70px" srcSet="https://media.magloft.app/pdf-import/1144/images/img_17-1.jpg?optimizer=image&amp;format=webp&amp;width=16&amp;aspectRatio=1.33 16w, https://media.magloft.app/pdf-import/1144/images/img_17-1.jpg?optimizer=image&amp;format=webp&amp;width=32&amp;aspectRatio=1.33 32w, https://media.magloft.app/pdf-import/1144/images/img_17-1.jpg?optimizer=image&amp;format=webp&amp;width=48&amp;aspectRatio=1.33 48w, https://media.magloft.app/pdf-import/1144/images/img_17-1.jpg?optimizer=image&amp;format=webp&amp;width=54&amp;aspectRatio=1.33 54w, https://media.magloft.app/pdf-import/1144/images/img_17-1.jpg?optimizer=image&amp;format=webp&amp;width=64&amp;aspectRatio=1.33 64w, https://media.magloft.app/pdf-import/1144/images/img_17-1.jpg?optimizer=image&amp;format=webp&amp;width=70&amp;aspectRatio=1.33 70w, https://media.magloft.app/pdf-import/1144/images/img_17-1.jpg?optimizer=image&amp;format=webp&amp;width=82&amp;aspectRatio=1.33 82w, https://media.magloft.app/pdf-import/1144/images/img_17-1.jpg?optimizer=image&amp;format=webp&amp;width=96&amp;aspectRatio=1.33 96w, https://media.magloft.app/pdf-import/1144/images/img_17-1.jpg?optimizer=image&amp;format=webp&amp;width=96&amp;aspectRatio=1.33 96w, https://media.magloft.app/pdf-import/1144/images/img_17-1.jpg?optimizer=image&amp;format=webp&amp;width=110&amp;aspectRatio=1.33 110w, https://media.magloft.app/pdf-import/1144/images/img_17-1.jpg?optimizer=image&amp;format=webp&amp;width=128&amp;aspectRatio=1.33 128w, https://media.magloft.app/pdf-import/1144/images/img_17-1.jpg?optimizer=image&amp;format=webp&amp;width=128&amp;aspectRatio=1.33 128w, https://media.magloft.app/pdf-import/1144/images/img_17-1.jpg?optimizer=image&amp;format=webp&amp;width=138&amp;aspectRatio=1.33 138w, https://media.magloft.app/pdf-import/1144/images/img_17-1.jpg?optimizer=image&amp;format=webp&amp;width=192&amp;aspectRatio=1.33 192w, https://media.magloft.app/pdf-import/1144/images/img_17-1.jpg?optimizer=image&amp;format=webp&amp;width=200&amp;aspectRatio=1.33 200w, https://media.magloft.app/pdf-import/1144/images/img_17-1.jpg?optimizer=image&amp;format=webp&amp;width=252&amp;aspectRatio=1.33 252w, https://media.magloft.app/pdf-import/1144/images/img_17-1.jpg?optimizer=image&amp;format=webp&amp;width=256&amp;aspectRatio=1.33 256w, https://media.magloft.app/pdf-import/1144/images/img_17-1.jpg?optimizer=image&amp;format=webp&amp;width=260&amp;aspectRatio=1.33 260w, https://media.magloft.app/pdf-import/1144/images/img_17-1.jpg?optimizer=image&amp;format=webp&amp;width=298&amp;aspectRatio=1.33 298w, https://media.magloft.app/pdf-import/1144/images/img_17-1.jpg?optimizer=image&amp;format=webp&amp;width=378&amp;aspectRatio=1.33 378w, https://media.magloft.app/pdf-import/1144/images/img_17-1.jpg?optimizer=image&amp;format=webp&amp;width=384&amp;aspectRatio=1.33 384w, https://media.magloft.app/pdf-import/1144/images/img_17-1.jpg?optimizer=image&amp;format=webp&amp;width=384&amp;aspectRatio=1.33 384w, https://media.magloft.app/pdf-import/1144/images/img_17-1.jpg?optimizer=image&amp;format=webp&amp;width=520&amp;aspectRatio=1.33 520w, https://media.magloft.app/pdf-import/1144/images/img_17-1.jpg?optimizer=image&amp;format=webp&amp;width=640&amp;aspectRatio=1.33 640w, https://media.magloft.app/pdf-import/1144/images/img_17-1.jpg?optimizer=image&amp;format=webp&amp;width=756&amp;aspectRatio=1.33 756w, https://media.magloft.app/pdf-import/1144/images/img_17-1.jpg?optimizer=image&amp;format=webp&amp;width=828&amp;aspectRatio=1.33 828w, https://media.magloft.app/pdf-import/1144/images/img_17-1.jpg?optimizer=image&amp;format=webp&amp;width=1080&amp;aspectRatio=1.33 1080w, https://media.magloft.app/pdf-import/1144/images/img_17-1.jpg?optimizer=image&amp;format=webp&amp;width=1200&amp;aspectRatio=1.33 1200w, https://media.magloft.app/pdf-import/1144/images/img_17-1.jpg?optimizer=image&amp;format=webp&amp;width=1920&amp;aspectRatio=1.33 1920w, https://media.magloft.app/pdf-import/1144/images/img_17-1.jpg?optimizer=image&amp;format=webp&amp;width=2048&amp;aspectRatio=1.33 2048w" src="https://media.magloft.app/pdf-import/1144/images/img_17-1.jpg?optimizer=image&amp;format=webp&amp;width=2048&amp;aspectRatio=1.33"/></div><div class="Block_article-contents__M6B6V"><h3>CluePoints appoint Richard Young as chief strategy officer</h3><p>Cluepoints, a data quality oversight and and risk-based quality management software provider, has announced the appointment of Richard Young as its chief strategy officer.</p></div></a><a class="Block_article-card__mncKE" href="/articles/dr-souad-kechairi-appointed-chief-medical-officer-at-pll-therape-d039"><div class="Block_article-cover__vLhzO"><img alt="article-category" loading="lazy" decoding="async" data-nimg="fill" style="position:absolute;height:100%;width:100%;left:0;top:0;right:0;bottom:0;color:transparent;background-size:cover;background-position:50% 50%;background-repeat:no-repeat;background-image:url(&quot;data:image/svg+xml;charset=utf-8,%3Csvg xmlns=&#x27;http%3A//www.w3.org/2000/svg&#x27;%3E%3Cimage style=&#x27;filter:blur(20px)&#x27; preserveAspectRatio=&#x27;none&#x27; x=&#x27;0&#x27; y=&#x27;0&#x27; height=&#x27;100%25&#x27; width=&#x27;100%25&#x27; href=&#x27;data:image/gif;base64,R0lGODlhAQABAPAAANzc3P///yH5BAAAAAAALAAAAAABAAEAAAICRAEAOw==&#x27;/%3E%3C/svg%3E&quot;)" sizes="70px" srcSet="https://media.magloft.app/pdf-import/1144/images/img_16-2.jpg?optimizer=image&amp;format=webp&amp;width=16&amp;aspectRatio=1.33 16w, https://media.magloft.app/pdf-import/1144/images/img_16-2.jpg?optimizer=image&amp;format=webp&amp;width=32&amp;aspectRatio=1.33 32w, https://media.magloft.app/pdf-import/1144/images/img_16-2.jpg?optimizer=image&amp;format=webp&amp;width=48&amp;aspectRatio=1.33 48w, https://media.magloft.app/pdf-import/1144/images/img_16-2.jpg?optimizer=image&amp;format=webp&amp;width=54&amp;aspectRatio=1.33 54w, https://media.magloft.app/pdf-import/1144/images/img_16-2.jpg?optimizer=image&amp;format=webp&amp;width=64&amp;aspectRatio=1.33 64w, https://media.magloft.app/pdf-import/1144/images/img_16-2.jpg?optimizer=image&amp;format=webp&amp;width=70&amp;aspectRatio=1.33 70w, https://media.magloft.app/pdf-import/1144/images/img_16-2.jpg?optimizer=image&amp;format=webp&amp;width=82&amp;aspectRatio=1.33 82w, https://media.magloft.app/pdf-import/1144/images/img_16-2.jpg?optimizer=image&amp;format=webp&amp;width=96&amp;aspectRatio=1.33 96w, https://media.magloft.app/pdf-import/1144/images/img_16-2.jpg?optimizer=image&amp;format=webp&amp;width=96&amp;aspectRatio=1.33 96w, https://media.magloft.app/pdf-import/1144/images/img_16-2.jpg?optimizer=image&amp;format=webp&amp;width=110&amp;aspectRatio=1.33 110w, https://media.magloft.app/pdf-import/1144/images/img_16-2.jpg?optimizer=image&amp;format=webp&amp;width=128&amp;aspectRatio=1.33 128w, https://media.magloft.app/pdf-import/1144/images/img_16-2.jpg?optimizer=image&amp;format=webp&amp;width=128&amp;aspectRatio=1.33 128w, https://media.magloft.app/pdf-import/1144/images/img_16-2.jpg?optimizer=image&amp;format=webp&amp;width=138&amp;aspectRatio=1.33 138w, https://media.magloft.app/pdf-import/1144/images/img_16-2.jpg?optimizer=image&amp;format=webp&amp;width=192&amp;aspectRatio=1.33 192w, https://media.magloft.app/pdf-import/1144/images/img_16-2.jpg?optimizer=image&amp;format=webp&amp;width=200&amp;aspectRatio=1.33 200w, https://media.magloft.app/pdf-import/1144/images/img_16-2.jpg?optimizer=image&amp;format=webp&amp;width=252&amp;aspectRatio=1.33 252w, https://media.magloft.app/pdf-import/1144/images/img_16-2.jpg?optimizer=image&amp;format=webp&amp;width=256&amp;aspectRatio=1.33 256w, https://media.magloft.app/pdf-import/1144/images/img_16-2.jpg?optimizer=image&amp;format=webp&amp;width=260&amp;aspectRatio=1.33 260w, https://media.magloft.app/pdf-import/1144/images/img_16-2.jpg?optimizer=image&amp;format=webp&amp;width=298&amp;aspectRatio=1.33 298w, https://media.magloft.app/pdf-import/1144/images/img_16-2.jpg?optimizer=image&amp;format=webp&amp;width=378&amp;aspectRatio=1.33 378w, https://media.magloft.app/pdf-import/1144/images/img_16-2.jpg?optimizer=image&amp;format=webp&amp;width=384&amp;aspectRatio=1.33 384w, https://media.magloft.app/pdf-import/1144/images/img_16-2.jpg?optimizer=image&amp;format=webp&amp;width=384&amp;aspectRatio=1.33 384w, https://media.magloft.app/pdf-import/1144/images/img_16-2.jpg?optimizer=image&amp;format=webp&amp;width=520&amp;aspectRatio=1.33 520w, https://media.magloft.app/pdf-import/1144/images/img_16-2.jpg?optimizer=image&amp;format=webp&amp;width=640&amp;aspectRatio=1.33 640w, https://media.magloft.app/pdf-import/1144/images/img_16-2.jpg?optimizer=image&amp;format=webp&amp;width=756&amp;aspectRatio=1.33 756w, https://media.magloft.app/pdf-import/1144/images/img_16-2.jpg?optimizer=image&amp;format=webp&amp;width=828&amp;aspectRatio=1.33 828w, https://media.magloft.app/pdf-import/1144/images/img_16-2.jpg?optimizer=image&amp;format=webp&amp;width=1080&amp;aspectRatio=1.33 1080w, https://media.magloft.app/pdf-import/1144/images/img_16-2.jpg?optimizer=image&amp;format=webp&amp;width=1200&amp;aspectRatio=1.33 1200w, https://media.magloft.app/pdf-import/1144/images/img_16-2.jpg?optimizer=image&amp;format=webp&amp;width=1920&amp;aspectRatio=1.33 1920w, https://media.magloft.app/pdf-import/1144/images/img_16-2.jpg?optimizer=image&amp;format=webp&amp;width=2048&amp;aspectRatio=1.33 2048w" src="https://media.magloft.app/pdf-import/1144/images/img_16-2.jpg?optimizer=image&amp;format=webp&amp;width=2048&amp;aspectRatio=1.33"/></div><div class="Block_article-contents__M6B6V"><h3>Dr Souad Kechairi appointed chief medical officer at PLL Therapeutics</h3><p>Dr Souad Kechairi has been appointed chief medical officer at PLL Therapeutics, a biopharmaceutical company specialising in polypeptides.</p></div></a><a class="Block_article-card__mncKE" href="/articles/shawn-cross-appointed-as-chief-financial-officer-for-pacira-bios-f0ba"><div class="Block_article-cover__vLhzO"><img alt="article-category" loading="lazy" decoding="async" data-nimg="fill" style="position:absolute;height:100%;width:100%;left:0;top:0;right:0;bottom:0;color:transparent;background-size:cover;background-position:50% 50%;background-repeat:no-repeat;background-image:url(&quot;data:image/svg+xml;charset=utf-8,%3Csvg xmlns=&#x27;http%3A//www.w3.org/2000/svg&#x27;%3E%3Cimage style=&#x27;filter:blur(20px)&#x27; preserveAspectRatio=&#x27;none&#x27; x=&#x27;0&#x27; y=&#x27;0&#x27; height=&#x27;100%25&#x27; width=&#x27;100%25&#x27; href=&#x27;data:image/gif;base64,R0lGODlhAQABAPAAANzc3P///yH5BAAAAAAALAAAAAABAAEAAAICRAEAOw==&#x27;/%3E%3C/svg%3E&quot;)" sizes="70px" srcSet="https://media.magloft.app/pdf-import/1144/images/img_17-2.jpg?optimizer=image&amp;format=webp&amp;width=16&amp;aspectRatio=1.33 16w, https://media.magloft.app/pdf-import/1144/images/img_17-2.jpg?optimizer=image&amp;format=webp&amp;width=32&amp;aspectRatio=1.33 32w, https://media.magloft.app/pdf-import/1144/images/img_17-2.jpg?optimizer=image&amp;format=webp&amp;width=48&amp;aspectRatio=1.33 48w, https://media.magloft.app/pdf-import/1144/images/img_17-2.jpg?optimizer=image&amp;format=webp&amp;width=54&amp;aspectRatio=1.33 54w, https://media.magloft.app/pdf-import/1144/images/img_17-2.jpg?optimizer=image&amp;format=webp&amp;width=64&amp;aspectRatio=1.33 64w, https://media.magloft.app/pdf-import/1144/images/img_17-2.jpg?optimizer=image&amp;format=webp&amp;width=70&amp;aspectRatio=1.33 70w, https://media.magloft.app/pdf-import/1144/images/img_17-2.jpg?optimizer=image&amp;format=webp&amp;width=82&amp;aspectRatio=1.33 82w, https://media.magloft.app/pdf-import/1144/images/img_17-2.jpg?optimizer=image&amp;format=webp&amp;width=96&amp;aspectRatio=1.33 96w, https://media.magloft.app/pdf-import/1144/images/img_17-2.jpg?optimizer=image&amp;format=webp&amp;width=96&amp;aspectRatio=1.33 96w, https://media.magloft.app/pdf-import/1144/images/img_17-2.jpg?optimizer=image&amp;format=webp&amp;width=110&amp;aspectRatio=1.33 110w, https://media.magloft.app/pdf-import/1144/images/img_17-2.jpg?optimizer=image&amp;format=webp&amp;width=128&amp;aspectRatio=1.33 128w, https://media.magloft.app/pdf-import/1144/images/img_17-2.jpg?optimizer=image&amp;format=webp&amp;width=128&amp;aspectRatio=1.33 128w, https://media.magloft.app/pdf-import/1144/images/img_17-2.jpg?optimizer=image&amp;format=webp&amp;width=138&amp;aspectRatio=1.33 138w, https://media.magloft.app/pdf-import/1144/images/img_17-2.jpg?optimizer=image&amp;format=webp&amp;width=192&amp;aspectRatio=1.33 192w, https://media.magloft.app/pdf-import/1144/images/img_17-2.jpg?optimizer=image&amp;format=webp&amp;width=200&amp;aspectRatio=1.33 200w, https://media.magloft.app/pdf-import/1144/images/img_17-2.jpg?optimizer=image&amp;format=webp&amp;width=252&amp;aspectRatio=1.33 252w, https://media.magloft.app/pdf-import/1144/images/img_17-2.jpg?optimizer=image&amp;format=webp&amp;width=256&amp;aspectRatio=1.33 256w, https://media.magloft.app/pdf-import/1144/images/img_17-2.jpg?optimizer=image&amp;format=webp&amp;width=260&amp;aspectRatio=1.33 260w, https://media.magloft.app/pdf-import/1144/images/img_17-2.jpg?optimizer=image&amp;format=webp&amp;width=298&amp;aspectRatio=1.33 298w, https://media.magloft.app/pdf-import/1144/images/img_17-2.jpg?optimizer=image&amp;format=webp&amp;width=378&amp;aspectRatio=1.33 378w, https://media.magloft.app/pdf-import/1144/images/img_17-2.jpg?optimizer=image&amp;format=webp&amp;width=384&amp;aspectRatio=1.33 384w, https://media.magloft.app/pdf-import/1144/images/img_17-2.jpg?optimizer=image&amp;format=webp&amp;width=384&amp;aspectRatio=1.33 384w, https://media.magloft.app/pdf-import/1144/images/img_17-2.jpg?optimizer=image&amp;format=webp&amp;width=520&amp;aspectRatio=1.33 520w, https://media.magloft.app/pdf-import/1144/images/img_17-2.jpg?optimizer=image&amp;format=webp&amp;width=640&amp;aspectRatio=1.33 640w, https://media.magloft.app/pdf-import/1144/images/img_17-2.jpg?optimizer=image&amp;format=webp&amp;width=756&amp;aspectRatio=1.33 756w, https://media.magloft.app/pdf-import/1144/images/img_17-2.jpg?optimizer=image&amp;format=webp&amp;width=828&amp;aspectRatio=1.33 828w, https://media.magloft.app/pdf-import/1144/images/img_17-2.jpg?optimizer=image&amp;format=webp&amp;width=1080&amp;aspectRatio=1.33 1080w, https://media.magloft.app/pdf-import/1144/images/img_17-2.jpg?optimizer=image&amp;format=webp&amp;width=1200&amp;aspectRatio=1.33 1200w, https://media.magloft.app/pdf-import/1144/images/img_17-2.jpg?optimizer=image&amp;format=webp&amp;width=1920&amp;aspectRatio=1.33 1920w, https://media.magloft.app/pdf-import/1144/images/img_17-2.jpg?optimizer=image&amp;format=webp&amp;width=2048&amp;aspectRatio=1.33 2048w" src="https://media.magloft.app/pdf-import/1144/images/img_17-2.jpg?optimizer=image&amp;format=webp&amp;width=2048&amp;aspectRatio=1.33"/></div><div class="Block_article-contents__M6B6V"><h3>Shawn Cross appointed as chief financial officer for Pacira Biosciences</h3><p>Pacira biosciences, specialist in non-opioid pain therapies, has appointed Shawn Cross as its chief financial officer. In this role, Mr Cross will take over all responsibility for the company’s financial operations.</p></div></a><a class="Block_article-card__mncKE" href="/articles/dr-souad-kechairi-appointed-chief-medical-officer-at-pll-therape"><div class="Block_article-cover__vLhzO"><img alt="article-category" loading="lazy" decoding="async" data-nimg="fill" style="position:absolute;height:100%;width:100%;left:0;top:0;right:0;bottom:0;color:transparent;background-size:cover;background-position:50% 50%;background-repeat:no-repeat;background-image:url(&quot;data:image/svg+xml;charset=utf-8,%3Csvg xmlns=&#x27;http%3A//www.w3.org/2000/svg&#x27;%3E%3Cimage style=&#x27;filter:blur(20px)&#x27; preserveAspectRatio=&#x27;none&#x27; x=&#x27;0&#x27; y=&#x27;0&#x27; height=&#x27;100%25&#x27; width=&#x27;100%25&#x27; href=&#x27;data:image/gif;base64,R0lGODlhAQABAPAAANzc3P///yH5BAAAAAAALAAAAAABAAEAAAICRAEAOw==&#x27;/%3E%3C/svg%3E&quot;)" sizes="70px" srcSet="https://media.magloft.app/pdf-import/1144/images/img_16-2.jpg?optimizer=image&amp;format=webp&amp;width=16&amp;aspectRatio=1.33 16w, https://media.magloft.app/pdf-import/1144/images/img_16-2.jpg?optimizer=image&amp;format=webp&amp;width=32&amp;aspectRatio=1.33 32w, https://media.magloft.app/pdf-import/1144/images/img_16-2.jpg?optimizer=image&amp;format=webp&amp;width=48&amp;aspectRatio=1.33 48w, https://media.magloft.app/pdf-import/1144/images/img_16-2.jpg?optimizer=image&amp;format=webp&amp;width=54&amp;aspectRatio=1.33 54w, https://media.magloft.app/pdf-import/1144/images/img_16-2.jpg?optimizer=image&amp;format=webp&amp;width=64&amp;aspectRatio=1.33 64w, https://media.magloft.app/pdf-import/1144/images/img_16-2.jpg?optimizer=image&amp;format=webp&amp;width=70&amp;aspectRatio=1.33 70w, https://media.magloft.app/pdf-import/1144/images/img_16-2.jpg?optimizer=image&amp;format=webp&amp;width=82&amp;aspectRatio=1.33 82w, https://media.magloft.app/pdf-import/1144/images/img_16-2.jpg?optimizer=image&amp;format=webp&amp;width=96&amp;aspectRatio=1.33 96w, https://media.magloft.app/pdf-import/1144/images/img_16-2.jpg?optimizer=image&amp;format=webp&amp;width=96&amp;aspectRatio=1.33 96w, https://media.magloft.app/pdf-import/1144/images/img_16-2.jpg?optimizer=image&amp;format=webp&amp;width=110&amp;aspectRatio=1.33 110w, https://media.magloft.app/pdf-import/1144/images/img_16-2.jpg?optimizer=image&amp;format=webp&amp;width=128&amp;aspectRatio=1.33 128w, https://media.magloft.app/pdf-import/1144/images/img_16-2.jpg?optimizer=image&amp;format=webp&amp;width=128&amp;aspectRatio=1.33 128w, https://media.magloft.app/pdf-import/1144/images/img_16-2.jpg?optimizer=image&amp;format=webp&amp;width=138&amp;aspectRatio=1.33 138w, https://media.magloft.app/pdf-import/1144/images/img_16-2.jpg?optimizer=image&amp;format=webp&amp;width=192&amp;aspectRatio=1.33 192w, https://media.magloft.app/pdf-import/1144/images/img_16-2.jpg?optimizer=image&amp;format=webp&amp;width=200&amp;aspectRatio=1.33 200w, https://media.magloft.app/pdf-import/1144/images/img_16-2.jpg?optimizer=image&amp;format=webp&amp;width=252&amp;aspectRatio=1.33 252w, https://media.magloft.app/pdf-import/1144/images/img_16-2.jpg?optimizer=image&amp;format=webp&amp;width=256&amp;aspectRatio=1.33 256w, https://media.magloft.app/pdf-import/1144/images/img_16-2.jpg?optimizer=image&amp;format=webp&amp;width=260&amp;aspectRatio=1.33 260w, https://media.magloft.app/pdf-import/1144/images/img_16-2.jpg?optimizer=image&amp;format=webp&amp;width=298&amp;aspectRatio=1.33 298w, https://media.magloft.app/pdf-import/1144/images/img_16-2.jpg?optimizer=image&amp;format=webp&amp;width=378&amp;aspectRatio=1.33 378w, https://media.magloft.app/pdf-import/1144/images/img_16-2.jpg?optimizer=image&amp;format=webp&amp;width=384&amp;aspectRatio=1.33 384w, https://media.magloft.app/pdf-import/1144/images/img_16-2.jpg?optimizer=image&amp;format=webp&amp;width=384&amp;aspectRatio=1.33 384w, https://media.magloft.app/pdf-import/1144/images/img_16-2.jpg?optimizer=image&amp;format=webp&amp;width=520&amp;aspectRatio=1.33 520w, https://media.magloft.app/pdf-import/1144/images/img_16-2.jpg?optimizer=image&amp;format=webp&amp;width=640&amp;aspectRatio=1.33 640w, https://media.magloft.app/pdf-import/1144/images/img_16-2.jpg?optimizer=image&amp;format=webp&amp;width=756&amp;aspectRatio=1.33 756w, https://media.magloft.app/pdf-import/1144/images/img_16-2.jpg?optimizer=image&amp;format=webp&amp;width=828&amp;aspectRatio=1.33 828w, https://media.magloft.app/pdf-import/1144/images/img_16-2.jpg?optimizer=image&amp;format=webp&amp;width=1080&amp;aspectRatio=1.33 1080w, https://media.magloft.app/pdf-import/1144/images/img_16-2.jpg?optimizer=image&amp;format=webp&amp;width=1200&amp;aspectRatio=1.33 1200w, https://media.magloft.app/pdf-import/1144/images/img_16-2.jpg?optimizer=image&amp;format=webp&amp;width=1920&amp;aspectRatio=1.33 1920w, https://media.magloft.app/pdf-import/1144/images/img_16-2.jpg?optimizer=image&amp;format=webp&amp;width=2048&amp;aspectRatio=1.33 2048w" src="https://media.magloft.app/pdf-import/1144/images/img_16-2.jpg?optimizer=image&amp;format=webp&amp;width=2048&amp;aspectRatio=1.33"/></div><div class="Block_article-contents__M6B6V"><h3>Dr Souad Kechairi appointed chief medical officer at PLL Therapeutics</h3><p>Dr Souad Kechairi has been appointed chief medical officer at PLL Therapeutics, a biopharmaceutical company specialising in polypeptides.</p></div></a><a class="Block_article-card__mncKE" href="/articles/prilenia-appoints-new-staff-to-advance-company-s-development-and"><div class="Block_article-cover__vLhzO"><img alt="article-category" loading="lazy" decoding="async" data-nimg="fill" style="position:absolute;height:100%;width:100%;left:0;top:0;right:0;bottom:0;color:transparent;background-size:cover;background-position:50% 50%;background-repeat:no-repeat;background-image:url(&quot;data:image/svg+xml;charset=utf-8,%3Csvg xmlns=&#x27;http%3A//www.w3.org/2000/svg&#x27;%3E%3Cimage style=&#x27;filter:blur(20px)&#x27; preserveAspectRatio=&#x27;none&#x27; x=&#x27;0&#x27; y=&#x27;0&#x27; height=&#x27;100%25&#x27; width=&#x27;100%25&#x27; href=&#x27;data:image/gif;base64,R0lGODlhAQABAPAAANzc3P///yH5BAAAAAAALAAAAAABAAEAAAICRAEAOw==&#x27;/%3E%3C/svg%3E&quot;)" sizes="70px" srcSet="https://media.magloft.app/pdf-import/1125/images/pages/pg-020.jpg?optimizer=image&amp;format=webp&amp;width=16&amp;aspectRatio=1.33 16w, https://media.magloft.app/pdf-import/1125/images/pages/pg-020.jpg?optimizer=image&amp;format=webp&amp;width=32&amp;aspectRatio=1.33 32w, https://media.magloft.app/pdf-import/1125/images/pages/pg-020.jpg?optimizer=image&amp;format=webp&amp;width=48&amp;aspectRatio=1.33 48w, https://media.magloft.app/pdf-import/1125/images/pages/pg-020.jpg?optimizer=image&amp;format=webp&amp;width=54&amp;aspectRatio=1.33 54w, https://media.magloft.app/pdf-import/1125/images/pages/pg-020.jpg?optimizer=image&amp;format=webp&amp;width=64&amp;aspectRatio=1.33 64w, https://media.magloft.app/pdf-import/1125/images/pages/pg-020.jpg?optimizer=image&amp;format=webp&amp;width=70&amp;aspectRatio=1.33 70w, https://media.magloft.app/pdf-import/1125/images/pages/pg-020.jpg?optimizer=image&amp;format=webp&amp;width=82&amp;aspectRatio=1.33 82w, https://media.magloft.app/pdf-import/1125/images/pages/pg-020.jpg?optimizer=image&amp;format=webp&amp;width=96&amp;aspectRatio=1.33 96w, https://media.magloft.app/pdf-import/1125/images/pages/pg-020.jpg?optimizer=image&amp;format=webp&amp;width=96&amp;aspectRatio=1.33 96w, https://media.magloft.app/pdf-import/1125/images/pages/pg-020.jpg?optimizer=image&amp;format=webp&amp;width=110&amp;aspectRatio=1.33 110w, https://media.magloft.app/pdf-import/1125/images/pages/pg-020.jpg?optimizer=image&amp;format=webp&amp;width=128&amp;aspectRatio=1.33 128w, https://media.magloft.app/pdf-import/1125/images/pages/pg-020.jpg?optimizer=image&amp;format=webp&amp;width=128&amp;aspectRatio=1.33 128w, https://media.magloft.app/pdf-import/1125/images/pages/pg-020.jpg?optimizer=image&amp;format=webp&amp;width=138&amp;aspectRatio=1.33 138w, https://media.magloft.app/pdf-import/1125/images/pages/pg-020.jpg?optimizer=image&amp;format=webp&amp;width=192&amp;aspectRatio=1.33 192w, https://media.magloft.app/pdf-import/1125/images/pages/pg-020.jpg?optimizer=image&amp;format=webp&amp;width=200&amp;aspectRatio=1.33 200w, https://media.magloft.app/pdf-import/1125/images/pages/pg-020.jpg?optimizer=image&amp;format=webp&amp;width=252&amp;aspectRatio=1.33 252w, https://media.magloft.app/pdf-import/1125/images/pages/pg-020.jpg?optimizer=image&amp;format=webp&amp;width=256&amp;aspectRatio=1.33 256w, https://media.magloft.app/pdf-import/1125/images/pages/pg-020.jpg?optimizer=image&amp;format=webp&amp;width=260&amp;aspectRatio=1.33 260w, https://media.magloft.app/pdf-import/1125/images/pages/pg-020.jpg?optimizer=image&amp;format=webp&amp;width=298&amp;aspectRatio=1.33 298w, https://media.magloft.app/pdf-import/1125/images/pages/pg-020.jpg?optimizer=image&amp;format=webp&amp;width=378&amp;aspectRatio=1.33 378w, https://media.magloft.app/pdf-import/1125/images/pages/pg-020.jpg?optimizer=image&amp;format=webp&amp;width=384&amp;aspectRatio=1.33 384w, https://media.magloft.app/pdf-import/1125/images/pages/pg-020.jpg?optimizer=image&amp;format=webp&amp;width=384&amp;aspectRatio=1.33 384w, https://media.magloft.app/pdf-import/1125/images/pages/pg-020.jpg?optimizer=image&amp;format=webp&amp;width=520&amp;aspectRatio=1.33 520w, https://media.magloft.app/pdf-import/1125/images/pages/pg-020.jpg?optimizer=image&amp;format=webp&amp;width=640&amp;aspectRatio=1.33 640w, https://media.magloft.app/pdf-import/1125/images/pages/pg-020.jpg?optimizer=image&amp;format=webp&amp;width=756&amp;aspectRatio=1.33 756w, https://media.magloft.app/pdf-import/1125/images/pages/pg-020.jpg?optimizer=image&amp;format=webp&amp;width=828&amp;aspectRatio=1.33 828w, https://media.magloft.app/pdf-import/1125/images/pages/pg-020.jpg?optimizer=image&amp;format=webp&amp;width=1080&amp;aspectRatio=1.33 1080w, https://media.magloft.app/pdf-import/1125/images/pages/pg-020.jpg?optimizer=image&amp;format=webp&amp;width=1200&amp;aspectRatio=1.33 1200w, https://media.magloft.app/pdf-import/1125/images/pages/pg-020.jpg?optimizer=image&amp;format=webp&amp;width=1920&amp;aspectRatio=1.33 1920w, https://media.magloft.app/pdf-import/1125/images/pages/pg-020.jpg?optimizer=image&amp;format=webp&amp;width=2048&amp;aspectRatio=1.33 2048w" src="https://media.magloft.app/pdf-import/1125/images/pages/pg-020.jpg?optimizer=image&amp;format=webp&amp;width=2048&amp;aspectRatio=1.33"/></div><div class="Block_article-contents__M6B6V"><h3>Prilenia appoints new staff to advance company’s development plans</h3><p>Prilenia, a clinical stage biotech focusing on neurodegenerative and neurodevelopmental disorders, has announced the appointment of two new senior staff members ‒ Rob Lauzen as chief financial officer (CFO) and Jason Marks as chief legal officer (CLO).</p></div></a><a class="Block_article-card__mncKE" href="/articles/steriline-s-founder-passes-torch-to-children-with-ceo-and-cso"><div class="Block_article-cover__vLhzO"><img alt="article-category" loading="lazy" decoding="async" data-nimg="fill" style="position:absolute;height:100%;width:100%;left:0;top:0;right:0;bottom:0;color:transparent;background-size:cover;background-position:50% 50%;background-repeat:no-repeat;background-image:url(&quot;data:image/svg+xml;charset=utf-8,%3Csvg xmlns=&#x27;http%3A//www.w3.org/2000/svg&#x27;%3E%3Cimage style=&#x27;filter:blur(20px)&#x27; preserveAspectRatio=&#x27;none&#x27; x=&#x27;0&#x27; y=&#x27;0&#x27; height=&#x27;100%25&#x27; width=&#x27;100%25&#x27; href=&#x27;data:image/gif;base64,R0lGODlhAQABAPAAANzc3P///yH5BAAAAAAALAAAAAABAAEAAAICRAEAOw==&#x27;/%3E%3C/svg%3E&quot;)" sizes="70px" srcSet="https://media.magloft.app/pdf-import/1125/images/img_20-1.jpg?optimizer=image&amp;format=webp&amp;width=16&amp;aspectRatio=1.33 16w, https://media.magloft.app/pdf-import/1125/images/img_20-1.jpg?optimizer=image&amp;format=webp&amp;width=32&amp;aspectRatio=1.33 32w, https://media.magloft.app/pdf-import/1125/images/img_20-1.jpg?optimizer=image&amp;format=webp&amp;width=48&amp;aspectRatio=1.33 48w, https://media.magloft.app/pdf-import/1125/images/img_20-1.jpg?optimizer=image&amp;format=webp&amp;width=54&amp;aspectRatio=1.33 54w, https://media.magloft.app/pdf-import/1125/images/img_20-1.jpg?optimizer=image&amp;format=webp&amp;width=64&amp;aspectRatio=1.33 64w, https://media.magloft.app/pdf-import/1125/images/img_20-1.jpg?optimizer=image&amp;format=webp&amp;width=70&amp;aspectRatio=1.33 70w, https://media.magloft.app/pdf-import/1125/images/img_20-1.jpg?optimizer=image&amp;format=webp&amp;width=82&amp;aspectRatio=1.33 82w, https://media.magloft.app/pdf-import/1125/images/img_20-1.jpg?optimizer=image&amp;format=webp&amp;width=96&amp;aspectRatio=1.33 96w, https://media.magloft.app/pdf-import/1125/images/img_20-1.jpg?optimizer=image&amp;format=webp&amp;width=96&amp;aspectRatio=1.33 96w, https://media.magloft.app/pdf-import/1125/images/img_20-1.jpg?optimizer=image&amp;format=webp&amp;width=110&amp;aspectRatio=1.33 110w, https://media.magloft.app/pdf-import/1125/images/img_20-1.jpg?optimizer=image&amp;format=webp&amp;width=128&amp;aspectRatio=1.33 128w, https://media.magloft.app/pdf-import/1125/images/img_20-1.jpg?optimizer=image&amp;format=webp&amp;width=128&amp;aspectRatio=1.33 128w, https://media.magloft.app/pdf-import/1125/images/img_20-1.jpg?optimizer=image&amp;format=webp&amp;width=138&amp;aspectRatio=1.33 138w, https://media.magloft.app/pdf-import/1125/images/img_20-1.jpg?optimizer=image&amp;format=webp&amp;width=192&amp;aspectRatio=1.33 192w, https://media.magloft.app/pdf-import/1125/images/img_20-1.jpg?optimizer=image&amp;format=webp&amp;width=200&amp;aspectRatio=1.33 200w, https://media.magloft.app/pdf-import/1125/images/img_20-1.jpg?optimizer=image&amp;format=webp&amp;width=252&amp;aspectRatio=1.33 252w, https://media.magloft.app/pdf-import/1125/images/img_20-1.jpg?optimizer=image&amp;format=webp&amp;width=256&amp;aspectRatio=1.33 256w, https://media.magloft.app/pdf-import/1125/images/img_20-1.jpg?optimizer=image&amp;format=webp&amp;width=260&amp;aspectRatio=1.33 260w, https://media.magloft.app/pdf-import/1125/images/img_20-1.jpg?optimizer=image&amp;format=webp&amp;width=298&amp;aspectRatio=1.33 298w, https://media.magloft.app/pdf-import/1125/images/img_20-1.jpg?optimizer=image&amp;format=webp&amp;width=378&amp;aspectRatio=1.33 378w, https://media.magloft.app/pdf-import/1125/images/img_20-1.jpg?optimizer=image&amp;format=webp&amp;width=384&amp;aspectRatio=1.33 384w, https://media.magloft.app/pdf-import/1125/images/img_20-1.jpg?optimizer=image&amp;format=webp&amp;width=384&amp;aspectRatio=1.33 384w, https://media.magloft.app/pdf-import/1125/images/img_20-1.jpg?optimizer=image&amp;format=webp&amp;width=520&amp;aspectRatio=1.33 520w, https://media.magloft.app/pdf-import/1125/images/img_20-1.jpg?optimizer=image&amp;format=webp&amp;width=640&amp;aspectRatio=1.33 640w, https://media.magloft.app/pdf-import/1125/images/img_20-1.jpg?optimizer=image&amp;format=webp&amp;width=756&amp;aspectRatio=1.33 756w, https://media.magloft.app/pdf-import/1125/images/img_20-1.jpg?optimizer=image&amp;format=webp&amp;width=828&amp;aspectRatio=1.33 828w, https://media.magloft.app/pdf-import/1125/images/img_20-1.jpg?optimizer=image&amp;format=webp&amp;width=1080&amp;aspectRatio=1.33 1080w, https://media.magloft.app/pdf-import/1125/images/img_20-1.jpg?optimizer=image&amp;format=webp&amp;width=1200&amp;aspectRatio=1.33 1200w, https://media.magloft.app/pdf-import/1125/images/img_20-1.jpg?optimizer=image&amp;format=webp&amp;width=1920&amp;aspectRatio=1.33 1920w, https://media.magloft.app/pdf-import/1125/images/img_20-1.jpg?optimizer=image&amp;format=webp&amp;width=2048&amp;aspectRatio=1.33 2048w" src="https://media.magloft.app/pdf-import/1125/images/img_20-1.jpg?optimizer=image&amp;format=webp&amp;width=2048&amp;aspectRatio=1.33"/></div><div class="Block_article-contents__M6B6V"><h3>Steriline’s founder ‘passes torch’ to children with CEO and CSO appointments</h3><p>Aseptic packaging company Steriline’s founder Gerardo Fumagalli has ‘passed the torch’ to his children Illaria Fumagalli and Federico Fumagalli, who have been appointed to chief executive officer and chief sales officer, respectively. Gerardo will continue on as chairman of the board of directors.</p></div></a><a class="Block_article-card__mncKE" href="/articles/eli-lilly-expands-with-two-senior-hires-in-public-affairs-and-co"><div class="Block_article-cover__vLhzO"><img alt="article-category" loading="lazy" decoding="async" data-nimg="fill" style="position:absolute;height:100%;width:100%;left:0;top:0;right:0;bottom:0;color:transparent;background-size:cover;background-position:50% 50%;background-repeat:no-repeat;background-image:url(&quot;data:image/svg+xml;charset=utf-8,%3Csvg xmlns=&#x27;http%3A//www.w3.org/2000/svg&#x27;%3E%3Cimage style=&#x27;filter:blur(20px)&#x27; preserveAspectRatio=&#x27;none&#x27; x=&#x27;0&#x27; y=&#x27;0&#x27; height=&#x27;100%25&#x27; width=&#x27;100%25&#x27; href=&#x27;data:image/gif;base64,R0lGODlhAQABAPAAANzc3P///yH5BAAAAAAALAAAAAABAAEAAAICRAEAOw==&#x27;/%3E%3C/svg%3E&quot;)" sizes="70px" srcSet="https://media.magloft.app/pdf-import/1125/images/img_21-1.jpg?optimizer=image&amp;format=webp&amp;width=16&amp;aspectRatio=1.33 16w, https://media.magloft.app/pdf-import/1125/images/img_21-1.jpg?optimizer=image&amp;format=webp&amp;width=32&amp;aspectRatio=1.33 32w, https://media.magloft.app/pdf-import/1125/images/img_21-1.jpg?optimizer=image&amp;format=webp&amp;width=48&amp;aspectRatio=1.33 48w, https://media.magloft.app/pdf-import/1125/images/img_21-1.jpg?optimizer=image&amp;format=webp&amp;width=54&amp;aspectRatio=1.33 54w, https://media.magloft.app/pdf-import/1125/images/img_21-1.jpg?optimizer=image&amp;format=webp&amp;width=64&amp;aspectRatio=1.33 64w, https://media.magloft.app/pdf-import/1125/images/img_21-1.jpg?optimizer=image&amp;format=webp&amp;width=70&amp;aspectRatio=1.33 70w, https://media.magloft.app/pdf-import/1125/images/img_21-1.jpg?optimizer=image&amp;format=webp&amp;width=82&amp;aspectRatio=1.33 82w, https://media.magloft.app/pdf-import/1125/images/img_21-1.jpg?optimizer=image&amp;format=webp&amp;width=96&amp;aspectRatio=1.33 96w, https://media.magloft.app/pdf-import/1125/images/img_21-1.jpg?optimizer=image&amp;format=webp&amp;width=96&amp;aspectRatio=1.33 96w, https://media.magloft.app/pdf-import/1125/images/img_21-1.jpg?optimizer=image&amp;format=webp&amp;width=110&amp;aspectRatio=1.33 110w, https://media.magloft.app/pdf-import/1125/images/img_21-1.jpg?optimizer=image&amp;format=webp&amp;width=128&amp;aspectRatio=1.33 128w, https://media.magloft.app/pdf-import/1125/images/img_21-1.jpg?optimizer=image&amp;format=webp&amp;width=128&amp;aspectRatio=1.33 128w, https://media.magloft.app/pdf-import/1125/images/img_21-1.jpg?optimizer=image&amp;format=webp&amp;width=138&amp;aspectRatio=1.33 138w, https://media.magloft.app/pdf-import/1125/images/img_21-1.jpg?optimizer=image&amp;format=webp&amp;width=192&amp;aspectRatio=1.33 192w, https://media.magloft.app/pdf-import/1125/images/img_21-1.jpg?optimizer=image&amp;format=webp&amp;width=200&amp;aspectRatio=1.33 200w, https://media.magloft.app/pdf-import/1125/images/img_21-1.jpg?optimizer=image&amp;format=webp&amp;width=252&amp;aspectRatio=1.33 252w, https://media.magloft.app/pdf-import/1125/images/img_21-1.jpg?optimizer=image&amp;format=webp&amp;width=256&amp;aspectRatio=1.33 256w, https://media.magloft.app/pdf-import/1125/images/img_21-1.jpg?optimizer=image&amp;format=webp&amp;width=260&amp;aspectRatio=1.33 260w, https://media.magloft.app/pdf-import/1125/images/img_21-1.jpg?optimizer=image&amp;format=webp&amp;width=298&amp;aspectRatio=1.33 298w, https://media.magloft.app/pdf-import/1125/images/img_21-1.jpg?optimizer=image&amp;format=webp&amp;width=378&amp;aspectRatio=1.33 378w, https://media.magloft.app/pdf-import/1125/images/img_21-1.jpg?optimizer=image&amp;format=webp&amp;width=384&amp;aspectRatio=1.33 384w, https://media.magloft.app/pdf-import/1125/images/img_21-1.jpg?optimizer=image&amp;format=webp&amp;width=384&amp;aspectRatio=1.33 384w, https://media.magloft.app/pdf-import/1125/images/img_21-1.jpg?optimizer=image&amp;format=webp&amp;width=520&amp;aspectRatio=1.33 520w, https://media.magloft.app/pdf-import/1125/images/img_21-1.jpg?optimizer=image&amp;format=webp&amp;width=640&amp;aspectRatio=1.33 640w, https://media.magloft.app/pdf-import/1125/images/img_21-1.jpg?optimizer=image&amp;format=webp&amp;width=756&amp;aspectRatio=1.33 756w, https://media.magloft.app/pdf-import/1125/images/img_21-1.jpg?optimizer=image&amp;format=webp&amp;width=828&amp;aspectRatio=1.33 828w, https://media.magloft.app/pdf-import/1125/images/img_21-1.jpg?optimizer=image&amp;format=webp&amp;width=1080&amp;aspectRatio=1.33 1080w, https://media.magloft.app/pdf-import/1125/images/img_21-1.jpg?optimizer=image&amp;format=webp&amp;width=1200&amp;aspectRatio=1.33 1200w, https://media.magloft.app/pdf-import/1125/images/img_21-1.jpg?optimizer=image&amp;format=webp&amp;width=1920&amp;aspectRatio=1.33 1920w, https://media.magloft.app/pdf-import/1125/images/img_21-1.jpg?optimizer=image&amp;format=webp&amp;width=2048&amp;aspectRatio=1.33 2048w" src="https://media.magloft.app/pdf-import/1125/images/img_21-1.jpg?optimizer=image&amp;format=webp&amp;width=2048&amp;aspectRatio=1.33"/></div><div class="Block_article-contents__M6B6V"><h3>Eli Lilly expands with two senior hires in Public Affairs and Communications team</h3><p>Pharmaceutical company Eli Lilly has announced the appointment of two senior positions in its public affairs and communications team.</p></div></a><a class="Block_article-card__mncKE" href="/articles/dr-anada-gubbi-appointed-by-sfa-therapeutics-as-director-of-bios"><div class="Block_article-cover__vLhzO"><img alt="article-category" loading="lazy" decoding="async" data-nimg="fill" style="position:absolute;height:100%;width:100%;left:0;top:0;right:0;bottom:0;color:transparent;background-size:cover;background-position:50% 50%;background-repeat:no-repeat;background-image:url(&quot;data:image/svg+xml;charset=utf-8,%3Csvg xmlns=&#x27;http%3A//www.w3.org/2000/svg&#x27;%3E%3Cimage style=&#x27;filter:blur(20px)&#x27; preserveAspectRatio=&#x27;none&#x27; x=&#x27;0&#x27; y=&#x27;0&#x27; height=&#x27;100%25&#x27; width=&#x27;100%25&#x27; href=&#x27;data:image/gif;base64,R0lGODlhAQABAPAAANzc3P///yH5BAAAAAAALAAAAAABAAEAAAICRAEAOw==&#x27;/%3E%3C/svg%3E&quot;)" sizes="70px" srcSet="https://media.magloft.app/pdf-import/1125/images/img_21-2.jpg?optimizer=image&amp;format=webp&amp;width=16&amp;aspectRatio=1.33 16w, https://media.magloft.app/pdf-import/1125/images/img_21-2.jpg?optimizer=image&amp;format=webp&amp;width=32&amp;aspectRatio=1.33 32w, https://media.magloft.app/pdf-import/1125/images/img_21-2.jpg?optimizer=image&amp;format=webp&amp;width=48&amp;aspectRatio=1.33 48w, https://media.magloft.app/pdf-import/1125/images/img_21-2.jpg?optimizer=image&amp;format=webp&amp;width=54&amp;aspectRatio=1.33 54w, https://media.magloft.app/pdf-import/1125/images/img_21-2.jpg?optimizer=image&amp;format=webp&amp;width=64&amp;aspectRatio=1.33 64w, https://media.magloft.app/pdf-import/1125/images/img_21-2.jpg?optimizer=image&amp;format=webp&amp;width=70&amp;aspectRatio=1.33 70w, https://media.magloft.app/pdf-import/1125/images/img_21-2.jpg?optimizer=image&amp;format=webp&amp;width=82&amp;aspectRatio=1.33 82w, https://media.magloft.app/pdf-import/1125/images/img_21-2.jpg?optimizer=image&amp;format=webp&amp;width=96&amp;aspectRatio=1.33 96w, https://media.magloft.app/pdf-import/1125/images/img_21-2.jpg?optimizer=image&amp;format=webp&amp;width=96&amp;aspectRatio=1.33 96w, https://media.magloft.app/pdf-import/1125/images/img_21-2.jpg?optimizer=image&amp;format=webp&amp;width=110&amp;aspectRatio=1.33 110w, https://media.magloft.app/pdf-import/1125/images/img_21-2.jpg?optimizer=image&amp;format=webp&amp;width=128&amp;aspectRatio=1.33 128w, https://media.magloft.app/pdf-import/1125/images/img_21-2.jpg?optimizer=image&amp;format=webp&amp;width=128&amp;aspectRatio=1.33 128w, https://media.magloft.app/pdf-import/1125/images/img_21-2.jpg?optimizer=image&amp;format=webp&amp;width=138&amp;aspectRatio=1.33 138w, https://media.magloft.app/pdf-import/1125/images/img_21-2.jpg?optimizer=image&amp;format=webp&amp;width=192&amp;aspectRatio=1.33 192w, https://media.magloft.app/pdf-import/1125/images/img_21-2.jpg?optimizer=image&amp;format=webp&amp;width=200&amp;aspectRatio=1.33 200w, https://media.magloft.app/pdf-import/1125/images/img_21-2.jpg?optimizer=image&amp;format=webp&amp;width=252&amp;aspectRatio=1.33 252w, https://media.magloft.app/pdf-import/1125/images/img_21-2.jpg?optimizer=image&amp;format=webp&amp;width=256&amp;aspectRatio=1.33 256w, https://media.magloft.app/pdf-import/1125/images/img_21-2.jpg?optimizer=image&amp;format=webp&amp;width=260&amp;aspectRatio=1.33 260w, https://media.magloft.app/pdf-import/1125/images/img_21-2.jpg?optimizer=image&amp;format=webp&amp;width=298&amp;aspectRatio=1.33 298w, https://media.magloft.app/pdf-import/1125/images/img_21-2.jpg?optimizer=image&amp;format=webp&amp;width=378&amp;aspectRatio=1.33 378w, https://media.magloft.app/pdf-import/1125/images/img_21-2.jpg?optimizer=image&amp;format=webp&amp;width=384&amp;aspectRatio=1.33 384w, https://media.magloft.app/pdf-import/1125/images/img_21-2.jpg?optimizer=image&amp;format=webp&amp;width=384&amp;aspectRatio=1.33 384w, https://media.magloft.app/pdf-import/1125/images/img_21-2.jpg?optimizer=image&amp;format=webp&amp;width=520&amp;aspectRatio=1.33 520w, https://media.magloft.app/pdf-import/1125/images/img_21-2.jpg?optimizer=image&amp;format=webp&amp;width=640&amp;aspectRatio=1.33 640w, https://media.magloft.app/pdf-import/1125/images/img_21-2.jpg?optimizer=image&amp;format=webp&amp;width=756&amp;aspectRatio=1.33 756w, https://media.magloft.app/pdf-import/1125/images/img_21-2.jpg?optimizer=image&amp;format=webp&amp;width=828&amp;aspectRatio=1.33 828w, https://media.magloft.app/pdf-import/1125/images/img_21-2.jpg?optimizer=image&amp;format=webp&amp;width=1080&amp;aspectRatio=1.33 1080w, https://media.magloft.app/pdf-import/1125/images/img_21-2.jpg?optimizer=image&amp;format=webp&amp;width=1200&amp;aspectRatio=1.33 1200w, https://media.magloft.app/pdf-import/1125/images/img_21-2.jpg?optimizer=image&amp;format=webp&amp;width=1920&amp;aspectRatio=1.33 1920w, https://media.magloft.app/pdf-import/1125/images/img_21-2.jpg?optimizer=image&amp;format=webp&amp;width=2048&amp;aspectRatio=1.33 2048w" src="https://media.magloft.app/pdf-import/1125/images/img_21-2.jpg?optimizer=image&amp;format=webp&amp;width=2048&amp;aspectRatio=1.33"/></div><div class="Block_article-contents__M6B6V"><h3>Dr Anada Gubbi appointed by SFA Therapeutics as director of Biostatistics</h3><p>SFA Therapeutics, a clinical-stage biopharmaceutical company, has announced that it has appointed Dr Anada Gubbi as director of biostatistics. Dr Gubbi will be responsible for assisting SFA Therapeutics in effectively developing drug candidates for the treatment of inflammatory diseases.</p></div></a><a class="Block_article-card__mncKE" href="/articles/curve-therapeutics-bolsters-its-leadership-team-with-appointment"><div class="Block_article-cover__vLhzO"><img alt="article-category" loading="lazy" decoding="async" data-nimg="fill" style="position:absolute;height:100%;width:100%;left:0;top:0;right:0;bottom:0;color:transparent;background-size:cover;background-position:50% 50%;background-repeat:no-repeat;background-image:url(&quot;data:image/svg+xml;charset=utf-8,%3Csvg xmlns=&#x27;http%3A//www.w3.org/2000/svg&#x27;%3E%3Cimage style=&#x27;filter:blur(20px)&#x27; preserveAspectRatio=&#x27;none&#x27; x=&#x27;0&#x27; y=&#x27;0&#x27; height=&#x27;100%25&#x27; width=&#x27;100%25&#x27; href=&#x27;data:image/gif;base64,R0lGODlhAQABAPAAANzc3P///yH5BAAAAAAALAAAAAABAAEAAAICRAEAOw==&#x27;/%3E%3C/svg%3E&quot;)" sizes="70px" srcSet="https://media.magloft.app/pdf-import/1085/images/pages/pg-021.jpg?optimizer=image&amp;format=webp&amp;width=16&amp;aspectRatio=1.33 16w, https://media.magloft.app/pdf-import/1085/images/pages/pg-021.jpg?optimizer=image&amp;format=webp&amp;width=32&amp;aspectRatio=1.33 32w, https://media.magloft.app/pdf-import/1085/images/pages/pg-021.jpg?optimizer=image&amp;format=webp&amp;width=48&amp;aspectRatio=1.33 48w, https://media.magloft.app/pdf-import/1085/images/pages/pg-021.jpg?optimizer=image&amp;format=webp&amp;width=54&amp;aspectRatio=1.33 54w, https://media.magloft.app/pdf-import/1085/images/pages/pg-021.jpg?optimizer=image&amp;format=webp&amp;width=64&amp;aspectRatio=1.33 64w, https://media.magloft.app/pdf-import/1085/images/pages/pg-021.jpg?optimizer=image&amp;format=webp&amp;width=70&amp;aspectRatio=1.33 70w, https://media.magloft.app/pdf-import/1085/images/pages/pg-021.jpg?optimizer=image&amp;format=webp&amp;width=82&amp;aspectRatio=1.33 82w, https://media.magloft.app/pdf-import/1085/images/pages/pg-021.jpg?optimizer=image&amp;format=webp&amp;width=96&amp;aspectRatio=1.33 96w, https://media.magloft.app/pdf-import/1085/images/pages/pg-021.jpg?optimizer=image&amp;format=webp&amp;width=96&amp;aspectRatio=1.33 96w, https://media.magloft.app/pdf-import/1085/images/pages/pg-021.jpg?optimizer=image&amp;format=webp&amp;width=110&amp;aspectRatio=1.33 110w, https://media.magloft.app/pdf-import/1085/images/pages/pg-021.jpg?optimizer=image&amp;format=webp&amp;width=128&amp;aspectRatio=1.33 128w, https://media.magloft.app/pdf-import/1085/images/pages/pg-021.jpg?optimizer=image&amp;format=webp&amp;width=128&amp;aspectRatio=1.33 128w, https://media.magloft.app/pdf-import/1085/images/pages/pg-021.jpg?optimizer=image&amp;format=webp&amp;width=138&amp;aspectRatio=1.33 138w, https://media.magloft.app/pdf-import/1085/images/pages/pg-021.jpg?optimizer=image&amp;format=webp&amp;width=192&amp;aspectRatio=1.33 192w, https://media.magloft.app/pdf-import/1085/images/pages/pg-021.jpg?optimizer=image&amp;format=webp&amp;width=200&amp;aspectRatio=1.33 200w, https://media.magloft.app/pdf-import/1085/images/pages/pg-021.jpg?optimizer=image&amp;format=webp&amp;width=252&amp;aspectRatio=1.33 252w, https://media.magloft.app/pdf-import/1085/images/pages/pg-021.jpg?optimizer=image&amp;format=webp&amp;width=256&amp;aspectRatio=1.33 256w, https://media.magloft.app/pdf-import/1085/images/pages/pg-021.jpg?optimizer=image&amp;format=webp&amp;width=260&amp;aspectRatio=1.33 260w, https://media.magloft.app/pdf-import/1085/images/pages/pg-021.jpg?optimizer=image&amp;format=webp&amp;width=298&amp;aspectRatio=1.33 298w, https://media.magloft.app/pdf-import/1085/images/pages/pg-021.jpg?optimizer=image&amp;format=webp&amp;width=378&amp;aspectRatio=1.33 378w, https://media.magloft.app/pdf-import/1085/images/pages/pg-021.jpg?optimizer=image&amp;format=webp&amp;width=384&amp;aspectRatio=1.33 384w, https://media.magloft.app/pdf-import/1085/images/pages/pg-021.jpg?optimizer=image&amp;format=webp&amp;width=384&amp;aspectRatio=1.33 384w, https://media.magloft.app/pdf-import/1085/images/pages/pg-021.jpg?optimizer=image&amp;format=webp&amp;width=520&amp;aspectRatio=1.33 520w, https://media.magloft.app/pdf-import/1085/images/pages/pg-021.jpg?optimizer=image&amp;format=webp&amp;width=640&amp;aspectRatio=1.33 640w, https://media.magloft.app/pdf-import/1085/images/pages/pg-021.jpg?optimizer=image&amp;format=webp&amp;width=756&amp;aspectRatio=1.33 756w, https://media.magloft.app/pdf-import/1085/images/pages/pg-021.jpg?optimizer=image&amp;format=webp&amp;width=828&amp;aspectRatio=1.33 828w, https://media.magloft.app/pdf-import/1085/images/pages/pg-021.jpg?optimizer=image&amp;format=webp&amp;width=1080&amp;aspectRatio=1.33 1080w, https://media.magloft.app/pdf-import/1085/images/pages/pg-021.jpg?optimizer=image&amp;format=webp&amp;width=1200&amp;aspectRatio=1.33 1200w, https://media.magloft.app/pdf-import/1085/images/pages/pg-021.jpg?optimizer=image&amp;format=webp&amp;width=1920&amp;aspectRatio=1.33 1920w, https://media.magloft.app/pdf-import/1085/images/pages/pg-021.jpg?optimizer=image&amp;format=webp&amp;width=2048&amp;aspectRatio=1.33 2048w" src="https://media.magloft.app/pdf-import/1085/images/pages/pg-021.jpg?optimizer=image&amp;format=webp&amp;width=2048&amp;aspectRatio=1.33"/></div><div class="Block_article-contents__M6B6V"><h3>Curve Therapeutics bolsters its leadership team with appointment of Simon Jones</h3><p>With his 20 years of expertise and proven track record in biotech and pharmaceutical industries, Curve Therapeutics appoints Simon Jones as chief financial officer and chief operating officer.</p></div></a><a class="Block_article-card__mncKE" href="/articles/adam-rosenberg-replaces-dr-carlo-incerti-as-new-chair-of-the-boa"><div class="Block_article-cover__vLhzO"><img alt="article-category" loading="lazy" decoding="async" data-nimg="fill" style="position:absolute;height:100%;width:100%;left:0;top:0;right:0;bottom:0;color:transparent;background-size:cover;background-position:50% 50%;background-repeat:no-repeat;background-image:url(&quot;data:image/svg+xml;charset=utf-8,%3Csvg xmlns=&#x27;http%3A//www.w3.org/2000/svg&#x27;%3E%3Cimage style=&#x27;filter:blur(20px)&#x27; preserveAspectRatio=&#x27;none&#x27; x=&#x27;0&#x27; y=&#x27;0&#x27; height=&#x27;100%25&#x27; width=&#x27;100%25&#x27; href=&#x27;data:image/gif;base64,R0lGODlhAQABAPAAANzc3P///yH5BAAAAAAALAAAAAABAAEAAAICRAEAOw==&#x27;/%3E%3C/svg%3E&quot;)" sizes="70px" srcSet="https://media.magloft.app/pdf-import/1085/images/img_21-1.jpg?optimizer=image&amp;format=webp&amp;width=16&amp;aspectRatio=1.33 16w, https://media.magloft.app/pdf-import/1085/images/img_21-1.jpg?optimizer=image&amp;format=webp&amp;width=32&amp;aspectRatio=1.33 32w, https://media.magloft.app/pdf-import/1085/images/img_21-1.jpg?optimizer=image&amp;format=webp&amp;width=48&amp;aspectRatio=1.33 48w, https://media.magloft.app/pdf-import/1085/images/img_21-1.jpg?optimizer=image&amp;format=webp&amp;width=54&amp;aspectRatio=1.33 54w, https://media.magloft.app/pdf-import/1085/images/img_21-1.jpg?optimizer=image&amp;format=webp&amp;width=64&amp;aspectRatio=1.33 64w, https://media.magloft.app/pdf-import/1085/images/img_21-1.jpg?optimizer=image&amp;format=webp&amp;width=70&amp;aspectRatio=1.33 70w, https://media.magloft.app/pdf-import/1085/images/img_21-1.jpg?optimizer=image&amp;format=webp&amp;width=82&amp;aspectRatio=1.33 82w, https://media.magloft.app/pdf-import/1085/images/img_21-1.jpg?optimizer=image&amp;format=webp&amp;width=96&amp;aspectRatio=1.33 96w, https://media.magloft.app/pdf-import/1085/images/img_21-1.jpg?optimizer=image&amp;format=webp&amp;width=96&amp;aspectRatio=1.33 96w, https://media.magloft.app/pdf-import/1085/images/img_21-1.jpg?optimizer=image&amp;format=webp&amp;width=110&amp;aspectRatio=1.33 110w, https://media.magloft.app/pdf-import/1085/images/img_21-1.jpg?optimizer=image&amp;format=webp&amp;width=128&amp;aspectRatio=1.33 128w, https://media.magloft.app/pdf-import/1085/images/img_21-1.jpg?optimizer=image&amp;format=webp&amp;width=128&amp;aspectRatio=1.33 128w, https://media.magloft.app/pdf-import/1085/images/img_21-1.jpg?optimizer=image&amp;format=webp&amp;width=138&amp;aspectRatio=1.33 138w, https://media.magloft.app/pdf-import/1085/images/img_21-1.jpg?optimizer=image&amp;format=webp&amp;width=192&amp;aspectRatio=1.33 192w, https://media.magloft.app/pdf-import/1085/images/img_21-1.jpg?optimizer=image&amp;format=webp&amp;width=200&amp;aspectRatio=1.33 200w, https://media.magloft.app/pdf-import/1085/images/img_21-1.jpg?optimizer=image&amp;format=webp&amp;width=252&amp;aspectRatio=1.33 252w, https://media.magloft.app/pdf-import/1085/images/img_21-1.jpg?optimizer=image&amp;format=webp&amp;width=256&amp;aspectRatio=1.33 256w, https://media.magloft.app/pdf-import/1085/images/img_21-1.jpg?optimizer=image&amp;format=webp&amp;width=260&amp;aspectRatio=1.33 260w, https://media.magloft.app/pdf-import/1085/images/img_21-1.jpg?optimizer=image&amp;format=webp&amp;width=298&amp;aspectRatio=1.33 298w, https://media.magloft.app/pdf-import/1085/images/img_21-1.jpg?optimizer=image&amp;format=webp&amp;width=378&amp;aspectRatio=1.33 378w, https://media.magloft.app/pdf-import/1085/images/img_21-1.jpg?optimizer=image&amp;format=webp&amp;width=384&amp;aspectRatio=1.33 384w, https://media.magloft.app/pdf-import/1085/images/img_21-1.jpg?optimizer=image&amp;format=webp&amp;width=384&amp;aspectRatio=1.33 384w, https://media.magloft.app/pdf-import/1085/images/img_21-1.jpg?optimizer=image&amp;format=webp&amp;width=520&amp;aspectRatio=1.33 520w, https://media.magloft.app/pdf-import/1085/images/img_21-1.jpg?optimizer=image&amp;format=webp&amp;width=640&amp;aspectRatio=1.33 640w, https://media.magloft.app/pdf-import/1085/images/img_21-1.jpg?optimizer=image&amp;format=webp&amp;width=756&amp;aspectRatio=1.33 756w, https://media.magloft.app/pdf-import/1085/images/img_21-1.jpg?optimizer=image&amp;format=webp&amp;width=828&amp;aspectRatio=1.33 828w, https://media.magloft.app/pdf-import/1085/images/img_21-1.jpg?optimizer=image&amp;format=webp&amp;width=1080&amp;aspectRatio=1.33 1080w, https://media.magloft.app/pdf-import/1085/images/img_21-1.jpg?optimizer=image&amp;format=webp&amp;width=1200&amp;aspectRatio=1.33 1200w, https://media.magloft.app/pdf-import/1085/images/img_21-1.jpg?optimizer=image&amp;format=webp&amp;width=1920&amp;aspectRatio=1.33 1920w, https://media.magloft.app/pdf-import/1085/images/img_21-1.jpg?optimizer=image&amp;format=webp&amp;width=2048&amp;aspectRatio=1.33 2048w" src="https://media.magloft.app/pdf-import/1085/images/img_21-1.jpg?optimizer=image&amp;format=webp&amp;width=2048&amp;aspectRatio=1.33"/></div><div class="Block_article-contents__M6B6V"><h3>Adam Rosenberg replaces Dr Carlo Incerti as new chair of the board at VectorY Therapeutics</h3><p>Vectory Therapeutics has announced the appointment of Adam Rosenberg as chair of the board, replacin Dr Carlo Incerti.</p></div></a><a class="Block_article-card__mncKE" href="/articles/dr-jonathan-appleby-appointed-by-mogrify-as-chief-scientific-off"><div class="Block_article-cover__vLhzO"><img alt="article-category" loading="lazy" decoding="async" data-nimg="fill" style="position:absolute;height:100%;width:100%;left:0;top:0;right:0;bottom:0;color:transparent;background-size:cover;background-position:50% 50%;background-repeat:no-repeat;background-image:url(&quot;data:image/svg+xml;charset=utf-8,%3Csvg xmlns=&#x27;http%3A//www.w3.org/2000/svg&#x27;%3E%3Cimage style=&#x27;filter:blur(20px)&#x27; preserveAspectRatio=&#x27;none&#x27; x=&#x27;0&#x27; y=&#x27;0&#x27; height=&#x27;100%25&#x27; width=&#x27;100%25&#x27; href=&#x27;data:image/gif;base64,R0lGODlhAQABAPAAANzc3P///yH5BAAAAAAALAAAAAABAAEAAAICRAEAOw==&#x27;/%3E%3C/svg%3E&quot;)" sizes="70px" srcSet="https://media.magloft.app/pdf-import/1085/images/pages/pg-021.jpg?optimizer=image&amp;format=webp&amp;width=16&amp;aspectRatio=1.33 16w, https://media.magloft.app/pdf-import/1085/images/pages/pg-021.jpg?optimizer=image&amp;format=webp&amp;width=32&amp;aspectRatio=1.33 32w, https://media.magloft.app/pdf-import/1085/images/pages/pg-021.jpg?optimizer=image&amp;format=webp&amp;width=48&amp;aspectRatio=1.33 48w, https://media.magloft.app/pdf-import/1085/images/pages/pg-021.jpg?optimizer=image&amp;format=webp&amp;width=54&amp;aspectRatio=1.33 54w, https://media.magloft.app/pdf-import/1085/images/pages/pg-021.jpg?optimizer=image&amp;format=webp&amp;width=64&amp;aspectRatio=1.33 64w, https://media.magloft.app/pdf-import/1085/images/pages/pg-021.jpg?optimizer=image&amp;format=webp&amp;width=70&amp;aspectRatio=1.33 70w, https://media.magloft.app/pdf-import/1085/images/pages/pg-021.jpg?optimizer=image&amp;format=webp&amp;width=82&amp;aspectRatio=1.33 82w, https://media.magloft.app/pdf-import/1085/images/pages/pg-021.jpg?optimizer=image&amp;format=webp&amp;width=96&amp;aspectRatio=1.33 96w, https://media.magloft.app/pdf-import/1085/images/pages/pg-021.jpg?optimizer=image&amp;format=webp&amp;width=96&amp;aspectRatio=1.33 96w, https://media.magloft.app/pdf-import/1085/images/pages/pg-021.jpg?optimizer=image&amp;format=webp&amp;width=110&amp;aspectRatio=1.33 110w, https://media.magloft.app/pdf-import/1085/images/pages/pg-021.jpg?optimizer=image&amp;format=webp&amp;width=128&amp;aspectRatio=1.33 128w, https://media.magloft.app/pdf-import/1085/images/pages/pg-021.jpg?optimizer=image&amp;format=webp&amp;width=128&amp;aspectRatio=1.33 128w, https://media.magloft.app/pdf-import/1085/images/pages/pg-021.jpg?optimizer=image&amp;format=webp&amp;width=138&amp;aspectRatio=1.33 138w, https://media.magloft.app/pdf-import/1085/images/pages/pg-021.jpg?optimizer=image&amp;format=webp&amp;width=192&amp;aspectRatio=1.33 192w, https://media.magloft.app/pdf-import/1085/images/pages/pg-021.jpg?optimizer=image&amp;format=webp&amp;width=200&amp;aspectRatio=1.33 200w, https://media.magloft.app/pdf-import/1085/images/pages/pg-021.jpg?optimizer=image&amp;format=webp&amp;width=252&amp;aspectRatio=1.33 252w, https://media.magloft.app/pdf-import/1085/images/pages/pg-021.jpg?optimizer=image&amp;format=webp&amp;width=256&amp;aspectRatio=1.33 256w, https://media.magloft.app/pdf-import/1085/images/pages/pg-021.jpg?optimizer=image&amp;format=webp&amp;width=260&amp;aspectRatio=1.33 260w, https://media.magloft.app/pdf-import/1085/images/pages/pg-021.jpg?optimizer=image&amp;format=webp&amp;width=298&amp;aspectRatio=1.33 298w, https://media.magloft.app/pdf-import/1085/images/pages/pg-021.jpg?optimizer=image&amp;format=webp&amp;width=378&amp;aspectRatio=1.33 378w, https://media.magloft.app/pdf-import/1085/images/pages/pg-021.jpg?optimizer=image&amp;format=webp&amp;width=384&amp;aspectRatio=1.33 384w, https://media.magloft.app/pdf-import/1085/images/pages/pg-021.jpg?optimizer=image&amp;format=webp&amp;width=384&amp;aspectRatio=1.33 384w, https://media.magloft.app/pdf-import/1085/images/pages/pg-021.jpg?optimizer=image&amp;format=webp&amp;width=520&amp;aspectRatio=1.33 520w, https://media.magloft.app/pdf-import/1085/images/pages/pg-021.jpg?optimizer=image&amp;format=webp&amp;width=640&amp;aspectRatio=1.33 640w, https://media.magloft.app/pdf-import/1085/images/pages/pg-021.jpg?optimizer=image&amp;format=webp&amp;width=756&amp;aspectRatio=1.33 756w, https://media.magloft.app/pdf-import/1085/images/pages/pg-021.jpg?optimizer=image&amp;format=webp&amp;width=828&amp;aspectRatio=1.33 828w, https://media.magloft.app/pdf-import/1085/images/pages/pg-021.jpg?optimizer=image&amp;format=webp&amp;width=1080&amp;aspectRatio=1.33 1080w, https://media.magloft.app/pdf-import/1085/images/pages/pg-021.jpg?optimizer=image&amp;format=webp&amp;width=1200&amp;aspectRatio=1.33 1200w, https://media.magloft.app/pdf-import/1085/images/pages/pg-021.jpg?optimizer=image&amp;format=webp&amp;width=1920&amp;aspectRatio=1.33 1920w, https://media.magloft.app/pdf-import/1085/images/pages/pg-021.jpg?optimizer=image&amp;format=webp&amp;width=2048&amp;aspectRatio=1.33 2048w" src="https://media.magloft.app/pdf-import/1085/images/pages/pg-021.jpg?optimizer=image&amp;format=webp&amp;width=2048&amp;aspectRatio=1.33"/></div><div class="Block_article-contents__M6B6V"><h3>Dr Jonathan Appleby appointed by Mogrify as chief scientific officer</h3><p>Mogrify has announced the appointment of Dr Jonathan Appleby as chief scientific officer.</p></div></a><a class="Block_article-card__mncKE" href="/articles/move-of-the-month-75bc"><div class="Block_article-cover__vLhzO"><img alt="article-category" loading="lazy" decoding="async" data-nimg="fill" style="position:absolute;height:100%;width:100%;left:0;top:0;right:0;bottom:0;color:transparent;background-size:cover;background-position:50% 50%;background-repeat:no-repeat;background-image:url(&quot;data:image/svg+xml;charset=utf-8,%3Csvg xmlns=&#x27;http%3A//www.w3.org/2000/svg&#x27;%3E%3Cimage style=&#x27;filter:blur(20px)&#x27; preserveAspectRatio=&#x27;none&#x27; x=&#x27;0&#x27; y=&#x27;0&#x27; height=&#x27;100%25&#x27; width=&#x27;100%25&#x27; href=&#x27;data:image/gif;base64,R0lGODlhAQABAPAAANzc3P///yH5BAAAAAAALAAAAAABAAEAAAICRAEAOw==&#x27;/%3E%3C/svg%3E&quot;)" sizes="70px" srcSet="https://media.magloft.app/pdf-import/1085/images/pages/pg-021.jpg?optimizer=image&amp;format=webp&amp;width=16&amp;aspectRatio=1.33 16w, https://media.magloft.app/pdf-import/1085/images/pages/pg-021.jpg?optimizer=image&amp;format=webp&amp;width=32&amp;aspectRatio=1.33 32w, https://media.magloft.app/pdf-import/1085/images/pages/pg-021.jpg?optimizer=image&amp;format=webp&amp;width=48&amp;aspectRatio=1.33 48w, https://media.magloft.app/pdf-import/1085/images/pages/pg-021.jpg?optimizer=image&amp;format=webp&amp;width=54&amp;aspectRatio=1.33 54w, https://media.magloft.app/pdf-import/1085/images/pages/pg-021.jpg?optimizer=image&amp;format=webp&amp;width=64&amp;aspectRatio=1.33 64w, https://media.magloft.app/pdf-import/1085/images/pages/pg-021.jpg?optimizer=image&amp;format=webp&amp;width=70&amp;aspectRatio=1.33 70w, https://media.magloft.app/pdf-import/1085/images/pages/pg-021.jpg?optimizer=image&amp;format=webp&amp;width=82&amp;aspectRatio=1.33 82w, https://media.magloft.app/pdf-import/1085/images/pages/pg-021.jpg?optimizer=image&amp;format=webp&amp;width=96&amp;aspectRatio=1.33 96w, https://media.magloft.app/pdf-import/1085/images/pages/pg-021.jpg?optimizer=image&amp;format=webp&amp;width=96&amp;aspectRatio=1.33 96w, https://media.magloft.app/pdf-import/1085/images/pages/pg-021.jpg?optimizer=image&amp;format=webp&amp;width=110&amp;aspectRatio=1.33 110w, https://media.magloft.app/pdf-import/1085/images/pages/pg-021.jpg?optimizer=image&amp;format=webp&amp;width=128&amp;aspectRatio=1.33 128w, https://media.magloft.app/pdf-import/1085/images/pages/pg-021.jpg?optimizer=image&amp;format=webp&amp;width=128&amp;aspectRatio=1.33 128w, https://media.magloft.app/pdf-import/1085/images/pages/pg-021.jpg?optimizer=image&amp;format=webp&amp;width=138&amp;aspectRatio=1.33 138w, https://media.magloft.app/pdf-import/1085/images/pages/pg-021.jpg?optimizer=image&amp;format=webp&amp;width=192&amp;aspectRatio=1.33 192w, https://media.magloft.app/pdf-import/1085/images/pages/pg-021.jpg?optimizer=image&amp;format=webp&amp;width=200&amp;aspectRatio=1.33 200w, https://media.magloft.app/pdf-import/1085/images/pages/pg-021.jpg?optimizer=image&amp;format=webp&amp;width=252&amp;aspectRatio=1.33 252w, https://media.magloft.app/pdf-import/1085/images/pages/pg-021.jpg?optimizer=image&amp;format=webp&amp;width=256&amp;aspectRatio=1.33 256w, https://media.magloft.app/pdf-import/1085/images/pages/pg-021.jpg?optimizer=image&amp;format=webp&amp;width=260&amp;aspectRatio=1.33 260w, https://media.magloft.app/pdf-import/1085/images/pages/pg-021.jpg?optimizer=image&amp;format=webp&amp;width=298&amp;aspectRatio=1.33 298w, https://media.magloft.app/pdf-import/1085/images/pages/pg-021.jpg?optimizer=image&amp;format=webp&amp;width=378&amp;aspectRatio=1.33 378w, https://media.magloft.app/pdf-import/1085/images/pages/pg-021.jpg?optimizer=image&amp;format=webp&amp;width=384&amp;aspectRatio=1.33 384w, https://media.magloft.app/pdf-import/1085/images/pages/pg-021.jpg?optimizer=image&amp;format=webp&amp;width=384&amp;aspectRatio=1.33 384w, https://media.magloft.app/pdf-import/1085/images/pages/pg-021.jpg?optimizer=image&amp;format=webp&amp;width=520&amp;aspectRatio=1.33 520w, https://media.magloft.app/pdf-import/1085/images/pages/pg-021.jpg?optimizer=image&amp;format=webp&amp;width=640&amp;aspectRatio=1.33 640w, https://media.magloft.app/pdf-import/1085/images/pages/pg-021.jpg?optimizer=image&amp;format=webp&amp;width=756&amp;aspectRatio=1.33 756w, https://media.magloft.app/pdf-import/1085/images/pages/pg-021.jpg?optimizer=image&amp;format=webp&amp;width=828&amp;aspectRatio=1.33 828w, https://media.magloft.app/pdf-import/1085/images/pages/pg-021.jpg?optimizer=image&amp;format=webp&amp;width=1080&amp;aspectRatio=1.33 1080w, https://media.magloft.app/pdf-import/1085/images/pages/pg-021.jpg?optimizer=image&amp;format=webp&amp;width=1200&amp;aspectRatio=1.33 1200w, https://media.magloft.app/pdf-import/1085/images/pages/pg-021.jpg?optimizer=image&amp;format=webp&amp;width=1920&amp;aspectRatio=1.33 1920w, https://media.magloft.app/pdf-import/1085/images/pages/pg-021.jpg?optimizer=image&amp;format=webp&amp;width=2048&amp;aspectRatio=1.33 2048w" src="https://media.magloft.app/pdf-import/1085/images/pages/pg-021.jpg?optimizer=image&amp;format=webp&amp;width=2048&amp;aspectRatio=1.33"/></div><div class="Block_article-contents__M6B6V"><h3>Professor yih-shing duh appointed as chief scientific advisor by H.E.L. Group</h3><p>Professor Yih-Shing Duh appointed as chief scientific advisor by H.E.L. Group</p></div></a><a class="Block_article-card__mncKE" href="/articles/enhanc3d-genomics-appoints-hazel-jones-as-ceo"><div class="Block_article-cover__vLhzO"><img alt="article-category" loading="lazy" decoding="async" data-nimg="fill" style="position:absolute;height:100%;width:100%;left:0;top:0;right:0;bottom:0;color:transparent;background-size:cover;background-position:50% 50%;background-repeat:no-repeat;background-image:url(&quot;data:image/svg+xml;charset=utf-8,%3Csvg xmlns=&#x27;http%3A//www.w3.org/2000/svg&#x27;%3E%3Cimage style=&#x27;filter:blur(20px)&#x27; preserveAspectRatio=&#x27;none&#x27; x=&#x27;0&#x27; y=&#x27;0&#x27; height=&#x27;100%25&#x27; width=&#x27;100%25&#x27; href=&#x27;data:image/gif;base64,R0lGODlhAQABAPAAANzc3P///yH5BAAAAAAALAAAAAABAAEAAAICRAEAOw==&#x27;/%3E%3C/svg%3E&quot;)" sizes="70px" srcSet="https://media.magloft.app/pdf-import/1071/images/img_21-1.jpg?optimizer=image&amp;format=webp&amp;width=16&amp;aspectRatio=1.33 16w, https://media.magloft.app/pdf-import/1071/images/img_21-1.jpg?optimizer=image&amp;format=webp&amp;width=32&amp;aspectRatio=1.33 32w, https://media.magloft.app/pdf-import/1071/images/img_21-1.jpg?optimizer=image&amp;format=webp&amp;width=48&amp;aspectRatio=1.33 48w, https://media.magloft.app/pdf-import/1071/images/img_21-1.jpg?optimizer=image&amp;format=webp&amp;width=54&amp;aspectRatio=1.33 54w, https://media.magloft.app/pdf-import/1071/images/img_21-1.jpg?optimizer=image&amp;format=webp&amp;width=64&amp;aspectRatio=1.33 64w, https://media.magloft.app/pdf-import/1071/images/img_21-1.jpg?optimizer=image&amp;format=webp&amp;width=70&amp;aspectRatio=1.33 70w, https://media.magloft.app/pdf-import/1071/images/img_21-1.jpg?optimizer=image&amp;format=webp&amp;width=82&amp;aspectRatio=1.33 82w, https://media.magloft.app/pdf-import/1071/images/img_21-1.jpg?optimizer=image&amp;format=webp&amp;width=96&amp;aspectRatio=1.33 96w, https://media.magloft.app/pdf-import/1071/images/img_21-1.jpg?optimizer=image&amp;format=webp&amp;width=96&amp;aspectRatio=1.33 96w, https://media.magloft.app/pdf-import/1071/images/img_21-1.jpg?optimizer=image&amp;format=webp&amp;width=110&amp;aspectRatio=1.33 110w, https://media.magloft.app/pdf-import/1071/images/img_21-1.jpg?optimizer=image&amp;format=webp&amp;width=128&amp;aspectRatio=1.33 128w, https://media.magloft.app/pdf-import/1071/images/img_21-1.jpg?optimizer=image&amp;format=webp&amp;width=128&amp;aspectRatio=1.33 128w, https://media.magloft.app/pdf-import/1071/images/img_21-1.jpg?optimizer=image&amp;format=webp&amp;width=138&amp;aspectRatio=1.33 138w, https://media.magloft.app/pdf-import/1071/images/img_21-1.jpg?optimizer=image&amp;format=webp&amp;width=192&amp;aspectRatio=1.33 192w, https://media.magloft.app/pdf-import/1071/images/img_21-1.jpg?optimizer=image&amp;format=webp&amp;width=200&amp;aspectRatio=1.33 200w, https://media.magloft.app/pdf-import/1071/images/img_21-1.jpg?optimizer=image&amp;format=webp&amp;width=252&amp;aspectRatio=1.33 252w, https://media.magloft.app/pdf-import/1071/images/img_21-1.jpg?optimizer=image&amp;format=webp&amp;width=256&amp;aspectRatio=1.33 256w, https://media.magloft.app/pdf-import/1071/images/img_21-1.jpg?optimizer=image&amp;format=webp&amp;width=260&amp;aspectRatio=1.33 260w, https://media.magloft.app/pdf-import/1071/images/img_21-1.jpg?optimizer=image&amp;format=webp&amp;width=298&amp;aspectRatio=1.33 298w, https://media.magloft.app/pdf-import/1071/images/img_21-1.jpg?optimizer=image&amp;format=webp&amp;width=378&amp;aspectRatio=1.33 378w, https://media.magloft.app/pdf-import/1071/images/img_21-1.jpg?optimizer=image&amp;format=webp&amp;width=384&amp;aspectRatio=1.33 384w, https://media.magloft.app/pdf-import/1071/images/img_21-1.jpg?optimizer=image&amp;format=webp&amp;width=384&amp;aspectRatio=1.33 384w, https://media.magloft.app/pdf-import/1071/images/img_21-1.jpg?optimizer=image&amp;format=webp&amp;width=520&amp;aspectRatio=1.33 520w, https://media.magloft.app/pdf-import/1071/images/img_21-1.jpg?optimizer=image&amp;format=webp&amp;width=640&amp;aspectRatio=1.33 640w, https://media.magloft.app/pdf-import/1071/images/img_21-1.jpg?optimizer=image&amp;format=webp&amp;width=756&amp;aspectRatio=1.33 756w, https://media.magloft.app/pdf-import/1071/images/img_21-1.jpg?optimizer=image&amp;format=webp&amp;width=828&amp;aspectRatio=1.33 828w, https://media.magloft.app/pdf-import/1071/images/img_21-1.jpg?optimizer=image&amp;format=webp&amp;width=1080&amp;aspectRatio=1.33 1080w, https://media.magloft.app/pdf-import/1071/images/img_21-1.jpg?optimizer=image&amp;format=webp&amp;width=1200&amp;aspectRatio=1.33 1200w, https://media.magloft.app/pdf-import/1071/images/img_21-1.jpg?optimizer=image&amp;format=webp&amp;width=1920&amp;aspectRatio=1.33 1920w, https://media.magloft.app/pdf-import/1071/images/img_21-1.jpg?optimizer=image&amp;format=webp&amp;width=2048&amp;aspectRatio=1.33 2048w" src="https://media.magloft.app/pdf-import/1071/images/img_21-1.jpg?optimizer=image&amp;format=webp&amp;width=2048&amp;aspectRatio=1.33"/></div><div class="Block_article-contents__M6B6V"><h3>Enhanc3D Genomics appoints Hazel Jones as CEO</h3><p>Enhanc3D Genomics has announced the appointment of Hazel Jones as chief executive officer (CEO), following a successful six-month term as interim CEO and COO.</p></div></a><a class="Block_article-card__mncKE" href="/articles/closed-loop-medicine-appoints-paul-johnson-as-non-executive-dire"><div class="Block_article-cover__vLhzO"><img alt="article-category" loading="lazy" decoding="async" data-nimg="fill" style="position:absolute;height:100%;width:100%;left:0;top:0;right:0;bottom:0;color:transparent;background-size:cover;background-position:50% 50%;background-repeat:no-repeat;background-image:url(&quot;data:image/svg+xml;charset=utf-8,%3Csvg xmlns=&#x27;http%3A//www.w3.org/2000/svg&#x27;%3E%3Cimage style=&#x27;filter:blur(20px)&#x27; preserveAspectRatio=&#x27;none&#x27; x=&#x27;0&#x27; y=&#x27;0&#x27; height=&#x27;100%25&#x27; width=&#x27;100%25&#x27; href=&#x27;data:image/gif;base64,R0lGODlhAQABAPAAANzc3P///yH5BAAAAAAALAAAAAABAAEAAAICRAEAOw==&#x27;/%3E%3C/svg%3E&quot;)" sizes="70px" srcSet="https://media.magloft.app/pdf-import/1071/images/pages/pg-021.jpg?optimizer=image&amp;format=webp&amp;width=16&amp;aspectRatio=1.33 16w, https://media.magloft.app/pdf-import/1071/images/pages/pg-021.jpg?optimizer=image&amp;format=webp&amp;width=32&amp;aspectRatio=1.33 32w, https://media.magloft.app/pdf-import/1071/images/pages/pg-021.jpg?optimizer=image&amp;format=webp&amp;width=48&amp;aspectRatio=1.33 48w, https://media.magloft.app/pdf-import/1071/images/pages/pg-021.jpg?optimizer=image&amp;format=webp&amp;width=54&amp;aspectRatio=1.33 54w, https://media.magloft.app/pdf-import/1071/images/pages/pg-021.jpg?optimizer=image&amp;format=webp&amp;width=64&amp;aspectRatio=1.33 64w, https://media.magloft.app/pdf-import/1071/images/pages/pg-021.jpg?optimizer=image&amp;format=webp&amp;width=70&amp;aspectRatio=1.33 70w, https://media.magloft.app/pdf-import/1071/images/pages/pg-021.jpg?optimizer=image&amp;format=webp&amp;width=82&amp;aspectRatio=1.33 82w, https://media.magloft.app/pdf-import/1071/images/pages/pg-021.jpg?optimizer=image&amp;format=webp&amp;width=96&amp;aspectRatio=1.33 96w, https://media.magloft.app/pdf-import/1071/images/pages/pg-021.jpg?optimizer=image&amp;format=webp&amp;width=96&amp;aspectRatio=1.33 96w, https://media.magloft.app/pdf-import/1071/images/pages/pg-021.jpg?optimizer=image&amp;format=webp&amp;width=110&amp;aspectRatio=1.33 110w, https://media.magloft.app/pdf-import/1071/images/pages/pg-021.jpg?optimizer=image&amp;format=webp&amp;width=128&amp;aspectRatio=1.33 128w, https://media.magloft.app/pdf-import/1071/images/pages/pg-021.jpg?optimizer=image&amp;format=webp&amp;width=128&amp;aspectRatio=1.33 128w, https://media.magloft.app/pdf-import/1071/images/pages/pg-021.jpg?optimizer=image&amp;format=webp&amp;width=138&amp;aspectRatio=1.33 138w, https://media.magloft.app/pdf-import/1071/images/pages/pg-021.jpg?optimizer=image&amp;format=webp&amp;width=192&amp;aspectRatio=1.33 192w, https://media.magloft.app/pdf-import/1071/images/pages/pg-021.jpg?optimizer=image&amp;format=webp&amp;width=200&amp;aspectRatio=1.33 200w, https://media.magloft.app/pdf-import/1071/images/pages/pg-021.jpg?optimizer=image&amp;format=webp&amp;width=252&amp;aspectRatio=1.33 252w, https://media.magloft.app/pdf-import/1071/images/pages/pg-021.jpg?optimizer=image&amp;format=webp&amp;width=256&amp;aspectRatio=1.33 256w, https://media.magloft.app/pdf-import/1071/images/pages/pg-021.jpg?optimizer=image&amp;format=webp&amp;width=260&amp;aspectRatio=1.33 260w, https://media.magloft.app/pdf-import/1071/images/pages/pg-021.jpg?optimizer=image&amp;format=webp&amp;width=298&amp;aspectRatio=1.33 298w, https://media.magloft.app/pdf-import/1071/images/pages/pg-021.jpg?optimizer=image&amp;format=webp&amp;width=378&amp;aspectRatio=1.33 378w, https://media.magloft.app/pdf-import/1071/images/pages/pg-021.jpg?optimizer=image&amp;format=webp&amp;width=384&amp;aspectRatio=1.33 384w, https://media.magloft.app/pdf-import/1071/images/pages/pg-021.jpg?optimizer=image&amp;format=webp&amp;width=384&amp;aspectRatio=1.33 384w, https://media.magloft.app/pdf-import/1071/images/pages/pg-021.jpg?optimizer=image&amp;format=webp&amp;width=520&amp;aspectRatio=1.33 520w, https://media.magloft.app/pdf-import/1071/images/pages/pg-021.jpg?optimizer=image&amp;format=webp&amp;width=640&amp;aspectRatio=1.33 640w, https://media.magloft.app/pdf-import/1071/images/pages/pg-021.jpg?optimizer=image&amp;format=webp&amp;width=756&amp;aspectRatio=1.33 756w, https://media.magloft.app/pdf-import/1071/images/pages/pg-021.jpg?optimizer=image&amp;format=webp&amp;width=828&amp;aspectRatio=1.33 828w, https://media.magloft.app/pdf-import/1071/images/pages/pg-021.jpg?optimizer=image&amp;format=webp&amp;width=1080&amp;aspectRatio=1.33 1080w, https://media.magloft.app/pdf-import/1071/images/pages/pg-021.jpg?optimizer=image&amp;format=webp&amp;width=1200&amp;aspectRatio=1.33 1200w, https://media.magloft.app/pdf-import/1071/images/pages/pg-021.jpg?optimizer=image&amp;format=webp&amp;width=1920&amp;aspectRatio=1.33 1920w, https://media.magloft.app/pdf-import/1071/images/pages/pg-021.jpg?optimizer=image&amp;format=webp&amp;width=2048&amp;aspectRatio=1.33 2048w" src="https://media.magloft.app/pdf-import/1071/images/pages/pg-021.jpg?optimizer=image&amp;format=webp&amp;width=2048&amp;aspectRatio=1.33"/></div><div class="Block_article-contents__M6B6V"><h3>Closed Loop Medicine appoints Paul Johnson as non-executive director</h3><p>Closed loop medicine has announced the appointment of Paul Johnson as an independent non-executive director.</p></div></a><a class="Block_article-card__mncKE" href="/articles/sphere-fluidics-appoints-curtis-nicholson-as-director-of-sales-e"><div class="Block_article-cover__vLhzO"><img alt="article-category" loading="lazy" decoding="async" data-nimg="fill" style="position:absolute;height:100%;width:100%;left:0;top:0;right:0;bottom:0;color:transparent;background-size:cover;background-position:50% 50%;background-repeat:no-repeat;background-image:url(&quot;data:image/svg+xml;charset=utf-8,%3Csvg xmlns=&#x27;http%3A//www.w3.org/2000/svg&#x27;%3E%3Cimage style=&#x27;filter:blur(20px)&#x27; preserveAspectRatio=&#x27;none&#x27; x=&#x27;0&#x27; y=&#x27;0&#x27; height=&#x27;100%25&#x27; width=&#x27;100%25&#x27; href=&#x27;data:image/gif;base64,R0lGODlhAQABAPAAANzc3P///yH5BAAAAAAALAAAAAABAAEAAAICRAEAOw==&#x27;/%3E%3C/svg%3E&quot;)" sizes="70px" srcSet="https://media.magloft.app/pdf-import/1071/images/img_21-2.jpg?optimizer=image&amp;format=webp&amp;width=16&amp;aspectRatio=1.33 16w, https://media.magloft.app/pdf-import/1071/images/img_21-2.jpg?optimizer=image&amp;format=webp&amp;width=32&amp;aspectRatio=1.33 32w, https://media.magloft.app/pdf-import/1071/images/img_21-2.jpg?optimizer=image&amp;format=webp&amp;width=48&amp;aspectRatio=1.33 48w, https://media.magloft.app/pdf-import/1071/images/img_21-2.jpg?optimizer=image&amp;format=webp&amp;width=54&amp;aspectRatio=1.33 54w, https://media.magloft.app/pdf-import/1071/images/img_21-2.jpg?optimizer=image&amp;format=webp&amp;width=64&amp;aspectRatio=1.33 64w, https://media.magloft.app/pdf-import/1071/images/img_21-2.jpg?optimizer=image&amp;format=webp&amp;width=70&amp;aspectRatio=1.33 70w, https://media.magloft.app/pdf-import/1071/images/img_21-2.jpg?optimizer=image&amp;format=webp&amp;width=82&amp;aspectRatio=1.33 82w, https://media.magloft.app/pdf-import/1071/images/img_21-2.jpg?optimizer=image&amp;format=webp&amp;width=96&amp;aspectRatio=1.33 96w, https://media.magloft.app/pdf-import/1071/images/img_21-2.jpg?optimizer=image&amp;format=webp&amp;width=96&amp;aspectRatio=1.33 96w, https://media.magloft.app/pdf-import/1071/images/img_21-2.jpg?optimizer=image&amp;format=webp&amp;width=110&amp;aspectRatio=1.33 110w, https://media.magloft.app/pdf-import/1071/images/img_21-2.jpg?optimizer=image&amp;format=webp&amp;width=128&amp;aspectRatio=1.33 128w, https://media.magloft.app/pdf-import/1071/images/img_21-2.jpg?optimizer=image&amp;format=webp&amp;width=128&amp;aspectRatio=1.33 128w, https://media.magloft.app/pdf-import/1071/images/img_21-2.jpg?optimizer=image&amp;format=webp&amp;width=138&amp;aspectRatio=1.33 138w, https://media.magloft.app/pdf-import/1071/images/img_21-2.jpg?optimizer=image&amp;format=webp&amp;width=192&amp;aspectRatio=1.33 192w, https://media.magloft.app/pdf-import/1071/images/img_21-2.jpg?optimizer=image&amp;format=webp&amp;width=200&amp;aspectRatio=1.33 200w, https://media.magloft.app/pdf-import/1071/images/img_21-2.jpg?optimizer=image&amp;format=webp&amp;width=252&amp;aspectRatio=1.33 252w, https://media.magloft.app/pdf-import/1071/images/img_21-2.jpg?optimizer=image&amp;format=webp&amp;width=256&amp;aspectRatio=1.33 256w, https://media.magloft.app/pdf-import/1071/images/img_21-2.jpg?optimizer=image&amp;format=webp&amp;width=260&amp;aspectRatio=1.33 260w, https://media.magloft.app/pdf-import/1071/images/img_21-2.jpg?optimizer=image&amp;format=webp&amp;width=298&amp;aspectRatio=1.33 298w, https://media.magloft.app/pdf-import/1071/images/img_21-2.jpg?optimizer=image&amp;format=webp&amp;width=378&amp;aspectRatio=1.33 378w, https://media.magloft.app/pdf-import/1071/images/img_21-2.jpg?optimizer=image&amp;format=webp&amp;width=384&amp;aspectRatio=1.33 384w, https://media.magloft.app/pdf-import/1071/images/img_21-2.jpg?optimizer=image&amp;format=webp&amp;width=384&amp;aspectRatio=1.33 384w, https://media.magloft.app/pdf-import/1071/images/img_21-2.jpg?optimizer=image&amp;format=webp&amp;width=520&amp;aspectRatio=1.33 520w, https://media.magloft.app/pdf-import/1071/images/img_21-2.jpg?optimizer=image&amp;format=webp&amp;width=640&amp;aspectRatio=1.33 640w, https://media.magloft.app/pdf-import/1071/images/img_21-2.jpg?optimizer=image&amp;format=webp&amp;width=756&amp;aspectRatio=1.33 756w, https://media.magloft.app/pdf-import/1071/images/img_21-2.jpg?optimizer=image&amp;format=webp&amp;width=828&amp;aspectRatio=1.33 828w, https://media.magloft.app/pdf-import/1071/images/img_21-2.jpg?optimizer=image&amp;format=webp&amp;width=1080&amp;aspectRatio=1.33 1080w, https://media.magloft.app/pdf-import/1071/images/img_21-2.jpg?optimizer=image&amp;format=webp&amp;width=1200&amp;aspectRatio=1.33 1200w, https://media.magloft.app/pdf-import/1071/images/img_21-2.jpg?optimizer=image&amp;format=webp&amp;width=1920&amp;aspectRatio=1.33 1920w, https://media.magloft.app/pdf-import/1071/images/img_21-2.jpg?optimizer=image&amp;format=webp&amp;width=2048&amp;aspectRatio=1.33 2048w" src="https://media.magloft.app/pdf-import/1071/images/img_21-2.jpg?optimizer=image&amp;format=webp&amp;width=2048&amp;aspectRatio=1.33"/></div><div class="Block_article-contents__M6B6V"><h3>Sphere Fluidics appoints Curtis Nicholson as director of sales EMEA</h3><p>Sphere Fluidics has announced the appointment of Curtis Nicholson as director for sales for Europe, Middle East and Africa (EMEA).</p></div></a></div></div><div class="AdvertisementBlock_advertisement-block__8EDkY AdvertisementBlock_placeholder__jhbpI"><div class="AdvertisementBlock_placeholder-inner__UakOd spinner"></div></div></div></div></div><div class="HomeSection_home-section__C9q51 section" style="width:100%;background-color:transparent"><div class="HomeSection_block-layout-container___5hZr" style="max-width:100%"><div style="flex:5" class="HomeSection_block-layout-column__7m2l1"></div></div></div></div></div><script> //create a new element const terms = document.createElement('div'); //set id terms.setAttribute("id","billboard-banner"); //add the new element to html var body = document.querySelector('body'); body.appendChild(terms); document.querySelector("#billboard-banner").innerHTML = "<ins data-revive-zoneid='1573' data-revive-id='9c421b7e485bf2edfee09708a4d06e2e'></ins>"; //insert new element before header //document.body.insertAdjacentElement('afterbegin', terms); const insElement = document.querySelector("#__next"); insElement.before(terms); </script> <script async="" src="//ads.datateam.co.uk/www/delivery/asyncjs.php"></script><div class="_footer_j8nu5_1"><div class="_container_j8nu5_12"><div class="_footer-row_j8nu5_23"><div class="_footer-column_j8nu5_36 _flex-2_j8nu5_117"><div class="_footer-brand_j8nu5_43"><div class=""><img alt="Logo" loading="lazy" width="40" height="40" decoding="async" data-nimg="1" class="_footer-logo_j8nu5_57" style="color:transparent" srcSet="https://media.magloft.app/pwa-664/pwa/logo/8eb186e1-b2cb-4384-a0b7-515f62171b22.png 1x, https://media.magloft.app/pwa-664/pwa/logo/8eb186e1-b2cb-4384-a0b7-515f62171b22.png 2x" src="https://media.magloft.app/pwa-664/pwa/logo/8eb186e1-b2cb-4384-a0b7-515f62171b22.png"/></div><div class="_content_j8nu5_67"><h3>Pharmafocus</h3><p>Pharmaceutical Industry news, analysis and insights</p></div></div><div class="_footer-link-list_j8nu5_121"><div class="_block_j8nu5_129"><a class="_footer-link-item_j8nu5_92" rel="noreferrer" href="mailto:info@pharmafile.com"><div class="_form-email_1lm7t_143 _footer-icon_j8nu5_58 _icon_1lm7t_1 icon"></div><span>info@pharmafile.com</span></a></div><div class="_block_j8nu5_129"><a class="_footer-link-item_j8nu5_92" target="_blank" rel="noreferrer" href="http://www.pharmafile.com"><div class="_status-info_1lm7t_87 _footer-icon_j8nu5_58 _icon_1lm7t_1 icon"></div><span>Pharmafile.com</span></a><a class="_footer-link-item_j8nu5_92" target="_blank" rel="noreferrer" href="https://magazine.pharmafile.com"><div class="_status-info_1lm7t_87 _footer-icon_j8nu5_58 _icon_1lm7t_1 icon"></div><span>Pharmafile Magazine</span></a><a class="_footer-link-item_j8nu5_92" target="_blank" rel="noreferrer" href="http://www.samedanltd.com"><div class="_status-info_1lm7t_87 _footer-icon_j8nu5_58 _icon_1lm7t_1 icon"></div><span>Samedan</span></a></div><a target="_blank" rel="noreferrer" class="_footer-link-item_j8nu5_92" href="https://www.pharmafile.com/privacy-policy"><div class="_status-info_1lm7t_87 _footer-icon_j8nu5_58 _icon_1lm7t_1 icon"></div><span>Privacy Policy</span></a><a target="_blank" rel="noreferrer" class="_footer-link-item_j8nu5_92" href="https://www.pharmafile.com/terms-of-service"><div class="_status-info_1lm7t_87 _footer-icon_j8nu5_58 _icon_1lm7t_1 icon"></div><span>Terms of Service</span></a></div></div><div class="_footer-column_j8nu5_36 _flex-1_j8nu5_39"><div class="_footer-brand_j8nu5_43"><div class="_status-accent_1lm7t_91 _footer-icon_j8nu5_58 _icon_1lm7t_1 icon"></div><div class="_content_j8nu5_67"><h3>Categories</h3><p>Explore our inspiring content by topic</p></div></div><div class="_footer-link-list_j8nu5_121"><a class="_footer-link-item_j8nu5_92" href="/categories/uk-pharma-news"><div class="_nav-arrow-right_1lm7t_175 _footer-icon_j8nu5_58 _icon_1lm7t_1 icon"></div>UK News</a><a class="_footer-link-item_j8nu5_92" href="/categories/general-news"><div class="_nav-arrow-right_1lm7t_175 _footer-icon_j8nu5_58 _icon_1lm7t_1 icon"></div>General News</a><a class="_footer-link-item_j8nu5_92" href="/categories/approvals"><div class="_nav-arrow-right_1lm7t_175 _footer-icon_j8nu5_58 _icon_1lm7t_1 icon"></div>Approvals</a><a class="_footer-link-item_j8nu5_92" href="/categories/research-and-development"><div class="_nav-arrow-right_1lm7t_175 _footer-icon_j8nu5_58 _icon_1lm7t_1 icon"></div>R &amp; D</a><a class="_footer-link-item_j8nu5_92" href="/categories/mergers-acquisitions"><div class="_nav-arrow-right_1lm7t_175 _footer-icon_j8nu5_58 _icon_1lm7t_1 icon"></div>Mergers &amp; Acquisitions</a><a class="_footer-link-item_j8nu5_92" href="/categories/manufacturing-production"><div class="_nav-arrow-right_1lm7t_175 _footer-icon_j8nu5_58 _icon_1lm7t_1 icon"></div>Manufacturing</a><a class="_footer-link-item_j8nu5_92" href="/categories/clinical-trials"><div class="_nav-arrow-right_1lm7t_175 _footer-icon_j8nu5_58 _icon_1lm7t_1 icon"></div>Clinical Trials</a><a class="_footer-link-item_j8nu5_92" href="/categories/industry-insights"><div class="_nav-arrow-right_1lm7t_175 _footer-icon_j8nu5_58 _icon_1lm7t_1 icon"></div>Industry Insights</a><a class="_footer-link-item_j8nu5_92" href="/categories/appointments"><div class="_nav-arrow-right_1lm7t_175 _footer-icon_j8nu5_58 _icon_1lm7t_1 icon"></div>Appointments</a><a class="_footer-link-item_j8nu5_92" href="/categories/insider-interviews"><div class="_nav-arrow-right_1lm7t_175 _footer-icon_j8nu5_58 _icon_1lm7t_1 icon"></div>Interviews</a></div></div><div class="_footer-column_j8nu5_36 _flex-1_j8nu5_39"><div class="_footer-brand_j8nu5_43"><div class="_share-action_1lm7t_463 _footer-icon_j8nu5_58 _icon_1lm7t_1 icon"></div><div class="_content_j8nu5_67"><h3>Social Footprints</h3><p>Follow us on our Social Media Channels</p></div></div><div class="_footer-link-list_j8nu5_121"><a class="_footer-link-item_j8nu5_92" target="_blank" rel="noreferrer" href="https://twitter.com/Pharmafocus"><div class="_share-twitter_1lm7t_487 _footer-icon_j8nu5_58 _icon_1lm7t_1 icon"></div><span class="_footer-text_j8nu5_125">X</span></a><a class="_footer-link-item_j8nu5_92" target="_blank" rel="noreferrer" href="https://www.linkedin.com/company/pharmafile"><div class="_share-linkedin_1lm7t_483 _footer-icon_j8nu5_58 _icon_1lm7t_1 icon"></div><span class="_footer-text_j8nu5_125">linkedin</span></a></div></div></div></div></div></div><div class="Toastify"></div></div><script id="__NEXT_DATA__" type="application/json">{"props":{"pageProps":{"domain":"www.pharmafocus.com","pwa":{"id":664,"publicationId":14882,"pwaOptinId":656,"domain":"www.pharmafocus.com","config":{"access":{"concurrentLimit":null,"restrictAnonymous":null,"disableSignup":null,"disableLogin":null,"disableLoginMessage":null,"disableSearchIndexing":false,"signupUrl":null,"resetPasswordUrl":null,"isUsernameLogin":null,"disableEditProfile":null,"formUrl":null,"customMarginResetPassword":null},"push":{"google":{"serverPublicKey":"BGfKWie38SRvrZs4-bDa1N70rhULMBqX8nAvBZT_2OXsMQi3uRA0CaK4JKPuib9Ega28liCTGhBx0QCY4t1QU7o"}},"tracking":{"facebook":{"appId":null,"pixelId":null},"google":{"measurementId":"G-D8QLP3CKWG"},"gtm":null,"sentry":true},"payment":{"stripe":null,"bypassPayment":null,"mode":"none","external":null,"currency":null},"email":{"readerOptin":false},"firebase":{"projectId":"ipt-magloft","senderId":"497261264876","pairKey":null,"webAppConfig":{"apiKey":"AIzaSyBcHBC8k394YdXp19dZj2Xqe8CXCgThBZs","appId":"1:497261264876:web:98452398b320341bd68ac9","authDomain":"ipt-magloft.firebaseapp.com","databaseURL":null,"locationId":null,"messagingSenderId":"497261264876","projectId":"ipt-magloft","storageBucket":"ipt-magloft.appspot.com"}},"customHtml":{"head":"\u003cscript type=\"text/javascript\" src=\"https://cdn.jsdelivr.net/npm/cookie-bar/cookiebar-latest.min.js?customize=1\u0026always=1\u0026showNoConsent=1\" onload=\"setupCookieBar();\"\u003e\u003c/script\u003e\n\u003cmeta name=\"google-site-verification\" content=\"kuOvGxaH_NjG3aS7GSmbjjV-OjdOAWyiM3gEPGESeHQ\" /\u003e\n\u003cstyle\u003e\n#billboard-banner { text-align:center;}\n#billboard-banner img {width:100%; max-width:970px; height:auto; position:relative; top:70px;}\n.Layout_spacer__qTBD3 {margin-top:70px;}\n\u003c/style\u003e","body":"\u003cscript\u003e\n //create a new element\n const terms = document.createElement('div');\n //set id\n terms.setAttribute(\"id\",\"billboard-banner\");\n //add the new element to html\n var body = document.querySelector('body');\n body.appendChild(terms);\n document.querySelector(\"#billboard-banner\").innerHTML = \"\u003cins data-revive-zoneid='1573' data-revive-id='9c421b7e485bf2edfee09708a4d06e2e'\u003e\u003c/ins\u003e\"; \n //insert new element before header\n//document.body.insertAdjacentElement('afterbegin', terms);\n const insElement = document.querySelector(\"#__next\");\n insElement.before(terms);\n\u003c/script\u003e\n\u003cscript async src=\"//ads.datateam.co.uk/www/delivery/asyncjs.php\"\u003e\u003c/script\u003e"},"account":{"emailEditable":true,"customSubscriptionText":null,"customSubscriptionURL":null,"enableSubscriptionTitle":null},"checkout":null},"design":{"colors":{"backgroundColor":"#FFFFFF","primaryColor":"#1976D2","secondaryColor":"#795FF4","accentColor":"#D76FD6","infoColor":"#41638C","warningColor":"#EF9338","successColor":"#20AD27","dangerColor":"#DF4241","topMenuBackgroundColor":"#EE1C25","topMenuHeadingTitleColor":null,"topMenuHeadingIconColor":null,"topMenuItemTextColor":null,"topMenuItemIconColor":null,"footerMenuBackgroundColor":"#DF1111","footerMenuHeadingTitleColor":null,"footerMenuHeadingTextColor":null,"footerMenuHeadingIconColor":null,"footerMenuItemTextColor":null,"footerMenuItemIconColor":null},"images":{"icon":"https://cdn.magloft.com/pwa-664/pwa/logo/8eb186e1-b2cb-4384-a0b7-515f62171b22.png","feature":"https://cdn.magloft.com/defaults/feature-graphic.jpg","topMenuIcon":"https://cdn.magloft.com/pwa-664/pwa/top-menu-icon/c215ba48-44be-411d-8753-7438a6acf8fb.png","footerMenuIcon":null,"alphaChannelIcon":null},"fonts":{"heading":"trade-gothic-lt-bold","body":"open-sans","ui":"trade-gothic-lt-bold","topMenuTitle":"trade-gothic-lt-bold","topMenuItems":"trade-gothic-lt","topMenuSubtitle":"trade-gothic-lt","footerMenuTitle":null,"footerMenuItems":null},"menuItems":{"collections":{"title":"Magazines"},"articles":{"title":null},"account":{"title":null},"icons":{"enabled":true}},"footerShape":"flat","issueCoverAspectRatio":0.75,"fullscreenCollectionView":"auto","customOverlayToggleView":false,"defaultViewMode":"html","categories":"flat","purchaseList":true,"libraryList":false,"noteList":false,"textToSpeech":false},"layout":{"banners":[{"image":"https://cdn.magloft.com/pwa-1/pwa/banner/aea74608-e04a-4649-b817-c45cc439e28e.png","title":"Start trial now","isHidden":true,"action":{"type":"url","href":"https://www.magloft.com/","target":"_blank","pwaSubscriptionId":null,"pwaSubscription":null,"optinId":null,"optin":null}}],"bottomBanners":[{"image":"https://cdn.magloft.com/pwa-664/pwa/banner/1f66e6ea-9b3a-4477-aba1-18abf54619b8.png","title":null,"isHidden":true,"action":{"type":"url","href":"http://www.samedanltd.com/","target":"_blank","pwaSubscriptionId":null,"pwaSubscription":null,"optinId":null,"optin":null}}],"columnSeparator":"shadow","tabs":[{"route":"","title":"Home","icon":"menu-home","visible":true},{"route":"/articles","title":"Articles","icon":"menu-articles","visible":true},{"route":"/collections","title":"Collections","icon":"menu-issues","visible":true},{"route":"/account","title":"Account","icon":"menu-account","visible":true}],"topMenu":{"showLogo":true,"showSubtitle":false,"showTitle":false,"height":"64px"},"navbar":{"animation":false,"style":"logo-left"},"sections":[{"fullWidth":true,"backgroundColor":"transparent","columnSeparator":"none","columns":[{"size":5,"blocks":[{"type":"banner","image":"https://cdn.magloft.com/pwa-1/pwa/banner/aea74608-e04a-4649-b817-c45cc439e28e.png","isHidden":true,"title":"Start trial now","action":{"type":"url","href":"https://www.magloft.com/","target":"_blank","pwaSubscriptionId":null,"pwaSubscription":null,"optinId":null,"optin":null}}]}]},{"fullWidth":false,"backgroundColor":null,"columnSeparator":"shadow","columns":[{"size":8.5,"blocks":[{"type":"ad","title":"Advertisement","advertisementIds":[],"adCampaignId":892,"condition":null},{"type":"article-list","condition":null,"color":"#F90505","title":"Top Content","variant":"variant-b","articleIds":[262748,254614,260494,260493,260492,258749],"articles":null},{"type":"article-list","condition":null,"color":"#2873B0","title":"Industry Insights","variant":"variant-b","articleIds":[260492,260493,260494,258746,258745,257361],"articles":null},{"type":"article-category","condition":null,"color":"#F90505","title":"UK News","variant":"variant-c","categoryId":43138,"backgroundColor":null,"image":null,"articles":null,"category":null},{"type":"article-category","condition":null,"color":"#2873B0","title":"Global News","variant":"variant-c","categoryId":43140,"backgroundColor":null,"image":null,"articles":null,"category":null},{"type":"ad","title":"Advertisement","advertisementIds":[1319],"adCampaignId":null,"condition":null},{"type":"article-category","condition":null,"color":"#2873B0","title":"European News","variant":"variant-c","categoryId":43139,"backgroundColor":null,"image":null,"articles":null,"category":null},{"type":"guide-install","color":"#444558","title":"How to Install","condition":null}]},{"size":3.5,"blocks":[{"type":"issue-slider","condition":null,"color":"#2873B0","title":"Latest Editions","issueIds":[52826,52799,52483,52217,51921,51722,51533,51435,51240,51075,45938,45939,45940],"thumbnail":{"style":"full-cover","size":"medium"},"borderRadius":null,"zoomOnHover":true,"issues":null},{"type":"ad","title":"Advertisement","advertisementIds":[2210],"adCampaignId":null,"condition":null},{"type":"cta","condition":null,"icon":"symbol-gift","color":"#FB0505","title":"Newsletters","description":"Sign up to our newsletters and digital magazines","action":{"type":"url","href":"https://curwoodcmsltd.formstack.com/forms/samedan","target":"_blank","pwaSubscriptionId":null,"pwaSubscription":null,"optinId":null,"optin":null}},{"type":"ad","title":"Advertisement","advertisementIds":[2067],"adCampaignId":null,"condition":null},{"type":"cta","condition":null,"icon":"symbol-day","color":"#F90505","title":"Pharmafocus Archive","description":"Browse older editions","action":{"type":"url","href":"https://en.calameo.com/subscriptions/6188508","target":"_blank","pwaSubscriptionId":null,"pwaSubscription":null,"optinId":null,"optin":null}},{"type":"ad","title":"Advertisement","advertisementIds":[],"adCampaignId":1044,"condition":null},{"type":"article-category","condition":null,"color":"#F70707","title":"Appointments","variant":"variant-c","categoryId":43146,"backgroundColor":null,"image":null,"articles":null,"category":null},{"type":"ad","title":"Advertisement","advertisementIds":[2249,1320],"adCampaignId":null,"condition":null}]}]},{"fullWidth":true,"backgroundColor":"transparent","columnSeparator":"none","columns":[{"size":5,"blocks":[{"type":"banner","image":"https://cdn.magloft.com/pwa-664/pwa/banner/1f66e6ea-9b3a-4477-aba1-18abf54619b8.png","isHidden":true,"title":"","action":{"type":"url","href":"http://www.samedanltd.com/","target":"_blank","pwaSubscriptionId":null,"pwaSubscription":null,"optinId":null,"optin":null}}]}]}],"columns":[{"size":8.5,"blocks":[{"type":"ad","title":"Advertisement","advertisementIds":[],"adCampaignId":892,"condition":null},{"type":"article-list","condition":null,"color":"#F90505","title":"Top Content","variant":"variant-b","articleIds":[262748,254614,260494,260493,260492,258749],"articles":null},{"type":"article-list","condition":null,"color":"#2873B0","title":"Industry Insights","variant":"variant-b","articleIds":[260492,260493,260494,258746,258745,257361],"articles":null},{"type":"article-category","condition":null,"color":"#F90505","title":"UK News","variant":"variant-c","categoryId":43138,"backgroundColor":null,"image":null,"articles":null,"category":null},{"type":"article-category","condition":null,"color":"#2873B0","title":"Global News","variant":"variant-c","categoryId":43140,"backgroundColor":null,"image":null,"articles":null,"category":null},{"type":"ad","title":"Advertisement","advertisementIds":[1319],"adCampaignId":null,"condition":null},{"type":"article-category","condition":null,"color":"#2873B0","title":"European News","variant":"variant-c","categoryId":43139,"backgroundColor":null,"image":null,"articles":null,"category":null},{"type":"guide-install","color":"#444558","title":"How to Install","condition":null}]},{"size":3.5,"blocks":[{"type":"issue-slider","condition":null,"color":"#2873B0","title":"Latest Editions","issueIds":[52826,52799,52483,52217,51921,51722,51533,51435,51240,51075,45938,45939,45940],"thumbnail":{"style":"full-cover","size":"medium"},"borderRadius":null,"zoomOnHover":true,"issues":null},{"type":"ad","title":"Advertisement","advertisementIds":[2210],"adCampaignId":null,"condition":null},{"type":"cta","condition":null,"icon":"symbol-gift","color":"#FB0505","title":"Newsletters","description":"Sign up to our newsletters and digital magazines","action":{"type":"url","href":"https://curwoodcmsltd.formstack.com/forms/samedan","target":"_blank","pwaSubscriptionId":null,"pwaSubscription":null,"optinId":null,"optin":null}},{"type":"ad","title":"Advertisement","advertisementIds":[2067],"adCampaignId":null,"condition":null},{"type":"cta","condition":null,"icon":"symbol-day","color":"#F90505","title":"Pharmafocus Archive","description":"Browse older editions","action":{"type":"url","href":"https://en.calameo.com/subscriptions/6188508","target":"_blank","pwaSubscriptionId":null,"pwaSubscription":null,"optinId":null,"optin":null}},{"type":"ad","title":"Advertisement","advertisementIds":[],"adCampaignId":1044,"condition":null},{"type":"article-category","condition":null,"color":"#F70707","title":"Appointments","variant":"variant-c","categoryId":43146,"backgroundColor":null,"image":null,"articles":null,"category":null},{"type":"ad","title":"Advertisement","advertisementIds":[2249,1320],"adCampaignId":null,"condition":null}]}]},"seo":{"home":{"title":"Pharmafocus Magazine - covering pharma and biotech since 1986","description":"Reporting on the pharma industry, drug development \u0026 clinical trials, manufacturing, logistics, market access, and patients.\nFrom breaking stories to interviews with senior executives, we look at regulations \u0026 trends to provide useful market intelligence.","image":"https://cdn.magloft.com/pwa-664/seo/image/270800d8-b1de-41b8-86ad-5d262d2b9adf.png","imageAlt":"Pharmafocus Magazine"},"articles":{"title":"Pharmafocus - Articles","description":"Discover the latest articles published by Pharmafocus. Browse and customize the article feed to your preferences and explore latest trends","image":"https://cdn.magloft.com/pwa-664/seo/image/e7a95017-d617-4914-b4b3-09fcfc683f75.png","imageAlt":"Pharmafocus - Articles"},"issues":{"title":"Pharmafocus - Magazine Issues","description":"Explore the latest issues of Pharmafocus Magazine and keep up to date with the latest industry knowledge","image":"https://cdn.magloft.com/pwa-664/seo/image/b1c374f3-b368-4654-bf00-3b5ed81fe6c2.png","imageAlt":"Pharmafocus - Issues"},"account":{"title":"Pharmafocus - Account","description":"Manage your Pharmafocus Reader Account..","image":"https://cdn.magloft.com/pwa-664/seo/image/5ad881b1-a927-4fb1-b331-81963e9a0f84.png","imageAlt":"Reader Account"}},"strings":{"app":{"title":"Pharmafocus","subtitle":"Pharmaceutical Industry news, analysis and insights"},"social":{"facebook":null,"twitter":"https://twitter.com/Pharmafocus","linkedin":"https://www.linkedin.com/company/pharmafile","youtube":null,"instagram":null},"topMenu":{"title":null,"subtitle":null},"footerMenu":{"title":"Pharmafocus","subtitle":null,"description":null,"email":["info@pharmafile.com"],"privacyUrl":"https://www.pharmafile.com/privacy-policy","termsUrl":"https://www.pharmafile.com/terms-of-service","links":[{"name":"Pharmafile.com","url":"http://www.pharmafile.com"},{"name":"Pharmafile Magazine","url":"https://magazine.pharmafile.com"},{"name":"Samedan","url":"http://www.samedanltd.com"}]},"pages":null},"customFonts":[{"identifier":"trade-gothic-lt"},{"identifier":"trade-gothic-lt-bold"}],"phrases":{},"trialEndAt":null,"bypassSubscription":false},"publication":{"id":14882,"title":"Pharmafocus","properties":{"subtitle":null,"appIcon":"images/defaults/app-icon.png","promotionalText":null,"companyName":null,"emailReplyTo":"","privacyUrl":null,"termsUrl":null}},"categories":[{"id":43138,"slug":"uk-pharma-news","title":"UK News","color":"#444444","issueCount":3,"articleCount":79,"categoryGroupIds":[]},{"id":43139,"slug":"general-news","title":"General News","color":"#444444","issueCount":3,"articleCount":78,"categoryGroupIds":[]},{"id":43140,"slug":"approvals","title":"Approvals","color":"#444444","issueCount":3,"articleCount":159,"categoryGroupIds":[]},{"id":43141,"slug":"research-and-development","title":"R \u0026 D","color":"#444444","issueCount":1,"articleCount":174,"categoryGroupIds":[]},{"id":43143,"slug":"mergers-acquisitions","title":"Mergers \u0026 Acquisitions","color":"#444444","issueCount":0,"articleCount":69,"categoryGroupIds":[]},{"id":43144,"slug":"manufacturing-production","title":"Manufacturing","color":"#444444","issueCount":1,"articleCount":31,"categoryGroupIds":[]},{"id":43149,"slug":"clinical-trials","title":"Clinical Trials","color":"#444444","issueCount":2,"articleCount":33,"categoryGroupIds":[]},{"id":43145,"slug":"industry-insights","title":"Industry Insights","color":"#444444","issueCount":1,"articleCount":56,"categoryGroupIds":[]},{"id":43146,"slug":"appointments","title":"Appointments","color":"#444444","issueCount":2,"articleCount":87,"categoryGroupIds":[]},{"id":43147,"slug":"insider-interviews","title":"Interviews","color":"#444444","issueCount":0,"articleCount":9,"categoryGroupIds":[]},{"id":43148,"slug":"features","title":"Features","color":"#444444","issueCount":0,"articleCount":20,"categoryGroupIds":[]},{"id":43142,"slug":"industry-facts","title":"Industry Facts","color":"#444444","issueCount":2,"articleCount":23,"categoryGroupIds":[]}],"pwaSubscriptions":[],"categoryGroups":[],"layout":{"banners":[{"image":"https://cdn.magloft.com/pwa-1/pwa/banner/aea74608-e04a-4649-b817-c45cc439e28e.png","title":"Start trial now","isHidden":true,"action":{"type":"url","href":"https://www.magloft.com/","target":"_blank","pwaSubscriptionId":null,"pwaSubscription":null,"optinId":null,"optin":null}}],"bottomBanners":[{"image":"https://cdn.magloft.com/pwa-664/pwa/banner/1f66e6ea-9b3a-4477-aba1-18abf54619b8.png","title":null,"isHidden":true,"action":{"type":"url","href":"http://www.samedanltd.com/","target":"_blank","pwaSubscriptionId":null,"pwaSubscription":null,"optinId":null,"optin":null}}],"columnSeparator":"shadow","tabs":[{"route":"","title":"Home","icon":"menu-home","visible":true},{"route":"/articles","title":"Articles","icon":"menu-articles","visible":true},{"route":"/collections","title":"Collections","icon":"menu-issues","visible":true},{"route":"/account","title":"Account","icon":"menu-account","visible":true}],"topMenu":{"showLogo":true,"showSubtitle":false,"showTitle":false,"height":"64px"},"navbar":{"animation":false,"style":"logo-left"},"sections":[{"fullWidth":true,"backgroundColor":"transparent","columnSeparator":"none","columns":[{"size":5,"blocks":[{"type":"banner","image":"https://cdn.magloft.com/pwa-1/pwa/banner/aea74608-e04a-4649-b817-c45cc439e28e.png","isHidden":true,"title":"Start trial now","action":{"type":"url","href":"https://www.magloft.com/","target":"_blank","pwaSubscriptionId":null,"pwaSubscription":null,"optinId":null,"optin":null}}]}]},{"fullWidth":false,"backgroundColor":null,"columnSeparator":"shadow","columns":[{"size":8.5,"blocks":[{"type":"ad","title":"Advertisement","advertisementIds":[],"adCampaignId":892,"condition":null},{"type":"article-list","condition":null,"color":"#F90505","title":"Top Content","variant":"variant-b","articleIds":[262748,254614,260494,260493,260492,258749],"articles":[{"id":262748,"slug":"precision-medicine-and-the-role-of-pathologists-in-multidiscipli","issueId":null,"categoryIds":[],"title":"Precision medicine and the role of pathologists in multidisciplinary bladder cancer care","description":"How can the combined power of multidisciplinary teams and precision medicine be harnessed for people living with bladder cancer?","image":"https://cdn.magloft.com/pdf-import/1110/images/img_14-2.jpg","cover":"https://cdn.magloft.com/publication-14882/screenshots/articles/262748.jpg?ts=1725631974","date":1725577200000,"unlockType":"free","categories":[],"pdfPageId":null,"visible":null,"showOnToc":null,"bookmark":false,"position":27,"publicationId":14882,"pwaOptinId":null,"seoDescription":null,"classificationIds":[],"pwaSubscriptionIds":[],"source":"typeloft2","trending":false,"html":null,"keywordPhrase":null,"articleAssets":[]},{"id":260492,"slug":"sustainable-drug-delivery-devices-striking-a-balance-between-fu","issueId":null,"categoryIds":[],"title":"Sustainable drug delivery devices: striking a balance between aspirations and current possibilities","description":"Alex Fong and Olivia Houselander from Owen Mumford Pharmaceutical Services consider the action needed to make drug discovery processes more sustainable","image":"https://cdn.magloft.com/pdf-import/1085/images/img_14-4.jpg","cover":"https://cdn.magloft.com/publication-14882/screenshots/articles/260492.jpg?ts=1721301012","date":1721257200000,"unlockType":"free","categories":[],"pdfPageId":null,"visible":null,"showOnToc":null,"bookmark":false,"position":32,"publicationId":14882,"pwaOptinId":null,"seoDescription":null,"classificationIds":[],"pwaSubscriptionIds":[],"source":"typeloft2","trending":false,"html":null,"keywordPhrase":null,"articleAssets":[]},{"id":260493,"slug":"exploring-disease-modification-to-change-the-future-of-epilepsy","issueId":null,"categoryIds":[],"title":"Exploring disease modification to change the future of epilepsy treatment","description":"Konrad Werhahn from UCB discusses how disease-modifying solutions may introduce a new era in treatment for epilepsies","image":"https://cdn.magloft.com/pdf-import/1085/images/img_13-3.jpg","cover":"https://cdn.magloft.com/publication-14882/screenshots/articles/260493.jpg?ts=1721301214","date":1721257200000,"unlockType":"free","categories":[],"pdfPageId":null,"visible":null,"showOnToc":null,"bookmark":false,"position":31,"publicationId":14882,"pwaOptinId":null,"seoDescription":null,"classificationIds":[],"pwaSubscriptionIds":[],"source":"typeloft2","trending":false,"html":null,"keywordPhrase":null,"articleAssets":[]},{"id":260494,"slug":"the-role-of-ai-in-patient-support","issueId":null,"categoryIds":[],"title":"The role of AI in patient support","description":"Rajul Jain from ProPharma considers how AI can be used in patient support, especially considering how it can be used to streamline operations and supplement human expertise","image":"https://cdn.magloft.com/pdf-import/1085/images/img_16-4.jpg","cover":"https://cdn.magloft.com/publication-14882/screenshots/articles/260494.jpg?ts=1721297521","date":1721257200000,"unlockType":"free","categories":[],"pdfPageId":null,"visible":null,"showOnToc":null,"bookmark":false,"position":33,"publicationId":14882,"pwaOptinId":null,"seoDescription":null,"classificationIds":[],"pwaSubscriptionIds":[],"source":"typeloft2","trending":false,"html":null,"keywordPhrase":null,"articleAssets":[]},{"id":258749,"slug":"pride-month-and-lgbtq-healthcare","issueId":null,"categoryIds":[],"title":"Pride month and LGBTQ+ healthcare","description":"Betsy Goodfellow from Pharmafocus considers Pride month and the state of LGBTQ+ healthcare in the UK","image":"https://cdn.magloft.com/pdf-import/1071/images/img_18-4.jpg","cover":"https://cdn.magloft.com/publication-14882/screenshots/articles/258749.jpg?ts=1717595760","date":1717542000000,"unlockType":"free","categories":[],"pdfPageId":null,"visible":null,"showOnToc":null,"bookmark":false,"position":36,"publicationId":14882,"pwaOptinId":null,"seoDescription":null,"classificationIds":[],"pwaSubscriptionIds":[],"source":"typeloft2","trending":false,"html":null,"keywordPhrase":null,"articleAssets":[]},{"id":254614,"slug":"european-commission-approves-pfizer-s-velsipity-for-ulcerative-c","issueId":null,"categoryIds":[],"title":"European Commission approves Pfizer’s Velsipity for ulcerative colitis treatment","description":"Pfizer has announced that the EC has granted marketing authorisation for Velsipity (etrasimod) in the EU.","image":"https://cdn.magloft.com/pdf-import/1020/images/img_8-1.jpg","cover":"https://cdn.magloft.com/publication-14882/screenshots/articles/254614.jpg?ts=1709651668","date":1709510400000,"unlockType":"free","categories":[],"pdfPageId":null,"visible":null,"showOnToc":null,"bookmark":false,"position":17,"publicationId":14882,"pwaOptinId":null,"seoDescription":null,"classificationIds":[],"pwaSubscriptionIds":[],"source":"typeloft2","trending":false,"html":null,"keywordPhrase":null,"articleAssets":[]}]},{"type":"article-list","condition":null,"color":"#2873B0","title":"Industry Insights","variant":"variant-b","articleIds":[260492,260493,260494,258746,258745,257361],"articles":[{"id":260492,"slug":"sustainable-drug-delivery-devices-striking-a-balance-between-fu","issueId":null,"categoryIds":[],"title":"Sustainable drug delivery devices: striking a balance between aspirations and current possibilities","description":"Alex Fong and Olivia Houselander from Owen Mumford Pharmaceutical Services consider the action needed to make drug discovery processes more sustainable","image":"https://cdn.magloft.com/pdf-import/1085/images/img_14-4.jpg","cover":"https://cdn.magloft.com/publication-14882/screenshots/articles/260492.jpg?ts=1721301012","date":1721257200000,"unlockType":"free","categories":[],"pdfPageId":null,"visible":null,"showOnToc":null,"bookmark":false,"position":32,"publicationId":14882,"pwaOptinId":null,"seoDescription":null,"classificationIds":[],"pwaSubscriptionIds":[],"source":"typeloft2","trending":false,"html":null,"keywordPhrase":null,"articleAssets":[]},{"id":260493,"slug":"exploring-disease-modification-to-change-the-future-of-epilepsy","issueId":null,"categoryIds":[],"title":"Exploring disease modification to change the future of epilepsy treatment","description":"Konrad Werhahn from UCB discusses how disease-modifying solutions may introduce a new era in treatment for epilepsies","image":"https://cdn.magloft.com/pdf-import/1085/images/img_13-3.jpg","cover":"https://cdn.magloft.com/publication-14882/screenshots/articles/260493.jpg?ts=1721301214","date":1721257200000,"unlockType":"free","categories":[],"pdfPageId":null,"visible":null,"showOnToc":null,"bookmark":false,"position":31,"publicationId":14882,"pwaOptinId":null,"seoDescription":null,"classificationIds":[],"pwaSubscriptionIds":[],"source":"typeloft2","trending":false,"html":null,"keywordPhrase":null,"articleAssets":[]},{"id":260494,"slug":"the-role-of-ai-in-patient-support","issueId":null,"categoryIds":[],"title":"The role of AI in patient support","description":"Rajul Jain from ProPharma considers how AI can be used in patient support, especially considering how it can be used to streamline operations and supplement human expertise","image":"https://cdn.magloft.com/pdf-import/1085/images/img_16-4.jpg","cover":"https://cdn.magloft.com/publication-14882/screenshots/articles/260494.jpg?ts=1721297521","date":1721257200000,"unlockType":"free","categories":[],"pdfPageId":null,"visible":null,"showOnToc":null,"bookmark":false,"position":33,"publicationId":14882,"pwaOptinId":null,"seoDescription":null,"classificationIds":[],"pwaSubscriptionIds":[],"source":"typeloft2","trending":false,"html":null,"keywordPhrase":null,"articleAssets":[]},{"id":258745,"slug":"20-years-of-egfr-in-nsclc-how-precision-medicine-helps-navigate","issueId":null,"categoryIds":[],"title":"20 years of EGFR in NSCLC: how precision medicine helps navigate lung cancer challenges","description":"Henar Hevia at Johnson \u0026 Johnson considers the progress that has been made in lung cancer treatment since the discovery of EGFR, including the evolving treatment paradigm, the role of precision medicine in treatment decision-making and quality of life for patients receiving targeted treatments","image":"https://cdn.magloft.com/pdf-import/1071/images/img_14-3.jpg","cover":"https://cdn.magloft.com/publication-14882/screenshots/articles/258745.jpg?ts=1717596050","date":1717542000000,"unlockType":"free","categories":[],"pdfPageId":null,"visible":null,"showOnToc":null,"bookmark":false,"position":33,"publicationId":14882,"pwaOptinId":null,"seoDescription":null,"classificationIds":[],"pwaSubscriptionIds":[],"source":"typeloft2","trending":false,"html":null,"keywordPhrase":null,"articleAssets":[]},{"id":258746,"slug":"paediatric-clinical-trials-for-obesity-treatment","issueId":null,"categoryIds":[],"title":"Paediatric clinical trials for obesity treatment","description":"Alan Baldridge and Heather Peterson from ICON consider the prevalence of paediatric obesity and assess clinical trials of its treatments","image":"https://cdn.magloft.com/pdf-import/1071/images/img_16-2.jpg","cover":"https://cdn.magloft.com/publication-14882/screenshots/articles/258746.jpg?ts=1717595924","date":1717542000000,"unlockType":"free","categories":[],"pdfPageId":null,"visible":null,"showOnToc":null,"bookmark":false,"position":35,"publicationId":14882,"pwaOptinId":null,"seoDescription":null,"classificationIds":[],"pwaSubscriptionIds":[],"source":"typeloft2","trending":false,"html":null,"keywordPhrase":null,"articleAssets":[]},{"id":257361,"slug":"epilepsy-and-brain-health-a-call-for-global-action-and-unity","issueId":null,"categoryIds":[],"title":"Epilepsy and brain health: a call for global action and unity","description":"Rafal Kaminski from Angelini Pharma tells Pharmafocus about the global challenge of epilepsy as well as how his company is striving to bridge the gaps in epilepsy treatment","image":"https://cdn.magloft.com/pwa-664/article/image/c761b8da-dcc1-4126-820a-cfcd83c479a6.png","cover":"https://cdn.magloft.com/publication-14882/screenshots/articles/257361.jpg?ts=1714476255","date":1714345200000,"unlockType":"free","categories":[],"pdfPageId":null,"visible":null,"showOnToc":null,"bookmark":false,"position":32,"publicationId":14882,"pwaOptinId":null,"seoDescription":null,"classificationIds":[],"pwaSubscriptionIds":[],"source":"typeloft2","trending":false,"html":null,"keywordPhrase":null,"articleAssets":[]}]},{"type":"article-category","condition":null,"color":"#F90505","title":"UK News","variant":"variant-c","categoryId":43138,"backgroundColor":null,"image":null,"articles":[{"id":266508,"slug":"clue-points-launches-medical-safety-review-msr-software-for-c","issueId":null,"categoryIds":[],"title":"CluePoints launches Medical \u0026 Safety Review (MSR) software","description":"Risk-based quality management (RBQM) and data quality oversight software company Cluepoints launches its latest application, the medical \u0026 safety review (MSR), to simplify and streamline the medical analysis of study data through user-friendly dashboards, data manipulation and cleaning, query management and full transparency over the data history.","image":"https://cdn.magloft.com/pdf-import/1125/images/img_6-1.jpg","cover":"https://cdn.magloft.com/publication-14882/screenshots/articles/266508.jpg?ts=1728470493","date":1728601200000,"unlockType":"free","categories":[],"pdfPageId":null,"visible":null,"showOnToc":null,"bookmark":false,"position":11,"publicationId":14882,"pwaOptinId":null,"seoDescription":null,"classificationIds":[],"pwaSubscriptionIds":[],"source":"typeloft2","trending":false,"html":null,"keywordPhrase":null,"articleAssets":[]},{"id":266516,"slug":"next-generation-sequencing-partnership-announced-between-angle-p","issueId":null,"categoryIds":[],"title":"Next-generation sequencing partnership announced between ANGLE plc and NuProbe","description":"Liquid biopsy company ANGLE plc has announced a partnership with NuProbe, a genomics and molecular diagnostics company, to utilise the latter’s pan-cancer next-generation sequencing (NGS) panel.","image":"https://cdn.magloft.com/pdf-import/1125/images/img_10-2.jpg","cover":"https://cdn.magloft.com/publication-14882/screenshots/articles/266516.jpg?ts=1728498303","date":1728601200000,"unlockType":"free","categories":[],"pdfPageId":null,"visible":null,"showOnToc":null,"bookmark":false,"position":20,"publicationId":14882,"pwaOptinId":null,"seoDescription":null,"classificationIds":[],"pwaSubscriptionIds":[],"source":"typeloft2","trending":false,"html":null,"keywordPhrase":null,"articleAssets":[]},{"id":266499,"slug":"fda-approves-first-drug-in-50-years-for-treatment-of-schizophren","issueId":null,"categoryIds":[],"title":"FDA approves first drug in 50 years for treatment of schizophrenia in adults","description":"Earlier this September, the US Food and Drug Administration (FDA) granted approval for PureTech Health’s Karxt for the treatment of schizophrenia in adults, triggering royalty payments of $29m to PureTech. It will be the first approved mechanism by the FDAfor schizophrenia in over 50 years.","image":"https://cdn.magloft.com/pdf-import/1125/images/img_1-1.jpg","cover":"https://cdn.magloft.com/publication-14882/screenshots/articles/266499.jpg?ts=1728559805","date":1728514800000,"unlockType":"free","categories":[],"pdfPageId":null,"visible":null,"showOnToc":null,"bookmark":false,"position":1,"publicationId":14882,"pwaOptinId":null,"seoDescription":null,"classificationIds":[],"pwaSubscriptionIds":[],"source":"typeloft2","trending":false,"html":null,"keywordPhrase":null,"articleAssets":[]},{"id":266500,"slug":"research-collaboration-between-fda-and-owlstone-medical-set-to-s","issueId":null,"categoryIds":[],"title":"Research collaboration between FDA and Owlstone Medical set to see improvements in breath biopsies","description":"Owlstone Medical has entered into a research collaboration with the US Food and Drug administration’s (FDA) centre for devices and radiological health to develop methods for the confident identification of individual chemicals in the composure of breath.","image":"https://cdn.magloft.com/pdf-import/1125/images/img_2-3.jpg","cover":"https://cdn.magloft.com/publication-14882/screenshots/articles/266500.jpg?ts=1728470011","date":1728514800000,"unlockType":"free","categories":[],"pdfPageId":null,"visible":null,"showOnToc":null,"bookmark":false,"position":3,"publicationId":14882,"pwaOptinId":null,"seoDescription":null,"classificationIds":[],"pwaSubscriptionIds":[],"source":"typeloft2","trending":false,"html":null,"keywordPhrase":null,"articleAssets":[]},{"id":262719,"slug":"first-nasal-spray-for-treatment-of-anaphylaxis-approved-by-fda","issueId":null,"categoryIds":[],"title":"First nasal spray for treatment of anaphylaxis approved by FDA","description":"Ars pharmaceuticals has been granted approval by the us food and drug administration (fda) for their epinephrine nasal spray, neffy, to be used as treatment of type 1 allergic reactions including anaphylaxis.","image":"https://cdn.magloft.com/pdf-import/1110/images/img_1-1.jpg","cover":"https://cdn.magloft.com/publication-14882/screenshots/articles/262719.jpg?ts=1725620538","date":1725577200000,"unlockType":"free","categories":[],"pdfPageId":null,"visible":null,"showOnToc":null,"bookmark":false,"position":1,"publicationId":14882,"pwaOptinId":null,"seoDescription":null,"classificationIds":[],"pwaSubscriptionIds":[],"source":"typeloft2","trending":false,"html":null,"keywordPhrase":null,"articleAssets":[]},{"id":262727,"slug":"novo-holdings-invests-in-oxford-nanopore-technologies","issueId":null,"categoryIds":[],"title":"Novo Holdings invests in Oxford Nanopore Technologies","description":"Leading life science investor novo holdings has announced a £50m investment in oxford nanopore technologies. Oxford nanopore technologies is a leading uk-listed company currently specialising in a new generation of molecular sensing technology based on nanopores.","image":"https://cdn.magloft.com/pdf-import/1110/images/img_4-1.jpg","cover":"https://cdn.magloft.com/publication-14882/screenshots/articles/262727.jpg?ts=1725629148","date":1725577200000,"unlockType":"free","categories":[],"pdfPageId":null,"visible":null,"showOnToc":null,"bookmark":false,"position":8,"publicationId":14882,"pwaOptinId":null,"seoDescription":null,"classificationIds":[],"pwaSubscriptionIds":[],"source":"typeloft2","trending":false,"html":null,"keywordPhrase":null,"articleAssets":[]},{"id":262728,"slug":"cresset-collaborates-with-enamine-to-enable-the-design-of-new-ta","issueId":null,"categoryIds":[],"title":"Cresset collaborates with Enamine to enable the design of new targeted protein degraders","description":"Drug discovery company Cresset has announced the extension of its global collaboration with chemical and biological contract research organisation (cro) Enamine.","image":"https://cdn.magloft.com/pdf-import/1110/images/img_4-2.jpg","cover":"https://cdn.magloft.com/publication-14882/screenshots/articles/262728.jpg?ts=1725629190","date":1725577200000,"unlockType":"free","categories":[],"pdfPageId":null,"visible":null,"showOnToc":null,"bookmark":false,"position":9,"publicationId":14882,"pwaOptinId":null,"seoDescription":null,"classificationIds":[],"pwaSubscriptionIds":[],"source":"typeloft2","trending":false,"html":null,"keywordPhrase":null,"articleAssets":[]},{"id":262729,"slug":"first-oral-treatment-for-hormone-sensitive-prostate-cancer-recom","issueId":null,"categoryIds":[],"title":"First oral treatment for hormone-sensitive prostate cancer recommended by NICE","description":"Accord healthcare have recently announced that NICE have recommended the first oral androgen deprivation therapy (adt) treatment for hormone-sensitive prostate cancer. Prostate cancer is the most common cancer in men across the uk.","image":"https://cdn.magloft.com/pdf-import/1110/images/pages/pg-005.jpg","cover":"https://cdn.magloft.com/publication-14882/screenshots/articles/262729.jpg?ts=1725629243","date":1725577200000,"unlockType":"free","categories":[],"pdfPageId":null,"visible":null,"showOnToc":null,"bookmark":false,"position":10,"publicationId":14882,"pwaOptinId":null,"seoDescription":null,"classificationIds":[],"pwaSubscriptionIds":[],"source":"typeloft2","trending":false,"html":null,"keywordPhrase":null,"articleAssets":[]},{"id":262730,"slug":"verisense-announce-opening-of-digital-biobank","issueId":null,"categoryIds":[],"title":"Verisense announce opening of Digital Biobank","description":"This month, Verisense have announced that their digital biobank, with data from over one million people, is open for business.","image":"https://cdn.magloft.com/pdf-import/1110/images/img_5-1.jpg","cover":"https://cdn.magloft.com/publication-14882/screenshots/articles/262730.jpg?ts=1725629295","date":1725577200000,"unlockType":"free","categories":[],"pdfPageId":null,"visible":null,"showOnToc":null,"bookmark":false,"position":11,"publicationId":14882,"pwaOptinId":null,"seoDescription":null,"classificationIds":[],"pwaSubscriptionIds":[],"source":"typeloft2","trending":false,"html":null,"keywordPhrase":null,"articleAssets":[]},{"id":262731,"slug":"positive-results-announced-for-levicept-s-moderate-to-severe-ost","issueId":null,"categoryIds":[],"title":"Positive results announced for Levicept’s moderate-to-severe osteoarthritis treatment","description":"Biotechnology company Levicept has announced positive results from its phase 2 trial into levi-04 for the treatment of osteoarthritis.","image":"https://cdn.magloft.com/pdf-import/1110/images/img_6-1.jpg","cover":"https://cdn.magloft.com/publication-14882/screenshots/articles/262731.jpg?ts=1725617583","date":1725577200000,"unlockType":"free","categories":[],"pdfPageId":null,"visible":null,"showOnToc":null,"bookmark":false,"position":12,"publicationId":14882,"pwaOptinId":null,"seoDescription":null,"classificationIds":[],"pwaSubscriptionIds":[],"source":"typeloft2","trending":false,"html":null,"keywordPhrase":null,"articleAssets":[]},{"id":262732,"slug":"calliditas-therapeutics-announces-positive-phase-2b-data-in-prim","issueId":null,"categoryIds":[],"title":"Calliditas Therapeutics announces positive phase 2b data in Primary Biliary Cholangitis trial","description":"Calliditas therapeutics ab has recently announced that the phase 2b transform trial met its primary endpoint. The trial showed statistically significant improvement in alkaline phosphatase (alp) for both doses tested versus placebo. the trial evaluated setanaxib, a nox enzyme inhibitor, in patients with primary biliary cholangitis (pbc) and elevated liver stiffness.","image":"https://cdn.magloft.com/pdf-import/1110/images/pages/pg-007.jpg","cover":"https://cdn.magloft.com/publication-14882/screenshots/articles/262732.jpg?ts=1725630391","date":1725577200000,"unlockType":"free","categories":[],"pdfPageId":null,"visible":null,"showOnToc":null,"bookmark":false,"position":14,"publicationId":14882,"pwaOptinId":null,"seoDescription":null,"classificationIds":[],"pwaSubscriptionIds":[],"source":"typeloft2","trending":false,"html":null,"keywordPhrase":null,"articleAssets":[]},{"id":262733,"slug":"chmp-gives-positive-opinion-for-merck-s-keytruda-for-unresectabl","issueId":null,"categoryIds":[],"title":"CHMP gives positive opinion for Merck’s KEYTRUDA for unresectable or metastatic urothelial carcinoma","description":"Merck (known as MSDoutside of the US and Canada) has announced that its anti-pd-1 therapy, in combination with padcev (enfortuman vedotin-ejfv), has received a positive opinion from the European Medicines Agency (EMA)","image":"https://cdn.magloft.com/pdf-import/1110/images/img_7-1.jpg","cover":"https://cdn.magloft.com/publication-14882/screenshots/articles/262733.jpg?ts=1725630477","date":1725577200000,"unlockType":"free","categories":[],"pdfPageId":null,"visible":null,"showOnToc":null,"bookmark":false,"position":15,"publicationId":14882,"pwaOptinId":null,"seoDescription":null,"classificationIds":[],"pwaSubscriptionIds":[],"source":"typeloft2","trending":false,"html":null,"keywordPhrase":null,"articleAssets":[]},{"id":262734,"slug":"clinical-trials-for-personalised-cancer-vaccine-used-to-tackle-a","issueId":null,"categoryIds":[],"title":"Clinical trials for personalised cancer vaccine used to tackle aggressive brain tumours in young","description":"Researchers at the UCLA Health jonsson comprehensive cancer center have announced that they are launching a first-of-its-kind clinical trial to evaluate the safety and effectiveness of a cancer vaccine. The vaccine targets h3 g34-mutant diffuse hemispheric glioma, an aggressive brain tumour typically found in adolescents and young people.","image":"https://cdn.magloft.com/pdf-import/1110/images/img_6-2.jpg","cover":"https://cdn.magloft.com/publication-14882/screenshots/articles/262734.jpg?ts=1725617631","date":1725577200000,"unlockType":"free","categories":[],"pdfPageId":null,"visible":null,"showOnToc":null,"bookmark":false,"position":13,"publicationId":14882,"pwaOptinId":null,"seoDescription":null,"classificationIds":[],"pwaSubscriptionIds":[],"source":"typeloft2","trending":false,"html":null,"keywordPhrase":null,"articleAssets":[]},{"id":262735,"slug":"the-national-institute-for-health-and-care-excellence-announce-t","issueId":null,"categoryIds":[],"title":"The National Institute for Health and Care Excellence announce technology appraisal guidance","description":"The National Institute for Health and Care excellence (NICE) have recommended adult patients in England or Wales with moderately or severely active ulcerative colitis (uc) who have not responded well to or cannot tolerate conventional or biological therapy including a tumour necrosis factor (tnf) alpha inhibitor the option of skyrizi (risankizumab).","image":"https://cdn.magloft.com/pdf-import/1110/images/pages/pg-008.jpg","cover":"https://cdn.magloft.com/publication-14882/screenshots/articles/262735.jpg?ts=1725630562","date":1725577200000,"unlockType":"free","categories":[],"pdfPageId":null,"visible":null,"showOnToc":null,"bookmark":false,"position":16,"publicationId":14882,"pwaOptinId":null,"seoDescription":null,"classificationIds":[],"pwaSubscriptionIds":[],"source":"typeloft2","trending":false,"html":null,"keywordPhrase":null,"articleAssets":[]},{"id":262737,"slug":"european-commission-approves-combination-chemotherapy-for-treatm","issueId":null,"categoryIds":[],"title":"European Commission approves combination chemotherapy for treatment of advanced EGFR-mutated","description":"This month, Janssen-Cilag international, part of johnson \u0026 johnson (j\u0026j) has announced that the European Commission (EC) has approved a combined treatment of rybrevant (amivantamab) and chemotherapy (carboplatin and pemerexed) for the treatment of non-small cell lung cancer (nsclc) with an epidermal growth factor receptor (EGFR).","image":"https://cdn.magloft.com/pdf-import/1110/images/pages/pg-009.jpg","cover":"https://cdn.magloft.com/publication-14882/screenshots/articles/262737.jpg?ts=1725617944","date":1725577200000,"unlockType":"free","categories":[],"pdfPageId":null,"visible":null,"showOnToc":null,"bookmark":false,"position":19,"publicationId":14882,"pwaOptinId":null,"seoDescription":null,"classificationIds":[],"pwaSubscriptionIds":[],"source":"typeloft2","trending":false,"html":null,"keywordPhrase":null,"articleAssets":[]},{"id":262739,"slug":"eisai-and-eco-navi-sta-enter-dementia-collaboration","issueId":null,"categoryIds":[],"title":"Eisai and EcoNaviSta enter dementia collaboration","description":"Eisai and Econavista have announced that they have entered into a business alliance agreement, initiating their collaboration intended to build an ecosystem in the field of dementia.","image":"https://cdn.magloft.com/pdf-import/1110/images/img_10-2.jpg","cover":"https://cdn.magloft.com/publication-14882/screenshots/articles/262739.jpg?ts=1725618046","date":1725577200000,"unlockType":"free","categories":[],"pdfPageId":null,"visible":null,"showOnToc":null,"bookmark":false,"position":21,"publicationId":14882,"pwaOptinId":null,"seoDescription":null,"classificationIds":[],"pwaSubscriptionIds":[],"source":"typeloft2","trending":false,"html":null,"keywordPhrase":null,"articleAssets":[]}],"category":{"id":43138,"slug":"uk-pharma-news","title":"UK News","color":"#444444","issueCount":0,"articleCount":0,"categoryGroupIds":[]}},{"type":"article-category","condition":null,"color":"#2873B0","title":"Global News","variant":"variant-c","categoryId":43140,"backgroundColor":null,"image":null,"articles":[{"id":269386,"slug":"nice-gives-positive-recommendation-for-santen-s-roclanda-e19d","issueId":null,"categoryIds":[],"title":"NICE gives positive recommendation for Santen’s Roclanda","description":"The National Institute for Health and Care Excellence (NICE) has given a positive recommendation for Santen’s Roclanda (netarsudil 0.02% and latanoprost 0.005%) as an option for patients suffering from primary open-angle glaucoma (poag) or ocular hypertension.","image":"https://cdn.magloft.com/pdf-import/1144/images/pages/pg-012.jpg","cover":"https://cdn.magloft.com/publication-14882/screenshots/articles/269386.jpg?ts=1731583567","date":1731628800000,"unlockType":"free","categories":[],"pdfPageId":null,"visible":null,"showOnToc":null,"bookmark":false,"position":22,"publicationId":14882,"pwaOptinId":null,"seoDescription":null,"classificationIds":[],"pwaSubscriptionIds":[],"source":"typeloft2","trending":false,"html":null,"keywordPhrase":null,"articleAssets":[]},{"id":269387,"slug":"chmp-adopts-positive-opinion-for-new-breast-cancer-drug-kisqual-db01","issueId":null,"categoryIds":[],"title":"CHMP adopts positive opinion for new breast cancer drug, Kisquali, from Novartis","description":"Last month, the Committee for Medicinal Products for Human Use (CHMP), which is part of the European Medicines Agency (EMA) announced that it has adopted a positive opinion for Novartis’ Kisquali (ribociclib) as an adjuvant in the treatment of adults with hormone receptor-positive/human epidermal growth factor 2negative (hr+/her2-) early breast cancer (ebc).","image":"https://cdn.magloft.com/pdf-import/1144/images/img_12-1.jpg","cover":"https://cdn.magloft.com/publication-14882/screenshots/articles/269387.jpg?ts=1731583498","date":1731628800000,"unlockType":"free","categories":[],"pdfPageId":null,"visible":null,"showOnToc":null,"bookmark":false,"position":21,"publicationId":14882,"pwaOptinId":null,"seoDescription":null,"classificationIds":[],"pwaSubscriptionIds":[],"source":"typeloft2","trending":false,"html":null,"keywordPhrase":null,"articleAssets":[]},{"id":269388,"slug":"eplontersen-recommended-for-eu-approval-by-chmp-for-treatment-of-aaa6","issueId":null,"categoryIds":[],"title":"Eplontersen recommended for EU approval by CHMP for hereditary transthyretin-mediated amyloidosis","description":"Wainzua (Eplotersen), produced by AstraZeneca and Ionis, has been recommended for approval in the EU by the European Medicines Agency’s (EMA’s) Committee for Medicinal Products for Human Use (CHMP). The drug will be used as a treatment for hereditary transthyretin-mediated amyloidosis in adult patients who have stage 1 or 2 polyneuropathy (commonly referred to as hattr-pn or attrv-pn).","image":"https://cdn.magloft.com/pdf-import/1144/images/img_13-1.jpg","cover":"https://cdn.magloft.com/publication-14882/screenshots/articles/269388.jpg?ts=1731583612","date":1731628800000,"unlockType":"free","categories":[],"pdfPageId":null,"visible":null,"showOnToc":null,"bookmark":false,"position":23,"publicationId":14882,"pwaOptinId":null,"seoDescription":null,"classificationIds":[],"pwaSubscriptionIds":[],"source":"typeloft2","trending":false,"html":null,"keywordPhrase":null,"articleAssets":[]},{"id":269389,"slug":"cytex-ortho-receives-fda-greenlight-for-clinical-trials-into-join-f46a","issueId":null,"categoryIds":[],"title":"CytexOrtho receives FDA greenlight for clinical trials into joint repair technology","description":"Clinical stage medical device company CytexOrtho has announced approval from the US Food and Drug Administration (FDA) for its planned phase 1 clinical trial into orthopaedic joint preservation and repair.","image":"https://cdn.magloft.com/pdf-import/1144/images/img_13-2.jpg","cover":"https://cdn.magloft.com/publication-14882/screenshots/articles/269389.jpg?ts=1731583651","date":1731628800000,"unlockType":"free","categories":[],"pdfPageId":null,"visible":null,"showOnToc":null,"bookmark":false,"position":24,"publicationId":14882,"pwaOptinId":null,"seoDescription":null,"classificationIds":[],"pwaSubscriptionIds":[],"source":"typeloft2","trending":false,"html":null,"keywordPhrase":null,"articleAssets":[]},{"id":269229,"slug":"survey-from-roche-finds-worryingly-low-understandings-about-hpv","issueId":null,"categoryIds":[],"title":"Survey from Roche finds worryingly low understandings about HPV and cervical cancer","description":"Questioning almost 9,000 participants across 12 countries in Latin America and Europe, the research revealed significant knowledge gaps surrounding human papillomavirus (HPV) and highlighted several significant barriers preventing women from screening for it.","image":"https://cdn.magloft.com/pdf-import/1144/images/img_1-1.jpg","cover":"https://cdn.magloft.com/publication-14882/screenshots/articles/269229.jpg?ts=1731342387","date":1731283200000,"unlockType":"free","categories":[],"pdfPageId":null,"visible":null,"showOnToc":null,"bookmark":false,"position":1,"publicationId":14882,"pwaOptinId":null,"seoDescription":null,"classificationIds":[],"pwaSubscriptionIds":[],"source":"typeloft2","trending":false,"html":null,"keywordPhrase":null,"articleAssets":[]},{"id":269230,"slug":"best-in-class-ai-model-from-bioptimus-integrated-into-proscia-s","issueId":null,"categoryIds":[],"title":"Best-in-class AI model from Bioptimus integrated into Proscia’s leading software platform","description":"French start-up Bioptimus has announced that its H-optimus-o biology reference artificial intelligence (AI) foundation model has been wholly integrated into Proscia’s Concentriq Embeddings software platform, with the aim of enabling quicker and more efficient breakthroughs in AI development for therapeutic research.","image":"https://cdn.magloft.com/pdf-import/1144/images/img_2-4.jpg","cover":"https://cdn.magloft.com/publication-14882/screenshots/articles/269230.jpg?ts=1731342089","date":1731283200000,"unlockType":"free","categories":[],"pdfPageId":null,"visible":null,"showOnToc":null,"bookmark":false,"position":3,"publicationId":14882,"pwaOptinId":null,"seoDescription":null,"classificationIds":[],"pwaSubscriptionIds":[],"source":"typeloft2","trending":false,"html":null,"keywordPhrase":null,"articleAssets":[]},{"id":269239,"slug":"hiv-vaccine-candidate-successfully-optimised-for-industrial-prod","issueId":null,"categoryIds":[],"title":"HIV vaccine candidate successfully optimised for industrial production","description":"Sumagen Canada Inc, a biotech company based in both South Korea and Canada has partnered with CDMO Naobios to industrialise Sumagen’s human immunodeficiency virus (HIV)-1 vaccine candidate (SAV0001) at bench scale.","image":"https://cdn.magloft.com/pdf-import/1144/images/img_5-2.jpg","cover":"https://cdn.magloft.com/publication-14882/screenshots/articles/269239.jpg?ts=1731321762","date":1731283200000,"unlockType":"free","categories":[],"pdfPageId":null,"visible":null,"showOnToc":null,"bookmark":false,"position":11,"publicationId":14882,"pwaOptinId":null,"seoDescription":null,"classificationIds":[],"pwaSubscriptionIds":[],"source":"typeloft2","trending":false,"html":null,"keywordPhrase":null,"articleAssets":[]},{"id":269243,"slug":"aravax-successfully-recruits-for-phase-3-peanut-allergy-treatmen","issueId":null,"categoryIds":[],"title":"Aravax successfully recruits for phase 3 peanut allergy treatment study","description":"Clinical-stage biotech company Aravax has announced that it has completed phase 2 recruitment for its precision therapy (pvx108) study, which investigates treatment of peanut allergies.","image":"https://cdn.magloft.com/pdf-import/1144/images/img_10-1.jpg","cover":"https://cdn.magloft.com/publication-14882/screenshots/articles/269243.jpg?ts=1731337390","date":1731283200000,"unlockType":"free","categories":[],"pdfPageId":null,"visible":null,"showOnToc":null,"bookmark":false,"position":16,"publicationId":14882,"pwaOptinId":null,"seoDescription":null,"classificationIds":[],"pwaSubscriptionIds":[],"source":"typeloft2","trending":false,"html":null,"keywordPhrase":null,"articleAssets":[]},{"id":266509,"slug":"headlands-research-opens-new-clinical-trials-site-in-el-paso-te","issueId":null,"categoryIds":[],"title":"Headlands Research opens new clinical trials site in El Paso, Texas, to serve Hispanic population","description":"Headlands Research, a multinational network of clinical research sites, has launched a new clinical trials site in El Paso, Texas, US.","image":"https://cdn.magloft.com/pdf-import/1125/images/img_6-2.jpg","cover":"https://cdn.magloft.com/publication-14882/screenshots/articles/266509.jpg?ts=1731321994","date":1728601200000,"unlockType":"free","categories":[],"pdfPageId":null,"visible":null,"showOnToc":null,"bookmark":false,"position":12,"publicationId":14882,"pwaOptinId":null,"seoDescription":null,"classificationIds":[],"pwaSubscriptionIds":[],"source":"typeloft2","trending":false,"html":null,"keywordPhrase":null,"articleAssets":[]},{"id":266511,"slug":"biologic-medicine-dupixent-approved-by-fda-for-copd-patients-in","issueId":null,"categoryIds":[],"title":"Biologic medicine Dupixent approved by FDA for COPD patients in the US","description":"The US Food and Drug Administration has approved Sanofi’s Dupixent as an add-on maintenance treatment for adults with inadequately controlled chronic obstructive pulmonary disease (COPD) and an eosinophilic phenotype.","image":"https://cdn.magloft.com/pdf-import/1125/images/img_8-1.jpg","cover":"https://cdn.magloft.com/publication-14882/screenshots/articles/266511.jpg?ts=1728470719","date":1728601200000,"unlockType":"free","categories":[],"pdfPageId":null,"visible":null,"showOnToc":null,"bookmark":false,"position":15,"publicationId":14882,"pwaOptinId":null,"seoDescription":null,"classificationIds":[],"pwaSubscriptionIds":[],"source":"typeloft2","trending":false,"html":null,"keywordPhrase":null,"articleAssets":[]},{"id":266512,"slug":"tiziana-life-sciences-awarded-4m-grant-by-nih-to-study-anti-cd3","issueId":null,"categoryIds":[],"title":"Tiziana Life Sciences awarded $4m grant by NIH to study anti-CD3 in Alzheimer’s disease","description":"Tiziana Life Sciences, a biotechnology company developing immunomodulation therapies, announced that the National Institutes of Health (NIH),'s National Institute on Aging has awarded a $4m grant to Dr Howard Weiner as principal investigator at Brigham and Women’s Hospital to be the key research site to study nasal anti-cd3 for the treatment of alzheimer’s disease (ad).","image":"https://cdn.magloft.com/pdf-import/1125/images/img_7-1.jpg","cover":"https://cdn.magloft.com/publication-14882/screenshots/articles/266512.jpg?ts=1728470644","date":1728601200000,"unlockType":"free","categories":[],"pdfPageId":null,"visible":null,"showOnToc":null,"bookmark":false,"position":14,"publicationId":14882,"pwaOptinId":null,"seoDescription":null,"classificationIds":[],"pwaSubscriptionIds":[],"source":"typeloft2","trending":false,"html":null,"keywordPhrase":null,"articleAssets":[]},{"id":266513,"slug":"european-commission-approves-astellas-pharma-s-gej-adenocarcinom","issueId":null,"categoryIds":[],"title":"European Commission approves Astellas Pharma’s GEJ adenocarcinoma treatment","description":"The European Commission (EC) has approved Astellas Pharma’s vyloy (zolbetuximab) in combination with fluoropyrimidine and platinum-containing chemotherapy as a treatment for adult patients with locally advanced unresectable or metastatic human epidermal growth factor receptor 2 (HER2)negative gastric or gastro-oesophageal junction (GEJ) adenocarcinoma whose tumours are claudin (CLDN) 18.2 positive.","image":"https://cdn.magloft.com/pdf-import/1125/images/pages/pg-008.jpg","cover":"https://cdn.magloft.com/publication-14882/screenshots/articles/266513.jpg?ts=1728470753","date":1728601200000,"unlockType":"free","categories":[],"pdfPageId":null,"visible":null,"showOnToc":null,"bookmark":false,"position":16,"publicationId":14882,"pwaOptinId":null,"seoDescription":null,"classificationIds":[],"pwaSubscriptionIds":[],"source":"typeloft2","trending":false,"html":null,"keywordPhrase":null,"articleAssets":[]},{"id":266514,"slug":"ministry-of-health-labour-and-welfare-of-japan-approves-new-dru","issueId":null,"categoryIds":[],"title":"Ministry of Health, Labour and Welfare of Japan approves new drug for early Alzheimer’s disease","description":"The Ministry of Health, Labour and Welfare Japan has approved treatment for Eli Lilly’s KINSULA, indicated for adult patients with early symptomatic Alzheimer’s disease (AD). This also includes patients with mild dementia stage AD, and mild cognitive impairment.","image":"https://cdn.magloft.com/pdf-import/1125/images/img_9-2.jpg","cover":"https://cdn.magloft.com/publication-14882/screenshots/articles/266514.jpg?ts=1728470865","date":1728601200000,"unlockType":"free","categories":[],"pdfPageId":null,"visible":null,"showOnToc":null,"bookmark":false,"position":18,"publicationId":14882,"pwaOptinId":null,"seoDescription":null,"classificationIds":[],"pwaSubscriptionIds":[],"source":"typeloft2","trending":false,"html":null,"keywordPhrase":null,"articleAssets":[]},{"id":266517,"slug":"new-collaboration-agreement-announced-between-emih-association-a","issueId":null,"categoryIds":[],"title":"New collaboration agreement announced between EMIH association and the MTIG","description":"The European Microbiome Innovation for Health (EMIH) association and the Microbiome Therapeutics Innovation Group (MTIG) have announced a new collaborative agreement. The agreement seeks to advance microbiome drug development by improving collaboration between the two microbiome focused coalitions. ","image":"https://cdn.magloft.com/pdf-import/1125/images/img_10-1.jpg","cover":"https://cdn.magloft.com/publication-14882/screenshots/articles/266517.jpg?ts=1728644043","date":1728601200000,"unlockType":"free","categories":[],"pdfPageId":null,"visible":null,"showOnToc":null,"bookmark":false,"position":19,"publicationId":14882,"pwaOptinId":null,"seoDescription":null,"classificationIds":[],"pwaSubscriptionIds":[],"source":"typeloft2","trending":false,"html":null,"keywordPhrase":null,"articleAssets":[]},{"id":266499,"slug":"fda-approves-first-drug-in-50-years-for-treatment-of-schizophren","issueId":null,"categoryIds":[],"title":"FDA approves first drug in 50 years for treatment of schizophrenia in adults","description":"Earlier this September, the US Food and Drug Administration (FDA) granted approval for PureTech Health’s Karxt for the treatment of schizophrenia in adults, triggering royalty payments of $29m to PureTech. It will be the first approved mechanism by the FDAfor schizophrenia in over 50 years.","image":"https://cdn.magloft.com/pdf-import/1125/images/img_1-1.jpg","cover":"https://cdn.magloft.com/publication-14882/screenshots/articles/266499.jpg?ts=1728559805","date":1728514800000,"unlockType":"free","categories":[],"pdfPageId":null,"visible":null,"showOnToc":null,"bookmark":false,"position":1,"publicationId":14882,"pwaOptinId":null,"seoDescription":null,"classificationIds":[],"pwaSubscriptionIds":[],"source":"typeloft2","trending":false,"html":null,"keywordPhrase":null,"articleAssets":[]},{"id":266505,"slug":"third-application-for-orion-s-prostate-cancer-drug-submitted-by","issueId":null,"categoryIds":[],"title":"Third application for Orion’s prostate cancer drug submitted by partner Bayer","description":"Finnish pharmaceutical company Orion has announced that its partner Bayer is applying for a third application of its prostate cancer drug, darolutamide, in the US.","image":"https://cdn.magloft.com/pdf-import/1125/images/pages/pg-004.jpg","cover":"https://cdn.magloft.com/publication-14882/screenshots/articles/266505.jpg?ts=1728470396","date":1728514800000,"unlockType":"free","categories":[],"pdfPageId":null,"visible":null,"showOnToc":null,"bookmark":false,"position":8,"publicationId":14882,"pwaOptinId":null,"seoDescription":null,"classificationIds":[],"pwaSubscriptionIds":[],"source":"typeloft2","trending":false,"html":null,"keywordPhrase":null,"articleAssets":[]}],"category":{"id":43140,"slug":"approvals","title":"Approvals","color":"#444444","issueCount":0,"articleCount":0,"categoryGroupIds":[]}},{"type":"ad","title":"Advertisement","advertisementIds":[1319],"adCampaignId":null,"condition":null},{"type":"article-category","condition":null,"color":"#2873B0","title":"European News","variant":"variant-c","categoryId":43139,"backgroundColor":null,"image":null,"articles":[{"id":269366,"slug":"survey-from-roche-finds-worryingly-low-understandings-about-hpv-a2ec","issueId":null,"categoryIds":[],"title":"Survey from Roche finds worryingly low understandings about HPV and cervical cancer","description":"Questioning almost 9,000 participants across 12 countries in Latin America and Europe, the research revealed significant knowledge gaps surrounding human papillomavirus (HPV) and highlighted several significant barriers preventing women from screening for it.","image":"https://cdn.magloft.com/pdf-import/1144/images/img_1-1.jpg","cover":"https://cdn.magloft.com/publication-14882/screenshots/articles/269366.jpg?ts=1731584570","date":1731628800000,"unlockType":"free","categories":[],"pdfPageId":null,"visible":null,"showOnToc":null,"bookmark":false,"position":1,"publicationId":14882,"pwaOptinId":null,"seoDescription":null,"classificationIds":[],"pwaSubscriptionIds":[],"source":"typeloft2","trending":false,"html":null,"keywordPhrase":null,"articleAssets":[]},{"id":269368,"slug":"best-in-class-ai-model-from-bioptimus-integrated-into-proscia-s-5dd5","issueId":null,"categoryIds":[],"title":"Best-in-class AI model from Bioptimus integrated into Proscia’s leading software platform","description":"French start-up Bioptimus has announced that its H-optimus-o biology reference artificial intelligence (AI) foundation model has been wholly integrated into Proscia’s Concentriq embeddings software platform, with the aim of enabling quicker and more efficient breakthroughs in ai development for therapeutic research.","image":"https://cdn.magloft.com/pdf-import/1144/images/img_2-4.jpg","cover":"https://cdn.magloft.com/publication-14882/screenshots/articles/269368.jpg?ts=1731685050","date":1731628800000,"unlockType":"free","categories":[],"pdfPageId":null,"visible":null,"showOnToc":null,"bookmark":false,"position":3,"publicationId":14882,"pwaOptinId":null,"seoDescription":null,"classificationIds":[],"pwaSubscriptionIds":[],"source":"typeloft2","trending":false,"html":null,"keywordPhrase":null,"articleAssets":[]},{"id":269373,"slug":"almirall-s-immunoskin-event-returns-for-a-third-year-discussing-cab8","issueId":null,"categoryIds":[],"title":"Almirall’s Immunoskin event returns for a third year, discussing medical dermatology advances","description":"Hosted again in Barcelona, Spain, the Immunoskin conference ran from 26-27 October and brought together leading experts in dermatological conditions and treatments.","image":"https://cdn.magloft.com/pdf-import/1144/images/img_4-1.jpg","cover":"https://cdn.magloft.com/publication-14882/screenshots/articles/269373.jpg?ts=1731684693","date":1731628800000,"unlockType":"free","categories":[],"pdfPageId":null,"visible":null,"showOnToc":null,"bookmark":false,"position":8,"publicationId":14882,"pwaOptinId":null,"seoDescription":null,"classificationIds":[],"pwaSubscriptionIds":[],"source":"typeloft2","trending":false,"html":null,"keywordPhrase":null,"articleAssets":[]},{"id":269374,"slug":"eco-vadis-platinum-medal-given-to-liveo-research-s-singapore-phar-2ff8","issueId":null,"categoryIds":[],"title":"EcoVadis Platinum medal given to Liveo Research’s Singapore pharma packaging site","description":"Liveo Research, a leading primary packaging manufacturer, has had the EcoVadis rating of its Singapore site increased from gold to platinum. This means that the pharma packaging site is now rated in the top 1% of the 100,000 companies evaluated by ecovadis in its annual global surveys.","image":"https://cdn.magloft.com/pdf-import/1144/images/img_4-2.jpg","cover":"https://cdn.magloft.com/publication-14882/screenshots/articles/269374.jpg?ts=1731684636","date":1731628800000,"unlockType":"free","categories":[],"pdfPageId":null,"visible":null,"showOnToc":null,"bookmark":false,"position":9,"publicationId":14882,"pwaOptinId":null,"seoDescription":null,"classificationIds":[],"pwaSubscriptionIds":[],"source":"typeloft2","trending":false,"html":null,"keywordPhrase":null,"articleAssets":[]},{"id":269375,"slug":"hutchmed-set-to-receive-20m-in-funding-from-takeda-for-colorect-ebe1","issueId":null,"categoryIds":[],"title":"HUTCHMED set to receive $20m in funding from Takeda for colorectal cancer drug sales","description":"In late October, HUTCHMED’s partner Takeda will pay a milestone payment of $20m as the result of over $200m worth of sales for Fruzaqla (fruquintinib), which treats metastatic colorectal cancer (CRC).","image":"https://cdn.magloft.com/pdf-import/1144/images/img_5-1.jpg","cover":"https://cdn.magloft.com/publication-14882/screenshots/articles/269375.jpg?ts=1731582666","date":1731628800000,"unlockType":"free","categories":[],"pdfPageId":null,"visible":null,"showOnToc":null,"bookmark":false,"position":10,"publicationId":14882,"pwaOptinId":null,"seoDescription":null,"classificationIds":[],"pwaSubscriptionIds":[],"source":"typeloft2","trending":false,"html":null,"keywordPhrase":null,"articleAssets":[]},{"id":269376,"slug":"exhibitor-numbers-for-cphi-india-grow-for-third-year-in-a-row-w-ee82","issueId":null,"categoryIds":[],"title":"Exhibitor numbers for CPHI India grow for third year in a row, with 50,000 attendees expected","description":"Running from 26-28 November 2024, the largest pharma event in India is expected to have a record attendance of delegates from more than 150 countries, with over 2,000 exhibitors also expected.","image":"https://cdn.magloft.com/pdf-import/1144/images/img_6-1.jpg","cover":"https://cdn.magloft.com/publication-14882/screenshots/articles/269376.jpg?ts=1731582752","date":1731628800000,"unlockType":"free","categories":[],"pdfPageId":null,"visible":null,"showOnToc":null,"bookmark":false,"position":12,"publicationId":14882,"pwaOptinId":null,"seoDescription":null,"classificationIds":[],"pwaSubscriptionIds":[],"source":"typeloft2","trending":false,"html":null,"keywordPhrase":null,"articleAssets":[]},{"id":269377,"slug":"pac-bio-announces-update-to-sequencing-system-to-bring-down-cost-7ecd","issueId":null,"categoryIds":[],"title":"PacBio announces update to sequencing system to bring down cost of genome sample to below $500","description":"Announced by PacBio, known for developing sequencing solutions, SPRQ has the potential to significantly reduce the cost of sequencing genomes.","image":"https://cdn.magloft.com/pdf-import/1144/images/img_6-2.jpg","cover":"https://cdn.magloft.com/publication-14882/screenshots/articles/269377.jpg?ts=1731582787","date":1731628800000,"unlockType":"free","categories":[],"pdfPageId":null,"visible":null,"showOnToc":null,"bookmark":false,"position":13,"publicationId":14882,"pwaOptinId":null,"seoDescription":null,"classificationIds":[],"pwaSubscriptionIds":[],"source":"typeloft2","trending":false,"html":null,"keywordPhrase":null,"articleAssets":[]},{"id":269378,"slug":"hiv-vaccine-candidate-successfully-optimised-for-industrial-prod-07d5","issueId":null,"categoryIds":[],"title":"HIV vaccine candidate successfully optimised for industrial production","description":"Sumagen Canada Inc, a biotech company based in both South Korea and Canada, has partnered with CDMO Naobios to industrialise Sumagen’s human immunodeficiency virus (HIV)-1 vaccine candidate (sav0001) at bench scale.","image":"https://cdn.magloft.com/pdf-import/1144/images/img_5-2.jpg","cover":"https://cdn.magloft.com/publication-14882/screenshots/articles/269378.jpg?ts=1731582716","date":1731628800000,"unlockType":"free","categories":[],"pdfPageId":null,"visible":null,"showOnToc":null,"bookmark":false,"position":11,"publicationId":14882,"pwaOptinId":null,"seoDescription":null,"classificationIds":[],"pwaSubscriptionIds":[],"source":"typeloft2","trending":false,"html":null,"keywordPhrase":null,"articleAssets":[]},{"id":269380,"slug":"bayer-and-liveo-research-pair-to-launch-new-sustainable-blister-4a15","issueId":null,"categoryIds":[],"title":"Bayer and Liveo Research pair to launch new sustainable blister packaging","description":"The partnership between the two companies has resulted in the launching of a first-of-its-kind blister packaging, utilising polyethylene terephthalate (PET) instead of the more traditional poly vinyl chloride (PVC).","image":"https://cdn.magloft.com/pdf-import/1144/images/img_7-2.jpg","cover":"https://cdn.magloft.com/publication-14882/screenshots/articles/269380.jpg?ts=1731583143","date":1731628800000,"unlockType":"free","categories":[],"pdfPageId":null,"visible":null,"showOnToc":null,"bookmark":false,"position":15,"publicationId":14882,"pwaOptinId":null,"seoDescription":null,"classificationIds":[],"pwaSubscriptionIds":[],"source":"typeloft2","trending":false,"html":null,"keywordPhrase":null,"articleAssets":[]},{"id":269381,"slug":"nrg-therapeutics-secures-funding-for-development-of-treatment-fo-35cf","issueId":null,"categoryIds":[],"title":"NRG Therapeutics secures funding for development of treatment for neurodegenerative disease","description":"NRG Therapeutics has announced that its NRG5051 inhibitor has secured a $5m grant from the Michael J. Fox foundation for Parkinson’s research (MJFF).","image":"https://cdn.magloft.com/pdf-import/1144/images/img_7-1.jpg","cover":"https://cdn.magloft.com/publication-14882/screenshots/articles/269381.jpg?ts=1731582830","date":1731628800000,"unlockType":"free","categories":[],"pdfPageId":null,"visible":null,"showOnToc":null,"bookmark":false,"position":14,"publicationId":14882,"pwaOptinId":null,"seoDescription":null,"classificationIds":[],"pwaSubscriptionIds":[],"source":"typeloft2","trending":false,"html":null,"keywordPhrase":null,"articleAssets":[]},{"id":269240,"slug":"pac-bio-announces-update-to-sequencing-system-to-bring-down-cost","issueId":null,"categoryIds":[],"title":"PacBio announces update to sequencing system to bring down cost of genome sample to below $500","description":"Announced by PacBio, known for developing sequencing solutions, SPRQ has the potential to significantly reduce the cost of sequencing genomes.","image":"https://cdn.magloft.com/pdf-import/1144/images/img_6-2.jpg","cover":"https://cdn.magloft.com/publication-14882/screenshots/articles/269240.jpg?ts=1731321847","date":1731283200000,"unlockType":"free","categories":[],"pdfPageId":null,"visible":null,"showOnToc":null,"bookmark":false,"position":13,"publicationId":14882,"pwaOptinId":null,"seoDescription":null,"classificationIds":[],"pwaSubscriptionIds":[],"source":"typeloft2","trending":false,"html":null,"keywordPhrase":null,"articleAssets":[]},{"id":269242,"slug":"bayer-and-liveo-research-pair-to-launch-new-sustainable-blister","issueId":null,"categoryIds":[],"title":"Bayer and Liveo Research pair to launch new sustainable blister packaging","description":"The partnership between the two companies has resulted in the launching of a first-of-its-kind blister packaging, utilising polyethylene terephthalate (PET) instead of the more traditional poly vinyl chloride (PVC).","image":"https://cdn.magloft.com/pdf-import/1144/images/img_7-2.jpg","cover":"https://cdn.magloft.com/publication-14882/screenshots/articles/269242.jpg?ts=1731321932","date":1731283200000,"unlockType":"free","categories":[],"pdfPageId":null,"visible":null,"showOnToc":null,"bookmark":false,"position":15,"publicationId":14882,"pwaOptinId":null,"seoDescription":null,"classificationIds":[],"pwaSubscriptionIds":[],"source":"typeloft2","trending":false,"html":null,"keywordPhrase":null,"articleAssets":[]},{"id":269243,"slug":"aravax-successfully-recruits-for-phase-3-peanut-allergy-treatmen","issueId":null,"categoryIds":[],"title":"Aravax successfully recruits for phase 3 peanut allergy treatment study","description":"Clinical-stage biotech company Aravax has announced that it has completed phase 2 recruitment for its precision therapy (pvx108) study, which investigates treatment of peanut allergies.","image":"https://cdn.magloft.com/pdf-import/1144/images/img_10-1.jpg","cover":"https://cdn.magloft.com/publication-14882/screenshots/articles/269243.jpg?ts=1731337390","date":1731283200000,"unlockType":"free","categories":[],"pdfPageId":null,"visible":null,"showOnToc":null,"bookmark":false,"position":16,"publicationId":14882,"pwaOptinId":null,"seoDescription":null,"classificationIds":[],"pwaSubscriptionIds":[],"source":"typeloft2","trending":false,"html":null,"keywordPhrase":null,"articleAssets":[]},{"id":269244,"slug":"nrg-therapeutics-secures-funding-for-development-of-treatment-fo","issueId":null,"categoryIds":[],"title":"NRG Therapeutics secures funding for development of treatment for neurodegenerative disease","description":"NRG Therapeutics has announced that its NRG5051 inhibitor has secured a $5m grant from the Michael J. Fox Foundation for Parkinson’s Research (MJFF).","image":"https://cdn.magloft.com/pdf-import/1144/images/img_7-1.jpg","cover":"https://cdn.magloft.com/publication-14882/screenshots/articles/269244.jpg?ts=1731321895","date":1731283200000,"unlockType":"free","categories":[],"pdfPageId":null,"visible":null,"showOnToc":null,"bookmark":false,"position":14,"publicationId":14882,"pwaOptinId":null,"seoDescription":null,"classificationIds":[],"pwaSubscriptionIds":[],"source":"typeloft2","trending":false,"html":null,"keywordPhrase":null,"articleAssets":[]},{"id":269246,"slug":"chiesi-announces-phase-3-results-from-enzyme-replacement-study","issueId":null,"categoryIds":[],"title":"Chiesi announces phase 3 results from enzyme-replacement study","description":"Chiesi Global Rare Diseases has announced the results from its BRIGHT trial, which evaluates the efficacy of enzyme-replacement therapy drug ELFABRIO at twice the approved dose in patients who have been treated with agalsidase alfa or beta. ","image":"https://cdn.magloft.com/pdf-import/1144/images/img_10-2.jpg","cover":"https://cdn.magloft.com/publication-14882/screenshots/articles/269246.jpg?ts=1731322215","date":1731283200000,"unlockType":"free","categories":[],"pdfPageId":null,"visible":null,"showOnToc":null,"bookmark":false,"position":17,"publicationId":14882,"pwaOptinId":null,"seoDescription":null,"classificationIds":[],"pwaSubscriptionIds":[],"source":"typeloft2","trending":false,"html":null,"keywordPhrase":null,"articleAssets":[]},{"id":269247,"slug":"valiant-phase-3-trial-results-highlight-potential-treatment-for","issueId":null,"categoryIds":[],"title":"VALIANT phase 3 trial results highlight potential treatment for rare kidney diseases","description":"SOBI and Apellis Pharmaceuticals have announced the results from the VALIANT trial, which highlight that systemic pegcetacoplan treatment could benefit patients with c3 glomerulopathy (c3g) and primary immune complex membranoproliferative glomerulonephritis (ic-mpgn).","image":"https://cdn.magloft.com/pdf-import/1144/images/pages/pg-011.jpg","cover":"https://cdn.magloft.com/publication-14882/screenshots/articles/269247.jpg?ts=1731337187","date":1731283200000,"unlockType":"free","categories":[],"pdfPageId":null,"visible":null,"showOnToc":null,"bookmark":false,"position":18,"publicationId":14882,"pwaOptinId":null,"seoDescription":null,"classificationIds":[],"pwaSubscriptionIds":[],"source":"typeloft2","trending":false,"html":null,"keywordPhrase":null,"articleAssets":[]}],"category":{"id":43139,"slug":"general-news","title":"General News","color":"#444444","issueCount":0,"articleCount":0,"categoryGroupIds":[]}},{"type":"guide-install","color":"#444558","title":"How to Install","condition":null}]},{"size":3.5,"blocks":[{"type":"issue-slider","condition":null,"color":"#2873B0","title":"Latest Editions","issueIds":[52826,52799,52483,52217,51921,51722,51533,51435,51240,51075,45938,45939,45940],"thumbnail":{"style":"full-cover","size":"medium"},"borderRadius":null,"zoomOnHover":true,"issues":[{"id":51075,"slug":"january-february-2024","unlockType":"free","entryArticleSlug":null,"priceTier":null,"hasPdf":false,"publicationId":14882,"title":"Pharmafocus January/February 2024","description":"Welcome to the first Pharmafocus of 2024! ","date":null,"updatedAt":1707310914000,"coverUrl":"https://cdn.magloft.com/pwa-664/pdf-import/cover/c3992244-61cf-4e63-a755-0ae4043f7342.jpg","source":"typeloft2","aspectRatio":null,"categoryIds":[],"pwaOptinId":null,"pwaSubscriptionIds":[],"classificationIds":[],"sourceFile":null,"keywordPhrase":null,"seoDescription":null,"categories":[],"properties":{"allowPdfDownload":false,"allowRead":true,"pdfOnly":false,"checkoutUrl":null},"screenshots":[],"pdfData":[],"articles":null},{"id":51240,"slug":"march-2024","unlockType":"free","entryArticleSlug":null,"priceTier":null,"hasPdf":false,"publicationId":14882,"title":"Pharmafocus March 2024","description":"Welcome to the March 2024 issue of Pharmafocus!","date":null,"updatedAt":1709740998000,"coverUrl":"https://cdn.magloft.com/pwa-664/pdf-import/cover/060712ee-16a6-45f6-9966-46934c008537.jpg","source":"typeloft2","aspectRatio":null,"categoryIds":[],"pwaOptinId":null,"pwaSubscriptionIds":[],"classificationIds":[],"sourceFile":null,"keywordPhrase":null,"seoDescription":null,"categories":[],"properties":{"allowPdfDownload":false,"allowRead":true,"pdfOnly":false,"checkoutUrl":null},"screenshots":[],"pdfData":[],"articles":null},{"id":51435,"slug":"pharmafocus-april-2024","unlockType":"free","entryArticleSlug":null,"priceTier":null,"hasPdf":false,"publicationId":14882,"title":"Pharmafocus April 2024","description":"Welcome to the April 2024 issue of Pharmafocus!","date":null,"updatedAt":1712584463000,"coverUrl":"https://cdn.magloft.com/pwa-664/pdf-import/cover/6ecdf246-7e70-4b93-8ef2-6f0f97071612.jpg","source":"typeloft2","aspectRatio":null,"categoryIds":[],"pwaOptinId":null,"pwaSubscriptionIds":[],"classificationIds":[],"sourceFile":null,"keywordPhrase":null,"seoDescription":null,"categories":[],"properties":{"allowPdfDownload":false,"allowRead":true,"pdfOnly":false,"checkoutUrl":null},"screenshots":[],"pdfData":[],"articles":null},{"id":51533,"slug":"may-2024","unlockType":"free","entryArticleSlug":null,"priceTier":null,"hasPdf":false,"publicationId":14882,"title":"Pharmafocus May 2024","description":"Welcome to the May 2024 issue of Pharmafocus! ","date":null,"updatedAt":1714388722000,"coverUrl":"https://cdn.magloft.com/pwa-664/pdf-import/cover/9d532da4-36c1-4744-a074-cf2bc7a84d89.jpg","source":"typeloft2","aspectRatio":null,"categoryIds":[],"pwaOptinId":null,"pwaSubscriptionIds":[],"classificationIds":[],"sourceFile":null,"keywordPhrase":null,"seoDescription":null,"categories":[],"properties":{"allowPdfDownload":false,"allowRead":true,"pdfOnly":false,"checkoutUrl":null},"screenshots":[],"pdfData":[],"articles":null},{"id":51722,"slug":"june-2024","unlockType":"free","entryArticleSlug":null,"priceTier":null,"hasPdf":false,"publicationId":14882,"title":"Pharmafocus June 2024","description":"Welcome to the June 2024 issue of Pharmafocus! ","date":null,"updatedAt":1717595569000,"coverUrl":"https://cdn.magloft.com/pwa-664/pdf-import/cover/5b3cdd36-9928-4c26-a58f-5688ff552317.jpg","source":"typeloft2","aspectRatio":null,"categoryIds":[],"pwaOptinId":null,"pwaSubscriptionIds":[],"classificationIds":[],"sourceFile":null,"keywordPhrase":null,"seoDescription":null,"categories":[],"properties":{"allowPdfDownload":false,"allowRead":true,"pdfOnly":false,"checkoutUrl":null},"screenshots":[],"pdfData":[],"articles":null},{"id":51921,"slug":"july-august-2024","unlockType":"free","entryArticleSlug":null,"priceTier":null,"hasPdf":false,"publicationId":14882,"title":"Pharmafocus July/August 2024","description":"Welcome to the July/August 2024 issue of Pharmafocus! ","date":null,"updatedAt":1721303544000,"coverUrl":"https://cdn.magloft.com/pwa-664/pdf-import/cover/4fcbd25a-422f-4623-85da-91f331e9764f.jpg","source":"typeloft2","aspectRatio":null,"categoryIds":[],"pwaOptinId":null,"pwaSubscriptionIds":[],"classificationIds":[],"sourceFile":null,"keywordPhrase":null,"seoDescription":null,"categories":[],"properties":{"allowPdfDownload":false,"allowRead":true,"pdfOnly":false,"checkoutUrl":null},"screenshots":[],"pdfData":[],"articles":null},{"id":52217,"slug":"pharmafocus-september-2024","unlockType":"free","entryArticleSlug":null,"priceTier":null,"hasPdf":false,"publicationId":14882,"title":"Pharmafocus September 2024","description":"Welcome to the September 2024 issue of Pharmafocus! \nThis issue covers the latest news including new FDA approval for primary biliary cholangitis, NICE recommendations for skyrizi (risankizumab), CHMP opinion on Merck’s KEYTRUDA, as well as articles on precision medicine and oral peptides PLUS what to look out for at this year's CPHI in Milan! ","date":null,"updatedAt":1725970662000,"coverUrl":"https://cdn.magloft.com/pwa-664/issue/cover/8c56ddb8-0110-48f9-9380-d5f8d77b55b7.png","source":"typeloft2","aspectRatio":null,"categoryIds":[43138,43139,43140,43149],"pwaOptinId":null,"pwaSubscriptionIds":[],"classificationIds":[],"sourceFile":null,"keywordPhrase":null,"seoDescription":null,"categories":[{"id":43138,"slug":"category-43138","title":"UK News","color":"#444444","issueCount":0,"articleCount":0,"categoryGroupIds":[]}],"properties":{"allowPdfDownload":false,"allowRead":true,"pdfOnly":false,"checkoutUrl":null},"screenshots":[],"pdfData":[],"articles":null},{"id":52483,"slug":"pharmafocus-october-2024","unlockType":"free","entryArticleSlug":null,"priceTier":null,"hasPdf":false,"publicationId":14882,"title":"Pharmafocus October 2024","description":"Welcome to the October 2024 edition of Pharmafocus!","date":null,"updatedAt":1731675001000,"coverUrl":"https://cdn.magloft.com/pwa-664/pdf-import/cover/c2153c79-00ca-4630-a0f2-5b8f0b47a8cc.jpg","source":"typeloft2","aspectRatio":null,"categoryIds":[43138,43139,43140,43149,43145,43146,43142],"pwaOptinId":null,"pwaSubscriptionIds":[],"classificationIds":[],"sourceFile":null,"keywordPhrase":null,"seoDescription":null,"categories":[{"id":43138,"slug":"category-43138","title":"UK News","color":"#444444","issueCount":0,"articleCount":0,"categoryGroupIds":[]}],"properties":{"allowPdfDownload":false,"allowRead":true,"pdfOnly":false,"checkoutUrl":null},"screenshots":[],"pdfData":[],"articles":null},{"id":52826,"slug":"pharmafocus-november-2024","unlockType":"free","entryArticleSlug":null,"priceTier":null,"hasPdf":false,"publicationId":14882,"title":"Pharmafocus November 2024","description":"Welcome to Pharmafocus November 2024!","date":null,"updatedAt":1731925217000,"coverUrl":"https://cdn.magloft.com/pwa-664/pdf-import/cover/2db03f67-b154-4bb4-8f8a-9fd8660f932b.jpg","source":"typeloft2","aspectRatio":null,"categoryIds":[43138,43139,43140,43141,43146,43144,43142],"pwaOptinId":null,"pwaSubscriptionIds":[],"classificationIds":[],"sourceFile":null,"keywordPhrase":null,"seoDescription":null,"categories":[{"id":43138,"slug":"category-43138","title":"UK News","color":"#444444","issueCount":0,"articleCount":0,"categoryGroupIds":[]}],"properties":{"allowPdfDownload":false,"allowRead":true,"pdfOnly":false,"checkoutUrl":null},"screenshots":[],"pdfData":[],"articles":null}]},{"type":"ad","title":"Advertisement","advertisementIds":[2210],"adCampaignId":null,"condition":null},{"type":"cta","condition":null,"icon":"symbol-gift","color":"#FB0505","title":"Newsletters","description":"Sign up to our newsletters and digital magazines","action":{"type":"url","href":"https://curwoodcmsltd.formstack.com/forms/samedan","target":"_blank","pwaSubscriptionId":null,"pwaSubscription":null,"optinId":null,"optin":null}},{"type":"ad","title":"Advertisement","advertisementIds":[2067],"adCampaignId":null,"condition":null},{"type":"cta","condition":null,"icon":"symbol-day","color":"#F90505","title":"Pharmafocus Archive","description":"Browse older editions","action":{"type":"url","href":"https://en.calameo.com/subscriptions/6188508","target":"_blank","pwaSubscriptionId":null,"pwaSubscription":null,"optinId":null,"optin":null}},{"type":"ad","title":"Advertisement","advertisementIds":[],"adCampaignId":1044,"condition":null},{"type":"article-category","condition":null,"color":"#F70707","title":"Appointments","variant":"variant-c","categoryId":43146,"backgroundColor":null,"image":null,"articles":[{"id":269394,"slug":"darrin-schellin-appointed-new-ceo-at-pharma-tech-industries-cc9c","issueId":null,"categoryIds":[],"title":"Darrin Schellin appointed new CEO at Pharma Tech Industries","description":"Pharma Tech Industries, a pharmaceutical manufacturing and packaging solutions contractor for wellness products and medical devices, has announced the appointment of its new chief executive officer, Darrin T Schellin.","image":"https://cdn.magloft.com/pdf-import/1144/images/img_16-1.jpg","cover":"https://cdn.magloft.com/publication-14882/screenshots/articles/269394.jpg?ts=1731583891","date":1731628800000,"unlockType":"free","categories":[],"pdfPageId":null,"visible":null,"showOnToc":null,"bookmark":false,"position":30,"publicationId":14882,"pwaOptinId":null,"seoDescription":null,"classificationIds":[],"pwaSubscriptionIds":[],"source":"typeloft2","trending":false,"html":null,"keywordPhrase":null,"articleAssets":[]},{"id":269396,"slug":"clue-points-appoint-richard-young-as-chief-strategy-officer-94fe","issueId":null,"categoryIds":[],"title":"CluePoints appoint Richard Young as chief strategy officer","description":"Cluepoints, a data quality oversight and and risk-based quality management software provider, has announced the appointment of Richard Young as its chief strategy officer.","image":"https://cdn.magloft.com/pdf-import/1144/images/img_17-1.jpg","cover":"https://cdn.magloft.com/publication-14882/screenshots/articles/269396.jpg?ts=1731583976","date":1731628800000,"unlockType":"free","categories":[],"pdfPageId":null,"visible":null,"showOnToc":null,"bookmark":false,"position":32,"publicationId":14882,"pwaOptinId":null,"seoDescription":null,"classificationIds":[],"pwaSubscriptionIds":[],"source":"typeloft2","trending":false,"html":null,"keywordPhrase":null,"articleAssets":[]},{"id":269397,"slug":"dr-souad-kechairi-appointed-chief-medical-officer-at-pll-therape-d039","issueId":null,"categoryIds":[],"title":"Dr Souad Kechairi appointed chief medical officer at PLL Therapeutics","description":"Dr Souad Kechairi has been appointed chief medical officer at PLL Therapeutics, a biopharmaceutical company specialising in polypeptides.","image":"https://cdn.magloft.com/pdf-import/1144/images/img_16-2.jpg","cover":"https://cdn.magloft.com/publication-14882/screenshots/articles/269397.jpg?ts=1731682624","date":1731628800000,"unlockType":"free","categories":[],"pdfPageId":null,"visible":null,"showOnToc":null,"bookmark":false,"position":31,"publicationId":14882,"pwaOptinId":null,"seoDescription":null,"classificationIds":[],"pwaSubscriptionIds":[],"source":"typeloft2","trending":false,"html":null,"keywordPhrase":null,"articleAssets":[]},{"id":269398,"slug":"shawn-cross-appointed-as-chief-financial-officer-for-pacira-bios-f0ba","issueId":null,"categoryIds":[],"title":"Shawn Cross appointed as chief financial officer for Pacira Biosciences","description":"Pacira biosciences, specialist in non-opioid pain therapies, has appointed Shawn Cross as its chief financial officer. In this role, Mr Cross will take over all responsibility for the company’s financial operations.","image":"https://cdn.magloft.com/pdf-import/1144/images/img_17-2.jpg","cover":"https://cdn.magloft.com/publication-14882/screenshots/articles/269398.jpg?ts=1731584023","date":1731628800000,"unlockType":"free","categories":[],"pdfPageId":null,"visible":null,"showOnToc":null,"bookmark":false,"position":33,"publicationId":14882,"pwaOptinId":null,"seoDescription":null,"classificationIds":[],"pwaSubscriptionIds":[],"source":"typeloft2","trending":false,"html":null,"keywordPhrase":null,"articleAssets":[]},{"id":269261,"slug":"dr-souad-kechairi-appointed-chief-medical-officer-at-pll-therape","issueId":null,"categoryIds":[],"title":"Dr Souad Kechairi appointed chief medical officer at PLL Therapeutics","description":"Dr Souad Kechairi has been appointed chief medical officer at PLL Therapeutics, a biopharmaceutical company specialising in polypeptides.","image":"https://cdn.magloft.com/pdf-import/1144/images/img_16-2.jpg","cover":"https://cdn.magloft.com/publication-14882/screenshots/articles/269261.jpg?ts=1731330455","date":1731283200000,"unlockType":"free","categories":[],"pdfPageId":null,"visible":null,"showOnToc":null,"bookmark":false,"position":30,"publicationId":14882,"pwaOptinId":null,"seoDescription":null,"classificationIds":[],"pwaSubscriptionIds":[],"source":"typeloft2","trending":false,"html":null,"keywordPhrase":null,"articleAssets":[]},{"id":266526,"slug":"prilenia-appoints-new-staff-to-advance-company-s-development-and","issueId":null,"categoryIds":[],"title":"Prilenia appoints new staff to advance company’s development plans","description":"Prilenia, a clinical stage biotech focusing on neurodegenerative and neurodevelopmental disorders, has announced the appointment of two new senior staff members ‒ Rob Lauzen as chief financial officer (CFO) and Jason Marks as chief legal officer (CLO).","image":"https://cdn.magloft.com/pdf-import/1125/images/pages/pg-020.jpg","cover":"https://cdn.magloft.com/publication-14882/screenshots/articles/266526.jpg?ts=1728647038","date":1728601200000,"unlockType":"free","categories":[],"pdfPageId":null,"visible":null,"showOnToc":null,"bookmark":false,"position":30,"publicationId":14882,"pwaOptinId":null,"seoDescription":null,"classificationIds":[],"pwaSubscriptionIds":[],"source":"typeloft2","trending":false,"html":null,"keywordPhrase":null,"articleAssets":[]},{"id":266527,"slug":"steriline-s-founder-passes-torch-to-children-with-ceo-and-cso","issueId":null,"categoryIds":[],"title":"Steriline’s founder ‘passes torch’ to children with CEO and CSO appointments","description":"Aseptic packaging company Steriline’s founder Gerardo Fumagalli has ‘passed the torch’ to his children Illaria Fumagalli and Federico Fumagalli, who have been appointed to chief executive officer and chief sales officer, respectively. Gerardo will continue on as chairman of the board of directors.","image":"https://cdn.magloft.com/pdf-import/1125/images/img_20-1.jpg","cover":"https://cdn.magloft.com/publication-14882/screenshots/articles/266527.jpg?ts=1728558445","date":1728601200000,"unlockType":"free","categories":[],"pdfPageId":null,"visible":null,"showOnToc":null,"bookmark":false,"position":29,"publicationId":14882,"pwaOptinId":null,"seoDescription":null,"classificationIds":[],"pwaSubscriptionIds":[],"source":"typeloft2","trending":false,"html":null,"keywordPhrase":null,"articleAssets":[]},{"id":266529,"slug":"eli-lilly-expands-with-two-senior-hires-in-public-affairs-and-co","issueId":null,"categoryIds":[],"title":"Eli Lilly expands with two senior hires in Public Affairs and Communications team","description":"Pharmaceutical company Eli Lilly has announced the appointment of two senior positions in its public affairs and communications team.","image":"https://cdn.magloft.com/pdf-import/1125/images/img_21-1.jpg","cover":"https://cdn.magloft.com/publication-14882/screenshots/articles/266529.jpg?ts=1728558614","date":1728601200000,"unlockType":"free","categories":[],"pdfPageId":null,"visible":null,"showOnToc":null,"bookmark":false,"position":31,"publicationId":14882,"pwaOptinId":null,"seoDescription":null,"classificationIds":[],"pwaSubscriptionIds":[],"source":"typeloft2","trending":false,"html":null,"keywordPhrase":null,"articleAssets":[]},{"id":266530,"slug":"dr-anada-gubbi-appointed-by-sfa-therapeutics-as-director-of-bios","issueId":null,"categoryIds":[],"title":"Dr Anada Gubbi appointed by SFA Therapeutics as director of Biostatistics","description":"SFA Therapeutics, a clinical-stage biopharmaceutical company, has announced that it has appointed Dr Anada Gubbi as director of biostatistics. Dr Gubbi will be responsible for assisting SFA Therapeutics in effectively developing drug candidates for the treatment of inflammatory diseases.","image":"https://cdn.magloft.com/pdf-import/1125/images/img_21-2.jpg","cover":"https://cdn.magloft.com/publication-14882/screenshots/articles/266530.jpg?ts=1728558660","date":1728601200000,"unlockType":"free","categories":[],"pdfPageId":null,"visible":null,"showOnToc":null,"bookmark":false,"position":32,"publicationId":14882,"pwaOptinId":null,"seoDescription":null,"classificationIds":[],"pwaSubscriptionIds":[],"source":"typeloft2","trending":false,"html":null,"keywordPhrase":null,"articleAssets":[]},{"id":260498,"slug":"curve-therapeutics-bolsters-its-leadership-team-with-appointment","issueId":null,"categoryIds":[],"title":"Curve Therapeutics bolsters its leadership team with appointment of Simon Jones","description":"With his 20 years of expertise and proven track record in biotech and pharmaceutical industries, Curve Therapeutics appoints Simon Jones as chief financial officer and chief operating officer.","image":"https://cdn.magloft.com/pdf-import/1085/images/pages/pg-021.jpg","cover":"https://cdn.magloft.com/publication-14882/screenshots/articles/260498.jpg?ts=1721297869","date":1721257200000,"unlockType":"free","categories":[],"pdfPageId":null,"visible":null,"showOnToc":null,"bookmark":false,"position":37,"publicationId":14882,"pwaOptinId":null,"seoDescription":null,"classificationIds":[],"pwaSubscriptionIds":[],"source":"typeloft2","trending":false,"html":null,"keywordPhrase":null,"articleAssets":[]},{"id":260499,"slug":"adam-rosenberg-replaces-dr-carlo-incerti-as-new-chair-of-the-boa","issueId":null,"categoryIds":[],"title":"Adam Rosenberg replaces Dr Carlo Incerti as new chair of the board at VectorY Therapeutics","description":"Vectory Therapeutics has announced the appointment of Adam Rosenberg as chair of the board, replacin Dr Carlo Incerti.","image":"https://cdn.magloft.com/pdf-import/1085/images/img_21-1.jpg","cover":"https://cdn.magloft.com/publication-14882/screenshots/articles/260499.jpg?ts=1721297943","date":1721257200000,"unlockType":"free","categories":[],"pdfPageId":null,"visible":null,"showOnToc":null,"bookmark":false,"position":38,"publicationId":14882,"pwaOptinId":null,"seoDescription":null,"classificationIds":[],"pwaSubscriptionIds":[],"source":"typeloft2","trending":false,"html":null,"keywordPhrase":null,"articleAssets":[]},{"id":260500,"slug":"dr-jonathan-appleby-appointed-by-mogrify-as-chief-scientific-off","issueId":null,"categoryIds":[],"title":"Dr Jonathan Appleby appointed by Mogrify as chief scientific officer","description":"Mogrify has announced the appointment of Dr Jonathan Appleby as chief scientific officer.","image":"https://cdn.magloft.com/pdf-import/1085/images/pages/pg-021.jpg","cover":"https://cdn.magloft.com/publication-14882/screenshots/articles/260500.jpg?ts=1721298066","date":1721257200000,"unlockType":"free","categories":[],"pdfPageId":null,"visible":null,"showOnToc":null,"bookmark":false,"position":39,"publicationId":14882,"pwaOptinId":null,"seoDescription":null,"classificationIds":[],"pwaSubscriptionIds":[],"source":"typeloft2","trending":false,"html":null,"keywordPhrase":null,"articleAssets":[]},{"id":260502,"slug":"move-of-the-month-75bc","issueId":null,"categoryIds":[],"title":"Professor yih-shing duh appointed as chief scientific advisor by H.E.L. Group","description":"Professor Yih-Shing Duh appointed as chief scientific advisor by H.E.L. Group","image":"https://cdn.magloft.com/pdf-import/1085/images/pages/pg-021.jpg","cover":"https://cdn.magloft.com/publication-14882/screenshots/articles/260502.jpg?ts=1721298116","date":1721257200000,"unlockType":"free","categories":[],"pdfPageId":null,"visible":null,"showOnToc":null,"bookmark":false,"position":40,"publicationId":14882,"pwaOptinId":null,"seoDescription":null,"classificationIds":[],"pwaSubscriptionIds":[],"source":"typeloft2","trending":false,"html":null,"keywordPhrase":null,"articleAssets":[]},{"id":258750,"slug":"enhanc3d-genomics-appoints-hazel-jones-as-ceo","issueId":null,"categoryIds":[],"title":"Enhanc3D Genomics appoints Hazel Jones as CEO","description":"Enhanc3D Genomics has announced the appointment of Hazel Jones as chief executive officer (CEO), following a successful six-month term as interim CEO and COO.","image":"https://cdn.magloft.com/pdf-import/1071/images/img_21-1.jpg","cover":"https://cdn.magloft.com/publication-14882/screenshots/articles/258750.jpg?ts=1717588500","date":1717542000000,"unlockType":"free","categories":[],"pdfPageId":null,"visible":null,"showOnToc":null,"bookmark":false,"position":38,"publicationId":14882,"pwaOptinId":null,"seoDescription":null,"classificationIds":[],"pwaSubscriptionIds":[],"source":"typeloft2","trending":false,"html":null,"keywordPhrase":null,"articleAssets":[]},{"id":258751,"slug":"closed-loop-medicine-appoints-paul-johnson-as-non-executive-dire","issueId":null,"categoryIds":[],"title":"Closed Loop Medicine appoints Paul Johnson as non-executive director","description":"Closed loop medicine has announced the appointment of Paul Johnson as an independent non-executive director.","image":"https://cdn.magloft.com/pdf-import/1071/images/pages/pg-021.jpg","cover":"https://cdn.magloft.com/publication-14882/screenshots/articles/258751.jpg?ts=1717588528","date":1717542000000,"unlockType":"free","categories":[],"pdfPageId":null,"visible":null,"showOnToc":null,"bookmark":false,"position":40,"publicationId":14882,"pwaOptinId":null,"seoDescription":null,"classificationIds":[],"pwaSubscriptionIds":[],"source":"typeloft2","trending":false,"html":null,"keywordPhrase":null,"articleAssets":[]},{"id":258752,"slug":"sphere-fluidics-appoints-curtis-nicholson-as-director-of-sales-e","issueId":null,"categoryIds":[],"title":"Sphere Fluidics appoints Curtis Nicholson as director of sales EMEA","description":"Sphere Fluidics has announced the appointment of Curtis Nicholson as director for sales for Europe, Middle East and Africa (EMEA).","image":"https://cdn.magloft.com/pdf-import/1071/images/img_21-2.jpg","cover":"https://cdn.magloft.com/publication-14882/screenshots/articles/258752.jpg?ts=1717588484","date":1717542000000,"unlockType":"free","categories":[],"pdfPageId":null,"visible":null,"showOnToc":null,"bookmark":false,"position":39,"publicationId":14882,"pwaOptinId":null,"seoDescription":null,"classificationIds":[],"pwaSubscriptionIds":[],"source":"typeloft2","trending":false,"html":null,"keywordPhrase":null,"articleAssets":[]}],"category":{"id":43146,"slug":"appointments","title":"Appointments","color":"#444444","issueCount":0,"articleCount":0,"categoryGroupIds":[]}},{"type":"ad","title":"Advertisement","advertisementIds":[2249,1320],"adCampaignId":null,"condition":null}]}]},{"fullWidth":true,"backgroundColor":"transparent","columnSeparator":"none","columns":[{"size":5,"blocks":[{"type":"banner","image":"https://cdn.magloft.com/pwa-664/pwa/banner/1f66e6ea-9b3a-4477-aba1-18abf54619b8.png","isHidden":true,"title":"","action":{"type":"url","href":"http://www.samedanltd.com/","target":"_blank","pwaSubscriptionId":null,"pwaSubscription":null,"optinId":null,"optin":null}}]}]}],"columns":[{"size":8.5,"blocks":[{"type":"ad","title":"Advertisement","advertisementIds":[],"adCampaignId":892,"condition":null},{"type":"article-list","condition":null,"color":"#F90505","title":"Top Content","variant":"variant-b","articleIds":[262748,254614,260494,260493,260492,258749],"articles":null},{"type":"article-list","condition":null,"color":"#2873B0","title":"Industry Insights","variant":"variant-b","articleIds":[260492,260493,260494,258746,258745,257361],"articles":null},{"type":"article-category","condition":null,"color":"#F90505","title":"UK News","variant":"variant-c","categoryId":43138,"backgroundColor":null,"image":null,"articles":null,"category":null},{"type":"article-category","condition":null,"color":"#2873B0","title":"Global News","variant":"variant-c","categoryId":43140,"backgroundColor":null,"image":null,"articles":null,"category":null},{"type":"ad","title":"Advertisement","advertisementIds":[1319],"adCampaignId":null,"condition":null},{"type":"article-category","condition":null,"color":"#2873B0","title":"European News","variant":"variant-c","categoryId":43139,"backgroundColor":null,"image":null,"articles":null,"category":null},{"type":"guide-install","color":"#444558","title":"How to Install","condition":null}]},{"size":3.5,"blocks":[{"type":"issue-slider","condition":null,"color":"#2873B0","title":"Latest Editions","issueIds":[52826,52799,52483,52217,51921,51722,51533,51435,51240,51075,45938,45939,45940],"thumbnail":{"style":"full-cover","size":"medium"},"borderRadius":null,"zoomOnHover":true,"issues":null},{"type":"ad","title":"Advertisement","advertisementIds":[2210],"adCampaignId":null,"condition":null},{"type":"cta","condition":null,"icon":"symbol-gift","color":"#FB0505","title":"Newsletters","description":"Sign up to our newsletters and digital magazines","action":{"type":"url","href":"https://curwoodcmsltd.formstack.com/forms/samedan","target":"_blank","pwaSubscriptionId":null,"pwaSubscription":null,"optinId":null,"optin":null}},{"type":"ad","title":"Advertisement","advertisementIds":[2067],"adCampaignId":null,"condition":null},{"type":"cta","condition":null,"icon":"symbol-day","color":"#F90505","title":"Pharmafocus Archive","description":"Browse older editions","action":{"type":"url","href":"https://en.calameo.com/subscriptions/6188508","target":"_blank","pwaSubscriptionId":null,"pwaSubscription":null,"optinId":null,"optin":null}},{"type":"ad","title":"Advertisement","advertisementIds":[],"adCampaignId":1044,"condition":null},{"type":"article-category","condition":null,"color":"#F70707","title":"Appointments","variant":"variant-c","categoryId":43146,"backgroundColor":null,"image":null,"articles":null,"category":null},{"type":"ad","title":"Advertisement","advertisementIds":[2249,1320],"adCampaignId":null,"condition":null}]}]}},"__N_SSG":true},"page":"/domains/[domain]","query":{"domain":"www.pharmafocus.com"},"buildId":"1bBCYhXOG7wsYuaBifvjK","isFallback":false,"gsp":true,"scriptLoader":[]}</script></body></html>

Pages: 1 2 3 4 5 6 7 8 9 10